scientific journal | Q5633421 |
P6981 | ACNP journal ID | 18912 |
2107744 | ||
P8375 | Crossref journal ID | 1462 |
P1250 | Danish Bibliometric Research Indicator (BFI) SNO/CNO | 14008 |
P5963 | Elsevier journal ID | regulatory-peptides |
P1058 | ERA Journal ID | 39742 |
P8903 | HAL journal ID | 18546 |
P236 | ISSN | 0167-0115 |
1873-1686 | ||
P7363 | ISSN-L | 0167-0115 |
P1277 | JUFO ID | 66017 |
P1055 | NLM Unique ID | 8100479 |
P856 | official website | http://www.sciencedirect.com/science/journal/01670115/ |
P10283 | OpenAlex ID | S163817903 |
P3181 | OpenCitations bibliographic resource ID | 138138 |
P7662 | Scilit journal ID | 404337 |
P1156 | Scopus source ID | 14319 |
P495 | country of origin | Kingdom of the Netherlands | Q29999 |
P1240 | Danish Bibliometric Research Indicator level | 1 | |
P8875 | indexed in bibliographic review | Scopus | Q371467 |
P407 | language of work or name | English | Q1860 |
P123 | publisher | Elsevier BV | Q746413 |
P1476 | title | Regulatory Peptides |
Q73081500 | "Numerous new regulatory peptides" |
Q46178031 | (+/-)-CP-96,345, an NK1 receptor antagonist, has local anaesthetic-like effects in a mammalian sciatic nerve preparation |
Q70658183 | (D-Met2,Pro5) enkephalinamide causes a decrease in plasma prolactin levels of lactating rats continuously suckled and an increase in those deprived of their litter |
Q45942200 | 1,25-dihydroxyvitamin D inhibits human ANP gene promoter activity. |
Q71858130 | 11th International Symposium on Regulatory Peptides. Copenhagen, Denmark, September 3-7, 1996. Abstracts |
Q43915912 | 125I[Sar(1)Ile(8)] angiotensin II has a different affinity for AT(1) and AT(2) receptor subtypes in ovine tissues |
Q72748966 | 14th Annual meeting of the Bayliss and Starling Society. Southampton, July 4-5, 1994. Abstracts |
Q40894811 | 2-36[K4,RYYSA(19-23)]PP a novel Y5-receptor preferring ligand with strong stimulatory effect on food intake. |
Q73485376 | 21st Annual Winter Neuropeptide Conference. Breckenridge, Colorado, USA. January 29-February 1, 2000. Abstracts |
Q73413344 | 22nd Annual Winter Neuropeptide Conference. February 3-6, 2001. Breckenridge, Colorado, USA. Abstracts |
Q53783341 | 24-hour cerebrospinal fluid levels of vasopressin in hydrocephalic patients. |
Q48712308 | 24-hour variation in content and release of hypothalamic neuropeptides in the rat |
Q48250569 | 3.3 kb of 5' flanking DNA from the rat preprotachykinin gene directs high level expression of a reporter gene in microinjected dorsal root ganglion neurons but not in transgenic mice |
Q61865479 | 3.3KB of 5′-flanking DNA from the rat preprotachykinin gene directs high level expression of a reporter gene in microinjected dorsal root ganglion neurons but not in transgenic mice |
Q53910608 | 3H-substance P binding to guinea-pig ileum longitudinal smooth muscle membranes. |
Q72099843 | 3HSubstance P binds to two high-affinity sites in bovine retina |
Q74103717 | 3rd International Symposium on VIP, PACAP, and Related Peptides. Freiburg, Germany, September 17-20, 1997. Abstracts |
Q73301078 | 4th International Symposium on VIP, PACAP, Glucagon and Related Peptides. Elsinore, Denmark, September 1-4, 1999. Abstracts |
Q48329287 | 5-Hydroxytryptamine and (+)-lysergic acid diethylamide displace [3H]thyrotropin-releasing hormone at its binding sites in the rat limbic forebrain |
Q72521781 | 7B2 expression in intrapulmonary neuroepithelial bodies: immunocytochemical detection and colocalization with serotonin and calcitonin gene-related peptide |
Q67883542 | 9th International Symposium on Gastrointestinal Hormones. Leuven, Belgium, 1-5 September 1992. Abstracts |
Q78150612 | 9th Meeting of the European Neuropeptide Club. Ferrera, Italy, May 12-15, 1999. Abstracts |
Q47390545 | A 4-arm polyethylene glycol derivative conjugated with exendin-4 peptide and palmitylamine having dual-function of size-increase and albumin-binding for long hypoglycemic action |
Q70180728 | A calmodulin antagonist inhibits histamine-stimulated acid production by isolated rat parietal cells |
Q68020491 | A comparative study of the effects of neonatal androgenization and estrogenization on prolactin secretion in adult female rats |
Q44829850 | A comparison of grooming behavior potencies of neurohypophyseal nonapeptides |
Q68828013 | A comparison of structure-activity relationships within alpha-MSH on melanophores of Anolis carolinensis and Rana pipiens |
Q60731315 | A comparison of the ability of neurotensin and peptide histidine methionine to stimulate net fluid secretion into the small intestine of the anaesthetised rat |
Q44352960 | A comparison of the ability of opioid peptides and opiates to affect active avoidance conditioning in rats |
Q28568444 | A comparison of the effects of gastrin, somatostatin and dopamine receptor ligands on rat gastric enterochromaffin-like cell secretion and proliferation |
Q69917146 | A comparison of the effects of vasoactive intestinal polypeptide on secretion from the submaxillary gland of the sheep and pig |
Q42249460 | A comparison of the locomotor effects induced by centrally injected TRH and TRH analogues |
Q30746195 | A comparison of the neuropeptides from the retrocerebral complex of adult male and female Manduca sexta using MALDI-TOF mass spectrometry |
Q44700868 | A corticotropin-releasing hormone antisense oligodeoxynucleotide reduces spontaneous waking in the rat. |
Q38290158 | A decrease in angiotensin receptor binding in rat brain nuclei by antisense oligonucleotides to the angiotensin AT1 receptor. |
Q57112858 | A dose-equivalent comparison of the effects of continuous subcutaneous glucagon-like peptide 2 (GLP-2) infusions versus meal related GLP-2 injections in the treatment of short bowel syndrome (SBS) patients |
Q33198916 | A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica |
Q71363397 | A functional comparison of the rat type-1 angiotensin II receptors (AT1AR and AT1BR) |
Q49011988 | A galanin-mastoparan chimeric peptide activates the Na+,K(+)-ATPase and reverses its inhibition by ouabain. |
Q44344055 | A general procedure for analysis of proenkephalin B derived opioid peptides |
Q72591294 | A high-molecular IGF-2 immunoreactive peptide (pro-IGF-2?) in the insulin cells of the islets of Langerhans in pancreas of man and rat |
Q41014986 | A human bronchial epithelial cell line releases arginine vasopressin: involvement of Ca2+ -activated K+ channels |
Q40405565 | A human glucagon-like peptide-1 receptor polymorphism results in reduced agonist responsiveness |
Q44077189 | A locally generated angiotensin system in rat carotid body. |
Q72542643 | A microsphere study on the effects of somatostatin and secretin on regional blood flow in anesthetized dogs |
Q44451615 | A multi-tyrosinated sst1/2 receptor preferring somatostatin agonist inhibits reflex and immune-mediated secretion in the guinea pig colon |
Q48861813 | A new angiotensinergic system in the CNS of the rat. |
Q58105990 | A new class of potent gastrin antagonists |
Q57131850 | A new endogenous form of PYY isolated from canine ileum: Gly-extended PYY(1-36) |
Q71664549 | A new gonadotropin-releasing hormone (GnRH) superagonist in goldfish: influence of dialkyl-D-homoarginine at position 6 on gonadotropin-II and growth hormone release |
Q42462942 | A new in vitro model for studies of pancreatic polypeptide secretion and biochemistry |
Q53523097 | A new technique for in vivo imaging of specific GLP-1 binding sites: first results in small rodents. |
Q42493491 | A new vasoactive intestinal peptide antagonist discriminates VIP receptors on guinea pig trachea and human neuroblastoma cells |
Q58008618 | A non-conservative polymorphism in the IL-6 signal transducer (IL6ST)/gp130 is associated with myocardial infarction in a hypertensive population |
Q36691925 | A novel approach based on nanotechnology for investigating the chronic actions of short-lived peptides in specific sites of the brain |
Q67506692 | A novel bombesin receptor antagonist (2258U89), potently inhibits bombesin evoked release of gastrointestinal hormones from rats and dogs, in vitro and in vivo |
Q45244213 | A novel immunosuppressant FTY720 ameliorates proteinuria and alterations of intrarenal adrenomedullin in rats with autoimmune glomerulonephritis |
Q38466845 | A novel low molecular weight ecdysiotropin in post-diapause, pre-hatch eggs of the gypsy moth, Lymantria dispar L. (Lepidoptera: Lymantriidae). |
Q53239217 | A novel peptide prevents death in enriched neuronal cultures. |
Q69762514 | A novel radioimmunoassay for neuromedin K. I. Absence of neuromedin K-like immunoreactivity in guinea pig ileum and urinary bladder. II. Heterogeneity of tachykinins in guinea pig tissues |
Q44980558 | A novel role for cholecystokinin: regulation of mesenteric vascular resistance. |
Q42482594 | A novel role of thrombopoietin as a physiological modulator of coronary flow |
Q48250582 | A novel, selective radioligand, [125I]-[Lys5,Tyr(I2)7,MeLeu9,Nle10]-NKA(4-10), for the tachykinin NK-2 receptor. |
Q34580371 | A novel, simple bioactivity assay for relaxin based on inhibition of platelet aggregation. |
Q33197177 | A panel of 11 region-specific radioimmunoassays for measurements of human chromogranin A. |
Q81103398 | A panel of 13 region-specific radioimmunoassays for measurements of human chromogranin B |
Q62225066 | A polymorphism in the growth hormone-releasing hormone receptor gene: Clinical significance? |
Q47254162 | A possible high molecular weight precursor to vasoactive intestinal polypeptide sequestered into pheochromocytoma chromaffin granules |
Q39978895 | A potent, non-toxic insulin-releasing peptide isolated from an extract of the skin of the Asian frog, Hylarana guntheri (Anura:Ranidae). |
Q48491207 | A prolactin release inhibiting activity isolated from neurointermediate lobe extracts is an endothelin-like peptide |
Q45176349 | A proline-rich polypeptide complex and its nonapeptide fragment inhibit nitric oxide production induced in mice |
Q28256098 | A proposed bovine neuropeptide Y (NPY) receptor cDNA clone, or its human homologue, confers neither NPY binding sites nor NPY responsiveness on transfected cells |
Q70192862 | A qualitative comparison of canine plasma gastroenteropancreatic hormone response to bombesin and the porcine gastrin-releasing peptide (GRP) |
Q50802458 | A quantitative study of neuropeptide immunoreactive cell bodies of primary afferent sensory neurons following rat sciatic nerve peripheral axotomy |
Q33936241 | A regulatory role for neurokinin B in placental physiology and pre-eclampsia |
Q43752029 | A relationship between motilin and growth hormone secretagogue receptors |
Q41171358 | A review of the design, synthesis and biological activity of the bicyclic hexapeptide tachykinin NK2 antagonist MEN 10627. |
Q44980537 | A role for chromogranin A (4-16), a vasostatin-derived peptide, on human colonic motility. An in vitro study |
Q72099718 | A role for the C-terminal fragment of substance P, SP7−11 in the pathogenesis of arthritis |
Q43814000 | A role for the angiotensin AT4 receptor subtype in overcoming scopolamine-induced spatial memory deficits |
Q43286956 | A scrutiny of the biochemical pathways from Ang II to Ang-(3-4) in renal basolateral membranes |
Q72099834 | A selective and extremely potent antagonist of the neurokinin-1 receptor |
Q51552390 | A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. |
Q51546252 | A single session of circuit-resistance exercise effects on human peripheral blood lymphocyte ABCA1 expression and plasma HDL-C level. |
Q46509346 | A somatostatin receptor negatively coupled to adenylate cyclase in the human gastric cell line HGT-1. |
Q51660631 | A study on the peptidergic nerves (VIP, substance P) in the colon of patients with diverticular disease |
Q46175576 | A substance resembling somatomedin C in the American cockroach |
Q44710426 | A synthetic VIP peptide analogue inhibits neutrophil recruitment in rat airways in vivo |
Q73117209 | A synthetic peptide corresponding to amino acid residues 90 to 95 of human follicle-stimulating hormone beta-subunit delays the onset of puberty in female Swiss Webster mice |
Q48918740 | A synthetic peptide representing residues 7 to 21 of human luteinizing hormone beta-subunit binds calcium, facilitates calcium uptake by liposomes and possesses sequence similarity to calcium-binding domains of calmodulin |
Q71652923 | A thiorphan-sensitive mechanism regulates the action of both exogenous and endogenous calcitonin gene-related peptide (CGRP) in the guinea-pig ureter |
Q42607952 | A transcriptionally permissive epigenetic landscape at the vasoactive intestinal peptide receptor-1 promoter suggests a euchromatin nuclear position in murine CD4 T cells |
Q43625224 | A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. |
Q48493935 | ACTH-releasing activity of urotensin I and ovine CRF: interactions with arginine vasotocin, isotocin and arginine vasopressin |
Q48726535 | ANEPIII, a new recombinant neurotoxic polypeptide derived from scorpion peptide, inhibits delayed rectifier, but not A-type potassium currents in rat primary cultured hippocampal and cortical neurons |
Q45740702 | APM/CD13 and FOS in the hypothalamus of monosodium glutamate obese and food deprived rats |
Q45712621 | AT(1) receptor blockade with losartan during gestation in Wistar rats leads to an increase in thirst and sodium appetite in their adult female offspring |
Q46916656 | AT1 receptor antagonism ameliorates acute pancreatitis-associated pulmonary injury |
Q50769256 | AT1 receptor subtype mediates the inhibitory effect of central angiotensin II on cerebrospinal fluid formation in the rat. |
Q45244169 | ATP-stimulated ANP release through P1 receptor subtype |
Q35612921 | Ablation of Iqgap2 protects from diet-induced hepatic steatosis due to impaired fatty acid uptake |
Q73703299 | Abnormal afferent nerve endings in the soft palatal mucosa of sleep apnoics and habitual snorers |
Q44601148 | Abnormal rectal endocrine cells in patients with irritable bowel syndrome |
Q54448310 | Abnormalities of caerulein- and carbamylcholine-stimulated pancreatic enzyme secretion in the obese Zucker rat. |
Q80878317 | Abnormalities of the hypothalamo-pituitary-thyroid axis in the pro-opiomelanocortin deficient mouse |
Q43470104 | Abnormalities of the thyroid hormone negative feedback regulation of TSH secretion in spontaneously hypertensive rats |
Q38334822 | Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes |
Q48468479 | Abrogation of peripheral cholecystokinin-satiety in the capsaicin treated rat. |
Q42446056 | Absence of a relationship between immunoreactive-gastrin and somatostatin-like immunoreactivity secretion in the perfused rat stomach |
Q45244215 | Absence of diabetic hyperalgesia in bradykinin B1 receptor-knockout mice |
Q70985900 | Absence of seizure activity following focal cerebral injection of enkephalins in a primate |
Q80834531 | Abstracts of REGPEP 2004, the 15th International Symposium on regulatory peptides. Toulouse, France, September 19-22, 2004 |
Q79145978 | Abstracts of the 16th International Symposium on Regulatory Peptides, Hakone, Japan, August 30-September 2, 2006 |
Q69432625 | Abstracts of the 7th national scientific meeting of the Bayliss and Starling Society. 28-29 September 1987, Belfast, Northern Ireland |
Q67961945 | Abstracts of the 8th national scientific meeting of the Bayless and Starling Society. 15-16 September 1988, London, U.K. |
Q72599219 | Abstracts of the Bayliss & Starling Society. National scientific meeting, 18th-19th December 1984, Guildford, Surrey, U.K. Respiratory peptides in the brain and in the gastrointestinal tract |
Q71246598 | Abstracts of the First International Symposium on Vasoactive Intestinal Peptide (VIP) and Related Peptides. Brussels, Belgium, September 14-16, 1983 |
Q53902351 | Acceleration of pubertal development following central blockade of the Y1 subtype of neuropeptide Y receptors. |
Q28371554 | Acceleration of ulcer healing by cholecystokinin (CCK): role of CCK-A receptors, somatostatin, nitric oxide and sensory nerves |
Q42511416 | Accentuation of ANP secretion to endothelin-1 in hypertrophied atria |
Q67523580 | Achlorhydria induced changes in gastrin, somatostatin, H+/K(+)-ATPase and carbonic anhydrase in the sheep |
Q83211128 | Acipimox during exercise points to an inhibitory feedback of GH on ghrelin secretion in bulimic and healthy women |
Q41660310 | Acquired megacolon is associated with alteration of vasoactive intestinal peptide levels and acetylcholinesterase activity |
Q71774462 | Action and binding of the endothelin antagonist bosentan on astrocytes of cultured rat central nervous system. Electrophysiological and autoradiographic studies |
Q72900087 | Action of gastrointestinal hormones on the myoelectric activity of the sphincter of Oddi in living rabbit |
Q47217151 | Action of neurotensin on size, composition, and growth of pancreas and stomach in the rat. |
Q70775729 | Action of sauvagine on the mesenteric vascular bed of the dog |
Q51492354 | Action of substance P and interaction of calcitonin gene-related peptide and substance P on the cat antral circular muscle. |
Q43590042 | Action of the newly discovered mammalian tachykinins, substance K and neuromedin K, on gastroduodenal motility of anesthetized dogs |
Q72685449 | Actions of Fusinus FMRFamide-related peptides on the identified central neurones of the snail, Helix aspersa |
Q68053273 | Actions of gastrin-releasing peptide and related mammalian and amphibian peptides on ion transport in the porcine proximal jejunum |
Q42480349 | Actions of neuropeptide Y on basal, cyclic AMP-induced and neurally evoked ion transport in porcine distal jejunum |
Q44921489 | Activation of MAP kinase by MC4-R through PI3 kinase |
Q44831379 | Activation of corticotropin releasing factor receptor type 2 in the heart by corticotropin releasing factor offers cytoprotection against ischemic injury via PKA and PKC dependent signaling |
Q45712626 | Activation of extracellular signal regulated protein kinase by neuropeptide Y and pancreatic polypeptide in CHO cells expressing the NPY Y(1), Y(2), Y(4) and Y(5) receptor subtypes |
Q48312737 | Activation of paraventricular nucleus of hypothalamus 5-HT1A receptor on sodium intake |
Q81285468 | Activation of protein kinase A by atrial natriuretic peptide in neonatal rat cardiac fibroblasts: role in regulation of the local renin-angiotensin system |
Q69247472 | Activation of subfornical organ efferents stimulates oxytocin secretion in the rat |
Q46488549 | Activation of submucosal but not myenteric plexus of the gastrointestinal tract accompanies reduction of food intake by camostat |
Q42478163 | Activation of the melanocortin-4 receptor causes enhanced excitation in presympathetic paraventricular neurons in obese Zucker rats. |
Q46538303 | Activation of the serotonergic 5-HT1A receptor in the paraventricular nucleus of the hypothalamus inhibits water intake and increases urinary excretion in water-deprived rats |
Q39278099 | Activation of vagus nerve by semapimod alters substance P levels and decreases breast cancer metastasis |
Q78162211 | Active immunoneutralization of somatostatin in the sheep: effects on gastrointestinal somatostatin expression, storage and secretion |
Q71363391 | Activity of amylin at CGRP1-preferring receptors coupled to positive contractile response in rat ventricular cardiomyocytes |
Q48527142 | Activity of vertebrate gonadotropin-releasing hormones and analogs with variant amino acid residues in positions 5, 7 and 8 in the goldfish pituitary |
Q43546797 | Acute and chronic alterations in blood pressure variability following experimental subarachnoid haemorrhage |
Q51836492 | Acute and chronic effects of relaxin on vasoactivity, myogenic reactivity and compliance of the rat mesenteric arterial and venous vasculature. |
Q34590474 | Acute and repeated restraint differentially activate orexigenic pathways in the rat hypothalamus |
Q45894739 | Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study |
Q67464113 | Acute inflammation enhances substance P-induced plasma protein extravasation in the rat knee joint |
Q39676518 | Acute inhibition of carboxypeptidase E expression in AtT-20 cells does not affect regulated secretion of ACTH. |
Q45112797 | Acute insulin infusion decreases plasma ghrelin levels in uncomplicated obesity |
Q48123481 | Acute peripheral administration of synthetic human GLP-1 (7-36 amide) decreases circulating IL-6 in obese patients with type 2 diabetes mellitus: a potential role for GLP-1 in modulation of the diabetic pro-inflammatory state? |
Q82840636 | Acute psychological stress raises plasma ghrelin in the rat |
Q48384046 | Acute response of hypophysiotropic thyrotropin releasing hormone neurons and thyrotropin release to behavioral paradigms producing varying intensities of stress and physical activity |
Q61694360 | Adaptive upregulation of gastric and hypothalamic ghrelin receptors and increased plasma ghrelin in a model of cancer chemotherapy-induced dyspepsia |
Q39689508 | Addition of a cysteine to glucagon-like peptide-1 (GLP-1) conjugates GLP-1 to albumin in serum and prolongs GLP-1 action in vivo |
Q68931255 | Adenosine modulation of fat cell responsiveness to insulin and oxytocin |
Q42479070 | Adenosine reverses the stimulatory effect of angiotensin II on the renal Na+-ATPase activity through the A2 receptor |
Q49124443 | Adenoviral-mediated neuron specific transduction of angiotensin II type 2 receptors |
Q69089640 | Adenylate cyclase stimulation by VIP in rat and human parotid membranes |
Q54061294 | Adipokines and cardiometabolic function: How are they interlinked? |
Q79365020 | Adiponectin modulates carnitine palmitoyltransferase-1 through AMPK signaling cascade in rat cardiomyocytes |
Q46985171 | Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells |
Q68481232 | Administration of adrenocorticotropic hormone (ACTH) enhances Fos expression in the rat adrenal cortex |
Q48419852 | Adrenalectomy does not change CRF secretion induced by interleukin-1 from rat perifused hypothalami |
Q72663267 | Adrenalectomy reduces atrial natriuretic peptide stimulated guanylate cyclase activity in rat paraventricular nucleus |
Q69865525 | Adrenergic effects on renal secretion of epidermal growth factor in the rat |
Q40660038 | Adrenomedullin and adrenomedullin binding protein-1 downregulate TNF-alpha in macrophage cell line and rat Kupffer cells |
Q35095528 | Adrenomedullin and cancer |
Q35095496 | Adrenomedullin and heart failure |
Q51679689 | Adrenomedullin and mucosal defence: interaction between host and microorganism. |
Q43701521 | Adrenomedullin and proadrenomedullin N-terminal 20 peptide induce histamine release from rat peritoneal mast cell |
Q35095492 | Adrenomedullin and the renin-angiotensin-aldosterone system |
Q43737631 | Adrenomedullin gene delivery inhibits neointima formation in rat artery after balloon angioplasty |
Q35095513 | Adrenomedullin in perinatal medicine. |
Q35095508 | Adrenomedullin in the eye. |
Q48002584 | Adrenomedullin influences dissociated rat area postrema neurons |
Q42439050 | Adrenomedullin inhibits angiotensin AT1A receptor expression and function in cardiac fibroblasts. |
Q46779681 | Adrenomedullin inhibits angiotensin II-induced contraction in human aortic smooth muscle cells |
Q44384749 | Adrenomedullin is an autocrine/paracrine growth factor for rat vascular smooth muscle cells |
Q42486681 | Adrenomedullin prevents apoptosis in prostate cancer cells. |
Q52564416 | Adrenomedullin protects rat cerebral endothelial cells from oxidant damage in vitro. |
Q84779847 | Adrenomedullin reduces expression of adhesion molecules on lymphatic endothelial cells |
Q42436800 | Adrenomedullin stimulates somatostatin and thus inhibits histamine and acid secretion in the fundus of the stomach |
Q46520439 | Adrenomedullin(27-52) inhibits vascular calcification in rats |
Q35095504 | Adrenomedullin--a regulator of bone formation. |
Q81440605 | Adrenomedullin-induced dilation of human placental arteries is modulated by an endothelium-derived constricting factor |
Q71507388 | Adrenomedullin: localization in the gastrointestinal tract and effects on insulin secretion |
Q87670222 | Adropin: a new regulatory peptide in cardiovascular endocrinology |
Q33927953 | Advances in understanding neuronal somatostatin receptors |
Q44200153 | Age-dependent levels of plasma neuropeptides in normal children |
Q43192628 | Age-dependent role of vasopressin in susceptibility of gastric mucosa to indomethacin-induced injury |
Q67961942 | Age-related change in 7B2 (a novel pituitary polypeptide) concentrations in human cerebrospinal fluid |
Q71774465 | Age-related decline in thirst and sodium appetite in rats related to kininase II inhibition |
Q38338714 | Age-related differences in the thermogenic and ponderal effects following the administration of fragment peptides from the rat ob protein |
Q51485247 | Aging influences the level and functions of fasting plasma ghrelin levels: the POWIRS-Study. |
Q44583796 | Agonist function of the neurokinin receptor antagonist, [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, in monocytes |
Q38364014 | Agonist internalization by cloned Y1 neuropeptide Y (NPY) receptor in Chinese hamster ovary cells shows strong preference for NPY, endosome-linked entry and fast receptor recycling |
Q44921502 | Agonist-dependent internalization of the angiotensin II type one receptor (AT1): role of C-terminus phosphorylation in recruitment of beta-arrestins |
Q42507668 | Agonistic and antagonistic properties of angiotensin analogs at the AT2 receptor in PC12W cells |
Q40820073 | Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor |
Q28575020 | Agouti-related protein is a mediator of diabetic hyperphagia |
Q48263965 | Alcohol reverses the proconflict effect of corticotropin-releasing factor |
Q46928493 | Aldosterone increases RAMP1 expression in mesenteric arteries from spontaneously hypertensive rats. |
Q84044727 | Aldosterone induction of hepatic stellate cell contraction through activation of RhoA/ROCK-2 signaling pathway |
Q44921534 | Aldosterone modulates neural vasomotor response in hypertension: role of calcitonin gene-related peptide |
Q44016661 | Aliphatic amino acids in helix VI of the AT(1) receptor play a relevant role in agonist binding and activity |
Q59276576 | Allatostatic neuropeptides from the cockroach Blattella germanica (L.) (Dictyoptera, Blattellidae). Identification, immunolocalization and activity |
Q31011361 | Allatostatin gene expression in brain and midgut, and activity of synthetic allatostatins on feeding-related processes in the cockroach Blattella germanica. |
Q30757841 | Allatostatins from the retrocerebral complex and antennal pulsatile organ of the American cockroach: structural elucidation aided by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry |
Q42023010 | Alpha-amidation of gastrin is impaired by diethyldithiocarbamate |
Q50866007 | Alpha-calcitonin gene-related peptide is protective against pressure overload-induced heart failure. |
Q69836227 | Alpha-human atrial natriuretic polypeptide binding sites in human adrenal membrane fractions |
Q45202590 | Alteration of gene expression of G protein-coupled receptors in endocrine disruptors-caused hyperactive rats |
Q45151338 | Alteration of renal adrenomedullin and its receptor system in the severely hypertensive rat: effect of diuretic |
Q48637465 | Alteration of somatostatin but not growth hormone-releasing factor pituitary binding sites in obese Zucker rats |
Q46747685 | Alterations in aortic vascular reactivity to angiotensin 1-7 in 17-beta-estradiol-treated female SD rats. |
Q38517100 | Alterations in gene expression in the testis of angiotensin-(1-7)-receptor Mas-deficient mice. |
Q72671839 | Alterations in plasma and cerebrospinal fluid levels of neuropeptides in idiopathic senile anorexia |
Q68300523 | Alterations in regional brain neurotensin concentrations produced by atypical antipsychotic drugs |
Q41520214 | Alterations in the synthesis of insulin-like growth factor binding proteins and insulin-like growth factors in rat C6 glioma cells transfected with a gap junction connexin43 cDNA. |
Q47394873 | Alterations of adrenomedullin and its receptor system components in calcified vascular smooth muscle cells |
Q46283050 | Alterations of glucose-dependent insulinotropic polypeptide (GIP) during cold acclimation |
Q44334000 | Alterations within the endogenous opioid system in mice with targeted deletion of the neutral endopeptidase ('enkephalinase') gene |
Q71644381 | Altered bioelectrical and mechanical activities of rat gastric smooth muscle preparations by inhibiting enterocytogenin |
Q81401980 | Altered cardiovascular responses to chronic angiotensin II infusion in aged rats |
Q69556716 | Altered chemotactic peptide binding in tobacco smokers' neutrophils |
Q44384729 | Altered gene expression of adrenomedullin and its receptor system and molecular forms of tissue adrenomedullin in left ventricular hypertrophy induced by malignant hypertension |
Q46209323 | Altered influence of CCK-B/gastrin receptors on HDC expression in ECL cells after neoplastic transformation |
Q46187983 | Altered leptin secretion in hyperinsulinemic mice under hypoxic conditions |
Q72968179 | Altered levels of phosphatidylinositol phospholipase C activity in rat liver cells in response to insulin, epinephrine, acetylcholine and bacterial phospholipase C |
Q48735491 | Altered regulation of nitric oxide and natriuretic peptide system in cisplatin-induced nephropathy |
Q54369307 | Altered regulation of renal nitric oxide and atrial natriuretic peptide systems in angiotensin II-induced hypertension. |
Q43257430 | Altered regulation of renal nitric oxide, atrial natriuretic peptide and cyclooxygenase systems in aldosterone escape in rats |
Q46021667 | Altered regulation of renal sodium transporters and natriuretic peptide system in DOCA-salt hypertensive rats. |
Q45151347 | Altered renal response to acute volume expansion in transgenic rats harboring the human tissue kallikrein gene. |
Q80389383 | Altered role of C-type natriuretic peptide-activated pGC-cGMP-PDE3-cAMP signaling in hyperthyroid beating rabbit atria |
Q44016684 | Altered secretion and processing of epidermal growth factor in adrenergic-induced growth of the rat submandibular gland. |
Q48106577 | Alternative processing pathways for preprovasoactive intestinal peptide in the enteric nervous system of the rat. |
Q58448944 | Amidated and non-amidated glucagon-like peptide-1 (GLP-1): non-pancreatic effects (cephalic phase acid secretion) and stability in plasma in humans |
Q41130386 | Amiloride differentially modulates ANP binding in human thyroid cells and bovine endothelial cells |
Q59313008 | Amino acid sequences of both isoforms of crustacean hyperglycemic hormone (CHH) and corresponding precursor-related peptide in Cancer pagurus |
Q46520419 | Amino acids modulate the hypotensive effect of angiotensin-(1-7) at the caudal ventrolateral medulla in rats |
Q43701525 | Aminopeptidase activities after water deprivation in male and female rats. |
Q45244199 | Amphetamine, an appetite suppressant, decreases neuropeptide Y immunoreactivity in rat hypothalamic paraventriculum |
Q61866419 | Amphibian glucagon family peptides: potent metabolic regulators in fish hepatocytes |
Q71624633 | Amylin (islet amyloid polypeptide) inhibition of insulin release in the perfused rat pancreas: implication of the adenylate cyclase/cAMP system |
Q44932795 | Amylin causes anorexigenic effects via the hypothalamus and brain stem in chicks |
Q46501440 | Amylin induces natriuresis by a central angiotensin-dependent mechanism |
Q70545504 | Amylin inhibits glucose-induced insulin secretion in a dose-dependent manner. Study in the perfused rat pancreas |
Q44746249 | Amylin-induced suppression of ANP secretion through receptors for CGRP1 and salmon calcitonin |
Q67941719 | An amino-terminal fragment of cholecystokinin-58 is present in the gut: evidence for a similar processing site of procholecystokinin in canine gut and brain |
Q47871636 | An aminoisobutyric acid-containing analogue of the cockroach tachykinin-related peptide, LemTRP-1, with potent bioactivity and resistance to an insect angiotensin-converting enzyme |
Q36484871 | An angiotensin II receptor antagonist reduces inflammatory parameters in two models of colitis |
Q54496045 | An antimicrobial peptide from the skin secretions of the mountain chicken frog Leptodactylus fallax (Anura:Leptodactylidae). |
Q52535837 | An ecdysiostatin from flies. |
Q72001943 | An effect of somatostatin on neurotensin secretion |
Q48637417 | An immunocytochemical comparison of the angiotensin and vasopressin hypothalamo-neurohypophysial systems in normotensive rats |
Q44495089 | An increase in the synthesis and release of calcitonin gene-related peptide in two-kidney, one-clip hypertensive rats |
Q39556142 | An inhibitor of leukotriene synthesis affects vasopressin secretion following osmotic stimulus in rats |
Q73444360 | An interaction of opioids and galanin in dorsal horn of the spinal cord in mononeuropathic rats |
Q41551074 | An iontophoretic survey of opioid peptide actions in the rat limbic system: in search of opiate epileptogenic mechanisms |
Q36949127 | An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment. |
Q40112830 | An upstream CRE-E-box element is essential for gastrin-dependent activation of the cyclooxygenase-2 gene in human colon cancer cells |
Q95514578 | Analgesic and anti-inflammatory effectiveness of sitagliptin and vildagliptin in mice |
Q84950658 | Analgesic properties of chimeric peptide based on morphiceptin and PFRTic-amide |
Q48493847 | Analysis of angiotensin type 2 receptors in vasopressinergic neurons and pituitary in the rat. |
Q52103547 | Analysis of pancreatic polypeptide cDNA from the house musk shrew, Suncus murinus, suggests a phylogenetically closer relationship with humans than for other small laboratory animal species. |
Q44109107 | Analysis of structure-function relationships of neuropeptide Y using molecular dynamics simulations and pharmacological activity and binding measurements. |
Q42652046 | Analysis of the dual mechanism of ACTH release by arginine vasopressin and its analogs in conscious rats |
Q54535983 | Anatomical distribution and physiological effects of enkephalin in rat inferior olive. |
Q67695448 | Anatomical relationship between neuropeptide-containing fibers and efferent vagal neurons projecting to the rat corpus |
Q51735828 | Ang-(3-4) suppresses inhibition of renal plasma membrane calcium pump by Ang II. |
Q41572960 | Angiopeptin, the octapeptide analogue of somatostatin, decreases rat heart endothelial cell adhesiveness for mononuclear cells |
Q46591760 | Angiopoietin-1 increases arteriolar vasoconstriction to phenylephrine during sepsis. |
Q42480183 | Angiotensin II AT1 receptor mutants expressed in CHO cells caused morphological change and inhibition of cell growth |
Q53873385 | Angiotensin II AT2 receptor localization in cardiovascular tissues by its antibody developed in AT2 gene-deleted mice. |
Q36728062 | Angiotensin II AT2 receptor stimulation increases cerebrovascular resistance during hemorrhagic hypotension in rats |
Q42459731 | Angiotensin II activates JAK2/STAT3 pathway and induces interleukin-6 production in cultured rat brainstem astrocytes |
Q54581396 | Angiotensin II and Aldosterone stimulating NF-kappaB and AP-1 activation in hepatic fibrosis of rat. |
Q33611890 | Angiotensin II and aldosterone regulation |
Q44921511 | Angiotensin II and angiotensin-(1-7) inhibit the inner cortex Na+ -ATPase activity through AT2 receptor |
Q33718262 | Angiotensin II and connective tissue: homeostasis and reciprocal regulation |
Q48965983 | Angiotensin II and glutamate influence area postrema neurons in rat brain slices |
Q30304121 | Angiotensin II and nitric oxide: a question of balance |
Q70651999 | Angiotensin II binding sites in the rat fetus: characterization of receptor subtypes and interaction with guanyl nucleotides |
Q70652014 | Angiotensin II binding sites on micro-organisms contaminating cell cultures |
Q69332988 | Angiotensin II differentially affects cyclic AMP formation in intact adrenal glomerulosa cells and in purified membrane preparations |
Q48311566 | Angiotensin II in central nervous system physiology |
Q84184893 | Angiotensin II induces EMMPRIN expression in THP-1 macrophages via the NF-kappaB pathway |
Q46770374 | Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells |
Q46199397 | Angiotensin II induces superoxide generation via NAD(P)H oxidase activation in isolated rat pancreatic islets. |
Q34076068 | Angiotensin II mediated signal transduction. Important role of tyrosine kinases. |
Q44332829 | Angiotensin II mediates catecholamine and neuropeptide Y secretion in human adrenal chromaffin cells through the AT1 receptor |
Q48175939 | Angiotensin II neurotransmitter actions in paraventricular nucleus are potentiated by a nitric oxide synthase inhibitor |
Q64901885 | Angiotensin II receptor expression in the conduction system and arterial duct of neonatal and adult rat hearts. |
Q71742137 | Angiotensin II receptor subtype antagonists can both stimulate and inhibit salt appetite in rats |
Q49013066 | Angiotensin II receptors are reduced in the CNS of the young Brattleboro rat |
Q48292966 | Angiotensin II receptors in the human brain |
Q77123862 | Angiotensin II receptors induce tyrosine dephosphorylation in rat fetal membranes |
Q57630567 | Angiotensin II signal transduction pathways |
Q72154946 | Angiotensin II stabilizes a multimeric type 2 (AT2) receptor complex in murine neuroblastoma N1E-115 cells |
Q42517325 | Angiotensin II stimulates rat astrocyte mitogen-activated protein kinase activity and growth through EGF and PDGF receptor transactivation |
Q49117269 | Angiotensin II stimulates sperm motility |
Q45244197 | Angiotensin II suppresses growth arrest specific homeobox (Gax) expression via redox-sensitive mitogen-activated protein kinase (MAPK). |
Q46986151 | Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study. |
Q48319213 | Angiotensin II type 2 receptor expression in neuronal cultures from spontaneously hypertensive rat brain |
Q46414188 | Angiotensin II upregulates renin-angiotensin system in human isolated T lymphocytes |
Q36854986 | Angiotensin II- and IV-induced changes in cerebral blood flow. Roles of AT1, AT2, and AT4 receptor subtypes |
Q54533886 | Angiotensin II-induced JNK activation is mediated by NAD(P)H oxidase in isolated rat pancreatic islets. |
Q44332818 | Angiotensin II-induced release of oxytocin: interaction with norepinephrine and role in lactation |
Q77943856 | Angiotensin II: a reproductive hormone too? |
Q44397747 | Angiotensin IV interacts with a juxtamembrane site on AT(4)/IRAP suggesting an allosteric mechanism of enzyme modulation |
Q41417720 | Angiotensin acts at the subfornical organ to increase plasma oxytocin concentrations in the rat. |
Q33699045 | Angiotensin and aldosterone |
Q34268762 | Angiotensin and its AT2 receptor: new insights into an old system |
Q44980554 | Angiotensin converting enzyme and the arrhythmogenic action of angiotensin I: cardiac cell membrane as a site of angiotensin I conversion |
Q71742117 | Angiotensin in thirst and hydromineral balance. Festschrift to honor James T. Fitzsimons, on the occasion of his retirement from the Department of Physiology at Cambridge University |
Q46329613 | Angiotensin processing is partially carried out by carboxypeptidases in the rat mesenteric arterial bed perfusate |
Q41746684 | Angiotensin receptors and norepinephrine neuromodulation: implications of functional coupling |
Q47885872 | Angiotensin receptors and norepinephrine neuromodulation: implications of functional coupling |
Q42485647 | Angiotensin type 1 receptor is linked to inhibition of nitric oxide production in pulmonary endothelial cells |
Q73117217 | Angiotensin-(1-7) binds at the type 1 angiotensin II receptors in rat renal cortex |
Q44753735 | Angiotensin-(1-7) inhibits the angiotensin II-enhanced norepinephrine release in coarcted hypertensive rats |
Q54446381 | Angiotensin-(1-7) prevents atrial fibrosis and atrial fibrillation in long-term atrial tachycardia dogs. |
Q50518097 | Angiotensin-(1-7) receptor Mas is an essential modulator of extracellular matrix protein expression in the heart. |
Q73150070 | Angiotensin-(1-7) regulates the levels of angiotensin II receptor subtype AT1 mRNA differentially in a strain-specific fashion |
Q43818775 | Angiotensin-(1-7) reverts the stimulatory effect of angiotensin II on the proximal tubule Na(+)-ATPase activity via a A779-sensitive receptor |
Q44016672 | Angiotensin-(1-7) stimulates oxidative stress in rat kidney |
Q43147778 | Angiotensin-(1-7) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas. |
Q28293071 | Angiotensin-(1-7): a bioactive fragment of the renin-angiotensin system |
Q34019825 | Angiotensin-(1-7): an update. |
Q72001940 | Angiotensin-(1–7) binding at angiotensin II receptors in the rat brain |
Q54512890 | Angiotensin-(3-4) counteracts the Angiotensin II inhibitory action on renal Ca2+-ATPase through a cAMP/PKA pathway. |
Q48248313 | Angiotensin-(3-7) pressor effect at the rostral ventrolateral medulla |
Q67298650 | Angiotensin-converting enzyme (kinase II) in pituitary gland of spontaneously hypertensive rats |
Q45084828 | Angiotensin-converting enzyme 2 attenuates oxidative stress and VSMC proliferation via the JAK2/STAT3/SOCS3 and profilin-1/MAPK signaling pathways |
Q63322972 | Angiotensin-converting enzymes (ACE and ACE2) are downregulated in renal tumors |
Q41194928 | Angiotensin-related induction of immediate early genes in rat brain |
Q28572962 | Angiotensinergic and noradrenergic neurons in the rat and human heart |
Q33321748 | Angiotensinergic neurons in sympathetic coeliac ganglia innervating rat and human mesenteric resistance blood vessels |
Q44332872 | Angiotensins in plasma of hypertensive rats and human |
Q34112881 | Anorectic, thermogenic and anti-obesity activity of a selective orexin-1 receptor antagonist in ob/ob mice |
Q44921484 | Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor |
Q28330800 | Antagonists for the neurokinin NK-3 receptor evaluated in selective receptor systems |
Q42283607 | Antagonization of fentanyl-induced muscular rigidity by neurotensin at the locus coeruleus of the rat. |
Q72964097 | Anti-angiotensin antibodies cross-reactive with nonpeptide angiotensin antagonists as angiotensin receptor model |
Q38935461 | Anti-cancer, immunoregulatory, and antimicrobial activities of the frog skin host-defense peptides pseudhymenochirin-1Pb and pseudhymenochirin-2Pa. |
Q60349859 | Anti-edematogenic effects of velutinol A isolated from Mandevilla velutina: Evidence for a selective inhibition of kinin B1 receptor-mediated responses |
Q44643690 | Anti-inflammatory effects of leptin and cholecystokinin on acetic acid-induced colitis in rats: role of capsaicin-sensitive vagal afferent fibers. |
Q36101335 | Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists |
Q39067596 | Anti-tumor activities of the host-defense peptide hymenochirin-1B. |
Q40802192 | Antibodies raised against the extracellular tail of the CCKB/gastrin receptor inhibit gastrin-stimulated signalling. |
Q44888705 | Antibodies to FMRF amide, and the related pentapeptide LPLRF amide, reveal two groups of immunoreactive peptides in chicken brain |
Q46203073 | Antidiabetic effects of sub-chronic activation of the GIP receptor alone and in combination with background exendin-4 therapy in high fat fed mice |
Q40836812 | Antiepileptic effects of NPY on pentylenetetrazole seizures |
Q42029851 | Antifeeding properties of myosuppressin in a generalist phytophagous leafworm, Spodoptera littoralis (Boisduval). |
Q46893456 | Antiinflammatory and analgesic activity of CP-96,345: on orally active non-peptide substance P receptor antagonist |
Q41635865 | Antimicrobial and immunomodulatory properties of PGLa-AM1, CPF-AM1, and magainin-AM1: potent activity against oral pathogens. |
Q67668050 | Antinociceptive and substance P antagonistic effects of intrathecally injected spantide II in rat: no signs of motor impairment or neurotoxicity |
Q45192651 | Antinociceptive effects in mice after intrathecal injection of a substance P receptor antagonist, Spantide: lack of 'neurotoxic' action |
Q60054770 | Antinociceptive effects of novel, selective tachykinin receptor antagonists in thermal and chemical analgesia tests |
Q40491076 | Antinociceptive properties and inhibition of neurogenic inflammation with potent SP antagonists belonging to perhydroisoindolones |
Q44350641 | Antinociceptive role of galanin in the spinal cord of rats with inflammation, an involvement of opioid systems |
Q44343086 | Antinociceptive role of oxytocin in the nucleus raphe magnus of rats, an involvement of μ-opioid receptor |
Q40793063 | Antipyresis due to centrally administered vasopressin differentially alters thermoregulatory effectors depending on the ambient temperature |
Q40254312 | Antipyretic effect of central [Pyr1]apelin13 on LPS-induced fever in the rat. |
Q48159606 | Antisecretory effects of neuropeptide Y in the mouse colon are region-specific and are lost in DSS-induced colitis |
Q69369771 | Antisecretory effects of somatostatin and vasopressin in the rat colon descendens in vitro |
Q46520436 | Antisecretory factor modulates GABAergic transmission in the rat hippocampus |
Q72307451 | Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin |
Q52205337 | Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. |
Q44341347 | Antisense oligodeoxynucleotide to a delta-opioid receptor blocks the antinociception induced by cold water swimming |
Q51120664 | Antisense oligonucleotide inhibition of tryptophan hydroxylase activity in mouse brain. |
Q38301352 | Antisense oligonucleotide to AT1 receptor mRNA inhibits central angiotensin induced thirst and vasopressin |
Q70959645 | Antisense oligonucleotides in in vivo regulatory peptide research |
Q72380386 | Antisera raised against eledoisin and kassinin detect elevated levels of immunoreactive material in plasma and tumor tissues from patients with carcinoid tumors |
Q70970701 | Antisera raised against eledoisin and kassinin detect immunoreactive material in rat tissue extracts: tissue distribution and chromatographic characterization |
Q46742278 | Antral content, secretion and peripheral metabolism of N-terminal progastrin fragments |
Q42503573 | Antral gastrin- and somatostatin-producing cells and intraluminal peptide secretion in normal subjects and duodenal ulcer patients with and without vagotomy |
Q34478501 | Anxiogenic-like effect of the NPY Y1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in rats. |
Q47921153 | Anxiolytic action of neuromedin-U and neurotransmitters involved in mice |
Q41091229 | Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test |
Q28303722 | Apelin and its receptor are expressed in human osteoblasts |
Q81802134 | Apelin cells in the rat stomach |
Q62618483 | Apelin effects in human splanchnic arteries. Role of nitric oxide and prostanoids |
Q39722218 | Apelin is a novel islet peptide. |
Q46796908 | Apelin protects myocardial injury induced by isoproterenol in rats |
Q84573884 | Apelin receptor expression in ischemic and non- ischemic kidneys and cardiovascular responses to apelin in chronic two-kidney-one-clip hypertension in rats |
Q46894075 | Apelin reduces myocardial reperfusion injury independently of PI3K/Akt and P70S6 kinase |
Q48842600 | Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding |
Q83158702 | Apelin-12 stimulates acid secretion through an increase of histamine release in rat stomachs |
Q59694067 | Apelin: A new plasma marker of cardiopulmonary disease |
Q81469239 | Appearance of prolactin-releasing peptide-producing cells in the area postrema of postnatal rats |
Q58448125 | Appetite reduction and weight loss during antiviral therapy for hepatitis C are associated with impaired gastric emptying and altered gastrointestinal hormone secretion |
Q43183779 | Appetite suppression through smelling of dark chocolate correlates with changes in ghrelin in young women. |
Q77425686 | Application of region-specific immunoassay for human chromogranin A: substantial clue for detection and measurement of chromogranin A in human plasma |
Q57268795 | Approaches in the study of the posttranslational processing of opioid peptide peptide precursors: Focus on prodynorphin |
Q126816905 | Are CCK-8 effects on food-intake mediated via direct access to the brain? |
Q72287111 | Are enterochromaffinlike cell tumours reversible? An experimental study on gastric carcinoids induced in Mastomys by histamine2-receptor blockade |
Q36864733 | Are mu-opioid receptors involved in the control of endothelin-1 release from the pituitary gland in normal and dehydrated rats? |
Q71696084 | Are radioligand antagonist/agonist binding ratios in rat pancreas predictive of functional efficacy of cholecystokinin receptor agonists and antagonists? |
Q40535062 | Arg-vasopressin increases proliferation of human osteoblast-like cells and decreases production of interleukin-6 and macrophage colony-stimulating factor |
Q52293393 | Arginine vasopressin and a vasopressin antagonist peptide: opposite effects on extinction of active avoidance in rats. |
Q41554213 | Arginine vasopressin deficient Brattleboro rats fail to develop tolerance to the hypothermic effects of ethanol. |
Q48251951 | Arginine vasopressin induces periaqueductal gray release of enkephalin and endorphin relating to pain modulation in the rat. |
Q48123488 | Arginine vasopressin remolds the spontaneous discharges disturbed by amyloid β protein in hippocampal CA1 region of rats |
Q47954348 | Arginine vasopressin, via activation of post-junctional V1 receptors, induces contractile effects in mouse distal colon. |
Q126324570 | Arginine-vasopressin as target of angiotensin II in the brain in vitro |
Q42994778 | Arginine-vasopressin directly promotes a thermogenic and pro-inflammatory adipokine expression profile in brown adipocytes |
Q84976697 | Arterial stiffness and novel biomarkers in patients with abdominal aortic aneurysms |
Q40766331 | Arthropod venoms affecting cell signalling system |
Q28568528 | Ascorbic acid decreases neutral endopeptidase activity in cultured osteoblastic cells |
Q51554557 | Association between plasma ghrelin and motilin levels during MMC cycle in conscious dogs. |
Q82695166 | Association between the AGTR1 polymorphism +1166A>C and serum levels of high-sensitivity C-reactive protein |
Q39320536 | Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer |
Q38331642 | Association of leptin receptor (OB-Rb), NPY and GLP-1 gene expression in the ovine and murine brainstem |
Q47224862 | Association of weight regain with specific methylation levels in the NPY and POMC promoters in leukocytes of obese men: a translational study |
Q58846248 | Atrial natriuretic factor as marker of myocardial compromise in Chagas' disease |
Q42520834 | Atrial natriuretic factor decreases renal dopamine turnover and catabolism without modifying its release |
Q71615472 | Atrial natriuretic factor enhances induced salivary secretion in the rat |
Q54264853 | Atrial natriuretic factor in ovine pregnancy: plasma levels, molecular forms and biological activity. |
Q73393076 | Atrial natriuretic factor inhibits norepinephrine biosynthesis and turnover in the rat hypothalamus |
Q46612996 | Atrial natriuretic factor intracellular signaling in the rat submandibular gland. |
Q42474486 | Atrial natriuretic factor is unlikely to be involved in the reduced aldosterone production in the Brattleboro rat. |
Q70581497 | Atrial natriuretic factor modifies bile flow and composition in the rat |
Q71712900 | Atrial natriuretic factor modifies the composition of induced-salivary secretion in the rat |
Q67900046 | Atrial natriuretic factor release during acute infusion of isoproterenol in the conscious rat |
Q42488474 | Atrial natriuretic factor stimulates luteal guanylate cyclase |
Q28567463 | Atrial natriuretic factor stimulates renal dopamine uptake mediated by natriuretic peptide-type A receptor |
Q42509271 | Atrial natriuretic factor-induced cGMP accumulation in rat anterior pituitary cells in culture is not coupled to hormonal secretion |
Q42509708 | Atrial natriuretic peptide does not affect corticotropin-releasing factor-, arginine vasopressin- and angiotensin II-induced adrenocorticotropic hormone release in vivo or in vitro |
Q44788426 | Atrial natriuretic peptide influence on nitric oxide system in kidney and heart |
Q44016658 | Atrial natriuretic peptide inhibits iodide uptake and thyroglobulin messenger ribonucleic acid expression in cultured bovine thyroid follicles |
Q40820071 | Atrial natriuretic peptide inhibits tumor necrosis factor-alpha production by interferon-gamma-activated macrophages via suppression of p38 mitogen-activated protein kinase and nuclear factor-kappa B activation |
Q57338535 | Atrial natriuretic peptide inhibits water and sodium intake in rabbits |
Q48731246 | Atrial natriuretic peptide reverses the negative functional effects of stunning in rabbit myocardium |
Q54456514 | Atrial natriuretic peptide suppresses Th17 development through regulation of cGMP-dependent protein kinase and PI3K-Akt signaling pathways. |
Q48363500 | Atrial natriuretic polypeptide-like immunoreactivity in the rat pituitary: light and electron microscopic studies |
Q70463389 | Atropine depresses release of neurotensin and its effect on the exocrine pancreas |
Q43963218 | Attenuation of negatively regulated ANP secretion by calcium in hypertrophied atria |
Q52185174 | Attenuation of scopolamine-induced spatial learning impairments by an angiotensin IV analog. |
Q32078843 | Atypical angiotensin receptors may mediate water intake induced by central injections of angiotensin II and of serotonin in pigeons |
Q45176373 | Augmentation of cocaine hyperactivity in rats by systemic ghrelin |
Q42127439 | Augmented cocaine conditioned place preference in rats pretreated with systemic ghrelin |
Q36894759 | Autoinhibition of endothelial nitric oxide synthase (eNOS) in gut smooth muscle by nitric oxide |
Q75196590 | Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium |
Q42439046 | Autonomic and neuroendocrine actions of adrenomedullin in the brain: mechanisms for homeostasis. |
Q46520450 | Autonomic control in rats with overactivity of tissue renin-angiotensin or kallikrein-kinin system. |
Q74472306 | Autoradiographic identification of a gastrin receptor on the human parietal cell |
Q72099715 | Autoradiographic localisation and characterisation of substance P binding sites in rat knees |
Q48395847 | Autoradiographic localization of 125I-galanin binding sites in the blowfly brain |
Q48947565 | Autoradiographic localization of angiotensin II receptors in developing rat cerebellum and brainstem |
Q69817675 | Autoradiographic localization of vasoactive intestinal peptide (VIP) binding sites in the human term placenta. Relationship with activation of adenylate cyclase |
Q35534764 | Autoradiographic localization of vasoactive intestinal polypeptide receptors in the rat mesenteric vascular tree |
Q72521788 | Autoradiographic study of motilin binding sites in the rabbit gastrointestinal tract |
Q48469466 | Autoradiographic visualization of the natriuretic peptide receptor-B in rat tissues |
Q39872284 | Autoregulation of human relaxin-2 gene expression critically involves relaxin and glucocorticoid receptor binding to glucocorticoid response half-sites in the relaxin-2 promoter |
Q68441916 | Autoregulation of renal hemodynamics is not impaired by a ‘physiologic’ dose of glucagon |
Q48916010 | B and C types natriuretic peptides modulate norepinephrine uptake and release in the rat hypothalamus |
Q49100898 | B-type natriuretic peptide (BNP) attenuates the L-type calcium current and regulates ventricular myocyte function. |
Q83211130 | B-type natriuretic peptide levels predict extent and severity of coronary disease in non-ST elevation coronary syndromes and normal left ventricular systolic function |
Q48024362 | BDNF-overexpression regulates the reactivity of small pulmonary arteries to neurokinin A. |
Q41171369 | BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties |
Q41447371 | BON cells display the intestinal pattern of neurotensin/neuromedin N precursor processing |
Q40161716 | BVT.3531 reduces body weight and activates K(ATP) channels in isolated arcuate neurons in rats. |
Q40463988 | Basal adrenocorticotropin (ACTH) secretion is negatively modulated by protein phosphatase 5 in mouse pituitary corticotropin AtT20 cells. |
Q49117776 | Basal hyperchlorhydria and its relation to the plasma concentrations of secretin, vasoactive intestinal polypeptide (VIP) and gastrin during prolonged strain |
Q77535607 | Base variant of human pancreatic secretory trypsin inhibitor in healing of stress-induced gastric lesions in rats |
Q83418567 | Basic aminopeptidase activity is an emerging biomarker in collagen-induced rheumatoid arthritis |
Q39823698 | Basic fibroblast growth factor upregulates adrenomedullin expression in ovarian epithelial carcinoma cells via JNK-AP-1 pathway |
Q69795687 | Bayliss & Starling annual meeting. Nottingham 1989. Abstracts |
Q72534526 | Bayliss and Starling 13th Annual Meeting. London, 13-14 September 1993. Abstracts |
Q28141287 | Bayliss and Starling and the nascence of endocrinology |
Q38021016 | Beginnings: a reflection on the history of gastrointestinal endocrinology |
Q46782668 | Behavioral and metabolic effects of central injections of orexins/hypocretins in pigeons (Columba livia). |
Q35944956 | Behavioral effects of local microinfusion of pituitary adenylate cyclase activating polypeptide (PACAP) into the paraventricular nucleus of the hypothalamus (PVN). |
Q48436618 | Behavioral effects of vasopressin and oxytocin within the medial preoptic area of the golden hamster |
Q34831100 | Behavioral perinatology: biobehavioral processes in human fetal development |
Q51022574 | Behavioural analysis of melanin-concentrating hormone in rats: evidence for orexigenic and anxiolytic properties. |
Q42642053 | Behavioural characterisation of young adult transgenic mice overexpressing galanin under the PDGF-B promoter |
Q60054771 | Behavioural evidence for CNS tachykinin-cholinergic interactions |
Q72572182 | Beneficial effect of somatostatin on galactosamine induced liver injury |
Q43770507 | Berberine against gastrointestinal peptides elevation and mucous secretion in hyperthyroid diarrheic rats |
Q70041793 | Beta-adrenergic control of atrial natriuretic factor secretion from dispersed rat atrial myocytes |
Q69900289 | Beta-adrenergic stimulation of gastrin release mediated by gastrin-releasing peptide in rat antral mucosa |
Q70942076 | Beta-adrenoceptor stimulation increases neuropeptide Y release from sympathetic nerves in intact rats |
Q50866001 | Beta-arrestin2 is involved in the increase of distal colonic contraction in diabetic rats. |
Q34367701 | Beta-cell selective K(ATP)-channel activation protects beta-cells and human islets from human islet amyloid polypeptide induced toxicity. |
Q70026587 | Beta-endorphin in the human gallbladder |
Q51750010 | Bimodal effects of chronically administered neurokinin B (NKB) on in vivo and in vitro cardiovascular responses in female rats. |
Q85895966 | Binding affinities and activation of Asp712Ala and Cys100Ser mutated kinin B1 receptor forms suggest a bimodal scheme for the molecule of bound-DABK |
Q52535842 | Binding affinity and physiological activity of some HVFLRFamide analogues on the oviducts of the locust, Locusta migratoria. |
Q41271532 | Binding and agonist/antagonist actions of M35, galanin(1-13)-bradykinin(2-9)amide chimeric peptide, in Rin m 5F insulinoma cells. |
Q68239629 | Binding and internalization of VIP in rat intestinal epithelial cells |
Q41565441 | Binding and signal transduction of the cloned vascular angiotensin II (AT1a) receptor cDNA stably expressed in Chinese hamster ovary cells |
Q69805919 | Binding and structural properties of oxytocin receptors in isolated rat epididymal adipocytes |
Q40581816 | Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism |
Q40491086 | Binding epitopes for peptide and non-peptide ligands on the NK1 (substance P) receptor |
Q40549188 | Binding of the new morphiceptin analogs to human MCF-7 breast cancer cells and their effect on growth. |
Q42557246 | Binding of valsartan to mammalian angiotensin AT1 receptors |
Q70111254 | Binding of vasoactive intestinal polypeptide (VIP) by human blood monocytes: demonstration of specific binding sites |
Q48690386 | Binding specificity of the mouse cerebral cortex receptor for small cholecystokinin peptides |
Q44827870 | Binding studies of substance P anterior pituitary binding sites: changes in substance P binding sites during the rat estrous cycle |
Q47394942 | BioPD: a web-based information center for bioactive peptides |
Q34062907 | Bioactive peptides from lizard venoms |
Q74472297 | Bioactivity of intraduodenally and intravenously infused fragments of luminal cholecystokinin releasing factor (LCRF) |
Q40829269 | Bioactivity of recombinant prorelaxin from the marmoset monkey |
Q77512749 | Bioassays for NPY receptors: old and new |
Q38291511 | Biochemical roles of the oligosaccharide chains in thyrostimulin, a heterodimeric hormone of glycoprotein hormone subunits alpha 2 (GPA2) and beta 5 (GPB5). |
Q35035998 | Biological actions of galanin |
Q41484776 | Biological actions of human and rat calcitonin and calcitonin gene-related peptide |
Q38313614 | Biological activity and antidiabetic potential of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide, GIP(1-16) and (Pro3)GIP(1-16). |
Q40172389 | Biological activity of AC3174, a peptide analog of exendin-4. |
Q74665094 | Biological activity of GLP-1-analogues with N-terminal modifications |
Q51766399 | Biological and conformational evaluation of angiotensin II lactam bridge containing analogues. |
Q41468627 | Biological effects of a novel intestinal peptide--inhibiting enterocytogenin on cultured 3T3 mouse fibroblasts and L5178Y mouse lymphoma cells |
Q68695373 | Biological effects of a proglumide derivative as cholecystokinin antagonist in conscious dogs |
Q48857733 | Biological effects of cysteamine: relationship to somatostatin depletion |
Q48295747 | Biological half-life and organ distribution of [3H]8-arginine vasopressin following administration of vasopressin receptor antagonist OPC-31260. |
Q33760027 | Biological relevance of pituitary adenylate cyclase-activating polypeptide (PACAP) in the gastrointestinal tract |
Q43597724 | Biosynthesis and degradation of the arginine-vasopressin-like insect diuretic hormone, a neurohormone in the migratory locust |
Q79742285 | Biphasic actions of angiotensin IV on renal blood flow in the rat |
Q43478150 | Bivariate assay for cleaved atrial natriuretic factor (ANF(101-105/106-126)) in sheep plasma |
Q74338139 | Blockade effects of (Nphe1)Nociceptin(1-13)-NH(2) on anti-nociception induced by intrathecal administration of nociceptin in rats |
Q42740934 | Blockade of angiotensin II improves hyperthyroid induced abnormal atrial electrophysiological properties |
Q48891842 | Blockade of central angiotensin II type 1 and type 2 receptors suppresses adrenalectomy-induced NaCl intake in rats |
Q72099823 | Blockade of cutaneous nerve-evoked responses by GR71251 in the isolated spinal cord preparation of newborn rat |
Q69025376 | Blockade of sensory nerve mediated contraction of the rabbit iris sphincter by a series of novel tachykinin antagonists |
Q48493827 | Blockade of the classical pathway of protein secretion does not affect the cellular exportation of lipocortin 1. |
Q44753743 | Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1. |
Q50859074 | Blood pressure, plasma NPY and catecholamines during physical exercise in relation to menstrual cycle, ovariectomy, and estrogen replacement. |
Q48721456 | Body temperature effects of opioids administered into the periaqueductal grey area of rat brain |
Q71507410 | Bombesin activation of phospholipase C beta 1 in rat acinar pancreatic cells involves the pertussis toxin-sensitive G alpha i3 protein |
Q41425570 | Bombesin and its analogues inhibit interleukin-2-induced proliferation of CTLL-2 cells |
Q39820926 | Bombesin enhances TGF-beta growth inhibitory effect through apoptosis induction in intestinal epithelial cells |
Q45362504 | Bombesin microinjected into the dorsal vagal complex inhibits vagally stimulated gastric acid secretion in the rat. |
Q46790368 | Bombesin potentiates the effect of acetylcholine on isolated strips of fish stomach |
Q72954210 | Bombesin production by human small cell carcinoma of the lung |
Q44290210 | Bombesin stimulates prolactin secretion from cultured rat pituitary tumour cells (GH4C1) via activation of phospholipase C. |
Q70096911 | Bombesin, neurotensin and pro-gamma-melanotropin immunoreactants in human milk |
Q70658188 | Bombesin-induced stimulation of cardiac parasympathetic innervation |
Q68755008 | Bombesin-like immunoreactive material in the gut, and the effect of bombesin on the stomach circulatory system of an elasmobranch fish, Squalus acanthias |
Q70022275 | Bombesin-like immunoreactivity in bovine adrenal medulla |
Q70686663 | Bombesin-like immunoreactivity in human gastrointestinal tract |
Q48971485 | Bombesin-like immunoreactivity in rat brain and gastrointestinal tract: influence of diet and starvation |
Q67797242 | Bombesin-like immunoreactivity in skates and the in vitro effect of bombesin on coronary vessels from the longnose skate, Raja rhina |
Q72265303 | Bombesin-like immunoreactivity in the rat larynx: increase in response to irradiation |
Q70141222 | Bombesin-like peptides in human small cell carcinoma of the lung |
Q42485384 | Bombesin-like peptides stimulate gastrin release from isolated rat G-cells |
Q33246311 | Bone abnormalities in adolescent leptin-deficient mice |
Q44849002 | Bone and joint neuropathy in rats with type-2 diabetes |
Q44495085 | Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects |
Q51452139 | Both afferent and efferent nerves are implicated in cholecytokinin motor actions in the small intestine of the rat. |
Q68972603 | Both somatostatin and the caudal neuropeptide, urotensin II, stimulate lipid mobilization from coho salmon liver incubated in vitro |
Q36883005 | Botulinum neurotoxin F, a VAMP-specific endopeptidase, inhibits Ca(2+)-stimulated GH secretion from rat pituitary cells |
Q51338550 | Bovine pancreatic secretion in the first week of life: potential involvement of intestinal CCK receptors. |
Q44616120 | Bradykinin B1 receptor stimulates the proximal tubule Na(+)-ATPase activity through protein kinase C pathway |
Q30658514 | Bradykinin and its receptors in non-mammalian vertebrates |
Q34590220 | Bradykinin and prostaglandin E₁ regulate calcitonin gene-related peptide expression in cultured rat sensory neurons |
Q78944804 | Bradykinin counteracts the stimulatory effect of angiotensin-(1-7) on the proximal tubule Na+ -ATPase activity through B2 receptor |
Q41171383 | Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors). |
Q53881031 | Bradykinin receptors: functional similarities in guinea pig gut muscle and mucosa. |
Q45234055 | Bradykinin upregulates IL-8 production in human gingival fibroblasts stimulated by interleukin-1beta and tumor necrosis factor alpha |
Q39992177 | Brain Natriuretic Peptide (BNP) regulates the production of inflammatory mediators in human THP-1 macrophages |
Q38331637 | Brain administration of OB protein (leptin) inhibits neuropeptide-Y-induced feeding in ob/ob mice |
Q40955661 | Brain angiotensin receptor subtypes AT1, AT2, and AT4 and their functions |
Q24569806 | Brain circuits regulating energy homeostasis |
Q48373236 | Brain leptin resistance in human obesity revisited |
Q73258928 | Brain oxytocin inhibits the (re)activity of the hypothalamo-pituitary-adrenal axis in male rats: involvement of hypothalamic and limbic brain regions |
Q73246725 | Brain oxytocin receptor antagonism disinhibits sodium appetite in preweanling rats |
Q72663265 | Brain somatostatinergic system at late pregnancy, parturition and the early postpartum period in the rat |
Q46877594 | Brain-derived neurotrophic factor enhances the contraction of intestinal muscle strips induced by SP and CGRP in mice |
Q70942113 | Bronchodilating effects of natriuretic and vasorelaxant peptides compared to salbutamol in asthmatics |
Q46871498 | Budesonide inhibits plasma extravasation induced by capsaicin and by substance P in the rat nasal mucosa. |
Q37479907 | C-terminal processing of GABARAP is not required for trafficking of the angiotensin II type 1A receptor |
Q71507398 | C-terminally shortened pituitary adenylate cyclase-activating peptides (PACAP) discriminate PACAP I, PACAP II-VIP1 and PACAP II-VIP2 recombinant receptors |
Q40921317 | C-type natriuretic peptide (CNP) effects on intracellular calcium [Ca2+]i in mouse gonadotrope-derived alphaT3-1 cell line |
Q33216230 | CART knock out mice have impaired insulin secretion and glucose intolerance, altered beta cell morphology and increased body weight |
Q52291674 | CART peptide 55-102 microinjected into the nucleus accumbens inhibits the expression of behavioral sensitization by amphetamine. |
Q44980563 | CART peptide: central mediator of leptin-induced adipose tissue apoptosis? |
Q33894586 | CART peptides |
Q43069590 | CB1 cannabinoid receptor expression is regulated by glucose and feeding in rat pancreatic islets. |
Q67866570 | CCK and PYY do not participate in the delayed inhibition of pancreatic secretion, after stimulation by duodenal oleic acid infusion |
Q73205401 | CCK antagonist pre-treatment inhibits meal-enhanced drug absorption in dogs |
Q40983021 | CCK receptor subtype in insulin-producing cells: a combined functional and in situ hybridization study in rat islets and a rat insulinoma cell line |
Q41694806 | CCK stimulates growth of six human pancreatic cancer cell lines in serum-free medium |
Q48561458 | CCK-8S activates c-Fos in a dose-dependent manner in nesfatin-1 immunoreactive neurons in the paraventricular nucleus of the hypothalamus and in the nucleus of the solitary tract of the brainstem |
Q73521135 | CCK-A receptor activation induces fos expression in myenteric neurons of rat small intestine |
Q43894624 | CCK-antagonist L-364,718: influence on rat pancreatic growth induced by caerulein and bombesin-like peptides |
Q73629304 | CCK-resistance in Zucker obese versus lean rats |
Q33611885 | CCK2 receptor antagonists: pharmacological tools to study the gastrin-ECL cell-parietal cell axis |
Q74665121 | CGRP 27-37 analogues with high affinity to the CGRP1 receptor show antagonistic properties in a rat blood flow assay |
Q42457689 | CGRP and substance P in intraepithelial neuronal structures of the human upper respiratory system |
Q73517104 | CGRP potentiates excitatory transmission to the circular muscle of guinea-pig colon |
Q50778254 | CGRP(8-37) and CGRP(32-37) contract the iris sphincter in the rabbit eye: antagonism by spantide and GR82334. |
Q49128132 | CNS mediated inhibition of gastric secretion by bombesin: independence from interaction with brain catecholaminergic, and serotoninergic pathways and pituitary hormones |
Q72534483 | CP-99,994, a nonpeptide antagonist of the tachykinin NK1 receptor |
Q73117227 | CRH-deficient mice have a normal anorectic response to chronic stress |
Q48456957 | CSF orexin-A/hypocretin-1 concentrations in patients with intracerebral hemorrhage (ICH). |
Q82691442 | CXCL14-like immunoreactivity in growth hormone-containing cells of urodele pituitaries |
Q71693700 | Ca2+ signaling through secretagogue and growth factor receptors on pancreatic AR42J cells |
Q41340746 | Caerulein and secretin induced pancreatic growth: a possible control by endogenous pancreatic somatostatin |
Q46195603 | Calcitonin Gene-Related Peptide (CGRP) modulates cholinergic neurotransmission in the small intestine of man, pig and guinea-pig via presynaptic CGRP receptors |
Q67879138 | Calcitonin and calcitonin gene-related peptide immunoreactivity and colocalization in newborn cat lung |
Q70775726 | Calcitonin and secretin inhibit bombesin-stimulated serum gastrin and gastric acid secretion in man |
Q45244208 | Calcitonin gene related peptide mediates cardioprotection by remote preconditioning |
Q71693697 | Calcitonin gene-related peptide (CGRP) and its effects on protein release in vitro in the developing submandibular gland of the rat |
Q51580012 | Calcitonin gene-related peptide (CGRP) in the circular muscle of guinea-pig colon: role as inhibitory transmitter and mechanisms of relaxation. |
Q73703286 | Calcitonin gene-related peptide (CGRP) increases cell surface area and induces expression of skeletal alpha-actin ANP mRNA in hypertrophying neonatal cardiomyocytes |
Q46928269 | Calcitonin gene-related peptide (CGRP) inhibits contractions of the prostatic stroma of the rat but not the guinea-pig |
Q53887662 | Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects. |
Q73022722 | Calcitonin gene-related peptide 8-37 inhibits the evoked discharge frequency of wide dynamic range neurons in dorsal horn of the spinal cord in rats |
Q48608524 | Calcitonin gene-related peptide acts within the central nervous system to inhibit gastric acid secretion |
Q44131105 | Calcitonin gene-related peptide and adrenomedullin release in humans: effects of exercise and hypoxia |
Q51708962 | Calcitonin gene-related peptide and capsaicin inhibit the circular muscle of the guinea-pig ileum. |
Q46586568 | Calcitonin gene-related peptide and the lung: neuronal coexistence with substance P, release by capsaicin and vasodilatory effect |
Q45176365 | Calcitonin gene-related peptide does not interact with sympathetic activity in myocardial ischemia |
Q42515966 | Calcitonin gene-related peptide in hamster lung and its coexistence with serotonin: a chemical and immunocytochemical study |
Q52485479 | Calcitonin gene-related peptide in the eye: release by sensory nerve stimulation and effects associated with neurogenic inflammation. |
Q71737672 | Calcitonin gene-related peptide is a potent intestinal, but not gastric, vasodilator in conscious dogs |
Q69097040 | Calcitonin gene-related peptide is metabolized by an endopeptidase hydrolyzing substance P |
Q60733612 | Calcitonin gene-related peptide neurons innervating the canine digestive system |
Q42490824 | Calcitonin gene-related peptide prevents blood-brain barrier injury and brain edema induced by focal cerebral ischemia reperfusion |
Q54443646 | Calcitonin gene-related peptide promotes the wound healing of human bronchial epithelial cells via PKC and MAPK pathways. |
Q73828199 | Calcitonin gene-related peptide regulates amino acid absorption across rat jejunum |
Q40244507 | Calcitonin gene-related peptide regulates the expression of vascular endothelial growth factor in human HaCaT keratinocytes by activation of ERK1/2 MAPK. |
Q68823564 | Calcitonin gene-related peptide-like immunoreactivity in the central nervous system and peripheral organs of rats |
Q46827670 | Calcitonin gene-related peptide-mediated cardioprotection of postconditioning in isolated rat hearts |
Q43625233 | Calcitonin gene-related peptide-mediated ischemic preconditioning in the rat heart: influence of age. |
Q42490126 | Calcitonin gene-related peptide: a sensory and motor neurotransmitter in the feline lower esophageal sphincter |
Q48219897 | Calcitonin gene-related peptide: antinociceptive activity in rats, comparison with calcitonin |
Q41639402 | Calcitonin inhibits the growth of human gastric carcinoma cell line KATO III |
Q73521122 | Calcitonin modifies ligand binding to muscarinic receptor in CNS membranes |
Q52216739 | Calcitonin, CGRP and helodermin in endocrine cells of the developing rat lung. |
Q46718578 | Calcium mobilization from fish scales is mediated by parathyroid hormone related protein via the parathyroid hormone type 1 receptor. |
Q51760605 | Calcium-regulating peptide hormones and blood electrolytic balance in chronic heart failure. |
Q48765681 | Caloric restriction causes secretagogue specific changes of gastric acid secretion in rats |
Q41661451 | Canine galanin: sequence, expression and pancreatic effects |
Q46921832 | Canine neurotensin, neurotensin6-13 and neuromedin N: primary structures and receptor activity |
Q48056614 | Canine prosomatostatin: isolation of a cDNA, regulation of gene expression, and characterization of post-translational processing intermediates |
Q73532144 | Canine vagus nerve stores cholecystokinin-58 and -8 but releases only cholecystokinin-8 upon electrical vagal stimulation |
Q46989963 | Cannabinoids inhibit insulin secretion and cytosolic Ca2+ oscillation in islet beta-cells via CB1 receptors |
Q63208639 | Capsaicin effects on substance P and CGRP in rat adjuvant arthritis |
Q42507776 | Capsaicin induced afferent denervation and receptor-linked responses to CGRP in the rat. |
Q72534467 | Capsaicin pretreatment increases inflammatory response to intratracheal instillation of endotoxin in rats |
Q67465044 | Capsaicin releases calcitonin gene-related peptide from the human iris and ciliary body in vitro |
Q46799533 | Capsaicin-evoked bradycardia in anesthetized guinea pigs is mediated by endogenous tachykinins |
Q46113255 | Capsaicin-evoked release of pituitary adenylate cyclase activating peptide (PACAP) and calcitonin gene-related peptide (CGRP) from rat spinal cord in vivo |
Q43918854 | Capsaicin-sensitive nerves influence the release of atrial natriuretic factor by atrial stretch in the rat |
Q44746252 | Capsaicin-sensitive neural pathway mediates atrial natriuretic factor (ANF) release in response to physiological stimuli |
Q73053547 | Capsaicin-sensitive vagal fibres and 5-HT3-, gastrin releasing peptide- and cholecystokinin A-receptors are involved in distension-induced inhibition of gastric emptying in the rat |
Q69887921 | Carbamylcholine, but not somatostatin or neurotensin, stimulates prostaglandin E2 release from the isolated perfused rat stomach |
Q72572185 | Carbohydrates modulate opiate receptor mediated mechanisms during postprandial endocrine function |
Q48121100 | Carboxypeptidase H-like immunoreactivity in the striatum of cats and monkeys |
Q44674633 | Cardiac C-type natriuretic peptide gene expression and plasma concentrations in neonatal piglets. |
Q81328306 | Cardiac effects of oxytocin: is there a role for this peptide in cardiovascular homeostasis? |
Q44240039 | Cardiac function in neuropeptide Y Y4 receptor-knockout mice |
Q36329875 | Cardiac intracrine renin angiotensin system. Part of genetic reprogramming? |
Q44183154 | Cardiac mast cells regulate myocyte ANP release via histamine H2 receptor in beating rabbit atria |
Q44495081 | Cardiac role of frog ANF: negative inotropism and binding sites in Rana esculenta |
Q54591392 | Cardioprotection by ischemic postconditioning is lost in isolated perfused heart from diabetic rats: Involvement of transient receptor potential vanilloid 1, calcitonin gene-related peptide and substance P. |
Q51452131 | Cardiorespiratory responses to intracerebroventricular injection of neuropeptide Y in anaesthetised dogs. |
Q45712616 | Cardiovascular actions of central neuromedin U in conscious rats |
Q51488599 | Cardiovascular actions of central neuropeptide W in conscious rats. |
Q45289963 | Cardiovascular and electrocardiographic parameters after tonin administration in Wistar rats. |
Q72321279 | Cardiovascular and renal functional effects of an antagonist of the guanylyl cyclase-linked ANF receptor |
Q48456899 | Cardiovascular and respiratory actions of pituitary adenylate cyclase-activating polypeptides |
Q51492322 | Cardiovascular and sympathetic effects of proadrenomedullin NH2-terminal 20 peptide in conscious rats. |
Q46019813 | Cardiovascular effects of ghrelin antagonist in conscious rats. |
Q28584139 | Cardiovascular effects of melanin-concentrating hormone |
Q46954723 | Cardiovascular expression of inflammatory signaling molecules, the kinin B1 receptor and COX2, in the rabbit: effects of LPS, anti-inflammatory and anti-hypertensive drugs |
Q43978225 | Cardiovascular responses induced by endothelin microinjection into area postrema |
Q84938201 | Cardiovascular responses to apelin in two-kidney-one-clip hypertensive rats and its receptor expression in ischemic and non-ischemic kidneys |
Q48503091 | Cardiovascular responses to intrathecal administration of arginine vasopressin in rats |
Q46156477 | Carnosine inhibits high glucose-induced mesangial cell proliferation through mediating cell cycle progression |
Q85335055 | Carnosine treatment in combination with ACE inhibition in diabetic rats |
Q68123924 | Cat gastrinoma and the sequence of cat gastrins |
Q51813225 | Catabolism of substance P and neurotensin in the rat stomach wall is susceptible to inhibitors of angiotensin converting enzyme. |
Q71737675 | Catecholamines inhibit alpha/beta interferon production induced by lipopolysaccharide |
Q44451609 | Catestatin (CgA344-364) stimulates rat mast cell release of histamine in a manner comparable to mastoparan and other cationic charged neuropeptides |
Q33838302 | Catestatin: a multifunctional peptide from chromogranin A |
Q48857725 | Catfish somatostatin is unique to piscine tissues |
Q40946065 | Cationic lipid-mediated delivery and expression of prepro-neuropeptide Y cDNA after intraventricular administration in rat: feasibility and limitations |
Q83431796 | Cell cycle regulation and proliferation in lichen sclerosus |
Q44200123 | Cell immunoblot assay study demonstrating the release of PACAP from individual anterior pituitary cells of rats and the effect of PACAP on LH release |
Q40657251 | Cell-specific expression of the glucose-dependent insulinotropic polypeptide gene functions through a GATA and an ISL-1 motif in a mouse neuroendocrine tumor cell line |
Q34384775 | Cellular distribution of chromogranin A in excitatory, inhibitory, aminergic and peptidergic neurons of the rodent central nervous system. |
Q31031910 | Cellular expression of CCK-A and CCK-B/gastrin receptors in human gastric mucosa |
Q28217617 | Cellular localization of orexin receptors in human adrenal gland, adrenocortical adenomas and pheochromocytomas |
Q78162196 | Cellular localization, expression and regulation of neuropeptide Y in kidneys of hypertensive rats |
Q40535069 | Cellular models for the analysis of signaling by protein kinase B and the forkhead transcription factor FKHR (Foxo1a). |
Q70959654 | Cellular uptake of intracerebrally administered oligodeoxynucleotides in mouse brain |
Q44545209 | Central CART gene delivery by recombinant AAV vector attenuates body weight gain in diet-induced-obese rats |
Q44921521 | Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue. |
Q49031930 | Central NPY-Y5 receptors activation plays a major role in fasting-induced pituitary-thyroid axis suppression in adult rat. |
Q48401559 | Central actions of angiotensin II on spontaneous baroreflex sensitivity in the trout Onc orhynchus mykiss |
Q48484423 | Central actions of calcitonin on body temperature and intestinal motility in rats: evidence for different mediations |
Q45151351 | Central administration of a nitric oxide precursor abolishes both the hypothalamic serotonin release and the hypophagia induced by interleukin-1beta in obese Zucker rats |
Q70959670 | Central administration of antisense oligodeoxynucleotides to neuropeptide Y (NPY) mRNA reveals the critical role of newly synthesized NPY in regulation of LHRH release |
Q44335064 | Central administration of beta-endorphin increases food intake in goldfish: pretreatment with the opioid antagonist naloxone |
Q86633187 | Central administration of mesotocin inhibits feeding behavior in chicks |
Q47860792 | Central administration of obestatin fails to show inhibitory effects on food and water intake in mice. |
Q52278739 | Central administration of thyrotropin-releasing hormone and histidyl-proline-diketopiperazine disrupts the acquisition of a food rewarded task by a non-aversive action. |
Q85175136 | Central alpha-MSH infusion in rats: disparate anorexic vs. metabolic changes with aging |
Q81103358 | Central and peripheral cardiovascular actions of apelin in conscious rats |
Q71367133 | Central and peripheral cholecystokinin receptors in chickens differ from those in mammals |
Q48316143 | Central and peripheral proglumide administration and cholecystokinin-induced satiety |
Q44577863 | Central catecholaminergic control of ACTH secretion |
Q40916634 | Central diabetes insipidus: oral treatment with dDAVP. |
Q82380331 | Central ghrelin inhibits reflex swallowing elicited by activation of the superior laryngeal nerve in the rat |
Q41194938 | Central inhibition of salt appetite by oxytocin in rats |
Q48311540 | Central injection in rats of alpha-melanocyte-stimulating hormone analog: effects on food intake and brain Fos. |
Q43431747 | Central insulin-angiotensin II interaction in blood pressure regulation in fructose overloaded rats. |
Q38300310 | Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: a long-term study |
Q44345177 | Central mu, delta- and kappa-opioid influences on intestinal water and electrolyte transport in dogs |
Q73828223 | Central natriuretic peptides regulation of peripheral atrial natriuretic factor release |
Q42208147 | Central nervous system action of TRH to stimulate gastric emptying in rats |
Q44070539 | Central nervous system actions of corticotropin-releasing factor on cardiovascular function in the absence of locomotor activity |
Q37153113 | Central nervous system regulation of adipocyte metabolism |
Q40916528 | Central oxytocin inhibition of food and salt ingestion: a mechanism for intake regulation of solute homeostasis |
Q44849000 | Central stresscopin modulates cardiovascular function through the adrenal medulla in conscious rats |
Q58819383 | Centrally acting leptin induces a resuscitating effect in haemorrhagic shock in rats |
Q68020499 | Centrally administered NPY stimulated gastric acid and pepsin secretion by a vagally mediated mechanism |
Q48217795 | Centrally administered insulin potentiates the pressor response to angiotensin II. |
Q71742127 | Centrally administered losartan inhibits the reduction in plasma renin concentration caused by intracerebroventricular hypertonic saline in Na-depleted sheep |
Q47993258 | Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF n |
Q43813995 | Centrally applied atrial natriuretic factor diminishes bile secretion in the rat. |
Q46364545 | Cerebrospinal fluid beta-endorphin in models of hyperalgesia in the rat. |
Q43879110 | Cerebrospinal fluid immunoreactive beta-endorphin concentration is increased by voluntary exercise in the spontaneously hypertensive rat. |
Q48247871 | Challenged sodium balance and expression of angiotensin type 1A receptor mRNA in the hypothalamus of Wistar and Dahl rat strains |
Q48367854 | Chamber-dependent circadian expression of cardiac natriuretic peptides. |
Q48434927 | Changes in body temperature and metabolic rate following microinjection of Met-enkephalinamide in the preoptic/anterior hypothalamus of rats |
Q71241822 | Changes in enkephalin and neuropeptide Y-like immunoreactivity in rabbit chromaffin tissues during perinatal development |
Q72591291 | Changes in enkephalin immunoreactivity of sympathetic ganglia and digestive tract of the cat after splanchnic nerve ligation |
Q44753723 | Changes in mechanism of PACAP-induced relaxation in longitudinal muscle of the distal colon of Wistar rats with age. |
Q73532152 | Changes in plasma adrenomedullin levels during the menstrual cycle |
Q51794334 | Changes in plasma atrial natriuretic peptide--immunoreactivity in patients undergoing coronary artery bypass graft placements. |
Q42484793 | Changes in rat atrial ANF granules induced by hindlimb suspension |
Q69247459 | Changes in rat liver cyclo(His-Pro) binding sites upon castration and testosterone administration |
Q71742157 | Changes of blood pressure responsiveness in rats exposed in utero and perinatally to a high-salt environment |
Q71634817 | Changes of spinal substance P, calcitonin gene-related peptide, somatostatin, Met-enkephalin and neurotensin in rats in response to formalin-induced pain |
Q84877914 | Changes of substance P during fracture healing in ovariectomized mice |
Q81015966 | Changes of the neuropeptides content and gene expression in spinal cord and dorsal root ganglion after noxious colorectal distension |
Q33196317 | Characterisation and distribution of calcitonin gene-related peptide in a primitive teleost, the eel, Anguilla anguilla and comparison with calcitonin |
Q70759785 | Characterisation of Met-enkephalin(Arg6,Phe7) immunoreactivity in human adrenal and human phaeochromocytoma |
Q44397757 | Characterisation of WE-14 in porcine ocular tissue. |
Q43766122 | Characterisation of a new chimeric ligand for galanin receptors: galanin(1-13)-[D-Trp(32)]-neuropeptide Y(25-36)amide |
Q71190916 | Characterisation of bombesin-like immunoreactivity in human fetal lung |
Q70985893 | Characterisation of gut hormones storage granules from normal human jejunum using metrizamide density gradients |
Q48857717 | Characterisation of immunoreactive somatostatin in human fetal hypothalamic tissue |
Q77512850 | Characterisation of the neuropeptide Y receptor that mediates feeding in the rat: a role for the Y5 receptor? |
Q70942068 | Characterisation of the processing by human neutral endopeptidase 24.11 of GLP-1(7-36) amide and comparison of the substrate specificity of the enzyme for other glucagon-like peptides |
Q68351028 | Characterisation of xenopsin immunoreactivity derived from pepsinised human skin and possible mechanism of in vivo generation |
Q42286092 | Characterisation, CNS distribution and function of NK2 receptors studied using potent NK2 receptor antagonists |
Q54602883 | Characteristic of GLP-1 effects on glucose metabolism in human skeletal muscle from obese patients. |
Q52216695 | Characteristics and developmental changes of ANP-binding sites in rat adrenal glands during the perinatal period. |
Q42506460 | Characteristics of distension-induced release of immunoreactive atrial natriuretic peptide in isolated perfused rabbit atria |
Q53576001 | Characteristics of gastrin controlled ECL cell specific gene expression. |
Q67281051 | Characterization and application of a radioimmunoassay for beta-endorphin using an antiserum with negligible cross-reactivity against beta-lipotropin |
Q48121087 | Characterization and content of VIP and VIP mRNA in rat fore-brain neurones |
Q71363408 | Characterization and distribution of bombesin binding sites in the goldfish hypothalamic feeding center and pituitary |
Q48485114 | Characterization and localization of galanin receptors in human entorhinal cortex |
Q38331647 | Characterization and molecular cloning of vascular neuropeptide Y receptor subtypes in pig and dog. |
Q72534471 | Characterization of NK-2 binding sites in rabbit lung tissue |
Q28580111 | Characterization of NPY receptors mediating contraction in rat intramyocardial coronary arteries |
Q44131099 | Characterization of VIP and PACAP receptors in cultured rat penis corpus cavernosum smooth muscle cells and their interaction with guanylate cyclase-B receptors |
Q71606192 | Characterization of VIP-and helodermin-preferring receptors on rat platelets |
Q48359606 | Characterization of Y1, Y2 and Y5 subtypes of the neuropeptide Y (NPY) receptor in rabbit kidney. Sensitivity of ligand binding to guanine nucleotides and phospholipase C inhibitors |
Q28505732 | Characterization of a calcitonin gene-related peptide (CGRP) receptor on mouse bone marrow cells |
Q69628173 | Characterization of a camel milk protein rich in proline identifies a new beta-casein fragment |
Q70942050 | Characterization of a functional angiotensin IV receptor on coronary microvascular endothelial cells |
Q83379357 | Characterization of a long-acting recombinant human serum albumin-atrial natriuretic factor (ANF) expressed in Pichia pastoris |
Q37229297 | Characterization of a novel ghrelin cell reporter mouse |
Q42043656 | Characterization of a novel peptide with allatotropic activity in the fall armyworm Spodoptera frugiperda. |
Q34183903 | Characterization of an amidated form of pancreatic polypeptide from the daddy sculpin (Cottus scorpius). |
Q44171382 | Characterization of an antiserum against an achetakinin I-analog and its use for the localization of Culekinin Depolarizing Peptide II in the mosquito, Culex salinarius |
Q73367087 | Characterization of an insulin-like growth factor (IGF) receptor and the insulin-like effects of IGF-1 in the bony fish, Lates calcarifer |
Q70651991 | Characterization of angiotensin AT1A receptor isoform by its ligand binding signature |
Q52312680 | Characterization of binding sites for calcitonin gene-related peptide in the mollusc gill. |
Q34321696 | Characterization of binding sites in rat for A, B and C-type natriuretic peptides |
Q40764725 | Characterization of bradykinin receptors in a human osteoblastic cell line |
Q48619954 | Characterization of cholecystokinin receptors in bullfrog (Rana catesbeiana) brain and pancreas |
Q69906457 | Characterization of coho salmon (Oncorhynchus kisutch) insulin |
Q44761561 | Characterization of content and chromatographic forms of neuropeptides in purified nerve varicosities prepared from guinea pig myenteric plexus |
Q71367126 | Characterization of endothelin receptor subtypes in isolated rat renal preglomerular microvessels |
Q42462990 | Characterization of functional receptors for vasoactive intestinal peptide (VIP) in rat peritoneal macrophages |
Q49018040 | Characterization of gastrin amidation in the rat and porcine antrum: comparison with the pituitary |
Q70581486 | Characterization of gastrin/CCK receptors on gastric carcinoid tumor membrane of Mastomys natalensis |
Q71507413 | Characterization of gene expression of VIP and VIP1-receptor in rat peritoneal lymphocytes and macrophages |
Q41587437 | Characterization of human plasma neurotensin-like immunoreactivity after fat ingestion |
Q71696080 | Characterization of novel peptoid agonists for the CCK-A receptor |
Q33216226 | Characterization of orexin A immunoreactivity in the rat area postrema |
Q38292294 | Characterization of orexins (hypocretins) and melanin-concentrating hormone in genetically obese mice |
Q87340771 | Characterization of pericardial and plasma ghrelin levels in patients with ischemic and non-ischemic heart disease |
Q48129954 | Characterization of rabbit kidney and brain pancreatic polypeptide-binding neuropeptide Y receptors: differences with Y1 and Y2 sites in sensitivity to amiloride derivatives affecting sodium transport |
Q73117205 | Characterization of rodent liver and kidney AVP receptors: pharmacologic evidence for species differences |
Q37109386 | Characterization of signaling pathways coupled to melatonin receptors in gastrointestinal smooth muscle |
Q69931255 | Characterization of somatostatin binding sites in isolated rat adipocytes |
Q73216403 | Characterization of somatostatin receptor subtypes mediating inhibition of nutrient-stimulated gastric acid and gastrin in dogs |
Q53873598 | Characterization of specific somatostatin binding sites in guinea pig lung. |
Q53933136 | Characterization of substance P-like immunoreactivity in peripheral sensory nerves and enteric nerves by high pressure liquid chromatography and radioimmunoassay. |
Q28212650 | Characterization of the NPGP receptor and identification of a novel short mRNA isoform in human hypothalamus |
Q71507381 | Characterization of the RFamide-like neuropeptides in the nervus terminalis of the goldfish (Carassius auratus) |
Q42066112 | Characterization of the adipokinetic hormone receptor form the fat body of Manduca sexta |
Q36837133 | Characterization of the binding properties and physiological action of divalinal-angiotensin IV, a putative AT4 receptor antagonist |
Q48250607 | Characterization of the cardiovascular and behavioral effects of centrally administered neuropeptide K in the conscious rat. |
Q46186975 | Characterization of the insulinostatic effect of urotensin II: a study in the perfused rat pancreas |
Q68248123 | Characterization of the murine pancreatic receptor for gastrin releasing peptide and bombesin |
Q73995554 | Characterization of the receptor response for the neuropeptide Y-evoked suppression of parasympathetically-mediated contractions in the guinea pig trachea |
Q93583850 | Characterization of two novel forms of cholecystokinin isolated from bovine upper intestine |
Q72668751 | Characterization of type I IGF receptor and IGF-I mRNA expression in cultured human and bovine glomerular cells |
Q40535049 | Charge delocalisation and the design of novel mastoparan analogues: enhanced cytotoxicity and secretory efficacy of [Lys5, Lys8, Aib10]MP. |
Q47923770 | Chemerin gene expression is regulated by food restriction and food restriction-refeeding in rat adipose tissue but not in liver |
Q68941640 | Chemical and immunochemical characterisation of substance P-like immunoreactivity and physalaemin-like immunoreactivity in a carcinoid tumour |
Q48507424 | Chemical characterization of vasoactive intestinal polypeptide-like immunoreactivity in ovine hypothalamus and intestine |
Q72321276 | Chemoattractant capacity of bombesin, gastrin-releasing peptide and neuromedin C is mediated through PKC activation in murine peritoneal leukocytes |
Q41944381 | Chloroquine alters the processing of secretin in isolated rat pancreatic acinar cells |
Q71176130 | Chlorpropamide-ethanol induced met-enkephalin secretion in dogs: release mechanisms and biochemical characterisation |
Q58828846 | Cholecystokinin (CCK) in the nervous system (Ellis Horwood health science series) |
Q48831330 | Cholecystokinin (CCK) release from rat brain slices in vitro is enhanced by agents which elevate intracellular cAMP. |
Q41618325 | Cholecystokinin (CCK)/gastrin-like immunoreactive neurones in the cerebral ganglion of the protochordate ascidians Styela clava and Ascidiella aspersa |
Q37432804 | Cholecystokinin and gut-brain signalling |
Q34060773 | Cholecystokinin and panic disorder--three unsettled questions |
Q73586946 | Cholecystokinin and peptide YY are released by fat in either proximal or distal small intestine in dogs |
Q68719702 | Cholecystokinin binding and degradation by isolated rat liver cells |
Q42435810 | Cholecystokinin but not ghrelin stimulates mucosal bicarbonate secretion in rat duodenum: independence of feeding status and cholinergic stimuli |
Q72001936 | Cholecystokinin evokes vasopressin release from perfused hypothalamic-neurohypophyseal explants |
Q48930997 | Cholecystokinin impact on rainbow trout glucose homeostasis: possible involvement of central glucosensors. |
Q70357170 | Cholecystokinin induces the interaction of its receptor with a guanine nucleotide binding protein |
Q72358270 | Cholecystokinin inhibits gastric emptying and contracts the pyloric sphincter in rats by interacting with low affinity CCK receptor sites |
Q68655177 | Cholecystokinin is a regulator of intestinal phase-stimulated PP release |
Q31943795 | Cholecystokinin octapeptide induces both proliferation and apoptosis in the rat pancreas |
Q33486647 | Cholecystokinin peptides in cerebrospinal fluid: a study in healthy male subjects. |
Q71606195 | Cholecystokinin, neuropeptide Y and galanin modulate the release of pancreatic somatostatin-25 and somatostatin-14 in vitro |
Q51609196 | Cholecystokinin, vasoactive intestinal peptide and peptide histidine methionine responses to feeding in anorexia nervosa |
Q48156181 | Cholecystokinin- and dexfenfluramine-induced anorexia compared using devazepide and c-fos expression in the rat brain |
Q46974410 | Cholecystokinin- and gastrin-induced protein and amylase secretion from the parotid gland of the anaesthetized rat. |
Q74419551 | Cholecystokinin- and secretin-releasing peptides in the intestine--a new regulatory interendocrine mechanism in the gastrointestinal tract |
Q50636141 | Cholecystokinin-58 and cholecystokinin-8 produce similar but not identical activations of myenteric plexus and dorsal vagal complex. |
Q52974639 | Cholecystokinin-8S levels in discrete hypothalamic nuclei of weanling rats exposed to maternal protein malnutrition. |
Q48431984 | Cholecystokinin-octapeptide like immunoreactivity in the area postrema of the rat and cat. |
Q72913307 | Cholecystokinin-octapeptide suppresses stress-induced eating by inducing hyperglycemia |
Q51595096 | Cholecystokinin-producing (I) cells of intestinal mucosa in dexamethasone-treated rats. |
Q68441913 | Cholecystokinins but not gastrin-17 release calcitonin from thyroid C-cells in the rat |
Q31943714 | Cholera and pertussis toxins inhibit differently hypothermic and anti-opioid effects of neuropeptide FF. |
Q45136835 | Cholesterol modulation of membrane fluidity and VIP receptor/effector system in rat prostatic epithelial cells. |
Q72104891 | Cholinergic dependency of stimulatory effects of neurotensin on exocrine pancreas in rats |
Q70442860 | Cholinergic mechanisms in intestinal phase insulin secretion in rats |
Q54590166 | Cholinergic stimulation of neuropeptide Y secretion from the isolated perfused rat stomach |
Q48485105 | Chromatographic and immunological identification of GnRH (gonadotropin-releasing hormone) variants. Occurrence of mammalian and a salmon-like GnRH in the forebrain of an eutherian mammal: Hydrochaeris hydrochaeris (Mammalia, Rodentia). |
Q48673183 | Chromatographic characterisation and biological activity of neuropeptides immunoreactive to antisera against Met5-enkephalin-Arg6-Phe7 (YGGFMRF) extracted from the blowfly Calliphora vomitoria (Diptera). |
Q69802350 | Chromatographic characterisation of the circulating neuropeptide Y immunoreactivity from patients with phaeochromocytoma |
Q48202785 | Chromatographic characterization of dynorphin and [Leu5]enkephalin immunoreactivity in guinea pig and rat testis |
Q44921540 | Chromogranin A as a determinant of midgut carcinoid tumour volume |
Q28580659 | Chromogranin A proteolysis to generate beta-granin and WE-14 in the adenohypophysis during the rat oestrous cycle |
Q46614930 | Chromogranin A, B and C: immunohistochemical localization in ovine pituitary and the relationship with hormone-containing cells |
Q28573872 | Chromogranin A-derived peptides: interaction with the rat posterior cerebral artery |
Q24644980 | Chromogranin A: a new proposal for trafficking, processing and induction of granule biogenesis |
Q28274432 | Chromogranin A: current status as a precursor for bioactive peptides and a granulogenic/sorting factor in the regulated secretory pathway |
Q46103439 | Chromogranin B: isolation from pheochromocytoma, N-terminal sequence, tissue distribution and secretory vesicle processing |
Q28303336 | Chromogranin from normal human adrenal glands: purification by monoclonal antibody affinity chromatography and partial N-terminal amino acid sequence |
Q34812133 | Chromogranin peptides in amyotrophic lateral sclerosis. |
Q73532164 | Chromogranin-B regulation of IAPP and insulin secretion |
Q48786896 | Chromogranin: widespread immunoreactivity in polypeptide hormone producing tissues and in serum |
Q44616116 | Chronic Helicobacter pylori infection results in gastric hypoacidity and hypergastrinemia in wild-type mice but vagally induced hypersecretion in gastrin-deficient mice |
Q67701871 | Chronic ICV infusion of neuropeptides alters lymphocyte populations in experimental rodents |
Q81420971 | Chronic administration of adrenomedullin attenuates the hypertension and increases renal nitric oxide synthase in Dahl salt-sensitive rats |
Q50471211 | Chronic administration of galanin attenuates the TNBS-induced colitis in rats. |
Q68837146 | Chronic ethanol exposure potentiates the locomotor-activating effects of corticotropin-releasing factor (CRF) in rats |
Q28578926 | Chronic ethanol or glucose consumption alter TRH content and pyroglutamyl aminopeptidase II activity in rat limbic regions |
Q42488297 | Chronic exposure of cultured rat pancreatic islets to elevated concentrations of islet amyloid polypeptide (IAPP) causes a decrease in islet DNA content and medium insulin accumulation |
Q52534447 | Chronic hypertension in ANP knockout mice: contribution of peripheral resistance. |
Q60585298 | Chronic hypoxia induced down-regulation of angiotensinogen expression in rat epididymis |
Q38290152 | Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats |
Q38333448 | Chronic infusion of angiotensin-(1-7) reduces heart angiotensin II levels in rats. |
Q41826000 | Chronic injection of pansomatostatin agonist ODT8-SST differentially modulates food intake and decreases body weight gain in lean and diet-induced obese rats |
Q71507392 | Chronic intracerebroventricular administration of beta-endorphin augments natural killer cell cytotoxicity in rats |
Q43878294 | Chronic intraparaventricular nuclear administration of orexin A in male rats does not alter thyroid axis or uncoupling protein-1 in brown adipose tissue |
Q73056801 | Chronic leptin administration promotes lipid utilization until fat mass is greatly reduced and preserves lean mass of normal female rats |
Q71363388 | Chronic systemic treatment with epidermal growth factor in the rat increases the mucosal surface of the small intestine |
Q43651978 | Chronotropic actions of cholecystokinin octapeptide on the rat heart |
Q72154954 | Chronotropic cardiac effects of NPY in conscious dogs: interactions with the autonomic nervous system and putative NPY receptors |
Q51638856 | Cimetidine fails to suppress the rise in plasma secretin during fasting. |
Q42471041 | Cimetidine inhibits the pentagastrin-induced release of calcitonin in normocalcaemic man. |
Q44909340 | Circadian influences on feeding-induced changes in ACTH and corticosterone secretion in rats |
Q69705193 | Circadian rhythm of neurotensin levels in rat small intestine |
Q44451618 | Circulating adrenomedullin is increased in relation with increased creatinine and atrial natriuretic peptide in liver-transplant recipients |
Q41179815 | Circulating endothelin influences area postrema neurons |
Q47744419 | Circulating endothelin parallels arterial blood pressure during sleep in healthy subjects |
Q35947002 | Circulating ghrelin and GLP-1 are not affected by habitual diet |
Q51393642 | Circulating ghrelin and ghrelin to obestatin ratio are low in patients with untreated mild-to-moderate hypertension |
Q51356179 | Circulating immunoreactive proANP1-30 and proANP31-67 responses to acute exercise. |
Q38331495 | Circulating leptin did not associate with the development of the hyperglycemia accompanied by insulin insensitivity in spontaneous noninsulin dependent diabetes mellitus model Otsuka-Long-Evans-Tokushima-Fatty rats |
Q41660220 | Circulating levels of IGFs and IGF binding proteins in human cord serum: relationships to intrauterine growth. |
Q48233473 | Circulatory and metabolic responses in awake dogs to infusion of iso-rANP/(rBNP). |
Q69444741 | Clearance of vasoactive intestinal polypeptide (VIP) in the porcine pulmonary circulation |
Q24304865 | Cloning and characterization of a secreted form of angiotensin-converting enzyme 2 |
Q47073882 | Cloning and characterization of a zebrafish Y2 receptor. |
Q58050253 | Cloning and expression of an isoform of the rmu-opioid receptor (rmuOR1B) |
Q48010785 | Cloning and functional expression of the guinea pig neuropeptide Y Y2 receptor |
Q77512740 | Cloning of a neuropeptide Y/peptide YY receptor from the Atlantic cod: the Yb receptor |
Q33211318 | Cloning of bradykinin precursor cDNAs from skin of Bombina maxima reveals novel bombinakinin M antagonists and a bradykinin potential peptide |
Q33224525 | Cloning of novel bombesin precursor cDNAs from skin of Bombina maxima |
Q42642351 | Cloning the full-length IL-2/15 receptor-beta cDNA sequence from mouse brain: evidence of enrichment in hippocampal formation neurons |
Q42099135 | Close arterial infusion of calcitonin gene-related peptide into the rat stomach inhibits aspirin- and ethanol-induced hemorrhagic damage |
Q69611223 | Co-existence of glicentin and peptide YY in colorectal L-cells in cat and man. An electron microscopic study |
Q127629528 | Co-localisation of three chromogranin A-derived peptides: vasostatin II; pancreastatin and WE-14 with follicle stimulating hormone and luteineizing hormone in the rat anterior pituitary |
Q39642271 | Co-operative effects of angiotensin II and caerulein in NFκB activation in pancreatic acinar cells in vitro |
Q42994711 | Cocaine- and amphetamine-regulated transcript (CART) peptide activates ERK pathways via NMDA receptors in rat spinal cord dorsal horn in an age-dependent manner. |
Q44710415 | Cocaine- and amphetamine-regulated transcript in the arcuate nucleus stimulates lipid metabolism to control body fat accrual on a high-fat diet |
Q34547802 | Cocaine- and amphetamine-regulated transcript is expressed in adipocytes and regulate lipid- and glucose homeostasis |
Q45244181 | Cocaine- and amphetamine-regulated transcript peptide potentiates spinal glutamatergic sympathoexcitation in anesthetized rats. |
Q40491103 | Coexistence and interaction of neuropeptides with substance P in primary sensory neurons, with special reference to galanin |
Q70816508 | Coexistence of peptide YY and glicentin immunoreactivity in endocrine cells of the gut |
Q81103379 | Coexpression of preprotachykinin A and B transcripts in the bovine corpus luteum and evidence for functional neurokinin receptor activity in luteal endothelial cells and ovarian macrophages |
Q68088424 | Colocalization of peptides and a catecholamine-synthesizing enzyme in intramural neurones of the newborn guinea-pig urinary bladder in culture |
Q42154496 | Combination of direct renin inhibition with angiotensin type 1 receptor blockade improves aldosterone but does not improve kidney injury in the transgenic Ren2 rat. |
Q78729800 | Combined non-radioactive detection of peptide hormones and their mRNAs in stomach somatostatin cells |
Q33182064 | Comparative analysis of the central CCK system in Fawn Hooded and Wistar Kyoto rats: extended localisation of CCK-A receptors throughout the rat brain using a novel radioligand |
Q48456961 | Comparative distribution of VIP in the central nervous system of various species measured by a new radioimmunoassay |
Q44200095 | Comparative distributions of pituitary adenylyl cyclase-activating polypeptide and its selective type I receptor mRNA in the frog (Xenopus laevis) brain |
Q69025373 | Comparative effect of chronic bombesin, gastrin-releasing peptide and caerulein on the rat pancreas |
Q45860858 | Comparative effects of metformin and pioglitazone on omentin and leptin concentrations in patients with newly diagnosed diabetes: a randomized clinical trial. |
Q54531323 | Comparative effects of vasoactive intestinal peptide and secretin on exocrine pancreatic secretion in the cat. |
Q48931798 | Comparative studies on the release of vasopressin and 7B2 from isolated hypothalami |
Q44643682 | Comparative study of biological activity of insulins of lower vertebrates in the novel adenylyl cyclase test-system. |
Q58105841 | Comparative study of oxyntomodulin and its C-terminal octapeptide on the gastric acid secretion in rat |
Q77763714 | Comparative vascular responses in elasmobranchs to different structures of neuropeptide Y and peptide YY |
Q48634420 | Comparison of Fos induced in rat brain by GLP-1 and amylin |
Q60570683 | Comparison of NT-proCNP and CNP plasma levels in heart failure, diabetes and cirrhosis patients |
Q48359630 | Comparison of Y-receptor subtype expression in the rat hippocampus |
Q46268996 | Comparison of a specific two-site immunoradiometric assay with radioimmunoassay for rat/human CRF-41. |
Q51815885 | Comparison of antagonist activity of spantide family at human neurokinin receptors measured by aequorin luminescence-based functional calcium assay. |
Q64989867 | Comparison of currents activated by noxious heat in rat and chicken primary sensory neurons. |
Q72099789 | Comparison of effects of morphine and CP-96,345, a substance P antagonist, administered intrathecally on the somatosympathetic reflex discharges in anesthetized rats |
Q68441920 | Comparison of half-disappearance times, distribution volumes and metabolic clearance rates of exogenous glucagon-like peptide 1 and glucagon in rats |
Q69958131 | Comparison of helodermin, VIP and PHI in pancreatic secretion and blood flow in dogs |
Q42280975 | Comparison of immunomodulatory functions of three peptides from the chicken bursa of Fabricius |
Q46421811 | Comparison of mammalian VIP bioactivities in dispersed acini from guinea pig pancreas |
Q41415941 | Comparison of motilin binding to crude homogenates of human and canine gastrointestinal smooth muscle tissue |
Q45126522 | Comparison of organ uptake and disappearance half-time of human epidermal growth factor and insulin |
Q73629325 | Comparison of responses to rat and human adrenomedullin in the hindlimb vascular bed of the cat |
Q72591269 | Comparison of the acute influence of neuropeptide Y and sympathetic stimulation on the composition of blood cells in the splenic vein in vivo |
Q72954202 | Comparison of the biologic actions of corticotropin-releasing factor and sauvagine |
Q69705198 | Comparison of the biological activity of canine and porcine motilin in rabbit |
Q63244976 | Comparison of the dependence potential of dihydroetorphine, etorphine and morphine |
Q68494712 | Comparison of the effects of neuropeptide Y (NPY) and 4-norleucine-NPY on isolated perfused rat hearts; effects of NPY on atrial and ventricular strips of rat heart and on rabbit heart mitochondria |
Q28298105 | Comparison of the effects of peripherally administered kisspeptins |
Q72540480 | Comparison of the gastric exocrine inhibitory activities and plasma kinetics of somatostatin-28 and somatostatin-14 in cats |
Q70163267 | Compensatory increase in adrenomedullary angiotensin-converting enzyme activity (kininase II) after unilateral adrenalectomy |
Q93561111 | Complete sulfation of jejunal gastrin in the human fetus |
Q41194923 | Complex activation of inducible transcription factors in the brain of normotensive and spontaneously hypertensive rats following central angiotensin II administration |
Q35935104 | Compound exocytosis of secretory granules containing salivary chromogranin A in granular duct cells in rat submandibular gland: the last study in collaboration with the late Professor Noboru Yanaihara at Yanaihara Institute |
Q68268217 | Computerized approach using autoradiography to quantify atrial natriuretic peptide receptors in the DOCA-salt hypertensive rat kidney |
Q72663273 | Concomitant increase in blood plasma levels of immunoreactive hemorphin-7 and beta-endorphin following long distance running |
Q27643080 | Conformational preferences and activities of peptides from the catecholamine release-inhibitory (catestatin) region of chromogranin A |
Q84950661 | Connective tissue growth factor level is increased in patients with liver cirrhosis but is not associated with complications or extent of liver injury |
Q46749196 | Consummatory behavior and metabolic indicators after central ghrelin injections in rats |
Q70438069 | Content and release of neurotensin in PC12 pheochromocytoma cell cultures: modulation by dexamethasone and nerve growth factor |
Q84941763 | Contribution of caveolin-1 to ventricular nitric oxide in age-related adaptation to hypovolemic state |
Q43207361 | Contribution of endogenous nitrergic and peptidergic influences to the altered neurally-induced gastric contractile responses in strips from dystrophic (mdx) mice |
Q37872839 | Contribution of neurotensin in the immune and neuroendocrine modulation of normal and abnormal enteric function |
Q71154536 | Contribution of the antrum and duodenum to circulating forms of gastrin in the dog |
Q51585285 | Control of gallbladder contractions by cholecystokinin through cholecystokinin-A receptors in the vagal pathway and gallbladder in the dog. |
Q41544085 | Conversion of substance P to C-terminal fragments in human plasma. |
Q42454017 | Cooperative effects of bombesin, substance P and methacholine on the release of intestinal neurotensin in rats |
Q44707306 | Cooperativity of thymopoietin 32–36 (the active site) and thymopoietin 38–45 in receptor binding |
Q35381245 | Corin-deficient W-sh mice poorly tolerate increased cardiac afterload |
Q31874783 | Correlation between neutral endopetidase (NEP) 3.4.24.11 in serum and the degree of the bronchial hyperreactivity |
Q33878097 | Correlation of type I insulin-like growth factor receptor (IGF-I-R) and insulin receptor-related receptor (IRR) messenger RNA levels in tumor cell lines from pediatric tumors of neuronal origin |
Q63184769 | Corrigendum to “Functional importance of GLP-1 receptor species and expression levels in cell lines” [Regul. Pept. 175 (2012) 21–29] |
Q115184995 | Corrigendum to “Interaction of AT1 receptors and V1a receptors-mediated effects in the central cardiovascular control during the post-infarct state” [Regul Pept 142 (2007) 86–94] |
Q49012005 | Corticostatins/defensins inhibit in vitro NK activity and cytokine production by human peripheral blood mononuclear cells |
Q52019506 | Corticosteroids induce the differential expression of TGFbeta isoforms, receptors and signaling in the gastric mucosa of suckling rats. |
Q38355495 | Corticotrophin-related peptides in the intermediate lobe of the rodent pituitary gland: characterization by high performance liquid chromatography and radioimmunoassay |
Q48940248 | Corticotropin releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus |
Q77535610 | Corticotropin releasing factor modulates interleukin-1-induced prostaglandin synthesis in fibroblasts: receptor binding and effects of antagonists |
Q56990808 | Corticotropin releasing factor receptors in inflamed tissue: Autoradiographic identification |
Q28569988 | Corticotropin releasing factor-distribution in rat intestine and role in neuroprotection |
Q70243421 | Corticotropin-releasing factor (CRF): mechanism to elevate mean arterial pressure and heart rate |
Q28565871 | Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior |
Q42208984 | Corticotropin-releasing factor acts centrally to suppress stimulated gastric contractility in the rat. |
Q48959688 | Corticotropin-releasing factor antagonist blocks stress-induced fighting in rats |
Q48974668 | Corticotropin-releasing factor elicits naloxone sensitive stress-like alterations in exploratory behavior in mice |
Q69874989 | Corticotropin-releasing factor inhibits gastric emptying in dogs |
Q42509703 | Corticotropin-releasing factor receptor antagonist: effects on the autonomic nervous system and cardiovascular function |
Q48395481 | Corticotropin-releasing factor-like peptide modifies the AMPA-, NMDA-dependent and GABAB-ergic properties of synaptic transmissions in vitro |
Q33372362 | Corticotropin-releasing factor: an inhibitor of vascular leakage in rat skeletal muscle and brain cortex after injury |
Q44753733 | Corticotropin-releasing hormone (CRH) produces analgesia in a thermal injury model independent of its effect on systemic beta-endorphin and corticosterone. |
Q69849914 | Corticotropin-releasing hormone and pituitary-adrenocortical responses in chronically stressed rats |
Q39784089 | Corticotropin-releasing hormone attenuates vascular endothelial growth factor release from human HaCaT keratinocytes |
Q46732047 | Corticotropin-releasing hormone stimulates adenylyl cyclase activity in the retinas of different animal species |
Q43274308 | Cortistatin attenuates vascular calcification in rats |
Q45151355 | Cortistatin radioligand binding in wild-type and somatostatin receptor-deficient mouse brain. |
Q72879317 | Cosecretion of islet amyloid polypeptide (IAPP) and insulin from isolated rat pancreatic islets following stimulation or inhibition of beta-cell function |
Q28566214 | Counteraction between angiotensin II and angiotensin-(1-7) via activating angiotensin type I and Mas receptor on rat renal mesangial cells |
Q41460929 | Coupling of pancreatic gastrin/cholecystokinin-B (G/CCKB) receptors to phospholipase C and protein kinase C in AR4-2J tumoral cells |
Q85408373 | Critical residues in the transmembrane helical bundle domains of the human motilin receptor for erythromycin binding and activity |
Q35776278 | Cross-regulation of VPAC2 receptor internalization by m2 receptors via c-Src-mediated phosphorylation of GRK2. |
Q57362271 | Crucial role of cytoskeleton reorganization in the negative inotropic effect of chromogranin A-derived peptides in eel and frog hearts |
Q43040309 | Culekinin depolarizing peptide: a mosquito leucokinin-like peptide that influences insect Malpighian tubule ion transport |
Q77305484 | Cumulative index, volumes 1-99 |
Q53962088 | Cyclic AMP modulates part of the relaxant action of calcitonin gene-related peptide in guinea pig gallbladder strips. |
Q51655665 | Cyclic AMP-mediated release of peptide YY (PYY) from the isolated perfused rabbit distal colon |
Q54267934 | Cyclooxygenase products mediate the cutaneous vasodilation induced by endothelin-1 in humans. |
Q46904373 | Cyclopamine inhibition of the sonic hedgehog pathway in the stomach requires concomitant acid inhibition |
Q43865613 | Cysteamine can induce duodenal ulceration in rats without depletion of immunoreactive somatostatin |
Q67488116 | Cysteamine induced-duodenal ulcers are associated with a selective depletion in gastric and duodenal calcitonin gene-related peptide-like immunoreactivity in rats |
Q69923339 | Cysteamine-induced reduction in gastrointestinal somatostatin: evidence for a region-specific loss in immunoreactivity |
Q48190464 | Cysteamine-induced reduction in tissue somatostatin immunoreactivity is associated with alterations in somatostatin mRNA. |
Q28138878 | Cysteine residues in a synthetic peptide corresponding to human follicle-stimulating hormone beta-subunit receptor-binding domain 81-95 [hFSH-beta-(81-95)] modulate the in vivo effects of hFSH-beta-(81-95) on the mouse estrous cycle |
Q42628735 | Cystinyl aminopeptidase activity is decreased in renal cell carcinomas. |
Q42527817 | Cytokine production by human thymic epithelial cells: control by the immune recognition of the neurohypophysial self-antigen. |
Q56990813 | Cytokine-induced antinociception mediated by opioids released from immune cells |
Q40491097 | Cytokines regulate substance P expression in sympathetic neurons |
Q40916684 | Cytoplasmic and nuclear signaling pathways of V1-vascular vasopressin receptors |
Q39777994 | Cytoskeleton mediates negative inotropism and lusitropism of chromogranin A-derived peptides (human vasostatin1-78 and rat CgA₁₋₆₄) in the rat heart. |
Q42169969 | Cytosolic Ca2+ responses to sub-picomolar and nanomolar PACAP in pancreatic beta-cells are mediated by VPAC2 and PAC1 receptors |
Q51754123 | DPP-4 inhibition improves glucose tolerance and increases insulin and GLP-1 responses to gastric glucose in association with normalized islet topography in mice with beta-cell-specific overexpression of human islet amyloid polypeptide. |
Q48013767 | DPP8 and DPP9 expression in cynomolgus monkey and Sprague Dawley rat tissues. |
Q28257599 | DPPIV inhibitors extend GLP-2 mediated tumour promoting effects on intestinal cancer cells |
Q44341397 | DPen2-[DPen5]enkephalin, a delta opioid receptor-selective analog of [Leu]enkephalin, impairs avoidance learning in an automated shelf-jump task in rats |
Q49141042 | Daily changes of neuropeptide Y-like immunoreactivity in the suprachiasmatic nucleus of the rat. |
Q84798806 | De novo generation of short antimicrobial peptides with simple amino acid composition |
Q71606181 | Deactivation of chemotaxis of human neutrophils by priming with secretogranin II-derived secretoneurin |
Q39858297 | Decrease in arterial pressure induced by adrenomedullin in the hypothalamic paraventricular nucleus is mediated by nitric oxide and GABA. |
Q85040588 | Decrease of serum chemerin concentration in patients with end stage renal disease after successful kidney transplantation |
Q44500852 | Decreased inflammatory responsiveness of hypophysectomized rats to heat is reversed by a corticotropin-releasing factor (CRF) antagonist |
Q44077182 | Decreased monoamine release in the median preoptic area following ventricular treatment with the angiotensin II antagonist saralasin in normotensive and spontaneously hypertensive rats |
Q72699383 | Decreased vasoactive intestinal polypeptide-immunoreactivity of parasympathetic neurons and target innervation following long-term sympathectomy |
Q33201877 | Defective insulin secretion during total parenteral nutrition in rat and its normalization by pituitary adenylate cyclase-activating polypeptide 27. |
Q44200105 | Defects in reproductive functions in PACAP-deficient female mice. |
Q31665544 | Degradation and glycemic effects of His(7)-glucitol glucagon-like peptide-1(7-36)amide in obese diabetic ob/ob mice. |
Q72534518 | Degradation and inactivation of human atrial natriuretic peptide by human pulmonary plasma membranes |
Q67977969 | Degradation and inactivation of rat atrial natriuretic peptide 1-28 by neutral endopeptidase-24.11 in rat pulmonary membranes |
Q34253816 | Degradation of cholecystokinin octapeptide, related fragments and analogs by human and rat plasma in vitro. |
Q54537452 | Degradation of cholecystokinin-like peptides by a crude rat brain synaptosomal fraction: A study by high pressure liquid chromatography |
Q72265276 | Degradation of endothelin-1 by extracts of rat lung, kidney, and liver |
Q73443332 | Degradation of insulin-like growth factors in small intestine of suckling rats |
Q71560509 | Degradation of luteinizing hormone-releasing hormone by serum and plasma in vitro |
Q44332892 | Degradation of thymic humoral factor gamma2 by human plasma: involvement of angiotensin converting enzyme |
Q67506691 | Demonstration of [125I]VIP binding sites and effects of VIP on cAMP-formation in rat insulinoma (RINm5F and RIN14B) cells |
Q54441121 | Demonstration of a beta-casomorphin immunoreactive material in the plasma of newborn calves after milk intake. |
Q43488930 | Demonstration of a functional receptor for vasoactive intestinal polypeptide on Molt 4b T lymphoblasts |
Q70812646 | Demonstration of a neuropeptide Y-like immunoreactivity in human phaeochromocytoma extracts |
Q33242182 | Demonstration of gonadotropin releasing-hormone receptors on gonadotrophs and somatotrophs of the goldfish: an electron microscope study |
Q40921311 | Demonstration of new sites of expression of the CCK-B/gastrin receptor in pancreatic acinar AR42J cells using immunoelectron microscopy |
Q40487470 | Dendritic and axonal mRNA trafficking |
Q44788432 | Dendroaspis natriuretic peptide and its functions in pig ovarian granulosa cells |
Q57099273 | Dendroaspis natriuretic peptide is the most potent natriuretic peptide to cause relaxation of lower esophageal sphincter |
Q46805065 | Dendroaspis natriuretic peptide protects the post-ischemic myocardial injury |
Q44921481 | Dendroaspis natriuretic peptide system and its paracrine function in rat colon |
Q69604658 | Depletion of large dense-cored vesicles from parasympathetic nerve terminals in rat parotid glands after prolonged stimulation of the auriculotemporal nerve |
Q41980371 | Depletion of neuropeptides in rat parotid glands and declining atropine-resistant salivary secretion upon continuous parasympathetic nerve stimulation |
Q51744380 | Depolarizing influences regulate somatostatin synthesis and processing in cultured cerebral cortical cells. |
Q72831557 | Depressor and natriuretic activities of several atrial peptides |
Q33216228 | Dermatoxin and phylloxin from the waxy monkey frog, Phyllomedusa sauvagei: cloning of precursor cDNAs and structural characterization from lyophilized skin secretion |
Q48093701 | Des-Leu angiotensin I: biosynthesis and drinking response |
Q46520442 | Des-aspartate-angiotensin I and angiotensin AT1 receptors in rat cardiac ventricles |
Q39044031 | Des-aspartate-angiotensin I attenuates ICAM-1 formation in hydrogen peroxide-treated L6 skeletal muscle cells and soleus muscle of mice subjected to eccentric exercise |
Q69529505 | Des-enkephalin-gamma-endorphin: bioavailability in rats following the subcutaneous and intramuscular route of administration |
Q35095523 | Desensitisation of adrenomedullin and CGRP receptors |
Q37585127 | Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment. |
Q72099885 | Desensitizing mechanism of capsaicin and nonanoyl vanillylamide on the vascular nociceptive response in the guinea pig |
Q28247192 | Design and characterization of a fluorescent ghrelin analog for imaging the growth hormone secretagogue receptor 1a |
Q72099836 | Design of a novel dipeptide substance P antagonist FK888 |
Q40916623 | Design of cyclic and linear peptide antagonists of vasopressin and oxytocin: current status and future directions |
Q71696075 | Design of novel cholecystokinin-B receptor ligands based on the 'double-ring system' approach |
Q106114443 | Design of peptides and peptidomimetics for delta and kappa opioid receptor subtypes |
Q40415004 | Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2. |
Q43473061 | Desmethylimipramine pretreatment prevents 6-hydroxydopamine induced somatostatin receptor reduction in the rat hippocampus |
Q40916648 | Desmopressin and hemostasis |
Q49018073 | Desmopressin, but not vasopressin, decreases activity of the hypothalamo-neurohypophysial system in Brattleboro rats |
Q46623664 | Detection of a novel immunoreactive endomorphin 2-like peptide in rat brain extracts |
Q56430001 | Detection of the messenger RNA coding for preproenkephalin A in bovine adrenal by in situ hybridization |
Q36101318 | Determinants of inducible brain natriuretic peptide promoter activity |
Q128054996 | Determination of amino acids in blood serum of patient with hepatic diseases |
Q51606760 | Determination of plasma cholecystokinin (CCK) concentrations by bioassay and radioimmunoassay in man. A critical evaluation |
Q40916628 | Development and pharmacological assessment of novel peptide and nonpeptide oxytocin antagonists |
Q40693303 | Development of a biologically active secretin analogue incorporating a radioiodinatable photolabile p-(4-hydroxybenzoyl)phenylalanine in position 10. |
Q69674882 | Development of cholecystokinin radioimmunoassay using synthetic CCK-10 as immunogen |
Q43286293 | Development of peptide receptor binding assays: methods to avoid false negatives |
Q42169844 | Development of the circadian melatonin rhythm and the effect of PACAP on melatonin release in the embryonic chicken pineal gland. An in vitro study |
Q45180989 | Developmental characteristics of substance P immunoreactivity within specific rabbit brainstem nuclei |
Q81299293 | Developmental expression and serotonergic regulation of relaxin 3/INSL7 in the nucleus incertus of rat brain |
Q52196126 | Developmental expression of NPY, PYY and PP in the rat pancreas and their coexistence with islet hormones. |
Q52210593 | Developmental expression of transforming growth factor-alpha in the upper digestive tract and pancreas of the rat. |
Q52194030 | Developmental gene expression of gastrin receptor in rat stomach. |
Q52222309 | Developmental regulation of insulin-like growth factor binding protein-2 in chick embryo serum and vitreous humor. |
Q41214222 | Developmentally regulated expression of IGF binding protein-3 (IGFBP-3) in human placental fibroblasts: effect of exogenous IGFBP-3 on IGF-1 action |
Q39436562 | Dexamethasone stimulates the expression of ghrelin and its receptor in rat hypothalamic 4B cells |
Q43963213 | Diabetes-induced changes of nitric oxide influence on the cardiovascular action of secretin |
Q67936617 | Diagnostic relevance of the amino-terminal cleavage peptide of procalcitonin (PAS-57), calcitonin and calcitonin gene-related peptide in medullary thyroid carcinoma patients |
Q47871704 | Diazepam binding inhibitor and total cholesterol plasma levels in cirrhosis and hepatocellular carcinoma |
Q46887040 | Diets influence the diabetic phenotype of transgenic mice expressing a dominant negative glucose-dependent insulinotropic polypeptide receptor (GIPRdn). |
Q67584425 | Difference between the antisecretory mechanisms of opioids and the somatostatin analogue octreotide in cholera toxin-induced small intestinal secretion in the rat |
Q48267539 | Differences between perinatal angiotensin binding in the brains of SHR and WKY rats |
Q42169023 | Differences in AMPK expression between subcutaneous and visceral adipose tissue in morbid obesity. |
Q49011080 | Differences in the pharmacological actions of intrathecally administered neurotensin and morphine |
Q46215006 | Differences in the potency o non-peptide antagonists selective for NK1 receptors, in inhibiting responses evoked by stimulation of sensory nerves |
Q72099846 | Different behavioral profiles of the non-peptide substance P (NK-1) antagonists CP-96,345 and RP 67580 |
Q48330215 | Different ionic requirements for somatostatin receptor subpopulations in the brain |
Q72719008 | Different modes of action of substance P in the motor control of the feline stomach and pylorus |
Q68974130 | Different peripheral and central antagonistic activity of new glutaramic acid derivatives on satiety induced by cholecystokinin in rats |
Q54700213 | Different relative abundance of neurotensin and neuromedin N in bovine ocular tissues |
Q42692292 | Different responses of galanin and calcitonin gene-related peptide to capsaicin stimulation on dorsal root ganglion neurons in vitro |
Q40667630 | Different role of intracellular loops of glucagon-like peptide-1 receptor in G-protein coupling |
Q72099816 | Differential SAR of quinuclidine SP antagonists between rat and human-type receptors |
Q72154967 | Differential actions of lamprey peptide methionine-tyrosine at Y1 and Y2 neuropeptide Y receptors |
Q43625228 | Differential alterations in tachykinin NK2 receptors in isolated colonic circular smooth muscle in inflammatory bowel disease and idiopathic chronic constipation |
Q48407930 | Differential behavioral effects of angiotensin II microinjected unilaterally into the CA1 hippocampal area |
Q71339449 | Differential distribution of molecular forms of cholecystokinin in human and porcine small intestinal mucosa |
Q43299461 | Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man. |
Q28611535 | Differential effect of protein and fat on plasma ghrelin levels in man |
Q31133748 | Differential effects of VIP and PACAP on survival of cultured adult rat myenteric neurons |
Q57959192 | Differential effects of deltorphin on arginine and galanin-induced growth hormone secretion in healthy man |
Q42446344 | Differential effects of histamine, vasoactive intestinal polypeptide, prostaglandin E2 and somatostatin on cyclic AMP-dependent protein kinase activation in gastric glands isolated from the guinea pig fundus and antrum |
Q68567835 | Differential effects of neuropeptides on coeliac and superior mesenteric blood flows in conscious rats |
Q72154948 | Differential effects of pertussis toxin on body temperature changes induced by neuropeptide Y and NPY2-36 |
Q28212665 | Differential effects of saralasin and ramiprilat, the inhibitors of renin-angiotensin system, on cerulein-induced acute pancreatitis |
Q44906880 | Differential expression of Y receptors and signaling pathways in intestinal circular and longitudinal smooth muscle |
Q40458435 | Differential expression of mRNAs for PACAP and its receptors during neural differentiation of embryonic stem cells. |
Q48096721 | Differential expression of the human, mouse and rat IGF-II genes |
Q54350868 | Differential gene expression and immune localization of the orexin system in the major salivary glands of pigs. |
Q73532160 | Differential glomerular response to continuous infusion of vasopressin in spontaneously hypertensive rats and Wistar-Kyoto rats |
Q40737566 | Differential glucocorticoid effects on repair mechanisms and NF-kappaB activity in the intestinal epithelium |
Q72892403 | Differential immunostaining of adenohypophysial cells with antisera to ACTH and beta-endorphin |
Q71241831 | Differential increase in neuropeptide Y-like levels and myenteric neuronal staining in diabetic rat intestine |
Q80722172 | Differential inhibition of galanin- and ghrelin-induced food intake by i.c.v. GLP-1(7-36)-amide |
Q42508150 | Differential insulin responses to oral and intravenous glucose in the transplantable rat insulinoma--a role for GIP. |
Q72433525 | Differential patterns of relaxation by atrial natriuretic peptide in major blood vessels of two distantly related teleosts |
Q68869982 | Differential patterns of relaxation by synthetic atrial peptide (APII) in the pulmonary artery, ascending and distal abdominal aorta |
Q45217436 | Differential rates of glucose metabolism across subregions of the subfornical organ in Brattleboro rats |
Q36732623 | Differential regional distribution of gonadotropin-releasing hormones in amphibian (clawed toad, Xenopus laevis) brain. |
Q80782511 | Differential regulated expression of keratinocyte growth factor and its receptor in experimental and human liver fibrosis |
Q38346307 | Differential regulation and roles of urocortins in human adrenal H295R cells |
Q28566753 | Differential regulation of activity-dependent neuroprotective protein in rat astrocytes by VIP and PACAP |
Q33202520 | Differential regulation of central vasopressin receptors in transgenic rats with low brain angiotensinogen |
Q40916541 | Differential regulation of neurohypophysial peptides in the paraventricular nucleus |
Q39877977 | Differential regulation of urocortins1-3 mRNA in human umbilical vein endothelial cells |
Q77425675 | Differential response of angiotensin peptides in the urine of hypertensive animals |
Q39553361 | Differential role of neurokinin receptors in human lymphocyte and monocyte chemotaxis |
Q54564829 | Differential sympathetic and angiotensinergic responses in rats submitted to low- or high-salt diet. |
Q48882392 | Differentiation between the somatostatin inhibition and the post-somatostatin rebound observed on growth hormone secretion in vitro |
Q46257666 | Differentiation of neuronal from non-neuronal Substance P. |
Q74248450 | Dihydrocapsaicin treatment depletes peptidergic nerve fibers of substance P and alters mast cell density in the respiratory tract of neonatal sheep |
Q63244978 | Dihydroetorphine, a potent opioid with low dependent potential |
Q40885860 | Diminished prohormone convertase 3 expression (PC1/PC3) inhibits progastrin post-translational processing |
Q28240838 | Dipeptidyl peptidase IV inhibitors: how do they work as new antidiabetic agents? |
Q39353196 | Dipeptidyl peptidase-4 expression is reduced in Crohn's disease |
Q33788748 | Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides |
Q73282387 | Direct action of growth hormone-releasing hormone agonist JI-38 on normal human fibroblasts: evidence from studies on cell proliferation and c-myc proto-oncogene expression |
Q71956640 | Direct and modulatory effects of FMRFamide, SKPYMRFamide and acety1-SKPYMRFamide on LPa2, LPa3, and RPa3 identified neurons of Helix lucorum |
Q67584434 | Direct effect of bombesin on pancreatic and gastric growth in suckling rats |
Q46963944 | Direct effects of casein phosphopeptides on growth and differentiation of in vitro cultured osteoblastic cells (MC3T3-E1). |
Q71870321 | Direct renovascular effect of somatostatin in the dog |
Q48278871 | Discordant expression of pro-B-type and pro-C-type natriuretic peptide in newborn infants of mothers with type 1 diabetes |
Q40491068 | Discovery of CP-96,345 and its characterization in disease models involving substance P |
Q44413571 | Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor |
Q48766571 | Discrimination of angiotensin II receptor subtype distribution in the rat brain using non-peptidic receptor antagonists |
Q40902535 | Discussion paper: towards a systematic classification for regulatory peptides |
Q48639831 | Disparate effects of intracisternal RX 77368 and ODT8-SS on gastric acid and serotonin release: role of adrenal catecholamines |
Q44131119 | Disregulation of proopiomelanocortin and contagious maladaptive behavior |
Q40356738 | Disruption of disulfide bond formation alters the trafficking of prothyrotropin releasing hormone (proTRH)-derived peptides |
Q43299462 | Distinct binding mode of 125I-AngII to AT1 receptor without the Cys18-Cys274 disulfide bridge. |
Q72639934 | Distinct classes of substance P receptors revealed by a comparison of the activities of substance P and some of its segments |
Q61737988 | Distinct conformational states of the CCK2R are associated with β-arrestin-2 recruitment or phospholipase-C activation |
Q85047958 | Distinct distribution of GLUT4 and insulin regulated aminopeptidase in the mouse kidney |
Q48249903 | Distinct effect of intracerebroventricular and intrathecal injections of nociceptin/orphanin FQ in the rat formalin test |
Q40491039 | Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2 and NK3 tachykinin receptors |
Q72568096 | Distribution and characterisation of immunoreactive somatostatin in human gastrointestinal tract |
Q48091772 | Distribution and characterisation of neuromedin U-like immunoreactivity in rat brain and intestine and in guinea pig intestine |
Q46107490 | Distribution and characterization of diazepam binding inhibitor (DBI) in peripheral tissues of rat. |
Q70812642 | Distribution and characterization of synenkephalin immunoreactivity in the bovine brain and pituitary |
Q72154972 | Distribution and chemical phenotypes of neuroendocrine cells in the human anal canal |
Q48140344 | Distribution and chromatographic analysis of galanin message-associated peptide (GMAP)-like immunoreactivity in the rat. |
Q48449785 | Distribution and chromatographic characterisation of CGRP-like immunoreactivity in the brain and gut of the rat. |
Q46238941 | Distribution and developmental changes in ghrelin-immunopositive cells in the gastrointestinal tract of African ostrich chicks |
Q45179814 | Distribution and function of brain natriuretic peptide in the stomach and small intestine of the rat. |
Q42441452 | Distribution and functional effects of neuropeptide Y on equine ureteral smooth muscle and resistance arteries. |
Q70743774 | Distribution and heterogeneity of immunoreactive cholecystokinin (CCK) in the mucosa of the porcine gastrointestinal tract |
Q68489801 | Distribution and localization of neurokinin A-like immunoreactivity and neurokinin B-like immunoreactivity in rat peripheral tissue |
Q38297795 | Distribution and localization of pituitary adenylate cyclase-activating polypeptide-specific receptor (PAC1R) in the rostral migratory stream of the infant mouse brain |
Q72533591 | Distribution and metabolism of exogenous somatostatin in the rat |
Q48880177 | Distribution and partial characterisation of immunoreactivity to the putative C-terminus of rat pancreastatin |
Q52201957 | Distribution and possible origin of galanin-like immunoreactive nerve fibers in the mammalian dental pulp. |
Q51829001 | Distribution and vasomotor effects of peptide HI (PHI) in feline cerebral blood vessels in vitro and in situ. |
Q48637405 | Distribution of Met5-enkephalin-Arg6-Gly7-Leu8-immunoreactivity in the rat and mouse pituitary gland |
Q44200133 | Distribution of PACAP and its mRNA in several nonneural tissues of rats demonstrated by sandwich enzyme immunoassay and RT-PCR technique. |
Q60731329 | Distribution of PHI in the mammalian respiratory tract and some aspects of its pharmacology |
Q82977495 | Distribution of a novel binding site for angiotensins II and III in mouse tissues |
Q48318910 | Distribution of angiotensin II receptor subtypes in the rabbit brain |
Q48625553 | Distribution of bombesin- and cholecystokinin-like immunoreactivity in rat and dog brain and gastrointestinal tract |
Q69735776 | Distribution of bombesin-like peptides in the alimentary canal of several vertebrate species |
Q49104833 | Distribution of calcitonin gene-related peptide and calcitonin-like immunoreactivity in trout |
Q71658607 | Distribution of calcitonin gene-related peptide-like immunoreactivity in the bovine conduction system: correlation with substance P |
Q69058558 | Distribution of calcitonin gene-related peptide-like immunoreactivity in various rat tissues: correlation with substance P and other tachykinins and sensitivity to capsaicin |
Q48827788 | Distribution of corticotropin-releasing factor in ovine brain determined by radioimmunoassay |
Q46142469 | Distribution of enkephalin immunoreactivity in sympathetic prevertebral ganglia and digestive tract of guinea-pigs and rats. |
Q68103152 | Distribution of i.v. administered epidermal growth factor in the rat |
Q48527004 | Distribution of locustamyotropin-like immunoreactivity in the nervous system of Locusta migratoria |
Q67239491 | Distribution of luteinizing hormone-releasing hormone receptors in the rat ovary |
Q68277509 | Distribution of neurokinin A-like and neurokinin B-like immunoreactivity in human peripheral tissues |
Q68567840 | Distribution of neuropeptide Y in the spinal cords of cat, dog, rat, man and pig |
Q85221474 | Distribution of neuropeptides in endocrine and exocrine pancreas of long-legged buzzard (Buteo rufinus): An immunohistochemical study |
Q68441910 | Distribution of pancreatic polypeptide-like immunoreactivity in rat tissues |
Q68676440 | Distribution of peptide YY in the gastrointestinal tract of the rat, dog, and monkey |
Q49141076 | Distribution of peptidergic nerves in the choroid plexus, focusing on coexistence of neuropeptide Y, vasoactive intestinal polypeptide and peptide histidine isoleucine |
Q70959663 | Distribution of phosphodiester and phosphorothioate oligonucleotides in rat brain after intraventricular and intrahippocampal administration determined by in situ hybridization |
Q40995850 | Distribution of protein phosphatases type 1 and 2A in RINm5F cells |
Q72022664 | Distribution of thyrotropin-releasing hormone receptor mRNA in rat peripheral tissues |
Q48915995 | Distribution of two VIP-related peptides, helospectin and pituitary adenylate cyclase activating peptide (PACAP), in the human upper respiratory system |
Q68494717 | Distribution, quantitation, and origin of immunoreactive neuropeptide Y in the human gastrointestinal tract |
Q41343303 | Disulfide bridges in extracellular domains of angiotensin II receptor type IA |
Q60437894 | Disulfide-containing peptides from the glandular skin secretions of froglets of the genus Crinia: Structure, activity and evolutionary trends |
Q56775046 | Diuresis and natriuresis produced by long term administration of a selective Angiotensin-(1–7) antagonist in normotensive and hypertensive rats |
Q73689721 | Diuretic and natriuretic action of adrenomedullin administered intracerebroventricularly in conscious rats |
Q48312779 | Diurnal rhythm of the in vivo release of enkephalin from the globus pallidus of the rat. |
Q48359556 | Divalent cations influencing neuropeptide Y receptor subtype binding in rat hippocampus and cortex membranes as well as in recombinant cells |
Q70923149 | Divergent mechanisms of insulin-like growth factor I and II on rat hepatocyte proliferation |
Q44848994 | Diverging vasorelaxing effects of C-type natriuretic peptide in renal resistance arteries and aortas of GC-A-deficient mice |
Q42169935 | Diverse effects of intrathecal pituitary adenylate cyclase-activating polypeptide on nociceptive transmission in mice spinal cord |
Q58449385 | Do enkephalins participate in vagal activation of gastric acid secretion in man? |
Q43089620 | Do enteric neurons make hypocretin? |
Q45346279 | Do normal plasma neurotensin concentrations increase ileal output? |
Q72099916 | Do substance P agonists insert into the lipid membrane? |
Q72099808 | Does substance P release mediate NANC nerve-mediated responses to field stimulation and ligands, in the rabbit isolated sphincter pupillae? |
Q73532174 | Does the response of the intestinal epithelium to keratinocyte growth factor vary according to the method of administration? |
Q40178167 | Does zaltoprofen antagonize the bradykinin receptors? |
Q44200117 | Dopamine- and cyclic AMP-regulated phosphoprotein-immunoreactive neurons activated by acute stress are innervated by fiber terminals immunopositive for pituitary adenylate cyclase-activating polypeptide in the extended amygdala in the rat. |
Q48345337 | Dopaminergic actions of parathyroid hormone in the rat medial basal hypothalamus in vitro |
Q48097672 | Dopaminergic regulation of three somatostatin mRNAs in goldfish brain |
Q60731330 | Dose-dependent effect of PHI on net fluid transport in the rat small intestine |
Q69881129 | Dose-dependent effects of linear and cyclic somatostatin on ethanol-induced gastric erosions: the role of mast cells and increased vascular permeability in the rat |
Q72538176 | Dose-dependent inhibitory and non-inhibitory action of somatostatin on insulin release in rats |
Q46520426 | Dose-linear pharmacokinetics, tissue distribution, and excretion of a recombinant fusion protein 125I-GST-TatdMt possessing potent anti-obesity activity. |
Q42454342 | Dose-related involvement of CCK in bombesin-induced pancreatic growth |
Q70243418 | Dose-response comparisons of canine plasma gastroenteropancreatic hormone responses to bombesin and the porcine gastrin-releasing peptide (GRP) |
Q73258934 | Dose-response effects of orexin-A on food intake and the behavioural satiety sequence in rats |
Q46570145 | Dose-response for inhibition by amylin of cholecystokinin-stimulated secretion of amylase and lipase in rats |
Q72358282 | Down regulation of the angiotensin II receptor subtype AT2 in human myometrium during pregnancy |
Q43915924 | Down-regulation of corticotropin-releasing hormone receptor type 2beta mRNA expression in the rat cardiovascular system following food deprivation |
Q44727328 | Dual effect of vasoactive intestinal peptide on the mitogenic response of rabbit spleen lymphocytes |
Q68084167 | Dual effects of calcitonin gene-related peptide on insulin secretion in the perfused dog pancreas |
Q42465151 | Dual effects of carnosine on energy metabolism of cultured cortical astrocytes under normal and ischemic conditions |
Q84241818 | Dual functions of beta-amyloid oligomer and fibril in Cu(II)-induced H2O2 production |
Q42478839 | Dynamic of the GRF-induced GH response in genetically obese Zucker rats: influence of central and peripheral factors |
Q34056725 | Dynamic regulation of leptin entry into brain by the blood-brain barrier |
Q28342662 | Dynorphin A (1–13) in the brain suppresses epinephrine-induced ventricular premature complexes and ventricular tachyarrhythmias |
Q69900293 | Dynorphin A immunoreactivity in human cerebrospinal fluid |
Q67523583 | Dynorphin B-like immunoreactivity in gastroduodenal biopsy specimens from gallstone patients |
Q42437650 | EPYLRFamide-mediated reduction of acetylcholine-induced inward currents in Helix lucorum-identified neurones: role of NAADP-dependent and IP3-dependent Ca2+ release from internal stores, calmodulin and Ca2+/calmodulin-dependent protein kinase II. |
Q51339617 | Early intervention with liraglutide improves glucose tolerance without affecting islet microcirculation in young Goto-Kakizaki rats. |
Q46401301 | Early life overfeeding decreases acylated ghrelin circulating levels and upregulates GHSR1a signaling pathway in white adipose tissue of obese young mice |
Q44332852 | Early regulation of hypothalamic arcuate nucleus CART gene expression by short photoperiod in the Siberian hamster |
Q45958146 | Ectopic expression of ghrelin affects gastric H(+)-K(+)-ATPase activity and expression of GHR/IGF-1 system in weaned mice. |
Q67488595 | Effect of 80 kDa protein of porcine follicular fluid on gonadotropin stimulated progesterone production in rat granulosa cells in vitro |
Q48163361 | Effect of ANEPIII, a novel recombinant neurotoxic polypeptide, on sodium channels in primary cultured rat hippocampal and cortical neurons |
Q77512793 | Effect of BIBP3226 on inositol phosphate accumulation and cytosolic calcium level in control and NPY Y1 receptor expressing CHO-K1 cells |
Q72099903 | Effect of CP-96,345 a non-peptide substance P antagonist, capsaicin, resiniferatoxin and ruthenium red on nociception |
Q46368090 | Effect of CP-96,345 on the [Met5]enkephalin washout withdrawal response of the guinea-pig isolated ileum |
Q51622506 | Effect of D-Ala-D-beta Nal-Ala-Trp-D-Phe-Lys-NH2 (KP-102) on GH secretion in urethan-anesthetized rats. |
Q47744476 | Effect of GIP, GLP-1, insulin and gastrin on ghrelin release in the isolated rat stomach |
Q45234056 | Effect of GLP-1 on glucose transport and its cell signalling in human myocytes. |
Q73246730 | Effect of L364718 on interdigestive pancreatic exocrine secretion and gastroduodenal motility in conscious sheep |
Q42169959 | Effect of PACAP on LH release studied by cell immunoblot assay depends on the gender, on the time of day and in female rats on the day of the estrous cycle |
Q71367151 | Effect of [1-Sar,8-Thr]-angiotensin II on the hyperglycemic response to hemorrhage in adrenodemedullated and guanethidine-treated rats |
Q42506128 | Effect of [D-Trp6]LHRH infusion on prolactin secretion by perifused rat pituitary cells |
Q67239483 | Effect of a test meal, duodenal acidification, and tetragastrin on the plasma concentration of β-endorphin-like immunoreactivity in man |
Q45151332 | Effect of acetic acid or trypsin application on rat colonic motility in vitro and modulation by two synthetic fragments of chromogranin A. |
Q46053036 | Effect of acidosis on the mechanism(s) of insulin-induced vasorelaxation in normal Wistar-Kyoto (WKY) rat aorta |
Q70582595 | Effect of adding albumin to solutions of cholecystokinin on pancreatic protein output and pancreatic polypeptide release |
Q46520447 | Effect of adrenomedullin and proadrenomedullin N-terminal 20 peptide on sugar transport in the rat intestine |
Q44077200 | Effect of age on alpha-calcitonin gene-related peptide-mediated delayed cardioprotection induced by intestinal preconditioning in rats |
Q28338488 | Effect of an anti-substance P serum on prolactin and gonadotropins in hyperprolactinemic rats |
Q70187766 | Effect of angiotensin II on ACTH release in vivo: role of corticotropin-releasing factor |
Q44313952 | Effect of angiotensin II on rhythmic per2 expression in the suprachiasmatic nucleus and heart and daily rhythm of activity in Wistar rats |
Q48353925 | Effect of angiotensin-(1-7) on ATPase activities in several tissues |
Q69444744 | Effect of antibodies to the neuropeptide GRP on distention-induced gastric acid secretion in the rat |
Q72699407 | Effect of antrectomy and drug-induced achlorhydria on urinary excretion of N-terminal big gastrin immunoreactivity in rats |
Q70942071 | Effect of antrectomy and truncal vagotomy on erythromycin induced pancreatic polypeptide secretion |
Q69902157 | Effect of atropine and somatostatin on bombesin-stimulated plasma gastrin, cholecystokinin and pancreatic polypeptide in man |
Q69876633 | Effect of atropine on plasma gastrin and somatostatin concentrations during sham feeding in man |
Q67250004 | Effect of beta-endorphin on gastric acid secretion and serum gastrin concentration in humans |
Q47871668 | Effect of bombesin at low doses on the secretion of the exocrine pancreas and on plasma gastrin concentration in the conscious pig. |
Q51657913 | Effect of bombesin upon plasma somatostatin-like immunoreactivity, insulin and glucagon in normal and chemically sympathectomized dogs. |
Q48891849 | Effect of brain angiotensin II AT1, AT2, and cholinergic receptor antagonism on drinking in water-deprived rats |
Q30671966 | Effect of calcitonin gene related peptide on the adenylate cyclase activity in abalone gill membranes |
Q68131329 | Effect of calcitonin gene-related peptide on glucose and gastric inhibitory polypeptide-stimulated insulin release from cultured newborn and adult rat islet cells |
Q73695544 | Effect of calcitonin gene-related peptide, neuropeptide Y, substance P, and vasoactive intestinal peptide on interleukin-1beta, interleukin-6 and tumor necrosis factor-alpha production by peripheral whole blood cells from rheumatoid arthritis and os |
Q39226033 | Effect of capsaicin and resiniferatoxin on peptidergic neurons in cultured dorsal root ganglion |
Q71774471 | Effect of castration on the VIPergic innervation and 125I-labelled vasoactive intestinal peptide (VIP) binding sites in the hamster seminal vesicle. A quantitative immunohistochemical and receptor autoradiographic study |
Q70070690 | Effect of central hypertonic stimulation on plasma atrial natriuretic peptide and oxytocin in conscious rats |
Q31095221 | Effect of central thyrotropin-releasing hormone on pancreatic blood flow in rats |
Q49048312 | Effect of cerebral ventricles perfusion with naloxone on trigemino-hypoglossal reflex in rats |
Q73629317 | Effect of cholecystokinin and gastrin on human peripheral blood lymphocyte functions, implication of cyclic AMP and interleukin 2 |
Q48494009 | Effect of cholecystokinin on feeding is attenuated in monosodium glutamate obese mice. |
Q44112099 | Effect of cholecystokinin receptor antagonists, MK-329 and L-365,260, on cholecystokinin-induced acid secretion and histidine decarboxylase activity in the rat. |
Q42526413 | Effect of chronic administration of a new potent agonist of GH-RH(1-29)NH2 on linear growth and GH responsiveness in rats |
Q44342815 | Effect of chronic administration of dihydropyridine Ca2+ channel ligands on sufentanil-induced tolerance to mu- and kappa-opioid agonists in the guinea pig ileum myenteric plexus |
Q42003186 | Effect of chymotrypsin on human cholecystokinin release: use of clostripain in the validation of a new radioimmunoassay |
Q69925379 | Effect of cimetidine, ranitidine and omeprazole on postprandial gastrin and somatostatin release in conscious dogs |
Q47871745 | Effect of continuous infusion of vasopressin on glomerular growth response in spontaneously hypertensive rats |
Q69842078 | Effect of cyclic nucleotides on bombesin-evoked gastrin release from isolated perfused rat stomach |
Q43324253 | Effect of daily pretrial injection of oxytocin on rat behavior in the open-field situation |
Q42994831 | Effect of dendroaspis natriuretic peptide (DNP) on L-type calcium channel current and its pathway |
Q46520464 | Effect of des-aspartate-angiotensin I on the actions of angiotensin II in the isolated renal and mesenteric vasculature of hypertensive and STZ-induced diabetic rats |
Q72721235 | Effect of deuterium oxide on gastrin release from rat antral mucosal fragments |
Q35613295 | Effect of dietary fatty acid composition on food intake, triglycerides, and hypothalamic peptides |
Q68494719 | Effect of different calcium modulators on motilin-induced contractions of the rabbit duodenum. Comparison with acetylcholine |
Q70581490 | Effect of difluoromethylornithine on atrial natriuretic peptide in rat atria |
Q70265799 | Effect of endogenous gastric inhibitory polypeptide (GIP) on the removal of triacylglycerol in dogs |
Q72246357 | Effect of endogenous opioids on vagally induced release of gastrin, somatostatin and bombesin-like immunoreactivity from the perfused rat stomach |
Q59874085 | Effect of enterostatin given intravenously and intracerebroventricularly on high-fat feeding in rats |
Q36747556 | Effect of epidermal growth factor, transforming growth factor alpha and nerve growth factor on gastric mucosal integrity and microcirculation in the rat. |
Q70158970 | Effect of erythromycin and of octreotide on motilin receptor density in the rabbit |
Q51351709 | Effect of exenatide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects. |
Q46448933 | Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes |
Q46356745 | Effect of exendin-4 treatment upon glucose uptake parameters in rat liver and muscle, in normal and type 2 diabetic state. |
Q44643687 | Effect of exogenous cholecystokinin on islet blood flow in anesthetized rats |
Q35165388 | Effect of extracellular and intracellular angiotensins on heart cell function; on the cardiac renin-angiotensin system |
Q42493494 | Effect of extracellular calcium depletion on the two-step ANP secretion in perfused rabbit atria |
Q69368054 | Effect of gamma-aminobutyric acid on bombesin-evoked release of somatostatin and gastrin from isolated rat stomach |
Q69861388 | Effect of gastrointestinal hormones on choleresis from the isolated perfused rat liver |
Q53587788 | Effect of ghrelin administration on phagocytic activity in acute cold-restraint stress exposed rats. |
Q50917034 | Effect of ghrelin on gastric myoelectric activity and gastric emptying in rats. |
Q70217477 | Effect of glucagon-like peptide-1 on insulin secretion |
Q58447773 | Effect of glucagon-like peptide-2 exposure on bone resorption: Effectiveness of high concentration versus prolonged exposure |
Q54163959 | Effect of histamine and cimetidine on amino acid meal-stimulated gastrin release at a controlled intragastric pH in healthy human beings. |
Q48868884 | Effect of hypothalamus lesions on the presence of CRF-immunoreactive nerve terminals in the median eminence and on the pituitary-adrenal response to stress |
Q43580592 | Effect of immobilization stress on neuropeptides and their receptors in rat central nervous system |
Q69444747 | Effect of immunoneutralisation of cholecystokinin on bombesin-stimulated pancreatic enzyme secretion in the rat |
Q70184595 | Effect of indomethacin and propranolol on the blood pressure and renin response to atriopeptin III in conscious rats |
Q42811462 | Effect of insulin detemir, compared to human insulin, on 3T3-L1 adipogenesis |
Q46791738 | Effect of intraperitoneal CCK-8 on food intake and brain orexin-A after 48 h of fasting in the rat. |
Q73954476 | Effect of islet amyloid polypeptide on somatostatin inhibition of insulin secretion from isolated rat pancreatic islets |
Q42462945 | Effect of jejunoileal bypass in the rat on the enteroinsular axis. |
Q70177053 | Effect of kassinin, neurokinin A and neurokinin B on drinking behaviour in the pigeon |
Q40657258 | Effect of leptin in proliferating and differentiated HC11 mouse mammary cells. |
Q43546801 | Effect of leptin on insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat. |
Q44520867 | Effect of leptin on the acute feeding-induced hypothalamic serotonergic stimulation in normal rats |
Q42540198 | Effect of lintitript, a new CCK-A receptor antagonist, on gastric emptying of a solid-liquid meal in humans |
Q68797587 | Effect of lipoproteins and growth factors on the proliferation of BHK-21 cells in serum free culture |
Q93583856 | Effect of medium-chain triglycerides and long-chain triglycerides on plasma pancreatic polypeptide secretion in man |
Q43192629 | Effect of melatonin supplementation on plasma vasopressin response to different conditions in rats with hyperthyroidism induced by L-thyroxine |
Q52540793 | Effect of middle cerebral artery occlusion on the passage of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier in the rat. |
Q51571053 | Effect of modulating voltage-dependent calcium channels on cholecystokinin and acetylcholine-induced contractions of the guinea pig gallbladder. |
Q43116896 | Effect of naloxone on the inhibitory effect of melatonin on the release of arginine-vasopressin induced by physical exercise in man. |
Q57085062 | Effect of nedocromil sodium on non-adrenergic, non-cholinergic neural responses in guinea pig bronchi in vitro |
Q81901806 | Effect of neuropeptide B on feeding behavior is influenced by endogenous corticotropin-releasing factor activities |
Q69628176 | Effect of neurotensin and neurotensin fragments on gastric acid secretion in man |
Q32078816 | Effect of nitric oxide on basal and stretch-induced release of atrial natriuretic factor (ANF) from isolated perfused rat atria |
Q48742472 | Effect of nitric oxide synthase inhibition on plasma motilin release in fasted dogs |
Q45112795 | Effect of nutritional rehabilitation on circulating ghrelin and growth hormone levels in patients with anorexia nervosa |
Q46387357 | Effect of obestatin on insulin, glucagon and somatostatin secretion in the perfused rat pancreas |
Q93639154 | Effect of oral nalmefene, an opiate-receptor antagonist, on meal-stimulated gastric acid secretion and serum gastrin concentration in man |
Q42527950 | Effect of oxytocin on growth hormone release in vitro |
Q42496845 | Effect of pancreastatin on pancreatic endocrine function in the conscious rat. |
Q41321973 | Effect of pancreatic enzyme supplementation on postprandial plasma cholecystokinin secretion in patients with pancreatic insufficiency |
Q46192117 | Effect of pancreatic polypeptide on the motility of the guinea-pig small intestine in vitro |
Q71241838 | Effect of peptide YY on gastric motor and secretory activity in vagally innervated and denervated corpus pouch dogs |
Q77512777 | Effect of peripheral axotomy on dorsal root ganglion neuron phenotype and autonomy behaviour in neuropeptide Y-deficient mice |
Q46615651 | Effect of peripherally administered ghrelin on gastric emptying and acid secretion in the rat. |
Q33442235 | Effect of peripherally-injected glucagon-like peptide-1 on gastric mucosal blood flow |
Q72495920 | Effect of physiological increments of blood glucose on plasma somatostatin and pancreatic polypeptide levels in dogs |
Q33301836 | Effect of pituitary adenylate cyclase-activating polypeptide (PACAP) on prolactin and somatolactin release from the goldfish pituitary in vitro |
Q42169885 | Effect of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38) on tissue oxygen content--treatment in central nervous system of mice. |
Q48152015 | Effect of ppMCH derived peptides on PBMC proliferation and cytokine expression |
Q71371301 | Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog |
Q67690056 | Effect of prolonged administration of long-acting somatostatin on caerulein, CCK-8 and GRP induced pancreatic growth in the rat |
Q37154450 | Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans |
Q73410276 | Effect of recombinant human interleukin-11 on motilin and substance P release in normal and inflamed rabbits |
Q68948674 | Effect of regulatory polypeptides on the substance P stimulated lower esophageal sphincter pressure in pigs |
Q71507385 | Effect of renin-angiotensin inhibition on glomerular injuries in DOCA-salt hypertensive rats |
Q45961848 | Effect of renoguanylin on hydrogen/bicarbonate ion transport in rat renal tubules. |
Q81009903 | Effect of reserpine on the generation of the chromogranin A-derived neuropeptide WE-14 in rat oxyntic mucosa |
Q69513877 | Effect of secretin and caerulein on pancreatic polypeptide and on insulin secretion from the isolated perfused ventral area of the rat pancreas |
Q53873594 | Effect of sensitization on somatostatin concentration and binding in cytosol from guinea pig airways. |
Q48168146 | Effect of short- and long-term physical activities on circulating granin protein levels |
Q68984012 | Effect of somatocrinin and a somatostatin antiserum on duodenal and gastric growth in the rat |
Q41457402 | Effect of somatostatin and two of its analogues on basal and arginine-stimulated insulin and glucagon secretion in the dog. |
Q51653706 | Effect of somatostatin on intestinal absorption of nutrients in the rat |
Q72526989 | Effect of somatostatin on the secretin-induced gastric secretions of pepsin and mucus in cats |
Q71644376 | Effect of splanchnic nerve section and compensatory adrenal hypertrophy on rat adrenal neuropeptide content |
Q42017250 | Effect of starvation on endocrine cells in the rat stomach |
Q46719733 | Effect of subchronic administration of tachykinin antagonists on response of guinea-pigs to mild and severe stress. |
Q72099745 | Effect of substance P on the expression of an adhesion molecule ICAM-1 in human vascular endothelial cells |
Q42974637 | Effect of supra-physiological dose administration of rhGH on pituitary-thyroid axis in healthy male athletes |
Q83115368 | Effect of sympathectomy and demedullation on increased myenteric and dorsal vagal complex Fos-like immunoreactivity by cholecystokinin-8 |
Q51660618 | Effect of tachykinins on the acetylcholine output stimulated by nicotine from guinea-pig bladder |
Q48153711 | Effect of the brain and suboesophageal ganglion on pupal development in Helicoverpa armigera through regulation of FXPRLamide neuropeptides |
Q46396612 | Effect of the nonpeptide NK-1 receptor antagonist CP-96,345 on the morphine withdrawal response of guinea-pigs |
Q67696497 | Effect of the specific cholecystokinin-receptor antagonist loxiglumide on bombesin stimulated pancreatic enzyme secretion in man |
Q60774386 | Effect of three galanin antagonists on the pressor response to galanin in the Cane toad, Bufo marinus |
Q48861178 | Effect of thyroid hormones on pituitary neuromedin B and possible interaction between thyroid hormones and neuromedin B on thyrotropin secretion |
Q72265283 | Effect of thyroid hormones on vasoactive intestinal polypeptide gene expression in the rat cerebral cortex and anterior pituitary |
Q49060425 | Effect of thyrotropin-releasing hormone on immune functions of peripheral blood mononuclear cells |
Q47376157 | Effect of total colectomy and PYY infusion on food intake and body weight in rats. |
Q53739382 | Effect of truncal vagotomy on intestinal phase of pancreatic polypeptide release in dogs. |
Q70163321 | Effect of truncal vagotomy on pancreatic polypeptide response after intravenous glucose administration |
Q44397764 | Effect of ulcerative colitis treatment on transforming growth factor beta(1) in plasma and rectal mucosa |
Q69921036 | Effect of vagotomy and atropine on plasma somatostatin response to a meal in conscious dogs |
Q52191809 | Effect of vasoactive intestinal peptide (VIP) on cytokine production and expression of VIP receptors in thymocyte subsets. |
Q43704680 | Effect of vasoactive intestinal polypeptide (VIP) on steroidogenesis in women |
Q70184599 | Effect of vasoactive intestinal polypeptide on the cyclic adenosine monophosphate generating system in rat kidney glomeruli and cortical tubules |
Q69930706 | Effect of vasopressin on the induction of adrenal tyrosine hydroxylase and phenylethanolamine N-methyltransferase |
Q46765993 | Effect of vasopressin on type IV collagen production in human mesangial cells |
Q48810712 | Effect of water deprivation, desmopressin (DDAVP) infusion, and oral loads of water, Na+ and NH4+ on urinary excretion of epidermal growth factor in the rat. |
Q40510527 | Effects and mechanisms of action of endothelins on non-vascular smooth muscle of the respiratory, gastrointestinal and urogenital tracts. |
Q41435190 | Effects of BIM26226, a potent and specific bombesin receptor antagonist, on amylase release and binding of bombesin-like peptides to AR4-2J cells |
Q48891814 | Effects of DOCA pretreatment on neuronal sensitivity and cell responsiveness to angiotensin II, in the bed nucleus of the stria terminalis in the rat. |
Q46107749 | Effects of Dendroaspis natriuretic peptide on delayed rectifier potassium currents and its mechanism |
Q44016655 | Effects of ECL cell extracts and granule/vesicle-enriched fractions from rat oxyntic mucosa on cAMP and IP(3) in rat osteoblast-like cells |
Q47885784 | Effects of OPC-21268, a vasopressin V1-receptor antagonist, on expression of growth factors from glomeruli in spontaneously hypertensive rats |
Q40497642 | Effects of PACAP on in vitro and in vivo neuronal cell death, platelet aggregation, and production of reactive oxygen radicals. |
Q67249990 | Effects of PHI on vasoactive intestinal peptide receptors and adenylate cyclase activity in lung membranes. A comparison in man, rat, mouse and guinea pig |
Q44591814 | Effects of VIP, PHM and substance P on blood vessels and secretory elements of the human submandibular gland |
Q44878428 | Effects of a chromogranin-derived peptide (CgA 47-66) in the writhing nociceptive response induced by acetic acid in rats |
Q38596544 | Effects of a long-acting LHRH agonist preparation on plasma gonadotropin and prolactin levels in castrated male rats and on the release of prolactin from ectopic pituitaries |
Q70545501 | Effects of a physiological dose of cholecystokinin on food intake and postprandial satiation in man |
Q72690811 | Effects of acute and chronic administration of secretin and caerulein on rat duodenal and gastric growth |
Q83961042 | Effects of acute and chronic relaxin-3 on food intake and energy expenditure in rats |
Q77763739 | Effects of acute stress on the contents of catecholamines and neuropeptides in chromaffin tissues of the newborn rabbit |
Q41357487 | Effects of adrenalectomy and aldosterone on the action of centrally administered rat atrial natriuretic peptide-(99-126). |
Q48187162 | Effects of adrenergic blockers on corticotropin-releasing factor-induced behavioral changes in rats |
Q44980547 | Effects of adrenomedullin on cell proliferation in rat adventitia induced by lysophosphatidic acid |
Q73689729 | Effects of aging and caloric restriction on IGF-I, IGF-I receptor, IGFBP-3 and IGFBP-4 gene expression in the rat stomach and colon |
Q44788422 | Effects of alpha calcitonin gene-related peptide in human bronchial smooth muscle and pulmonary artery |
Q46765544 | Effects of amylin on feeding of goldfish: interactions with CCK. |
Q48359500 | Effects of an antisense oligodeoxynucleotide for neuropeptide Y mRNA on in vivo luteinizing hormone-releasing hormone release in ovariectomized female rhesus monkeys |
Q48432885 | Effects of angiotensin II and its selective antagonists on inferior olivary neurones |
Q45274642 | Effects of angiotensin II type 1 receptor blockade on the oxidative stress in spontaneously hypertensive rat tissues |
Q42086362 | Effects of angiotensin analogues and angiotensin receptor antagonists on paraventricular neurones |
Q44788428 | Effects of angiotensin and vasopressin V(1) receptors on water and sodium intake induced by injection of vasopressin into lateral septal area. |
Q42437071 | Effects of atrial natriuretic factor on glucose metabolism in isolated adipocytes |
Q45127802 | Effects of atrial natriuretic factor on norepinephrine release in the rat hypothalamus |
Q40381465 | Effects of azathioprine and its metabolites on repair mechanisms of the intestinal epithelium in vitro |
Q48221502 | Effects of bestatin on the central cardiovascular regulatory mechanisms in the rat. |
Q51660449 | Effects of bradykinin on the canine proximal colon. |
Q70235239 | Effects of caerulein and bombesin on insulin and glucagon secretion from the isolated, perfused rat pancreas |
Q70463392 | Effects of caerulein on rat small and large intestinal fluid transport in vivo |
Q74419541 | Effects of calcitonin gene-related peptide on somatostatin and gastrin gene expression in rat antrum |
Q43242122 | Effects of cefaclor on gastric emptying and cholecystokinin release in healthy humans |
Q48450227 | Effects of central infusion and immunoneutralization of growth hormone on the timing of puberty and plasma leptin levels in the female rat. |
Q48583499 | Effects of central injection of L-carnosine on sympathetic nerve activity innervating brown adipose tissue and body temperature in rats |
Q28567270 | Effects of central neuromedin B and related peptides on blood glucose |
Q74248446 | Effects of centrally or systemically injected glucagon-like peptide-1 (7-36) amide on release of neurohypophysial hormones and blood pressure in the rat |
Q80345663 | Effects of cholecystokinin and bombesin on the expression of preprosomatostatin-encoding genes in goldfish forebrain |
Q70942088 | Effects of cholecystokinin and glucagon-like peptide 1 on the secretion of pancreatic polypeptide in mice |
Q69532680 | Effects of cholecystokinin octapeptide and carbachol on neonatal insulin secretory dynamics |
Q41660160 | Effects of cholecystokinin on cytosolic calcium in human pancreatic cancer cells |
Q79824576 | Effects of cholecystokinin-8 induced gastric dysmotility on bile regurgitation during stress and molecular mechanisms |
Q41288288 | Effects of cholera toxin, Escherichia coli heat stable toxin and sodium deoxycholate on neurotensin release from the ileum in vivo |
Q72677409 | Effects of chronic administration of somatostatin on rat exocrine pancreas |
Q48831316 | Effects of chronic central administration of losartan on the cardiovascular and hormonal responses to hemorrhage in conscious rats |
Q50700737 | Effects of chronic glucagon-like peptide-2 therapy during weaning in neonatal pigs. |
Q44344032 | Effects of chronic treatment with atypical neuroleptics on the biosynthesis and release of opioid peptides in guinea-pig ileum |
Q45068887 | Effects of cocaine-amphetamine regulated transcript (CART) on hormone release |
Q46474385 | Effects of cold exposure, exogenous melatonin and short-day treatment on the weight-regulation and body temperature of the Siberian hamster (Phodopus sungorus). |
Q44842784 | Effects of combined secretagogues and extracellular calcium on neonatal insulin release |
Q48858982 | Effects of cortisol treatment on brain and adrenal corticotropin-releasing hormone (CRH) content and other parameters regulated by CRH. |
Q72706903 | Effects of cysteamine on pro-somatostatin related peptides |
Q53830291 | Effects of dehydration on renal aminopeptidase activities in adult male and female rats. |
Q53753127 | Effects of dermorphin on gastrointestinal transit in rats. |
Q73150067 | Effects of des-aspartate-angiotensin I on angiotensin II-induced incorporation of phenylalanine and thymidine in cultured rat cardiomyocytes and aortic smooth muscle cells |
Q47235543 | Effects of des-aspartate-angiotensin I on neointima growth and cardiovascular hypertrophy |
Q47394925 | Effects of des-aspartate-angiotensin I on the actions of angiotensin III in the renal and mesenteric vasculature of normo- and hypertensive rats |
Q54732018 | Effects of des-aspartate-angiotensin I on the expression of angiotensin AT1 and AT2 receptors in ventricles of hypertrophic rat hearts. |
Q50897245 | Effects of dexamethasone on the profile of cytokine secretion in human whole blood cell cultures. |
Q31943825 | Effects of dopamine and dopamine-active compounds on oxytocin and vasopressin production in rat neurohypophyseal tissue cultures |
Q114684098 | Effects of duodenal acidification on secretin, motilin, somatostatin and vasoactive intestinal peptide in the anesthetized pig |
Q68821619 | Effects of enterally fed epidermal growth factor on the small and large intestine of the suckling rat |
Q72837513 | Effects of epidermal growth factor on gluconeogenesis and cellular redox state do not require Na+/H+ exchange or Na+/K(+)-ATPase activities |
Q46034630 | Effects of exogenous vasoactive intestinal peptide on mesenteric lymph pathway during early intestinal ischemia-reperfusion injury in rats. |
Q45017730 | Effects of felodipine combined with puerarin on ACE2-Ang (1-7)-Mas axis in renovascular hypertensive rat. |
Q46311670 | Effects of fixation for immunohistochemistry on tissue concentrations of substance P and somatostatin determined by radioimmunoassay |
Q70942060 | Effects of galanin on proinsulin mRNA and insulin biosynthesis in normal islets |
Q73150031 | Effects of galanin on wide-dynamic range neuron activity in the spinal dorsal horn of rats with sciatic nerve ligation |
Q46087107 | Effects of galanin-monoaminergic interactions on vasopressin secretion in rat neurohypophyseal cell cultures. |
Q46969316 | Effects of ghrelin on glucose-sensing and gastric distension sensitive neurons in rat dorsal vagal complex |
Q81201347 | Effects of ghrelin on growth hormone secretion in vivo in ruminants |
Q42458116 | Effects of ghrelin on insulin and glucagon secretion: a study of isolated pancreatic islets and intact mice |
Q80878322 | Effects of ghrelin on the proliferation and secretion of splenic T lymphocytes in mice |
Q72668739 | Effects of growth hormone and IGF-I on glomerular ultrafiltration in growth hormone-deficient rats |
Q42490047 | Effects of growth hormone releasing factor on pancreatic secretion in vivo and in vitro. |
Q74665127 | Effects of guanylin and uroguanylin on rat jejunal fluid and electrolyte transport: comparison with heat-stable enterotoxin |
Q46240960 | Effects of helodermin and VIP on insulin and glucagon secretion in the mouse |
Q44921536 | Effects of high-fat feeding and fasting on ghrelin expression in the mouse stomach |
Q93677273 | Effects of hormones (calcitonin, GIP) and pharmacological antagonists (ranitidine and famotidine) on isolated rat parietal cells |
Q43701518 | Effects of hydrosaline treatments on prolyl endopeptidase activity in rat tissues |
Q50487583 | Effects of hypoxia on endothelial/pericytic co-culture model of the blood-brain barrier. |
Q42169915 | Effects of in ovo treatment with PACAP antagonist on general activity, motor and social behavior of chickens |
Q47744506 | Effects of insulin, leptin, and glucagon on ghrelin secretion from isolated perfused rat stomach |
Q47319623 | Effects of interleukin-1 beta fragment (163-171) on progesterone and estradiol-17 beta release by bovine granulosa cells from different size follicles |
Q72265286 | Effects of intracerebral injections of VIP on jejunal alanine absorption and gastric acid secretion in rats |
Q72713170 | Effects of intracerebroventricular administration of neurotensin, substance P and calcitonin on gastrointestinal motility in normal and vagotomized rats |
Q45926063 | Effects of intracerebroventricular administration of the NPY-Y1 receptor antagonist, 1229U91, on hyperphagic and glycemic responses to acute and chronic intermediate insulin-induced hypoglycemia in female rats. |
Q71742124 | Effects of intracerebroventricular injections of losartan or PD123319 on arterial pressure and heart rate of sodium replete and sodium deplete rats |
Q44753730 | Effects of intracerebroventricularly injected glucagon-like peptide-1 on cardiovascular parameters; role of central cholinergic system and vasopressin |
Q77763734 | Effects of intraduodenal administration of tarazepide on pancreatic secretion and duodenal EMG in neonatal calves |
Q58447856 | Effects of intravenous infusions of PYY3-36 and GLP-1, as monoinfusion and in combination, on ad libitum energy intake in healthy obese subjects |
Q72265285 | Effects of intravenous vasoactive intestinal peptide injection on jejunal alanine absorption and gastric acid secretion in rats |
Q41636223 | Effects of intravenously administered Leu- or Met-enkephalin on arterial blood pressure |
Q48105295 | Effects of intraventricular administration of neuropeptide Y on feeding behavior in fasted female rats with ventromedial hypothalamic lesions |
Q48250738 | Effects of l-glutamate, substance P and substance P(1–7) on cardiovascular regulation in the nucleus tractus solitarius |
Q48377906 | Effects of lipopolysaccharide on neurokinin A content and release in the hypothalamic-pituitary axis |
Q43650443 | Effects of lixisenatide once daily on gastric emptying in type 2 diabetes--relationship to postprandial glycemia |
Q47871689 | Effects of long term treatment with corticotropin releasing factor on corticotropic tumor cells in vitro |
Q38310387 | Effects of losartan on angiotensin receptors in the hypertrophic rat heart |
Q48710338 | Effects of mammalian and avian neurotensins and neurotensin fragments on wet-dog shaking and body temperature in the rat. |
Q28573497 | Effects of maternal captopril treatment during late pregnancy on neonatal lung development in rats |
Q47393752 | Effects of maternal leptin treatment during lactation on the body weight and leptin resistance of adult offspring. |
Q46658165 | Effects of mid-jejunal compared to duodenal glucose infusion on peptide hormone release and appetite in healthy men. |
Q44306512 | Effects of morphine administration and its withdrawal on rat brain aminopeptidase activities |
Q68984009 | Effects of neurokinin A and calcitonin gene-related peptide on mucociliary activity in rabbit maxillary sinus |
Q70942109 | Effects of neuropeptide FF analogs on morphine analgesia in the nucleus raphe dorsalis |
Q44922783 | Effects of neuropeptide Y and noradrenaline on uterine artery blood pressure and blood flow velocity in the pregnant guinea-pig |
Q69592976 | Effects of neuropeptides on gastric acid and duodenal bicarbonate secretions in freely moving rats |
Q71363378 | Effects of neuropeptides on growth of cultivated rat molar pulp fibroblasts |
Q48491198 | Effects of neurotensin on caudate nucleus protein phosphorylation |
Q70526718 | Effects of neurotensin on small bowel propulsion in intact and vagotomized rats |
Q69432621 | Effects of nonapeptide antagonists on oxytocin- and arginine-vasopressin-induced analgesia in mice |
Q67464110 | Effects of noradrenaline and galanin on duodenal motility in the isolated perfused porcine pancreatico-duodenal block |
Q44352864 | Effects of opioid peptides on synaptic potentials in explants of rat hippocampus |
Q40752526 | Effects of orexin on cultured porcine adrenal medullary and cortex cells |
Q48691108 | Effects of orexin-monoaminergic interactions on oxytocin secretion in rat neurohypophyseal cell cultures. |
Q42717187 | Effects of orexins A and B on expression of orexin receptors and progesterone release in luteal and granulosa ovarian cells |
Q51544996 | Effects of orexins on energy balance and thermoregulation. |
Q42481835 | Effects of oxytocin on in vivo release of insulin and glucagon studied by microdialysis in the rat pancreas and autoradiographic evidence for [3H]oxytocin binding sites within the islets of Langerhans |
Q37386394 | Effects of pH and temperature on photoaffinity labeling of Family B G protein-coupled receptors |
Q67922880 | Effects of pancreastatin and chromogranin A on insulin release stimulated by various insulinotropic agents |
Q71644394 | Effects of pancreastatin and somatostatin on secretagogues-induced rise in intracellular free calcium in single rat pancreatic islet cells |
Q68719698 | Effects of pancreatic polypeptide on biliary flow and bile acid secretion stimulated by secretin and cholecystokinin in the conscious pig |
Q69643829 | Effects of pancreatic polypeptide on the pancreatic exocrine secretion stimulated by secretin and cholecystokinin in the conscious pig |
Q69958137 | Effects of peptide YY on intestinal blood flow distribution and motility in the dog |
Q60731317 | Effects of peptide histidine methionine (PHM) infusions on ileostomy output |
Q52138938 | Effects of peripherally injected pituitary peptides on recognition memory in pigeons. |
Q41500452 | Effects of peripherally injected vasopressin and des-glycinamide vasopressin on the extinction of a spatial learning task in rats |
Q46951032 | Effects of pinealectomy and exogenous melatonin on ghrelin and peptide YY in gastrointestinal system and neuropeptide Y in hypothalamic arcuate nucleus: immunohistochemical studies in male rats |
Q72657648 | Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the cardiovascular system |
Q42169892 | Effects of pituitary adenylate cyclase activating polypeptide in a rat model of traumatic brain injury |
Q45244174 | Effects of pituitary adenylate cyclase polypeptide (PACAP) on extinction of active avoidance learning in rats: involvement of neurotransmitters |
Q51585190 | Effects of pituitary adenylate cyclase-activating polypeptide on cardiovascular and respiratory responses in anaesthetised dogs. |
Q42465957 | Effects of porcine diazepam-binding inhibitor on insulin and glucagon secretion in vitro from the rat endocrine pancreas |
Q68165357 | Effects of proglumide on pancreatic endocrine and exocrine function in healthy humans |
Q72565577 | Effects of prostaglandin E2 and D2 on gastric somatostatin and gastrin secretion |
Q44324342 | Effects of rat and chicken calcitonin gene-related peptides (CGRP) upon calcium metabolism in chicks |
Q72679988 | Effects of regulatory peptides on the porcine lower oesophageal sphincter |
Q43878315 | Effects of restricted feeding on the activity of hypothalamic Orexin (OX)-A containing neurons and OX2 receptor mRNA level in the paraventricular nucleus of rats |
Q41520190 | Effects of serum and insulin-like growth factors on human neuroblastoma cell growth |
Q72930976 | Effects of solution of low pH and taurocholate on release of beta-endorphin-like immunoreactivity from human duodenal mucosa in vitro |
Q48250673 | Effects of subacute repeated injections of phencyclidine and MK-801 on substance P content in the rat brain |
Q69067217 | Effects of substance P, calcitonin gene-related peptide and capsaicin on tension and membrane potential of pig coronary artery in vitro |
Q46483283 | Effects of sucrose, glucose and fructose on peripheral and central appetite signals |
Q68948682 | Effects of tachykinins on the electrical activity of isolated canine tracheal epithelium: an exploratory study |
Q43286294 | Effects of the LHRH antagonist Cetrorelix on affective and cognitive functions in rats |
Q39867194 | Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity |
Q72591266 | Effects of the enkephalin analog (D-Met2,Pro5)-enkephalinamide on alpha-melanocyte-stimulating hormone secretion |
Q81305791 | Effects of the neuropeptide secretoneurin on natural killer cell migration and cytokine release |
Q71742145 | Effects of the selective tachykinin NK3 receptor agonist NH2-senktide on intraoral intake and taste reactivity responses elicited by NaCl in sodium-replete rats |
Q72154960 | Effects of three fragments of parathyroid hormone on calcium channel currents in neonatal rat ventricular cells |
Q68108900 | Effects of thyrotropin releasing hormone and its analogues on unconsciousness following head injury in mice |
Q44371087 | Effects of trypsin, thrombin and proteinase-activated receptors on guinea pig common bile duct motility |
Q81103396 | Effects of vasoactive intestinal peptide and galanin on survival of cultured porcine myenteric neurons |
Q44016668 | Effects of vasopressin on isolated rat adrenal chromaffin cells |
Q78162203 | Effects of vasopressin-mastoparan chimeric peptides on insulin release and G-protein activity |
Q72382063 | Effects of α-difluoromethylornithine on pancreatic growth induced by caerulein |
Q46255989 | Effects of β-endorphin, met-enkephalin and somatostatin on the neurotensin-induced neurogenic contraction in the guinea-pig ileum |
Q44921528 | Eight-residue Abeta peptides inhibit the aggregation and enzymatic activity of Abeta42. |
Q58047637 | Electrical stimulation of postganglionic cranial VIP nerve fibers enhances cerebral blood flow |
Q33210388 | Electron microscopy examination of galanin-like peptide (GALP)-containing neurons in the rat hypothalamus |
Q70842033 | Electrophysiological actions of neurotensin in rat cerebellum |
Q44335058 | Electrophysiological effects of opioid receptor selective agonists on guinea-pig papillary muscle |
Q40469544 | Electrophysiology of intestinal cholecystokinin secretion |
Q69209762 | Elevated VIP and endotoxin plasma levels in human gram-negative septic shock |
Q46073321 | Elevated expression of urotensin II and its receptor in skeletal muscle of diabetic mouse |
Q70775725 | Elevated levels of circulating pancreatic polypeptide in inflammatory and infectious disorders |
Q48707107 | Elevated levels of natriuretic peptides in lungs of hamsters with genetic cardiomyopathy |
Q51614331 | Elevated plasma levels of pancreastatin (PST) in patients with non-insulin-dependent diabetes mellitus (NIDDM). |
Q52578908 | Elevated renal norepinephrine in proANP gene-disrupted mice is associated with increased tyrosine hydroxylase expression in sympathetic ganglia. |
Q68792692 | Elevated serum gastrin after food intake or acid blockade evokes hypocalcemia |
Q46553614 | Elevation of plasma cholecystokinin (CCK) immunoreactivity by fat, protein, and amino acids in the cat, a carnivore |
Q71809296 | Elevation of plasma gastrin and pancreatic polypeptide by electrical vagal stimulation in sheep: effects of sequential stimulation |
Q71603483 | Elimination of radiolabelled recombinant human insulin-like growth factor binding protein-3 from the circulation, and its distribution amongst organs and tissues in adult male rats |
Q33288697 | Elucidation of the sequence of canine (pro)-calcitonin. A molecular biological and protein chemical approach |
Q33788759 | Emerging features of brain angiotensin receptors |
Q52177328 | Endocrine and behavioral traits in low-avoidance Sprague-Dawley rats. |
Q63283469 | Endocrine cells in the pancreas of the water buffalo |
Q78729824 | Endocrine cells with gastrin/cholecystokinin-like immunoreactivity in the pancreas of the spiny dogfish, Squalus acanthias |
Q48682719 | Endocrine function of neuropeptide Y knockout mice |
Q48109126 | Endocytosis of the vasopressin receptor by anterior pituitary cells is increased by corticotropin-releasing factor (CRF). |
Q47885884 | Endogenous CCK inhibits colonic contractions in unrestrained conscious rats |
Q67584440 | Endogenous CCK is not involved in the regulation of interdigestive gastrointestinal and gallbladder motility in conscious dogs |
Q73197742 | Endogenous adrenomedullin system regulates the growth of rat adrenocortical cells cultured in vitro |
Q37307404 | Endogenous angiotensinergic system in neurons of rat and human trigeminal ganglia |
Q43625217 | Endogenous cholecystokinin plays a role in down-regulation of pancreatic amylase independent of dietary carbohydrate in rats. |
Q44332866 | Endogenous ghrelin is an orexigenic peptide acting in the arcuate nucleus in response to fasting |
Q39851848 | Endogenous hyperinsulinaemia in insulinoma patients is not associated with changes in beta-cell area and turnover in the tumor-adjacent pancreas. |
Q44629196 | Endogenous neuropeptide Y mediates vasoconstriction during endotoxic and hemorrhagic shock |
Q41456260 | Endogenous peptides work at multiple sites in the nervous system in the control of gill behaviors in Aplysia |
Q73053556 | Endogenous prostaglandins are physiological regulators of endocrine cells in the gastroduodenal mucosa of the rat |
Q72235873 | Endogenous somatostatin possibly controls pancreatic growth: further evidence for feedback regulation |
Q46750060 | Endogenous vasoactive intestinal peptide (VIP) regulates somatostatin secretion by cultured fetal rat cerebral cortical and hypothalamic cells |
Q46932686 | Endomorphin synthesis in rat brain from intracerebroventricularly injected [3H]-Tyr-Pro: a possible biosynthetic route for endomorphins |
Q45930780 | Endothelial dysfunction induced by triglycerides is not restored by exenatide in rat conduit arteries ex vivo. |
Q44397788 | Endothelin ET(A) but not ET(B) receptors mediate contraction of common bile duct |
Q67936609 | Endothelin as a putative sensory neuropeptide in the guinea-pig: different properties in comparison with calcitonin gene-related peptide |
Q44746255 | Endothelin causes contraction of human esophageal muscularis mucosae through interaction with both ETA and ETB receptors |
Q41157603 | Endothelin degradation by vascular smooth muscle cells |
Q42437068 | Endothelin expression in human megakaryoblastic leukemia cell lines and normal platelet precursors |
Q39838334 | Endothelin receptor A expression in human inflammatory cells |
Q32078894 | Endothelin receptors in human and guinea-pig gallbladder muscle. |
Q45244165 | Endothelin receptors in lower esophageal sphincter circular smooth muscle |
Q52287211 | Endothelin-1 and big endothelin-1 levels in normal term pregnancy and in preeclampsia. |
Q42439527 | Endothelin-1 directly modulates its own secretion: studies utilising the cell immunoblot technique |
Q42485906 | Endothelin-1 expression in myenteric neurons cultured from rat small intestine |
Q73521129 | Endothelin-1 increases isoprenaline-enhanced cyclic AMP levels in cerebral cortex |
Q43766128 | Endothelin-1 induces contraction of human and Australian possum gallbladder in vitro |
Q43224009 | Endothelin-1 plasma concentrations in patients with retinitis pigmentosa |
Q44849010 | Endothelin-3 induced mesenteric vasoconstriction and PMN infiltration in the rat small intestine: role of endothelin receptors |
Q42443394 | Endothelin-3 reduces C-type natriuretic peptide-induced cyclic GMP formation in C6 glioma cells |
Q71606202 | Endothelin-A and -B receptors in human coronary arteries and veins |
Q41167463 | Endothelin-mediated constriction of prenodal lymphatic vessels in the canine forelimb |
Q67649882 | Endothelin: a potent stimulator of intestinal ion secretion in vitro |
Q45151341 | Endotoxin administration increases hypothalamic somatostatin mRNA through nitric oxide release |
Q45151364 | Enhanced dermal and retinal vascular permeability in streptozotocin-induced type 1 diabetes in Wistar rats: blockade with a selective bradykinin B1 receptor antagonist |
Q68198653 | Enhanced preservation of endosecretory granules in PP-cells of the canine pancreas |
Q81009918 | Enhanced running wheel activity of both Mch1r- and Pmch-deficient mice |
Q72440603 | Enhancement by streptozotocin-induced diabetes of pancreatic prolyl endopeptidase activity in neonatal rats |
Q46982593 | Enkephalin contents reflect noradrenergic large dense cored vesicle populations in vasa deferentia |
Q68300528 | Enkephalin-like immunoreactivity in ganglionic cells in the larynx and superior cervical ganglion of the rat |
Q51528948 | Enriched protein diet-modified ghrelin expression and secretion in rats. |
Q71672700 | Enteric release of vasoactive intestinal peptide after a peptone meal in the dog |
Q51600174 | Enteroendocrine peptides in a canine model of orthotopic jejunoileal autotransplantation. |
Q40916639 | Enuresis nocturna: long term use and safety aspects of minrin (desmopressin) spray |
Q67977961 | Enzymatic degradation of endothelin-1 by activated human polymorphonuclear neutrophils |
Q36817565 | Enzymatic pathways of the brain renin-angiotensin system: unsolved problems and continuing challenges. |
Q41423788 | Epidermal growth factor (EGF) inhibits both intrinsic factor secretion and acid secretion in histamine-stimulated isolated gastric glands |
Q68251406 | Epidermal growth factor binding to cortical basolateral membranes in compensatory renal hypertrophy |
Q68817828 | Epidermal growth factor in blood |
Q68097181 | Epidermal growth factor in plasma, serum and urine before and after prolonged exercise |
Q70685252 | Epidermal growth factor interferes with the effect of adrenaline on glucose production and on hepatic lipase secretion in rat hepatocytes |
Q53831847 | Epidermal growth factor reactivity in rat milk. |
Q48359530 | Epigenetic factors regulate the NPY expression in rat cortical neurons. |
Q38316016 | Epitope mapping of secreted mouse leptin utilizing peripherally administered synthetic peptides |
Q42089235 | Eplerenone inhibits the intracrine and extracellular actions of angiotensin II on the inward calcium current in the failing heart. On the presence of an intracrine renin angiotensin aldosterone system |
Q46632967 | Equipotent in vitro actions of alpha- and beta-CGRP on guinea pig basilar artery are likely to be mediated via CRLR derived CGRP receptors. |
Q73282403 | Erratum to Abstracts, Neuropeptides 2000 |
Q34316092 | Erythrocyte-based analgesic peptides |
Q46734721 | Erythropoietin acutely decreases airway resistance in the rat. |
Q38342219 | Erythropoietin as a possible mechanism for the effects of intermittent hypoxia on bodyweight, serum glucose and leptin in mice |
Q87340776 | Esmolol activates endogenous neurokinin activity inhibiting infarction-induced arrhythmias in rats: novel mechanisms of anti-arrhythmia |
Q69342009 | Establishment of highly specific radioimmunoassays for neurokinin A and neurokinin B and determination of tissue distribution of these peptides in rat central nervous system |
Q31943852 | Estrogen and androgen influence hypothalamic AVP and CRF concentrations in fetal and adult sheep |
Q48267919 | Estrogen stimulation of galanin gene expression and galanin-like immunoreactivity in the rat and its blockade by the estrogen antagonist keoxifene (LY156758) |
Q28572000 | Estrogen upregulates renal angiotensin II AT1 and AT2 receptors in the rat |
Q44397760 | Ethanol-induced suppression of LTP can be attenuated with an angiotensin IV analog |
Q48859126 | Ethanol-related changes in substance P in the hypothalamus and anterior pituitary |
Q86479304 | Evaluation of melatonin and prostaglandin E1 combination on necrotizing enterocolitis model in neonatal rats |
Q47202521 | Evaluation of new leptin fragments on food intake and body weight of normal rats. |
Q60349695 | Evaluation of salivary endothelin-1 levels in oral squamous cell carcinoma and oral leukoplakia |
Q38394353 | Evaluation of somatostatin receptor subtype expression in human neuroendocrine tumors using two sets of new monoclonal antibodies |
Q44397745 | Evaluation of the site(s) of glycation in human proinsulin by ion-trap LCQ electrospray ionization mass spectrometry |
Q54319364 | Evaluation of thyrotropin releasing hormone as a therapeutic intervention for endotoxemia. |
Q38325525 | Evidence against a direct effect of leptin on insulin-like growth factor-I (IGF-I), IGFBP-2 and IGF-I receptor expression in human SK-N-MC neuroepithelioma cells |
Q69861391 | Evidence against prostaglandin-mediation of somatostatin-inhibition of gastric secretions |
Q46623742 | Evidence for NK-1 receptor subtypes from in vivo bronchopulmonary and cardiovascular studies |
Q54579737 | Evidence for Somatostatin receptor 2 in thyroid tissue. |
Q69081213 | Evidence for a direct trophic effect of bombesin on the mouse pancreas: in vivo and cell culture studies |
Q73367077 | Evidence for a dual function of oxytocin in the control of growth hormone secretion in rats |
Q77123869 | Evidence for a functional hepatocyte growth factor receptor in human mesangial cells |
Q46159120 | Evidence for a modulatory role of orexin A on the nitrergic neurotransmission in the mouse gastric fundus |
Q72565574 | Evidence for a role of endogenous opiates in postprandial somatostatin release |
Q72580920 | Evidence for a role of somatostatin in lipid metabolism of liver and adipose tissue |
Q48284486 | Evidence for a subtype of insulin-like growth factor I receptor in brain |
Q78162207 | Evidence for calcitonin gene-related peptide-mediated ischemic preconditioning in the rat heart |
Q46692558 | Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides |
Q72551961 | Evidence for direct production of somatostatin-14 from a larger precursor than somatostatin-28 in a phaeochromocytoma |
Q44077169 | Evidence for non-neurotensin receptor-mediated effects of xenin (1-25)--focus on intestinal microcirculation |
Q42492284 | Evidence for phosphoramidon-sensitive cleavage of big endothelin-1 involved in endothelin-stimulated hepatic glucose production |
Q69456770 | Evidence for precursors of calcitonin/PDN 21 in human milk |
Q48359519 | Evidence for regulated expression of neuropeptide Y gene by rat and human cultured astrocytes |
Q67884919 | Evidence for secretion of 7B2 by A- and B-cells of hamster pancreatic islets |
Q69881133 | Evidence for somatostatin binding sites in rabbit kidney |
Q44288635 | Evidence for substance P as a functional neurotransmitter in guinea pig small intestinal mucosa |
Q77123851 | Evidence for the involvement of nitric oxide in the inhibitory effect of GSPYFVamide on Helix aspersa central neurones |
Q45151343 | Evidence for the presence of motilin, ghrelin, and the motilin and ghrelin receptor in neurons of the myenteric plexus |
Q72026617 | Evidence for the presence of prolyl oligopeptidase and its endogenous inhibitor in neonatal rat pancreatic beta-cells |
Q58457160 | Evidence for two insulin-like growth factor I receptors with distinct primary structure that are differentially expressed during development |
Q70297715 | Evidence for vasoactive intestinal polypeptide (VIP) altering the firing rate of preoptic, septal and midbrain central gray neurons |
Q38340470 | Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy |
Q44332877 | Evidence on the presence of secretin cells in the gastric antral and oxyntic mucosa |
Q73532155 | Evidence that NPY Y1 receptors are involved in stimulation of feeding by orexins (hypocretins) in sated rats |
Q113188361 | Evidence that PC2 is the endogenous pro-neurotensin convertase in rMTC 6–23 cells and that PC1- and PC2-transfected PC12 cells differentially process proneurotensin with intestinal and brain phenotypes, respectively |
Q42435920 | Evidence that bombesin releases extragastric gastrin in man. |
Q43769990 | Evidence that calcitonin gene-related peptide contributes to the capsaicin-induced relaxation of guinea pig cerebral arteries |
Q47885915 | Evidence that elevated plasma corticosterone levels are the cause of reduced hypothalamic corticotrophin-releasing hormone gene expression in diabetes |
Q48894502 | Evidence that endogenous thyrotropin-releasing hormone (TRH) may control vagal efferents to thyroid gland: neural inhibition by central administration of TRH antiserum |
Q71870318 | Evidence that galanin is a parasympathetic, rather than a sympathetic, neurotransmitter in the baboon pancreas |
Q41227913 | Evidence that gastrin enhances 45Ca uptake into bone through release of a gastric hormone |
Q41660208 | Evidence that limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3) occurs in the normal state outside of the bloodstream |
Q52535839 | Evidence that locustatachykinin I is involved in release of adipokinetic hormone from locust corpora cardiaca. |
Q74472301 | Evidence that peroral calcium does not activate the gastrin-ECL-cell axis in the rat |
Q42453800 | Evidence that proglumide and benzotript antagonize secretagogue stimulation of isolated gastric parietal cells |
Q73216396 | Evidence that rat stomach ECL cells represent the main source of circulating pancreastatin |
Q40855057 | Evidence that the hypothalamus exerts both stimulatory and inhibitory influences over adrenocorticotropin secretion and biosynthesis in the sheep |
Q46043615 | Evidence that vasoactive intestinal polypeptide is a parasympathetic neurotransmitter in the endocrine pancreas in dogs. |
Q41062351 | Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide |
Q34079561 | Evolutionary conservation of glucose-dependent insulinotropic polypeptide (GIP) gene regulation and the enteroinsular axis |
Q42490937 | Evolutionary expression of glucose-dependent-insulinotropic polypeptide (GIP). |
Q48682751 | Excitatory action of angiotensins II and IV on hippocampal neuronal activity in urethane anesthetized rats |
Q57099283 | Excitatory regulation of angiotensin II on gastric motility and its mechanism in guinea pig |
Q45935416 | Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states. |
Q87760632 | Exendin-4 promotes the membrane trafficking of the AMPA receptor GluR1 subunit and ADAM10 in the mouse neocortex |
Q67464117 | Exendin-4, a new peptide from Heloderma suspectum venom, potentiates cholecystokinin-induced amylase release from rat pancreatic acini |
Q48221586 | Exercise-induced hyperphagia in the hamster is associated with elevated plasma somatostatin-like immunoreactivity |
Q54786874 | Existence of ghrelin-immunopositive and -expressing cells in the proventriculus of the hatching and adult chicken. |
Q70391781 | Exocrine and endocrine secretion of renin and epidermal growth factor from the mouse submandibular glands |
Q70816513 | Exocrine pancreatic secretion in response to a new CCK-analog, CCK33 and caerulein in dogs |
Q44982154 | Exocrine pancreatic secretion: effect of subarachnoidal application of cholecystokinin octapeptide in rats |
Q71003429 | Exocrine secretion of epidermal growth factor from Brunner's glands. Stimulation by VIP and acetylcholine |
Q44921464 | Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage |
Q45712612 | Exogenous endothelin-1 improves microvascular oxygen balance during focal cerebral ischemia in the rat. |
Q38354354 | Exogenous leptin inhibits the secretion of pancreatic juice via a duodenal CCK1-vagal-dependent mechanism in anaesthetized rats |
Q84884437 | Exogenous oxytocin reverses the decrease of colonic smooth muscle contraction in antenatal maternal hypoxia mice via ganglia |
Q31047538 | Experimental data supporting the expression of the highly conserved GnRH-II in the brain and pituitary gland of rats. |
Q39682453 | Exploring PTX3 expression in Sus scrofa cardiac tissue using RNA sequencing |
Q34800899 | Exposure to the endocrine disruptor nonylphenol alters structure and function of thyroid gland in rats |
Q48328823 | Expression and activity of cocaine- and amphetamine-regulated transcript peptide(1-39) in the rat. |
Q42610805 | Expression and characterization of the preoptic regulatory factor-1 and -2 peptides |
Q57112141 | Expression and distribution of GnRH, LH, and FSH and their receptors in gastrointestinal tract of man and rat |
Q44240030 | Expression and distribution of pituitary adenylate cyclase-activating peptide in human prostate and prostate cancer tissues |
Q44643681 | Expression and localization of AT1 receptors in hepatic Kupffer cells: its potential role in regulating a fibrogenic response |
Q51746725 | Expression and release of progalanin in fibroblasts. |
Q40916672 | Expression cloning of the human V2 vasopressin receptor |
Q46688960 | Expression of AT2 receptors in rat fetal subdermal cells |
Q77943867 | Expression of IGF-1, IGF-1 receptor and TGF-beta following balloon angioplasty in atherosclerotic and normal rabbit iliac arteries: an immunocytochemical study |
Q71956626 | Expression of IGF-I, IGF-I receptor and IGF binding proteins-1, -2, -3, -4 and -5 in human atherectomy specimens |
Q48250590 | Expression of Krev-1 and c-H-ras proto-oncogenes in the rat spinal cord and the effects of noxious stimulation |
Q42169997 | Expression of PAC1 receptor in rat thymus after irradiation |
Q48250132 | Expression of PACAP and glutamate transporter proteins in satellite oligodendrocytes of the human CNS. |
Q46427214 | Expression of PCSK1 (PC1/3), PCSK2 (PC2) and PCSK3 (furin) in mouse small intestine. |
Q41271519 | Expression of angiotensin I-converting enzyme in the human gastric HGT-1 cell line |
Q48393465 | Expression of angiotensin type 1 and 2 receptors in brain after transient middle cerebral artery occlusion in rats |
Q83418572 | Expression of antimicrobial peptides and proteins in etanercept-treated psoriasis patients |
Q70959675 | Expression of antisense PC1 in stably transfected RIN5F cells significantly reduces CCK 8 biosynthesis |
Q43531647 | Expression of endothelin-1 system in a pig model of endotoxic shock |
Q45090594 | Expression of functional receptors for vasoactive intestinal peptide in freshly isolated and cultured gastric muscle cells |
Q54197547 | Expression of ghrelin and its receptor in rats after coronary artery ligation. |
Q79745276 | Expression of growth hormone-releasing hormone (GHRH) and splice variant of GHRH receptors in normal mouse tissues |
Q40015860 | Expression of growth hormone-releasing hormone receptor splice variant 1 in primary human melanomas |
Q44849008 | Expression of hypothalamic neuropeptides after acute TCDD treatment and distribution of Ah receptor repressor |
Q45812976 | Expression of inflammation-related genes in mouse spleen under tuftsin analog Selank |
Q41520235 | Expression of insulin-like growth factor binding protein-4 (IGFBP-4) by rat neural cells--comparison to other IGFBPs |
Q34175795 | Expression of mRNA for PACAP and its receptors in intra- and extra-adrenal human pheochromocytomas and their relationship to catecholamine synthesis |
Q44131094 | Expression of mRNA for growth hormone-releasing hormone and splice variants of GHRH receptors in human malignant bone tumors |
Q40497649 | Expression of mRNAs for PACAP and its receptor in human neuroblastomas and their relationship to catecholamine synthesis |
Q38506852 | Expression of nerve growth factor is upregulated in the rat thymic epithelial cells during thymus regeneration following acute thymic involution |
Q51461717 | Expression of neuropeptide W in rat stomach mucosa: regulation by nutritional status, glucocorticoids and thyroid hormones. |
Q51746915 | Expression of orexin A and its receptor 1 in the rat epididymis. |
Q48345880 | Expression of orexin receptors 1 (OX1R) and 2 (OX2R) in the porcine ovary during the oestrous cycle. |
Q81009926 | Expression of orexin receptors in the brain and peripheral tissues of the male sheep |
Q48965953 | Expression of pituitary adenylate cyclase activating peptide (PACAP) and PACAP type I receptors in the rat adrenal medulla |
Q72176496 | Expression of pituitary adenylate cyclase activating polypeptide (PACAP) gene by rat spermatogenic cells |
Q28569354 | Expression of pituitary adenylate cyclase-activating polypeptide and PACAP type 1 receptor in the rat gastric and colonic myenteric neurons |
Q67959875 | Expression of preproVIP-derived peptides in the human gastrointestinal tract: a biochemical and immunocytochemical study |
Q41675188 | Expression of preprodynorphin in human small cell lung carcinoma cell lines |
Q43701507 | Expression of receptors regulating gastric acidity in the developing sheep stomach |
Q72663270 | Expression of somatostatin mRNA and peptide in rat hippocampus after cerebral ischemia |
Q45274645 | Expression of somatostatin receptor mRNAs is regulated in vivo by growth hormone, insulin, and insulin-like growth factor-I in rainbow trout (Oncorhynchus mykiss). |
Q47744588 | Expression of somatostatin receptors 1 and 2 in the adult mouse kidney |
Q50486541 | Expression of substance P and nitric oxide synthase in vagal sensory neurons innervating the mouse airways. |
Q38321262 | Expression of the adrenomedullin gene in adipose tissue |
Q73629313 | Expression of the chromogranin A-derived peptides pancreastatin and WE14 in rat stomach ECL cells |
Q46073315 | Expression of the serotonin transporter SERT in the genital tract of cattle. |
Q47224456 | Expressions of neuropeptide Y and Y1 receptor in subcutaneous and visceral fat tissues in normal weight and obese humans and their correlations with clinical parameters and peripheral metabolic factors |
Q71652913 | Extraction and quantitation of neuropeptides in bone by radioimmunoassay |
Q31874715 | Extracts of ECL-cell granules/vesicles and of isolated ECL cells from rat oxyntic mucosa evoke a Ca2+ second messenger response in osteoblastic cells |
Q42454337 | Extrinsic control of the release of galanin and VIP from intrinsic nerves of isolated, perfused, porcine ileum |
Q52250799 | FMRFamide prevents habituation and potentiates the gill withdrawal reflex in the isolated gill preparation of Aplysia. |
Q48721036 | Facilitation of baroreceptor reflex response by endogenous somatostatin in the rat |
Q67920233 | Facilitation of cancer-associated anorexia by cholecystokinin |
Q70163315 | Facilitation of mounting behavior in male rats by intracranial injections of luteinizing hormone-releasing hormone |
Q51645906 | Fasting and postprandial plasma GIP values in man measured with seven different antisera. |
Q42462589 | Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans |
Q51634018 | Feedback regulation of glucose-dependent insulinotropic polypeptide (GIP) secretion by insulin in conscious rats. |
Q77601391 | Feeding and activity induced by orexin A in the lateral hypothalamus in rats |
Q43034800 | Feeding the mosquito Aedes aegypti with TMOF and its analogs; effect on trypsin biosynthesis and egg development |
Q47291162 | Fetal pulmonary immunoreactive adrenocorticotropin: molecular weight and cellular localization |
Q46182622 | Fetuin-A and arterial stiffness in patients with normal kidney function |
Q41383121 | Fibroblast growth factor as an intraovarian hormone: differential regulation of steroidogenesis by an angiogenic factor |
Q68719706 | Fibroblast mitogens in swine milk include an epidermal growth factor-related peptide |
Q30746188 | Fibrosis rather than blood pressure determines cardiac BNP expression in mice |
Q48621617 | First localization and biochemical identification of chromogranin B- and secretoneurin-like immunoreactivity in the fetal human vagal/nucleus solitary complex |
Q42009036 | Five functional adipokinetic peptides expressed in the corpus cardiacum of the moth genus Hippotion (Lepidoptera, Sphingidae). |
Q39954950 | Flow cytometric detection of progastrin interaction with gastrointestinal cells |
Q38495686 | Fluoxetine affects weight gain and expression of feeding peptides in the female goldfish brain. |
Q45091002 | Fluoxetine induced insulin-like growth factor II (IGF-II) changes in hypothalami of normal, exercised and food restricted rats |
Q42460385 | Fluoxetine pretreatment potentiates intracisternal TRH analogue-stimulated gastric acid secretion in rats |
Q48179714 | Focal cerebral ischaemia induces corticotropin releasing factor (CRF) vascular immunoreactivity in rat occluded hemisphere |
Q44077194 | Follicular fluid adrenomedullin concentrations in spontaneous and stimulated cycles: relationship to ovarian function and endothelin-1 and nitric oxide |
Q39850732 | Follistatin, induced by thyrotropin-releasing hormone (TRH), plays no role in prolactin expression but affects gonadotropin FSHbeta expression as a paracrine factor in pituitary somatolactotroph GH3 cells |
Q51535682 | Food deprivation enhances somatostatin and somatostatin receptor subtype expression in rat colon. |
Q46036487 | Food intake in rhesus monkeys following central administration of orexins. |
Q47184218 | Food intake inhibition and reduction in body weight gain in lean and obese rodents treated with GW438014A, a potent and selective NPY-Y5 receptor antagonist |
Q31874744 | Food restriction selectively increases hypothalamic orexin-B levels in lactating rats. |
Q54567118 | Foreword to special issue: molecular and cellular mechanisms of VIP, PACAP and secretin signaling applied to systems biology. |
Q77758251 | Formation of angiotensin-(1-7) from angiotensin II by the venom of Conus geographus |
Q40855062 | Forms of neurohypophysial peptides generated by tumors, and factors regulating their expression |
Q48250563 | Four novel tachykinins in frog (Rana catesbeiana) brain and intestine |
Q43284759 | Fragment analogs as better mimics of obestatin |
Q42801443 | Free-ligand accelerated dissociation of insulin-like growth factor 1 (IGF-1) from the type I IGF receptor is reduced by insulin-like growth factor binding protein 3. |
Q51545768 | From chronic kidney disease to transplantation: the roles of obestatin. |
Q43189789 | Fructose affects enzymes involved in the synthesis and degradation of hypothalamic endocannabinoids |
Q61051682 | Full-length and N-terminally truncated chicken intestinal diazepam-binding inhibitor |
Q73521134 | Functional CCK-A and Y2 receptors in guinea pig esophagus |
Q47667147 | Functional analysis of crustacean Hyperglycemic Hormone by in vivo assay with wild-type and mutant recombinant proteins |
Q42045617 | Functional analysis of the SGNP I in the pupal diapause of the oriental tobacco budworm, Helicoverpa assulta (Lepidoptera: Noctuidae). |
Q41698272 | Functional and molecular characterization of CCK receptors in the rat pancreatic acinar cell line AR 4-2J. |
Q46748743 | Functional aspects of cHH C-terminal amidation in crayfish species |
Q46527293 | Functional characterisation of tachykinin receptors in the circular muscle layer of the mouse ileum. |
Q40497615 | Functional characterization and purification of the secretin receptor expressed in baculovirus-infected insect cells |
Q73995543 | Functional characterization of neural and smooth muscle motilin receptors in the chicken proventriculus and ileum |
Q46445411 | Functional characterization of neurokinin receptors with agonists and antagonists |
Q67584417 | Functional control of chromogranin A and B concentrations in the body of the rat stomach |
Q41662398 | Functional effects of a family of galanin antagonists on the cardiovascular system in anaesthetised cats |
Q40414998 | Functional expression of neuropeptide Y receptors in human neuroblastoma cells |
Q47885807 | Functional impairment of the individual rat stomach ECL cell in response to sustained hypergastrinemia |
Q39411043 | Functional importance of GLP-1 receptor species and expression levels in cell lines. |
Q42461021 | Functional interaction between transforming growth factor alpha and capsaicin-sensitive sensory neurons in the rat stomach |
Q61774101 | Functional receptors for vasoactive intestinal polypeptide in cultured astroglia from neonatal rat brain |
Q80064307 | Functional relationship between subfornical organ cholinergic stimulation and nitrergic activation influencing cardiovascular and body fluid homeostasis |
Q51799424 | Functional rescue of a defective angiotensin II AT1 receptor mutant by the Mas protooncogene. |
Q40594841 | Functional significance of gastrin gene expression in human cancer cells |
Q68310809 | Further characterization of the in vitro hydrolysis of [Leu]- and [Met]enkephalin in rat plasma: HPLC-ECD measurement of substrate and metabolite concentrations |
Q44334452 | Further evidence that substance P is a mediator of both neurogenic inflammation and pain: two phenomena inhibited either by postsynaptic blockade of NK1 receptors or by presynpatic action of opioid receptor agonists |
Q44644385 | Further investigations on neurotensin as central modulator of intestinal motility in rats |
Q44520871 | Further studies on the effect of intracellular angiotensins on heart cell communication: on the role of endogenous angiotensin II. |
Q69040459 | Further studies on the effects of central administration of neuropeptide Y on neuroendocrine function in the male rat: relationship to hypothalamic catecholamines |
Q42943697 | Further studies on the effects of intracrine and extracellular angiotensin II on the regulation of heart cell volume. On the influence of aldosterone and spironolactone |
Q72287115 | G protein-coupled corticotropin-releasing hormone receptors in rat retina |
Q36101322 | GATA factors and transcriptional regulation of cardiac natriuretic peptide genes |
Q36075983 | GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice. |
Q46145546 | GIP and insulin release in relation to gastric emptying of a mixed meal in man. |
Q51474215 | GIP receptor mRNA expression in different fat tissue depots in postmenopausal non-diabetic women. |
Q41114801 | GIP(6-30amide) contains the high affinity binding region of GIP and is a potent inhibitor of GIP1-42 action in vitro |
Q24314716 | GIP, a G-protein-coupled receptor interacting protein |
Q80345666 | GIP1-39, a novel insulinotropic peptide form and aspects on its mechanism of action |
Q58829018 | GLP-1 analogue, Liraglutide protects human umbilical vein endothelial cells against high glucose induced endoplasmic reticulum stress |
Q58448618 | GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine |
Q44077198 | GLP-1 and GLP-2 act in concert to inhibit fasted, but not fed, small bowel motility in the rat. |
Q71342750 | GLP-1 depolarizes the rat pancreatic beta cell in a Na(+)-dependent manner |
Q33745485 | GLP-1 released to the mesenteric lymph duct in mice: effects of glucose and fat. |
Q73444367 | GLP-1-analogues resistant to degradation by dipeptidyl-peptidase IV in vitro |
Q47377801 | GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice |
Q51381163 | GLP-1-derived nonapeptide GLP-1(28-36)amide targets to mitochondria and suppresses glucose production and oxidative stress in isolated mouse hepatocytes. |
Q28289025 | GLP-1/GIP chimeric peptides define the structural requirements for specific ligand-receptor interaction of GLP-1 |
Q37441761 | GLP-1: broadening the incretin concept to involve gut motility |
Q60042081 | GLP-2 enhances barrier formation and attenuates TNFα-induced changes in a Caco-2 cell model of the intestinal barrier |
Q34367809 | GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors |
Q38248848 | GLP-2: what do we know? What are we going to discover? |
Q34403232 | GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity |
Q82305693 | GRANINS: thirty-five happy years in the granulosome world. Preface |
Q72599212 | GRP neurones in the rat small intestine issue long anal projections |
Q34157062 | GRP receptor-mediated immediate early gene expression and transcription factor Elk-1 activation in prostate cancer cells |
Q39817562 | Gaegurin-6 stimulates insulin secretion through calcium influx in pancreatic beta Rin5mf cells |
Q72099923 | Galanin analogues: agonist and antagonist |
Q75216296 | Galanin in pituitary adenomas |
Q42465469 | Galanin in the porcine pancreas |
Q67696501 | Galanin induces contraction of isolated cells from circular muscle layer of pig ileum |
Q67701876 | Galanin inhibits pancreatic amylase secretion in the pentobarbital-anesthetized rat |
Q67532261 | Galanin is more common than NPY in vascular sympathetic neurons of the brush-tailed possum |
Q44903816 | Galanin potentiates electrical stimulation and exogenous norepinephrine-induced contractions in the rat vas deferens |
Q48267925 | Galanin stimulates striatal acetylcholine release via a mechanism unrelated to cholinergic receptor stimulation. |
Q81201362 | Galanin-like peptide and ghrelin increase cytosolic Ca2+ in neurons containing growth hormone-releasing hormone in the arcuate nucleus |
Q34379903 | Galanin-like peptide in the brain: effects on feeding, energy metabolism and reproduction |
Q68869976 | Gallbladder CCK receptors: species differences in glycosylation of similar protein cores |
Q58868668 | Gamma-aminobutyric acid and chloride channels: Regulation by neuropeptides |
Q71852212 | Gamma-aminobutyric acid mediation of the inhibitory effect of nitric oxide on the arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia |
Q87581014 | Ganglioneuritis is common in rats with enteric neuropathy due to buserelin treatment |
Q41507171 | Gastric and intestinal release of vasoactive intestinal polypeptide in the milk-fed lamb |
Q48937837 | Gastric distension activates NUCB2/nesfatin-1-expressing neurons in the nucleus of the solitary tract |
Q51654260 | Gastric effects and side effects of synthetic secretin in man |
Q46612137 | Gastric emptying in response to IAPP and CCK in rats with subdiaphragmatic afferent vagotomy |
Q34060745 | Gastric endocrine cells: types, function and growth |
Q70304238 | Gastric inhibitory polypeptide enhancement of the insulin effect on fatty acid incorporation into adipose tissue in the rat |
Q34758871 | Gastric inhibitory polypeptide: the neglected incretin revisited |
Q72265299 | Gastric mucosal damage induced by 2-deoxy-D-glucose involves medullary TRH in the rat |
Q51558265 | Gastric submucosal microdialysis: a method to study gastrin- and food-evoked mobilization of ECL-cell histamine in conscious rats. |
Q69931250 | Gastrin and somatostatin in the rat antrum. The effect of removal of acid-secreting mucosa |
Q42513906 | Gastrin and the vagus interact in the trophic control of the rat oxyntic mucosa |
Q34060752 | Gastrin as a growth factor in the gastrointestinal tract |
Q46420296 | Gastrin receptor expression and function during rapid transformation of the enterochromaffin-like cells in an African rodent |
Q54879322 | Gastrin regulates the urokinase plasminogen activator system |
Q42494578 | Gastrin release in obese Zucker rats |
Q42466045 | Gastrin release: Antrum microdialysis reveals a complex neural control |
Q48673201 | Gastrin releasing peptide, but not pentagastrin, stimulates ACTH and cortisol secretion in conscious dogs |
Q42469454 | Gastrin response to candidate messengers in intact conscious rats monitored by antrum microdialysis |
Q31072048 | Gastrin stimulates receptor-mediated proliferation of human esophageal adenocarcinoma cells |
Q39684868 | Gastrin stimulates the VEGF-A promotor in a human colon cancer cell line |
Q71712897 | Gastrin-evoked secretion of pancreastatin and histamine from ECL cells and of acid from parietal cells in isolated, vascularly perfused rat stomach. Effects of isobutyl methylxanthin and alpha-fluoromethylhistidine |
Q51560185 | Gastrin-induced gene expression in oxyntic mucosa and ECL cells of rat stomach. |
Q68042494 | Gastrin-releasing peptide stimulates cholecystokinin secretion in perfused rat duodenum |
Q68086151 | Gastrin-releasing peptide: neuronal distribution and spatial relation to endocrine cells in the human upper gut |
Q67797249 | Gastrin/CCK antagonists and their use in gastrointestinal research. Bayliss and Starling Society 11th annual meeting. Liverpool, 23-24 September 1991 |
Q48736119 | Gastrin/cholecystokinin-like immunoreactive peptides in the Dungeness crab, Cancer magister (Dana): immunochemical and biological characterization |
Q68792695 | Gastrointestinal motor effects of corticotropin-releasing factor in mice |
Q46673143 | Gastroprotective action of orexin-A against stress-induced gastric damage is mediated by endogenous prostaglandins, sensory afferent neuropeptides and nitric oxide |
Q33267554 | Gender differences in the relationship between leptin, insulin resistance and the autonomic nervous system |
Q51568321 | Gender discrimination in the influence of hyperglycemia and hyperosmolarity on rat aortic tissue responses to insulin. |
Q48831309 | Gene expression of central and peripheral renin-angiotensin system components upon dietary sodium intake in rats |
Q58449118 | Gene expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat hypothalamus |
Q42464625 | Gene expression profiling of gastric mucosa in mice lacking CCK and gastrin receptors |
Q71982492 | Generation of cyclic guanosine monophosphate in brain slices incubated with atrial or C-type natriuretic peptides: comparison of the amplitudes and cellular distribution of the responses |
Q85911816 | Genetic and pharmacological mouse models of chronic melanocortin activation show enhanced baroreflex control of heart rate |
Q48861743 | Genetic deletion of angiotensin AT2 receptor leads to increased cell numbers in different brain structures of mice |
Q30968628 | Genetic suppression of ghrelin receptors activates brown adipocyte function and decreases fat storage in rats |
Q51704771 | Genetic variants at the resistin locus are associated with the plasma resistin concentration and cardiovascular risk factors. |
Q48634429 | Genomic structure and embryonic expression of the rat type 1 vasoactive intestinal polypeptide receptor gene |
Q44226456 | Gestational hypertension in atrial natriuretic peptide knockout mice and the developmental origins of salt-sensitivity and cardiac hypertrophy |
Q31015946 | Gestational regulation of the gene expression of C-type natriuretic peptide in mouse reproductive and embryonic tissue |
Q51462198 | Ghrelin accelerates gastric emptying via early manifestation of antro-pyloric coordination in conscious rats. |
Q81420982 | Ghrelin activates neuronal constitutive nitric oxide synthase in pancreatic islet cells while inhibiting insulin release and stimulating glucagon release |
Q59874024 | Ghrelin affects gastrectomy-induced decrease in UCP1 and β3-AR mRNA expression in mice |
Q46989966 | Ghrelin alleviates biliary obstruction-induced chronic hepatic injury in rats |
Q85225933 | Ghrelin and its receptor: the role of the ghrelin signaling system in regulating cardiac function |
Q53282048 | Ghrelin attenuates heat-induced degenerative effects in the rat testis. |
Q46520454 | Ghrelin blunted vascular calcification in vivo and in vitro in rats |
Q36959202 | Ghrelin deficiency does not influence feeding performance. |
Q39322098 | Ghrelin improves body weight loss and skeletal muscle catabolism associated with angiotensin II-induced cachexia in mice |
Q46087104 | Ghrelin inhibits apoptosis induced by high glucose and sodium palmitate in adult rat cardiomyocytes through the PI3K-Akt signaling pathway |
Q39751418 | Ghrelin inhibits cell apoptosis induced by lipotoxicity in pancreatic beta-cell line |
Q39283857 | Ghrelin is dispensable for embryonic pancreatic islet development and differentiation |
Q45244183 | Ghrelin is not suppressed in hyperglycemic clamps by gastric inhibitory polypeptide and arginine. |
Q43155672 | Ghrelin promotes antioxidant enzyme activity and reduces lipid peroxidation in the rat ovary |
Q46537243 | Ghrelin regulates adiposity in white adipose tissue and UCP1 mRNA expression in brown adipose tissue in mice |
Q46261080 | Ghrelin response to protein and carbohydrate meals in relation to food intake and glycerol levels in obese subjects |
Q31072035 | Ghrelin stimulates gastric emptying but is without effect on acid secretion and gastric endocrine cells |
Q46842930 | Ghrelin stimulates insulin-induced glucose uptake in adipocytes. |
Q44980534 | Ghrelin stimulates motility in the small intestine of rats through intrinsic cholinergic neurons |
Q47921130 | Ghrelin stimulates synaptic formation in cultured cortical networks in a dose-dependent manner |
Q35165380 | Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure |
Q48164015 | Ghrelin, leptin and adiponectin as possible predictors of the hedonic value of odors |
Q44248773 | Ghrelin, leptin and insulin in cirrhotic children and adolescents: relationship with cirrhosis severity and nutritional status |
Q46904940 | Ghrelin, leptin and insulin in healthy children: Relationship with anthropometry, gender, and age distribution |
Q84055907 | Ghrelin- and growth hormone secretagogue receptor-immunoreactive cells in Xenopus pancreas |
Q34560824 | Ghrelin--not just another stomach hormone |
Q48590978 | Ghrelin-containing neuron in cerebral cortex and hypothalamus linked with the DVC of brainstem in rat. |
Q44269710 | Ghrelin-leptin network influences serum chitinase 3-like protein 1 (YKL-40) levels in obese prepubertal children |
Q35994142 | Ghrelin: a gastric peptide that regulates food intake and energy homeostasis |
Q37728630 | Ghrelin: a potential therapeutic target for cancer |
Q43007440 | Glucagon suppression during OGTT worsens while suppression during IVGTT sustains alongside development of glucose intolerance in patients with chronic pancreatitis. |
Q61852990 | Glucagon, glicentin, proglucagon, PYY, PP and proPP-icosapeptide immunoreactivities of rectal carcinoid tumors and related non-tumor cells |
Q58448379 | Glucagon-like peptide 1 (GLP-1) suppresses ghrelin levels in humans via increased insulin secretion |
Q36075988 | Glucagon-like peptide 1 and its derivatives in the treatment of diabetes. |
Q79717077 | Glucagon-like peptide 1 receptor expression in primary porcine proximal tubular cells |
Q40535040 | Glucagon-like peptide 2 improves intestinal wound healing through induction of epithelial cell migration in vitro-evidence for a TGF--beta-mediated effect |
Q51491511 | Glucagon-like peptide 2 inhibits ghrelin secretion in humans. |
Q58447833 | Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice |
Q44016681 | Glucagon-like peptide-1 analogue LY315902: effect on intestinal motility and release of insulin and somatostatin |
Q44332899 | Glucagon-like peptide-1 inhibits glucagon-induced glycogenolysis in perivenous hepatocytes specifically |
Q48572584 | Glucagon-like peptide-1 receptor and proglucagon expression in mouse skin |
Q45176382 | Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism |
Q44753726 | Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum |
Q39593513 | Glucagon-like peptide-1(1-37) can enhance blood glucose homeostasis in mice |
Q34480233 | Glucagon-like peptide-2 stimulates mucosal microcirculation measured by laser Doppler flowmetry in end-jejunostomy short bowel syndrome patients |
Q43004493 | Glucagon-like peptide-2, but not glucose-dependent insulinotropic polypeptide, stimulates glucagon release in patients with type 1 diabetes |
Q36075973 | Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitter. |
Q45176353 | Glucocorticoid responses to stress in castrate and testosterone-replaced rams |
Q72699380 | Glucocorticoids and the renal Na-H antiporter: role in respiratory acidosis |
Q68258339 | Glucocorticoids upregulate the high affinity receptors for vasoactive intestinal peptide (VIP) on human mononuclear leucocytes in vitro |
Q48907106 | Glucoreceptors located in the brain mediate NPY release induced by hypoglycemia in normal men. |
Q40286779 | Glucose regulates expression of the nerve growth factor (NGF) receptors TrkA and p75NTR in rat islets and INS-1E beta-cells |
Q72526992 | Glucose regulation of arginine-induced pancreatic somatostatin release from the isolated perfused rat pancreas |
Q42453061 | Glucose- and concentration-dependence of vasopressin-induced hormone release by mouse pancreatic islets |
Q73703295 | Glucose-dependency of bradykinin-induced insulin secretion from the perfused rat pancreas |
Q87074298 | Glucose-dependent insulinotropic polypeptide lowers branched chain amino acids in hyperglycemic rats |
Q33987816 | Glucose-dependent insulinotropic polypeptide stimulates the proliferation of colorectal cancer cells. |
Q42513602 | Glutamate release from adult primary sensory neurons in culture is modulated by growth factors |
Q36075992 | Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans. |
Q28190029 | Glycine-extended adrenomedullin exerts vasodilator effect through amidation in the rat aorta |
Q37040793 | Glycine-extended gastrin precursors |
Q46709112 | Glycine-extended gastrin stimulates proliferation and inhibits apoptosis in colon cancer cells via cyclo-oxygenase-independent pathways |
Q72367622 | Glycine-extended post-translational processing intermediates of gastrin and cholecystokinin in the gut |
Q43287772 | Gonadal steroids modulated hypocretin/orexin type-1 receptor expression in a brain region, sex and daytime specific manner |
Q30991066 | Gonadins, a novel family of glutamyl-tripeptide amides present in the testis with activity in the hypophyseal-gonadal axis. |
Q54296160 | Gonadotropin-releasing hormone (GnRH) analogs: relationship between their structure, proteolytic inactivation and pharmacokinetics in rats. |
Q58853889 | Gonadotropin-releasing hormones in microdissected brain regions of an amphibian: concentration and anatomical distribution of immunoreactive mammalian GnRH and chicken GnRH II |
Q48247169 | Gonadotropin-releasing hormones, including a novel form, in snook Centropomus undecimalis, in comparison with forms in black sea bass Centropristis striata |
Q37636843 | Granin-derived peptides as diagnostic and prognostic markers for endocrine tumors |
Q37704780 | Granins and granin-related peptides in neuroendocrine tumours |
Q37769859 | Granins and their derived peptides in normal and tumoral chromaffin tissue: Implications for the diagnosis and prognosis of pheochromocytoma |
Q84106608 | Granins--peptides derived from the secretory proteins |
Q54416479 | Greater expression of inflammatory cytokines, adrenomedullin, and natriuretic peptide receptor-C in epicardial adipose tissue in coronary artery disease |
Q28569694 | Growth factor-dependent actions of PACAP on oligodendrocyte progenitor proliferation |
Q42833292 | Growth hormone induces apelin mRNA expression and secretion in mouse 3T3-L1 adipocytes |
Q44240044 | Growth hormone-releasing hormone facilitates hypoglycemia-induced release of cortisol |
Q43291636 | Growth hormone-releasing peptide-2 stimulates secretion and synthesis of adrenocorticotropic hormone in mouse pituitary |
Q69674873 | Growth of human pheochromocytomas in the anterior eye chamber of the rat. A histochemical study on amine and peptide content of pheochromocytoma tumour cells |
Q69925376 | Growth-inhibitory properties of vasoactive intestinal polypeptide |
Q45244158 | Growth-promoting effect of platelet-derived growth factor on rat cardiac myocytes |
Q72358285 | Growth-regulatory effect of gastrin on human colon cancer cell lines is determined by protein kinase a isoform content |
Q68943839 | Guanine nucleotides regulate [3H]substance P binding in rat small intestine |
Q33680659 | Guanylin regulatory peptides: structures, biological activities mediated by cyclic GMP and pathobiology |
Q45009306 | Guanylyl cyclase-C receptor mRNA distribution along the rat nephron |
Q34060758 | Gut hormones as pharmaceuticals. From enteroglucagon to GLP-1 and GLP-2. |
Q87554973 | Gut hormones--team workers or solo trippers? |
Q44921516 | Gut regulatory peptides bombesin and neurotensin reduce hepatic oxidative stress and histological alterations in bile duct ligated rats. |
Q42463507 | HIV envelope protein gp120 induces neuropeptide Y receptor-mediated proliferation of vascular smooth muscle cells: relevance to AIDS cardiovascular pathogenesis. |
Q45244188 | HLDF-6 peptide affects behavioral reactions and organism functions dependent on androgen hormones in normal and castrated male mice |
Q48552943 | Habituation of insulin-induced hypoglycemic transcription activation of lateral hypothalamic orexin-A-containing neurons to recurring exposure |
Q44016678 | Healing-promoting effect of bombesin treatment on chronic gastric ulcer in rats. |
Q41201572 | Heart rate response to peptide histidine valine in human subjects is not mediated through beta receptors |
Q34060728 | Helicobacter pylori infection and gastrin and cyclooxygenase expression in gastric and colorectal malignancies |
Q44489633 | Helodermin, but not cholecystokinin, somatostatin, or thyrotropin releasing hormone, acutely increases thyroid blood flow in the rat. |
Q69795684 | Helodermin-like peptides in noradrenaline cells of adrenal medulla |
Q34311578 | Helospectin and pituitary adenylate cyclase activating polypeptide in the human vagina |
Q67584428 | Helospectin-like immunoreactivity in the esophagus |
Q54238052 | Helospectin/helodermin-like peptides in guinea pig lung: distribution and dilatory effects. |
Q28116055 | Hematopoietic growth factor inducible neurokinin-1 type: a transmembrane protein that is similar to neurokinin 1 interacts with substance P |
Q54395897 | Hemodynamic effects of calcitonin gene-related peptide in conscious rats. |
Q31148402 | Hemodynamic effects of python neuropeptide gamma in the anesthetized python, Python regius. |
Q54368481 | Hemodynamic regulator and mitogenic growth factor: re-visiting the age old question with ACE2 and Jak2. |
Q71870315 | Hepatic inactivation of Leu-enkephalin |
Q68354573 | Hepatic metabolism of vasoactive intestinal polypeptide (VIP) in the rat |
Q84273091 | Hepatoprotective effect of ghrelin on carbon tetrachloride-induced acute liver injury in rats |
Q39475421 | Hepcidin increases intracellular Ca2+ of osteoblast hFOB1.19 through L-type Ca2+ channels |
Q67486210 | Heterogeneity of NK-2 tachykinin receptors in hamster and rabbit smooth muscles |
Q41110413 | Hexarelin, a novel GHRP-6 analog, stimulates growth hormone (GH) release in a GH-secreting rat cell line (GH1) insensitive to GH-releasing hormone |
Q72484679 | High biological activity of the synthetic replicates of somatostatin-28 and somatostatin-25 |
Q73444357 | High fat maintenance diet attenuates hindbrain neuronal response to CCK |
Q41259876 | High levels of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor mRNA expression in primary and tumor lymphoid cells |
Q69556713 | High plasma cholecystokinin response following ingestion of test meal by patients with non-insulin dependent diabetes mellitus |
Q67584438 | High potency of a new bombesin antagonist (RC-3095) in inhibiting serum gastrin levels; comparison of different routes of administration |
Q70842039 | High potency of bombesin for stimulation of human gastrin release and gastric acid secretion |
Q51029627 | High serum fasting peptide YY (3-36) is associated with obesity-associated insulin resistance and type 2 diabetes. |
Q43117155 | High sucrose intake in rats is associated with increased ACE2 and angiotensin-(1-7) levels in the adipose tissue. |
Q61774090 | High- and low-affinity binding sites for vasoactive intestinal peptide (VIP) in the rat kidney revealed by light microscopic autoradiography |
Q41825838 | High-affinity angiotensin receptors in rat adrenal medulla |
Q54966689 | High-salt intake primes the rat kidney to respond to a subthreshold uroguanylin dose during ex vivo renal perfusion |
Q51972702 | Hippocampal MMP-3 elevation is associated with passive avoidance conditioning. |
Q44753740 | Histamine and histidine decarboxylase are hallmark features of ECL cells but not G cells in rat stomach |
Q49162479 | Histamine release induced by human natriuretic peptide from rat peritoneal mast cells |
Q46985595 | Histamine-induced enhancement of vasopressin and oxytocin secretion in rat neurohypophyseal tissue cultures |
Q77966482 | Histidine decarboxylase in rat stomach ECL cells: relationship between enzyme activity and different molecular forms |
Q45253671 | Homologous pancreastatin inhibits insulin secretion without affecting glucagon and somatostatin release in the perfused rat pancreas |
Q69826719 | Homologous regulation of adenylate cyclase-coupled receptors for vasoactive intestinal peptide (VIP) on human mononuclear leucocytes |
Q34831119 | Hormone trajectories leading to human birth |
Q43546803 | Hormone-specific combinations of isoforms of adenylyl cyclase and phosphodiesterase in the rat liver |
Q48311559 | How to measure cholecystokinin in tissue, plasma and cerebrospinal fluid |
Q41520178 | Human IM-9 lymphoblasts as a model of the growth hormone-insulin-like growth factor axis: gene expression, and interactions of ligands with receptors and binding proteins |
Q37078853 | Human adrenomedullin combined with human adrenomedullin binding protein-1 is protective in gut ischemia and reperfusion injury in the rat |
Q42499909 | Human alpha-calcitonin gene-related peptide influences colonic secretion by acting on myenteric neurons |
Q74338160 | Human alpha-defensin 1 (HNP-1) inhibits adenoviral infection in vitro |
Q34388245 | Human catestatin peptides differentially regulate infarct size in the ischemic-reperfused rat heart |
Q72534514 | Human chromostatin inhibits endothelin-1-induced contractures in human blood vessels |
Q45351684 | Human epidermal growth factor-on molecular forms present in urine and blood |
Q70255936 | Human epidermal growth factor: renal production and absence from plasma |
Q46870549 | Human gastrin-releasing peptide: biological potency in humans |
Q48772234 | Human growth hormone releasing factor and somatostatin from two pancreatic tumors: isolation and characterization |
Q41520196 | Human hepatoma cells synthesize and secrete insulin-like growth factor Ia prohormone under growth hormone control |
Q41076026 | Human neuroblastoma cells use either insulin-like growth factor-I or insulin-like growth factor-II in an autocrine pathway via the IGF-I receptor: variability of IGF, IGF binding protein (IGFBP) and IGF receptor gene expression and IGF and IGFBP sec |
Q45244172 | Human neuropeptide Y signal peptide gain-of-function polymorphism is associated with increased body mass index: possible mode of function |
Q68336352 | Human β-casomorphin-8 immunoreactive material in the plasma of women during pregnancy and after delivery |
Q56990816 | Human μ receptor: Gene structure, expression, and μ/κ chimeras that define nontransmembrane domains influencing peptide binding affinities |
Q114684096 | Humoral stimulation of gastroduodenal HCO3− transport by luminal acidification |
Q73205417 | Hydrolysis of big endothelin-1 by a serine protease in the membrane fraction of human lung |
Q53756561 | Hypergastrinaemia evoked by omeprazole stimulates growth of gastric mucosa but not of pancreas or intestines in hamster, guinea pig and chicken. |
Q69500065 | Hypergastrinaemia produces trophic effects in stomach but not in pancreas and intestines |
Q43857739 | Hypergastrinemia increases gastric epithelial susceptibility to apoptosis. |
Q46656187 | Hyperphagia of hyperthyroidism: is neuropeptide Y involved? |
Q48956867 | Hyperpolarization-activated Cl- current elicited by pituitary adenylate cyclase activating polypeptide in Xenopus oocytes |
Q44710422 | Hypertension induced by nitric oxide synthase inhibition activates the atrial natriuretic peptide (ANP) system |
Q45176377 | Hypotensive effect of novel chimeric peptides of met-enkephalin and FMRFa |
Q48097659 | Hypothalamic accessory nuclei and their relation to the angiotensinergic and vasopressinergic systems |
Q81151828 | Hypothalamic angiotensinergic-noradrenergic systems interaction in fructose induced hypertension |
Q48552932 | Hypothalamic cardiovascular effects of angiotensin-(1-7) in spontaneously hypertensive rats |
Q59649460 | Hypothalamic gene expression following ghrelin therapy to gastrectomized rodents |
Q48359435 | Hypothalamic neuropeptide Y content and mRNA expression in weanling rats subjected to dietary manipulations during fetal and neonatal life |
Q40916595 | Hypothalamic slice-explant cultures as models for the long-term study of gene expression and cellular activity |
Q48489580 | Hypothalamic ventromedial and arcuate neurons of normal and postnatally overnourished rats differ in their responses to melanin-concentrating hormone |
Q48432313 | Hypothalamic-pituitary thyroid axis alterations in female mice with deletion of the neuromedin B receptor gene |
Q46009601 | Hypothesis: VPAC G protein-coupled receptors for vasoactive intestinal peptide constitute a dynamic system for signaling T cells from plasma membrane and nuclear membrane complexes. |
Q47345382 | ICV administration of anti-NPY antisense oligonucleotide: effects on feeding behavior, body weight, peptide content and peptide release |
Q47345376 | ICV administration of anti-corticotropin-releasing factor antisense oligonucleotide: effects on feeding behavior and body weight |
Q41520186 | IGF receptor function and regulation in autocrine human neuroblastoma cell growth |
Q46673149 | INGAP-PP up-regulates the expression of genes and proteins related to K+ ATP channels and ameliorates Ca2+ handling in cultured adult rat islets |
Q40399189 | INGAP-related pentadecapeptide: its modulatory effect upon insulin secretion |
Q73517108 | Idazoxan and the effect of intracerebroventricular oxytocin or vasopressin on sodium intake of sodium-depleted rats |
Q69444750 | Identification and characterization of N-glycosylated and phosphorylated variants of proenkephalin A-derived peptides in bovine adrenal medulla, spinal cord and ileum |
Q70652010 | Identification and characterization of a novel angiotensin binding site in cultured vascular smooth muscle cells that is specific for the hexapeptide (3-8) fragment of angiotensin II, angiotensin IV |
Q52344476 | Identification and characterization of functional angiotensin II receptors in human neuroblastoma cells. |
Q41465088 | Identification and distribution of immunoreactive peptide YY in the human, canine, and murine gastrointestinal tracts: species-related antibody recognition differences |
Q42631728 | Identification and functional analysis of a novel ligand for G protein-coupled receptor, Neuromedin S. |
Q43659702 | Identification and localization of material with gastrin-like immunoreactivity in the neural ganglion of a protochordate, Ciona intestinalis |
Q33216227 | Identification and molecular cloning of a novel neuromedin U analog from the skin secretions of toad Bombina maxima |
Q52535843 | Identification and partial characterization of receptors for allatostatins in brain and corpora allata of the cockroach Diploptera punctata using a binding assay and photoaffinity labeling. |
Q57012467 | Identification by direct radioimmunoassay of 1–13 heptadecapeptide gastrin and amino terminal extended 1–13G17 in antrum and duodenum |
Q93600559 | Identification by specific radioimmunoassay of two novel peptides derived from the C-terminus of porcine preprogastrin |
Q34086273 | Identification of CCK-B/gastrin receptor splice variants in human peripheral blood mononuclear cells |
Q48345330 | Identification of IGF-1 receptors in primitive vertebrates. |
Q28590269 | Identification of a novel brain derived neurotrophic factor (BDNF)-inhibitory factor: regulation of BDNF by teneurin C-terminal associated peptide (TCAP)-1 in immortalized embryonic mouse hypothalamic cells |
Q48682731 | Identification of amidated forms of GLP-1 in rat tissues using a highly sensitive radioimmunoassay |
Q73532148 | Identification of an NPY-Y1 receptor subtype in bovine chromaffin cells |
Q28138133 | Identification of an interaction between the angiotensin II receptor sub-type AT2 and the ErbB3 receptor, a member of the epidermal growth factor receptor family |
Q45057494 | Identification of bombesin receptors on isolated muscle cells from human intestine |
Q58853895 | Identification of chicken GnRH II in brains of metatherian and early-evolved eutherian species of mammals |
Q33312699 | Identification of flotillin-1 as an interacting protein for antisecretory factor |
Q41660163 | Identification of functional receptors for vasoactive intestinal peptide and neurotensin in the human submandibular gland duct cell line, HSG-PA |
Q68953864 | Identification of gastrin molecular variants in gastrinoma syndrome |
Q55039845 | Identification of ghrelin and its receptor in neurons of the rat arcuate nucleus. |
Q72321283 | Identification of immunoreactive atrial natriuretic peptide in the gallbladder and bile juice of rabbit, pig and human |
Q41064286 | Identification of insulin-like growth factor (IGF) and glucose transporter-1 and -3 mRNA in CNS tumors |
Q33201878 | Identification of leucomyosuppressin in the German cockroach, Blattella germanica, as an inhibitor of food intake. |
Q68932442 | Identification of luteinizing hormone releasing hormone-like immunoactivity in ovine cotyledons |
Q71371308 | Identification of oxytocin and vasopressin in the testis and in adrenal tissue |
Q33861206 | Identification of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type 1 receptor in human skin: expression of PACAP-38 is increased in patients with psoriasis |
Q77966492 | Identification of the TRH-like peptides pGlu-Glu-Pro amide and pGlu-Phe-Pro amide in rat thyroid: regulation by thyroid status |
Q36836312 | Identification of the dipteran Leu-callatostatin peptide family: characterisation of the prohormone gene from Calliphora vomitoria and Lucilia cuprina |
Q52551672 | Identification of the dipteran Leu-callatostatin peptide family: the pattern of precursor processing revealed by isolation studies in Calliphora vomitoria. |
Q45202572 | Identification of the prolactin-releasing peptide-producing cell in the rat adrenal gland |
Q30746207 | Identification of three novel Phyllomedusa sauvagei dermaseptins (sVI–sVIII) by cloning from a skin secretion-derived cDNA library |
Q52535835 | Identification of two allatostatins from the cricket, Gryllus bimaculatus de Geer (Ensifera, Gryllidae): additional members of a family of neuropeptides inhibiting juvenile hormone biosynthesis. |
Q70409995 | Identification, characterization and localization of thyrotropin-releasing hormone precursor peptides in perinatal rat pancreas |
Q58449254 | Identification, characterization and release of GRP gene-associated peptides from the normal porcine and human gastro-intestinal tract |
Q45796852 | Identification, tissue distribution and regulation of preproghrelin in the brain and gut of Schizothorax prenanti |
Q33196147 | Ileal VIP submucous neurons: confocal study of the area enlargement induced by myenteric denervation in weanling rats. |
Q40688095 | Immunity to T cell receptor peptides: theory and applications |
Q48320725 | Immunoactive iso-ANP/BNP in plasma, tissues and atrial granules of the rat. |
Q69917144 | Immunochemical characterisation of somatostatin in ruminants |
Q44016687 | Immunochemical characterization and measurement of neuronal type nitric oxide synthase in human neuroblastoma NB-OK-1 cell using novel anti-synthetic peptide antibody and specific immunoassay system |
Q72634996 | Immunochemical studies on big gastrin using NH2-terminal specific antisera |
Q44077166 | Immunocytochemical and biochemical identification of angiotensin II in human nasal tissue. |
Q60585314 | Immunocytochemical demonstration of neuropeptide F (Helix aspersa) immunoreactivity in Helix and related gastropod molluscs using an antiserum to a synthetic N-terminal fragment |
Q41660215 | Immunocytochemical detection of insulin receptor substrate-1 (IRS-1) in rat brain: colocalization with phosphotyrosine |
Q43581933 | Immunocytochemical distribution of EM66 within the hypothalamic parvocellular paraventricular nucleus: colocalization with CRH and TRH but no plasticity related to acute stress and thyroidectomy in the rat. |
Q48965926 | Immunocytochemical distribution of locustamyoinhibiting peptide (Lom-MIP) in the nervous system of Locusta migratoria. |
Q70285716 | Immunocytochemical evidence for a substance related to the bovine pancreatic polypeptide-peptide YY group of peptides in the human fetal gastrointestinal tract |
Q72748960 | Immunocytochemical evidence for chromogranin A and B in neuronal elements in human gut |
Q69488110 | Immunocytochemical evidence for the presence of S-100 protein in insulin-containing cells of cultured fetal rat islets |
Q48637432 | Immunocytochemical localisation of pancreastatin and chromogranin A in porcine neuroendocrine tissues |
Q28303724 | Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells |
Q46157100 | Immunocytochemical localisation of the icosapeptide fragment of the PP precursor: a marker for 'true' PP cells? |
Q68655180 | Immunocytochemical localization and identification of members of the pancreatic polypeptide (PP)-fold family in human thyroid C cells and medullary carcinomas |
Q74338154 | Immunocytochemical localization of angiotensin II receptor subtypes and angiotensin II with monoclonal antibodies in the rat adrenal gland |
Q69026468 | Immunocytochemical localization of galanin in the rat male and female genital tracts and motor effects in vitro |
Q122942497 | Immunocytochemical localization of neuropeptide F immunoreactivity in the circumoesophageal ganglia of the gastropod mollusc, Helix aspersa, using electron microscopy |
Q47993319 | Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells |
Q36491015 | Immunocytochemical location of thyrotropin-releasing hormone (TRH) in the B-cells of adult hypothyroid rat pancreas |
Q43943037 | Immunodetection of secretogranin II in animal and human tissues by new monoclonal antibodies |
Q34985117 | Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide |
Q81201380 | Immunohistochemical analysis of cholecystokinin A receptor distribution in the rat pancreas |
Q40594834 | Immunohistochemical colocalization of type II angiotensin receptors with somatostatin in rat pancreas |
Q48318923 | Immunohistochemical demonstration of angiotensin II receptors in rat brain by use of an anti-idiotypic antibody |
Q77763725 | Immunohistochemical demonstration of the intracellular localization of pituitary adenylate cyclase activating polypeptide-like immunoreactivity in the rat testis using the stamp preparation |
Q41540021 | Immunohistochemical evidence of gastro-entero-pancreatic neurohormonal peptides of vertebrate type in the nervous system of the larva of a dipteran insect, the hoverfly, Eristalis aeneus |
Q126436610 | Immunohistochemical investigations of the IGF-I receptors on the surface of ependymal cells of the hypothalamus median eminence |
Q38989382 | Immunohistochemical localization of gastrin C-terminus, gastric inhibitory peptide (GIP) and endorphin in the pancreas of lizards with special reference to the hibernation period |
Q44268372 | Immunohistochemical localization of neuron-specific enolase and calcitonin gene-related peptide in pig taste papillae |
Q54442274 | Immunohistochemical localization of neuron-specific enolase and calcitonin gene-related peptide in rat taste papillae. |
Q71687925 | Immunohistochemical localization of peptidergic nerve fibers and neuropeptide receptors in Peyer's patches of the cat ileum |
Q53920745 | Immunohistochemical localization of substance P, vasoactive intestinal polypeptide and gastrin-releasing peptide in vas deferens and seminal vesicle, and the effect of these and eight other neuropeptides on resting tension and neurally evoked contra |
Q48707148 | Immunohistochemical localization of type-II (AT2) angiotensin receptors with a polyclonal antibody against a peptide from the C-terminal tail. |
Q57269046 | Immunohistochemical localization of γ-melanocyte-stimulating hormone in the rat pituitary gland |
Q46731482 | Immunohistochemical localization to pyloric antral G cells of peptides derived from porcine preprogastrin |
Q48318889 | Immunohistochemical mapping of angiotensin AT1 receptors in the brain |
Q48250704 | Immunohistochemical study of substance P in the substantia nigra of multiple system atrophy |
Q51826761 | Immunohistochemical study on the ontogenetic development of the regional distribution of peptide YY, pancreatic polypeptide, and glucagon-like peptide 1 endocrine cells in bovine gastrointestinal tract. |
Q48359656 | Immunolocalization of neuropeptide Y in human pituitary tumours |
Q48918708 | Immunological analysis of angiotensin AT2 receptors in peripheral tissues of neonatal and adult rats |
Q45219485 | Immunomodulatory activities of the somatostatin analogue BIM 23014c: effects on murine lymphocyte proliferation and natural killer activity |
Q43963215 | Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic rats. |
Q70124504 | Immunoneutralization of oxytocin attenuates stress-induced corticotropin secretion in the rat |
Q41945933 | Immunoreactive atrial natriuretic peptide in the thyroid gland |
Q70018625 | Immunoreactive atrial natriuretic polypeptides in the adrenal medulla and sympathetic ganglia |
Q72403895 | Immunoreactive cholecystokinin in human and rat plasma: correlation of pancreatic secretion in response to CCK |
Q45961394 | Immunoreactive endomorphin 2 is generated extracellularly in rat isolated L4,5 dorsal root ganglia by DPP-IV. |
Q68053275 | Immunoreactive glucagons purified from dog pancreas, stomach and ileum |
Q52201958 | Immunoreactive mammalian and chicken-II GnRHs in Rana esculenta brain during development. |
Q72591284 | Immunoreactive neuropeptide Y (NPY) in plasma and platelets of rat and mouse strains and human volunteers |
Q48172648 | Immunoreactivity for diazepam binding inhibitor in Gomori-positive astrocytes |
Q73571487 | Immunoreactivity for the alpha-subunit of the pituitary glycoprotein hormones in pulmonary neuroendocrine cells of developing human lung and various perinatal diseases |
Q72521774 | Immunoregulatory properties of hexapeptide isolated from porcine bone marrow cell culture |
Q51372465 | Impact of atorvastatin on serum vaspin levels in hypercholesterolemic patients with moderate cardiovascular risk. |
Q42439482 | Impaired glucose-stimulated insulin secretion in the GK rat is associated with abnormalities in islet nitric oxide production |
Q46954719 | Impaired serum thyrotropin response to hypothyroidism in mice with disruption of neuromedin B receptor. |
Q40366277 | Implantation of fibre encapsulated RIN 1056a cells transfected with NPY cDNA into the lateral ventricle of rats alters body weight. |
Q83267563 | Implication of Substance P in myocardial contractile function during ischemia in rats |
Q40855082 | Implication of central neurohypophyseal hormone receptor-mediated action in timing of reproductive events: evidence from novel observations on the effect of a vasotocin analogue on singing behaviour of the canary |
Q70581494 | Importance of cholecystokinin in peptide-YY release in response to pancreatic juice diversion |
Q34079450 | Importance of lipid-exposed residues in transmembrane segment four for family B calcitonin receptor homo-dimerization |
Q51082352 | Improved conditioned avoidance learning by oxytocin administration in high-emotional male Sprague-Dawley rats. |
Q46614515 | Improved insulin sensitivity and metabolic flexibility in ghrelin receptor knockout mice |
Q74665117 | Improvement of preservation with cardioplegia induced by heat stress is mediated by calcitonin gene-related peptide |
Q42497981 | In man histamine and muscarinergic mechanisms are essential mediators of acid secretion in response to synthetic human gastrin (1-17). |
Q48828643 | In the trout, CRH and AVT synergize to stimulate ACTH release |
Q67270890 | In vitro and in vivo ACTH-releasing activity of ovine CRF, sauvagine and urotensin I |
Q42435833 | In vitro and in vivo angiogenic activity of osteoarthritic and osteoporotic osteoblasts is modulated by VEGF and vitamin D3 treatment |
Q40693313 | In vitro and in vivo treatment of colon cancer by VIP antagonists |
Q71774459 | In vitro microdialysis of baboon corpus luteum: effects of oxytocin on total and pulsatile progesterone secretion |
Q43717367 | In vitro release of growth hormone-releasing factor (GRF) from the hypothalamus: somatostatin inhibits GRF release |
Q48317011 | In vitro release of growth hormone-releasing factor from rat hypothalamus: effect of insulin-like growth factor-1. |
Q72358276 | In vitro steroidogenic effects of neuropeptide Y (NPY1-36), Y1 and Y2 receptor agonists (Leu31-Pro34 NPY, NPY18-36) and peptide YY (PYY) on rat adrenal capsule/zona glomerulosa |
Q72099826 | In vivo and in vitro activity of SR 48,968, a non-peptide tachykinin NK-2 receptor antagonist |
Q40960471 | In vivo antisense approaches to the role of immediate early gene expression in the brain |
Q70959649 | In vivo applications of antisense oligonucleotides for peptide research |
Q72001945 | In vivo central actions of rat amylin |
Q54593110 | In vivo characterization of a novel GnRH (gonadotropin-releasing hormone) antagonist, LXT-101, in normal male rats. |
Q72099854 | In vivo characterization of tachykinin receptors responsible for the central cardiovascular effects of substance P and neurokinin A |
Q72440628 | In vivo effect of chronic administration of vasoactive intestinal peptide on gut-associated lymphoid tissues in rats |
Q45176309 | In vivo effect of glucose-dependent insulinotropic peptide (GIP) on the gene expression of calcitonin peptides in human subcutaneous adipose tissue. |
Q51458344 | In vivo effects of TGFbeta1 on the growth of gastric epithelium in suckling rats. |
Q70685265 | In vivo modulation of gastrointestinal motor activity by Met-enkephalin, morphine and enkephalin analogs in chickens |
Q41566914 | In vivo modulation of intestinal motility and sites of opioid effects in the rat. |
Q45970555 | Increase of atrial ANP release by 2,3-butanedione monoxime in beating rabbit atria. |
Q40351775 | Increase of core temperature induced by corticotropin-releasing factor and urocortin: a comparative study. |
Q43766131 | Increased AT(1) receptors in adrenal gland of AT(2) receptor gene-disrupted mice |
Q37461915 | Increased angiotensin II AT1 receptor mRNA and binding in spleen and lung of AT2 receptor gene disrupted mice |
Q48359447 | Increased appetite augments hypothalamic NPY Y1 receptor gene expression: effects of anorexigenic ciliary neurotropic factor |
Q83431799 | Increased arginine-vasopressin response to hypertonic stimulation and upright posture in idiopathic hyperprolactinemia |
Q40174934 | Increased cell survival, migration, invasion, and Akt expression in PTHrP-overexpressing LoVo colon cancer cell lines |
Q56963164 | Increased circulating angiotensin-(1–7) protects white adipose tissue against development of a proinflammatory state stimulated by a high-fat diet |
Q50909506 | Increased circulating cholecystokinin contributes to anorexia and anxiety behavior in mice overexpressing pancreatic polypeptide. |
Q80056127 | Increased colonic apelin production in rodents with experimental colitis and in humans with IBD |
Q41340050 | Increased dynorphin immunoreactivity in spinal cord after traumatic injury |
Q46975094 | Increased expression in calcitonin-like receptor induced by aldosterone in cerebral arteries from spontaneously hypertensive rats does not correlate with functional role of CGRP receptor |
Q60713401 | Increased expression of (pro)renin receptor in the remnant kidneys of 5/6 nephrectomized rats |
Q73053552 | Increased expression of GAP-43 in small sensory neurons after stimulation by NGF indicative of neuroregeneration in capsaicin-treated rats |
Q48603745 | Increased hypocretin-1 (orexin-a) levels in cerebrospinal fluid of rats after short-term forced activity |
Q48715355 | Increased intestinal epithelial proliferation in metallothioneine-transforming growth factor alpha transgenic mice |
Q60433323 | Increased opioid efficacy for inhibition of adenylyl cyclase in rat brain and 7315c cell membranes induced by chronic naltrexone treatment |
Q47895617 | Increased plasma levels of adrenomedullin, a vasoactive peptide, in patients with end-stage pulmonary disease. |
Q67936614 | Increased plasma levels of neuropeptide Y-like immunoreactivity and catecholamines in severe hypertension remain after treatment to normotension in man |
Q43286292 | Increased plasma levels of the mature and intermediate forms of adrenomedullin in obesity |
Q54733633 | Increased potency of antagonists of substance P having asparagine in position 6. |
Q43110746 | Increased prolyl endopeptidase activity in human neoplasia. |
Q47285923 | Increased receptor sensitivity to neuropeptide Y in the hypothalamus may underlie transient hyperphagia and body weight gain |
Q71742150 | Increased salt preference in adult offspring raised by mother rats consuming excessive amounts of salt and water |
Q93677280 | Increased serum pancreatic polypeptide and serum gastrin secretion in patients with functional dyspepsia: correlation to the shape of the duodenal loop |
Q52907124 | Increased sodium appetite and thirst in rat induced by the ingredients of liquorice, glycyrrhizic acid and glycyrrhetinic acid. |
Q48628003 | Increased somatostatin mRNA expression in periventricular nucleus of rat hypothalamus during hypoxia |
Q46811971 | Increased substance P content in nerve fibers associated with mesenteric veins from deoxycorticosterone acetate (DOCA)-salt hypertensive rats |
Q48250599 | Increased synthesis of neurokinin B and enkephalin after chronic haloperidol treatment |
Q50866021 | Increased thymosin β4 levels in the serum and SF of knee osteoarthritis patients correlate with disease severity. |
Q52236565 | Increases in NPY in non-sympathetic nerve fibres supplying rat mesenteric vessels after immunosympathectomy |
Q72585239 | Increases in arterial blood pressure in the rat in response to a new vertebrate neuropeptide, LPLRFamide, and a related molluscan peptide, FMRFamide |
Q58448131 | Incretin physiology and pathophysiology |
Q40829262 | Indirect RT-PCR in-situ hybridization: a novel non-radioactive method for detecting glucose-dependent insulinotropic peptide |
Q46414669 | Induction of angiogenesis by murine resistin: putative role of PI3-kinase and NO-dependent pathways. |
Q48868138 | Induction of wet-dog shaking in rats by analogues and metabolites of thyrotrophin-releasing hormone (TRH). |
Q47895596 | Inflammatory cells as source of tachykinin-induced mucus secretion in chronic bronchitis |
Q73953339 | Inflammatory response to cold injury in remote organs is reduced by corticotropin-releasing factor |
Q44200102 | Influence of VIP on prolactinemia in turkey anterior pituitary cells: role of cAMP second messenger in VIP-induced prolactin gene expression |
Q67584415 | Influence of VIP on the number of enterochromaffin and mucosal mast cells in the colon of the rat |
Q35613524 | Influence of a long-term high-fat diet on ghrelin secretion and ghrelin-induced food intake in rats |
Q52973701 | Influence of bombesin on neuronal hypothalamic thermosensitivity during the early postnatal period in the Muscovy duck (Cairina moschata). |
Q70155301 | Influence of cholecystokinin on central monoaminergic pathways |
Q77475188 | Influence of diet composition on food intake and neuropeptide Y (NPY) gene expression in goldfish brain |
Q46329496 | Influence of endothelin ET(A) and ET(B) receptor antagonists on endothelin-induced contractions of the guinea pig isolated gall bladder |
Q70158966 | Influence of gastric inhibitory polypeptide (GIP) and glucose on the regulation of glucagon secretion by pancreatic alpha cells |
Q70685270 | Influence of glucagon-like peptide-1 on beta cell responsiveness |
Q73205409 | Influence of glucose concentration on the inhibitory effect of amylin on insulin secretion. Study in the perfused rat pancreas |
Q77535598 | Influence of high-carbohydrate enriched diets on plasma insulin levels and insulin and IGF-I receptors in trout |
Q44921470 | Influence of intravenously administered leptin on nitric oxide production, renal hemodynamics and renal function in the rat. |
Q43850972 | Influence of leptin on neurotransmitter overflow from the rat brain in vitro. |
Q45930622 | Influence of long-term growth hormone replacement on leptin and ghrelin in GH deficiency before and after glucose load. |
Q71852231 | Influence of nicotine on gastrin and peptide YY in the rat |
Q50794774 | Influence of opioids on substance P release evoked by antidromic stimulation of primary afferent fibers in the hind instep of rats |
Q81323640 | Influence of orexin A on the mechanical activity of mouse gastric strips |
Q44200089 | Influence of pinealectomy on levels of PACAP and cAMP in the chicken brain |
Q42626516 | Influence of place learning on somatostatin levels in the rat brain following environmental deprivation |
Q70091148 | Influence of pregnancy and sex steroids on concentration, motor effect and receptor binding of VIP in the rabbit female genital tract |
Q50507861 | Influence of secretin and L-NAME on vascular permeability in the coronary circulation of intact and diabetic rats. |
Q68092707 | Influence of somatostatin and epidermal growth factor (EGF) on the proliferation of thyroid follicular cells in organ culture |
Q42456624 | Influence of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg (ALPMHIR) on the release of endothelin-1 by endothelial cells. |
Q69944047 | Infusion of a novel peptide, calcitonin gene-related peptide (CGRP) in man. Pharmacokinetics and effects on gastric acid secretion and on gastrointestinal hormones |
Q47575736 | Infusion of epidermal growth factor in mice: organ distribution and urinary excretion |
Q67902306 | Inhibition by VIP and atriopeptin II on the field stimulation evoked release of [3H]noradrenaline in the rat portal vein |
Q48180656 | Inhibition of CRF- and urotensin I-stimulated ACTH release from goldfish pituitary cell columns by the CRF analogue alpha-helical CRF-(9-41). |
Q71603501 | Inhibition of IGF-I and b-FGF stimulated growth of human retinal endothelial cells by the somatostatin analogue, octreotide: a potential treatment for ocular neovascularization |
Q42486383 | Inhibition of acid secretory response and induction of ornithine decarboxylase and its mRNA by TGF alpha and EGF in isolated rat gastric glands |
Q55479918 | Inhibition of adenylyl cyclase activity by the cholecystokinin analog SNF 9007 in neuroblastoma x glioma NG108-15 hybrid cells. |
Q44352308 | Inhibition of an opioid-evoked vagal reflex in rats by naloxone, SMS 201-995 and ICI 154, 129. |
Q71606205 | Inhibition of cAMP-mediated relaxation of rabbit tracheal smooth muscle by neuropeptide Y |
Q60923071 | Inhibition of compensatory renal growth by the N-terminus of a sheep-derived peptide |
Q28196579 | Inhibition of cytosolic phospholipase A2 mRNA expression: a novel mechanism for acetylsalicylic acid-mediated growth inhibition and apoptosis in colon cancer cells |
Q32056116 | Inhibition of gastric acid secretion by galanin in rats. Relation to endogenous histamine release |
Q70297709 | Inhibition of gastric and pancreatic secretions by cerebroventricular injections of gastrin-releasing peptide and bombesin in rats |
Q73117243 | Inhibition of gastric emptying by bombesin-like peptides is dependent upon cholecystokinin-A receptor activation |
Q71708267 | Inhibition of gastrin-stimulated enterochromaffin-like cell proliferation and mucosal histamine production in the rat stomach by the somatostatin analogue octreotide |
Q71774486 | Inhibition of gastrin-stimulated gastric acid secretion by medium-chain triglycerides and long-chain triglycerides in healthy young men |
Q58448893 | Inhibition of human gastric lipase by intraduodenal fat involves glucagon-like peptide-1 and cholecystokinin |
Q51786550 | Inhibition of insulin release by galanin and gastrin-releasing peptide in the anaesthetized rat. |
Q43284761 | Inhibition of intracellular angiotensin II formation blocks high glucose effect on mesangial matrix |
Q42045331 | Inhibition of juvenile hormone biosynthesis in mosquitoes: effect of allatostatic head factors, PISCF- and YXFGL-amide-allatostatins |
Q45998976 | Inhibition of methyldigoxin-induced arrhythmias by pentadecapeptide BPC 157: a relation with NO-system. |
Q40749868 | Inhibition of mu and delta opioid receptor ligand binding by the peptide aldehyde protease inhibitor, leupeptin |
Q72176499 | Inhibition of murine peritoneal macrophage functions by sulfated cholecystokinin octapeptide |
Q28268759 | Inhibition of neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist |
Q71717805 | Inhibition of pancreatic exocrine secretion and augmentation of the release of gut glucagon-like immunoreactive materials by intraileal administration of bile in the dog |
Q71241829 | Inhibition of pentagastrin-induced pressor response in conscious rats by the CCK-B receptor antagonist CI-988 and chlordiazepoxide |
Q69674869 | Inhibition of pentagastrin-stimulated gastric acid secretion by intraileal administration of bile and elevation of plasma concentrations of gut glucagon-like immunoreactivity in anesthetized dogs |
Q72837526 | Inhibition of phase III activity by acid in canine stomach |
Q45176385 | Inhibition of phospholipase C-independent exocytotic responses in rat peritoneal mast cells by U73122. |
Q68054386 | Inhibition of polyamine synthesis impairs the secretion of atrial natriuretic peptide |
Q33225625 | Inhibition of substance P activity prevents stress-induced bladder damage |
Q46563343 | Inhibition of substance P-induced vascular leakage in rat by N-acetyl-neurotensin-(8-13). |
Q43818782 | Inhibition of voltage-gated Ca(2+) current by PACAP in rat adrenal chromaffin cells |
Q41350558 | Inhibitory effect of ODN, a naturally occurring processing product of diazepam binding inhibitor, on secretagogues-induced insulin secretion |
Q44643675 | Inhibitory effect of galanin on dopamine induced increased oxytocin secretion in rat neurohypophyseal tissue cultures |
Q44240032 | Inhibitory effect of galanin on dopamine-induced enhanced vasopressin secretion in rat neurohypophyseal tissue cultures |
Q45176388 | Inhibitory effect of ghrelin on food intake is mediated by the corticotropin-releasing factor system in neonatal chicks |
Q48918717 | Inhibitory effect of neuropeptide Y on growth hormone secretion in rats is mediated by both Y1- and Y2-receptor subtypes and abolished after anterolateral deafferentation of the medial basal hypothalamus |
Q72534501 | Inhibitory effect of neurotensin on proline |
Q48534735 | Inhibitory effect of nociceptin on somatostatin secretion of the isolated perfused rat stomach |
Q42490468 | Inhibitory effect of pancreastatin on pancreatic exocrine secretion in the conscious rat. |
Q43544821 | Inhibitory effect of rat amylin on the insulin responses to glucose and arginine in the perfused rat pancreas |
Q46489008 | Inhibitory effect of somatostatin on prostaglandin E2 synthesis by primary neonatal rat glial cells |
Q44409569 | Inhibitory effect of somatostatin on the NPY response to insulin-induced hypoglycemia and the role of endogenous opioids |
Q71687929 | Inhibitory effect of vasoactive intestinal peptide (VIP) on phagocytosis in mouse peritoneal macrophages |
Q42456465 | Inhibitory effects of cysteamine on neuroendocrine function |
Q71241834 | Inhibitory effects of gastrin releasing peptide on gastric emptying in rats |
Q46789609 | Inhibitory effects of pituitary adenylate cyclase activating polypeptide on histamine-induced respiratory resistance in anesthetized guinea pigs |
Q46009885 | Inhibitory effects of somatostatin on cholecystokinin octapeptide induced bile regurgitation under stress: ionic and molecular mechanisms. |
Q40491082 | Inhibitory effects of substance P analogs on the activation of GTP-binding regulatory proteins by receptors |
Q46470921 | Inhibitory influence of chromogranin A N-terminal fragment (vasostatin-1) on the spontaneous contractions of rat proximal colon |
Q48637497 | Inhibitory interactions between and opoid but not NPY mechanisms controlling the CRF-ACTH axis in the rat |
Q73150054 | Inhibitory neurogenic modulation of histamine-induced cutaneous plasma extravasation in the pigeon |
Q70942117 | Initiating and responsible enzyme of arginine vasopressin degradation in human placenta and pregnancy serum |
Q44583794 | Injected TFF1 and TFF3 bind to TFF2-immunoreactive cells in the gastrointestinal tract in rats. |
Q68948678 | Innervation of human omental arteries and veins and vasomotor response to noradrenaline, neuropeptide Y, substance P and vasoactive intestinal peptide |
Q60302875 | Innervation of the foramen Panizzae sphincter and the aortic anastomosis in the crocodile, Crocodylus porosus |
Q40916494 | Inputs from the nucleus tractus solitarii to the magnocellular neurosecretory system. |
Q67524490 | Insertion and internalization of vasoactive intestinal peptide (VIP) receptors in murine CD4 T lymphocytes |
Q36981951 | Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin |
Q36501592 | Insights into the impact of phenolic residue incorporation at each position along secretin for receptor binding and biological activity |
Q52222302 | Insulin II gene expression in rat central nervous system. |
Q70217474 | Insulin affects ionic composition of rainbow trout erythrocytes |
Q42504927 | Insulin and glucagon secretion in rats: effects of calcitonin gene-related peptide |
Q38530127 | Insulin and insulin-like growth factor-I (IGF-I) binding in fish red muscle: regulation by high insulin levels. |
Q49112993 | Insulin and insulin-like growth factor-I receptors in fish brain |
Q33207039 | Insulin feedback actions: complex effects involving isoforms of islet nitric oxide synthase |
Q41121052 | Insulin gene expression in immortalized rat hippocampal and pheochromocytoma-12 cell lines |
Q45152892 | Insulin hypoglycemia increases the levels of neuropeptide Y and calcitonin gene-related peptide, but not of chromogranins A and B, in rat chromaffin granules |
Q43862111 | Insulin inhibits lipolytic activity and degradation of beta-lipotropin in rabbit adipose tissue |
Q44746258 | Insulin stimulates placental leucine aminopeptidase/oxytocinase/insulin-regulated membrane aminopeptidase expression in BeWo choriocarcinoma cells |
Q68647463 | Insulin-induced hypoglycemia, L-dopa and arginine stimulate GH secretion through different mechanisms in man |
Q71603479 | Insulin-like growth factor (IGF) binding proteins and insulin-like growth factor secretion by cultured chondrocyte cells: identification, characterization and ontogeny during cell differentiation |
Q41520227 | Insulin-like growth factor (IGF) suppression of IGFBP-1 production: evidence for mediation by the type I IGF receptor |
Q48722728 | Insulin-like growth factor I (IGF-I) receptors and IGF-I action in oligodendrocytes from rat brains |
Q72440609 | Insulin-like growth factor I in human gastrointestinal exocrine secretions |
Q71603488 | Insulin-like growth factor binding protein-2, 28 kDa and 24 kDa insulin-like growth factor binding protein levels are decreased in fluid of dominant follicles, obtained from normal and polycystic ovaries |
Q71603490 | Insulin-like growth factor regulation of human endometrial stromal cell function: coordinate effects on insulin-like growth factor binding protein-1, cell proliferation and prolactin secretion |
Q41754814 | Insulin-like growth factor-1 inhibits colonic smooth muscle cell apoptosis in diabetic rats with colonic dysmotility |
Q41520221 | Insulin-like growth factor-I (IGF-I) dependent phosphorylation of the IGF-I receptor in MG-63 cells |
Q30968535 | Insulin-like growth factor-I down-regulates ghrelin receptor (growth hormone secretagogue receptor) expression in the rat pituitary |
Q34791776 | Insulin-like growth factor-I in wound healing of rat skin |
Q72307447 | Insulin-like growth factors enhance phagocytosis by human neutrophils in vitro |
Q52202986 | Insulin-like growth factors in chick embryo retina during development. |
Q84577174 | Insulin-like peptide 3 stimulates testosterone secretion in mouse Leydig cells via cAMP pathway |
Q39845114 | Insulinostatic activity of cerebellin--evidence from in vivo and in vitro studies in rats |
Q51643333 | Insulinotropic and gastrin-releasing action of gastrin-releasing peptide (GRP) |
Q71367143 | Insulinotropic effects of cholecystokinin, gastric inhibitory polypeptide and glucagon-like peptide-1 during perifusion of short-term cultured canine isolated islets |
Q42449382 | Intact neurotensin (NT) in human plasma: response to oral feeding |
Q77535618 | Integrins inhibit angiotensin II-induced contraction in rat aortic rings |
Q48960568 | Interaction between angiotensin III and alpha 2-adrenoceptors of the medulla oblongata involved in cardiovascular regulation in the rat. |
Q46730508 | Interaction between arginine vasopressin and angiotensin II receptors in the central regulation of sodium balance |
Q73444369 | Interaction between brain natriuretic peptide and atrial natriuretic peptide in caecal circular smooth muscle cells |
Q28575224 | Interaction of AT1 receptors and V1a receptors-mediated effects in the central cardiovascular control during the post-infarct state |
Q70130285 | Interaction of [125I]-Tyr4-bombesin with specific receptors on normal human pancreatic membranes |
Q54462176 | Interaction of atrial natriuretic peptide, urodilatin, guanylin and uroguanylin in the isolated perfused rat kidney. |
Q68994993 | Interaction of bradykinin and des-Arg9-bradykinin with isolated pig coronary arteries: mechanical and electrophysiological events |
Q67941723 | Interaction of neurotensin with caerulein or secretin on digestive tract growth in rats |
Q72059631 | Interaction of neurotensin with prostaglandin E2 and prostaglandin synthesis inhibitors: effects on colonic temperature in mice |
Q73403311 | Interaction of nicotine and a H2-receptor antagonist, famotidine, on gastrin and chromogranin A expression |
Q44921477 | Interaction of ovokinin(2-7) with vascular bradykinin 2 receptors |
Q72099773 | Interaction of substance P and leukotriene C4 in ethanol-induced mucosal injury of rat stomach |
Q46216868 | Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A(352-372)) with the chromaffin cell surface and Torpedo electroplax: implications for nicotinic cholinergic antagonism |
Q43878306 | Interaction of the hypocretins with neurotransmitters in the nucleus accumbens |
Q41194933 | Interaction of vasopressin and angiotensin II in central control of blood pressure and thirst |
Q48951330 | Interaction of β-endorphin, naloxone and dopamine: effects on melanocyte-stimulating hormone secretion of amphibian pituitaries in vitro |
Q38573390 | Interactions between NPY and its receptor: assessment using ant-NPY antibodies |
Q51660608 | Interactions between excitatory amino acids and tachykinins and long-term changes of synaptic responses in the rat spinal dorsal horn |
Q56428348 | Interactions between growth hormone-releasing hormone and glucocorticoids in male rats |
Q43701502 | Interactions between orexin A, NPY and galanin in the control of food intake of the goldfish, Carassius auratus. |
Q41167454 | Interactions between oxytocin, glucagon and glucose in normal and streptozotocin-induced diabetic rats |
Q46918790 | Interactions of chromogranin A-derived vasostatins and monolayers of phosphatidylserine, phosphatidylcholine and phosphatidylethanolamine |
Q59616303 | Interactions of exendin-(9–39) with the effects of glucagon-like peptide-1-(7–36) amide and of exendin-4 on arterial blood pressure and heart rate in rats |
Q45151335 | Interactions of galanin and opioids in nociceptive modulation in the arcuate nucleus of hypothalamus in rats |
Q70005835 | Interactive effects of intracisternal oxytocin and other centrally active substances on colonic temperatures of mice |
Q39579417 | Interferon-γ modulates intestinal epithelial cell function in-vitro through a TGFβ-dependent mechanism |
Q56990821 | Interleukin-1 -and corticotropin releasing factor-induced release of β-endorphin from immune cells and inhibition of inflammatory pain |
Q48491216 | Interleukin-1 beta increases synaptic inhibition in rat hippocampal pyramidal neurons in vitro |
Q68481224 | Interleukin-1 stimulates diglyceride accumulation in the absence of protein kinase C activation |
Q48875696 | Interleukin-1beta depolarizes magnocellular neurons in the paraventricular nucleus of the hypothalamus through prostaglandin-mediated activation of a non selective cationic conductance |
Q42449759 | Interleukin-1beta induces the novel adipokine chemerin in adipocytes in vitro |
Q77966500 | Interleukin-1beta potentiates endothelin ET(B) receptor-mediated contraction in cultured segments of human temporal artery |
Q48572389 | Intermedin 1-53 inhibits rat cardiac fibroblast activation induced by angiotensin II. |
Q46742282 | Internalization of cloned pancreatic polypeptide receptors is accelerated by all types of Y4 agonists |
Q46574253 | Internalization of neuropeptide Y Y1 and Y5 and of pancreatic polypeptide Y4 receptors is inhibited by lithium in preference to sodium and potassium ions |
Q47308448 | Internalization studies of chimeric neuropeptide Y receptors Y1 and Y2 suggest complex interactions between cytoplasmic domains |
Q72099694 | International Symposium on Substance P and Related Peptides: Pain, Inflammation, Visceral and CNS Functions. Proceedings. Shizuoka, Japan, November 3-6, 1992 |
Q68458452 | International Symposium on Tachykinins. 20-23 July 1988, Graz, Austria. Abstracts |
Q68306442 | International symposium on calcitonin gene-related peptide. Graz, Austria, 28-31 July 1991. Abstracts |
Q67900250 | International symposium on substance P and related peptides. Pain, inflammation, visceral and CNS functions. November 3-6, 1992, Shizuoka, Japan. Abstracts |
Q59537823 | Interrelationships between calcitonin gene-related peptide and sympathoadrenomedullary system: Effects of administration of epinephrine and norepinephrine in healthy man |
Q47987612 | Interstitial concentrations of adipokines in subcutaneous abdominal and femoral adipose tissue. |
Q80507477 | Intestinal fatty acid binding protein (I-FABP) as a possible biomarker of ileitis in patients with ulcerative colitis |
Q46791988 | Intestinal ischemia-reperfusion injury made leptin decreased |
Q44988468 | Intestinal protective effect of a commercial fish protein hydrolysate preparation |
Q40463994 | Intestinal trefoil factor promotes invasion in non-tumorigenic Rat-2 fibroblast cell. |
Q43776979 | Intracellular renin alters the electrical properties of the intact heart ventricle of adult Sprague Dawley rats |
Q42066115 | Intracellular signal transduction of PBAN action in lepidopteran insects: inhibition of sex pheromone production by compactin, an HMG CoA reductase inhibitor |
Q36101331 | Intracellular signaling following myocardial stretch: an autocrine/paracrine loop |
Q39883766 | Intracellular signaling pathways involved in inhibition of PAI-1 expression by CNP in endothelial cells |
Q28570602 | Intracerebral oxytocin modulates sleep-wake behaviour in male rats |
Q48793380 | Intracerebroventricular administration of angiotensin type 1 (AT1) receptor antisense oligonucleotides attenuate thirst in the rat. |
Q69192069 | Intracerebroventricular administration of calcitonin enhances glucose-stimulated release of insulin |
Q84623258 | Intracerebroventricular administration of vasoactive intestinal peptide inhibits food intake |
Q58329601 | Intracerebroventricular injection of neuropeptide Y modifies carbohydrate and lipid metabolism in chicks |
Q48013736 | Intracerebroventricular injection of stresscopin-related peptide enhances cardiovascular function in conscious rats |
Q48324212 | Intracerebroventricular injections of cholecystokinin octapeptide suppress feeding in rats--pharmacological characterization of this action |
Q54132271 | Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the rat. |
Q38357195 | Intracisternal administration of Angiotensin II AT1 receptor antisense oligodeoxynucleotides protects against cerebral ischemia in spontaneously hypertensive rats |
Q45244194 | Intracisternal galanin/angiotensin II interactions in central cardiovascular control. |
Q69196702 | Intracisternal injection of TRH precursor, TRH-glycine, stimulates gastric acid secretion in rats |
Q71644372 | Intracisternal injection of peptide YY inhibits gastric emptying in rats |
Q48247158 | Intracisternal neutral endopeptidase-24.11 inhibitors produce inhibition in gastric acid output: independence from opiate, bombesin, or neurotensin-mediated mechanisms |
Q46062348 | Intranasal administration of mouse [D-Leu-4]OB3, a synthetic peptide amide with leptin-like activity, enhances total uptake and bioavailability in Swiss Webster mice when compared to intraperitoneal, subcutaneous, and intramuscular delivery systems |
Q30496299 | Intraneuronal angiotensinergic system in rat and human dorsal root ganglia |
Q42498659 | Intraocular transplants of a human gastrinoma in immuno-suppressed rats: morphological, chromatographic and functional studies |
Q79705106 | Intrapulmonary potential of polyethylene glycol-modified glucagon-like peptide-1s as a type 2 anti-diabetic agent |
Q42483753 | Intratesticular injection of [D-Met2-Pro5]enkephalinamide suppresses testosterone secretion of the testis of immature rat. |
Q57653358 | Intrathecal administration of NK1 receptor antagonist, CP96345, inhibits the micturition reflex in the rat |
Q48345410 | Intrathecal bombesin-induced inhibition of gastrointestinal transit: requirement for an intact pituitary-adrenal axis |
Q93639151 | Intravenous histamine reduces bombesin-stimulated gastrin release in dogs |
Q44397784 | Intravenous urocortin II decreases blood pressure through CRF(2) receptor in rats |
Q48457388 | Intraventricular 6-hydroxydopamine increases thyrotropin-releasing hormone (TRH) content in regions of rat brain |
Q46606174 | Intraventricular injection of neuropeptide Y antisera curbs weight gain and feeding, and increases the display of sexual behaviors in obese Zucker female rats |
Q46180119 | Intravital microscopy: a new in vivo technique for visualizing and quantifying effects of regulatory peptides on choledochoduodenal junction motility |
Q45274658 | Investigation of the mechanisms involved in the central effects of glucagon-like peptide-1 on ethanol-induced gastric mucosal lesions |
Q33211317 | Investigation of the species selectivity of a nonpeptide CGRP receptor antagonist using a novel pharmacodynamic assay |
Q72099906 | Investigations of the expression and post-translational processing of the preprotachykinin-I (PPT-I) gene by rat pancreatic, insulin-producing tumor cell-lines |
Q45176363 | Involvement of CGRP in the inhibitory effect of rutaecarpine on vasoconstriction induced by anaphylaxis in guinea pig. |
Q44921505 | Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells |
Q42790768 | Involvement of Na,K-pump in SEPYLRFamide-mediated reduction of cholinosensitivity in Helix neurons |
Q49139533 | Involvement of ORL1 receptor and ERK kinase in the orphanin FQ-induced nociception in the nucleus accumbens of rats |
Q81239804 | Involvement of angiotensin-(1-7) in the hypothalamic hypotensive effect of captopril in sinoaortic denervated rats |
Q46837171 | Involvement of arachidonic acid metabolism and EGF receptor in neurotensin-induced prostate cancer PC3 cell growth |
Q44700869 | Involvement of atrial natriuretic peptide in blood pressure reduction induced by estradiol in spontaneously hypertensive rats |
Q71606185 | Involvement of beta-endorphin in the modulation of paw inflammatory edema in the rat |
Q48423582 | Involvement of brain ANG II in acute sodium depletion induced salty taste changes. |
Q36853571 | Involvement of calcium-activated potassium channels in the inhibitory prejunctional effect of morphine on peripheral sensory nerves |
Q44451612 | Involvement of capsaicin-sensitive sensory nerves in cardioprotection of rutaecarpine in rats |
Q79438039 | Involvement of endothelial NO in the dilator effect of VIP on rat isolated pulmonary artery |
Q45244162 | Involvement of hypothalamic neuropeptide Y in regulating the amphetamine-induced appetite suppression in streptozotocin diabetic rats |
Q44200144 | Involvement of intracellular Ca2+ elevation but not cyclic AMP in PACAP-induced p38 MAP kinase activation in PC12 cells. |
Q44352869 | Involvement of mu-receptors in the opioid-induced generation of bursting discharges in hippocampal pyramidal cells |
Q80236150 | Involvement of multiple signaling pathways in PACAP-induced EM66 secretion from chromaffin cells |
Q73150075 | Involvement of neuropeptide Y and Y1 receptor in antinociception in nucleus raphe magnus of rats |
Q43963211 | Involvement of nitric oxide and potassium channels in the bradykinin-induced vasodilatation in the rat kidney perfused ex situ |
Q44345662 | Involvement of opioid receptors in the oxytocin-induced antinociception in the central nervous system of rats |
Q77123827 | Involvement of ornithine decarboxylase and polyamines in epidermal growth factor-induced recovery of gastric mucosa from gastric lesions provoked by stress |
Q45228228 | Involvement of perivascular neuropeptide Y nerve fibres in uterine arterial vasoconstriction in conjunction with pregnancy |
Q71774478 | Involvement of phenylalanine 23 in the binding of IGF-1 to the insulin and type I IGF receptor |
Q71712887 | Involvement of phospholipase A2 and arachidonic acid in cholecystokinin-8-induced insulin secretion in rat islets |
Q73571471 | Involvement of prostaglandins and CGRP-dependent sensory afferents in peritoneal irritation-induced visceral pain |
Q42484657 | Involvement of ryanodine receptors in EPYLRFamide-mediated reduction of acetylcholine-induced inward currents in helix lucorum identified neurones |
Q48328831 | Involvement of stomach ghrelin and hypothalamic neuropeptides in tumor necrosis factor-alpha-induced hypophagia in mice |
Q72099766 | Involvement of substance P in the paroxysmal cough of pertussis |
Q72099741 | Involvement of substance P present in small-diameter afferent fibers in microcirculatory hemodynamics of the rat hind instep |
Q72534477 | Involvement of tachykinin and CGRP receptors in the cardio-pulmonary effects evoked by capsaicin in the guinea-pig |
Q48493840 | Involvement of tetrodoxin-sensitive sodium channels in rat growth hormone secretion induced by pituitary adenylate cyclase-activating polypeptide (PACAP). |
Q44384733 | Involvement of the central adrenomedullin peptides in the baroreflex |
Q41436799 | Involvement of the hypothalamus in opiate-stimulated prolactin secretion |
Q45930777 | Involvement of the intermediate nucleus of the lateral septal area on angiotensin II-induced dipsogenic and pressor responses. |
Q56983574 | Involvement of the nitric oxide pathway in nociceptive processes in the central nervous system in rats |
Q43878309 | Involvement of the serotonergic system in orexin-induced behavioral alterations in rats |
Q48436638 | Involvement of thyrotropin-releasing hormone (TRH) neural system of the brain in pentylenetetrazol-induced seizures |
Q40548411 | Involvement of transmitters in pituitary adenylate cyclase-activating polypeptide-induced hyperthermia. |
Q48264330 | Iodinated derivatives of the vasoactive intestinal polypeptide (VIP) are agonists at the cat pancreas and the rat submandibular salivary gland |
Q114684099 | Is GIP release influenced by intraduodenal acidification? |
Q87255079 | Is association between thyroid hormones and gut peptides, ghrelin and obestatin, able to suggest new regulatory relation between the HPT axis and gut? |
Q84569332 | Is caseinomacropeptide from milk proteins, an inhibitor of gastric secretion? |
Q48137100 | Is helodermin produced by medullary thyroid carcinoma cells and normal C-cells? Immunocytochemical evidence |
Q43670053 | Is helodermin-like immunoreactivity in human thyroid C cells due to a salmon calcitonin-like substance? |
Q72484697 | Is somatostatin or a somatostatin-like peptide involved in central nervous system control of gastric secretion? |
Q72099897 | Is the selective non-peptide NK-1 receptor antagonist CP96,345 a peripherally acting analgesic? |
Q44921496 | Is there a link between salt-intake and atrial natriuretic peptide system during hypertension induced by nitric oxide blockade? |
Q40916559 | Is there a paracellular water pathway in inner medullary collecting ducts (IMCD) from dehydrated rats? |
Q48359671 | Is there really an NPY Y3 receptor? |
Q54597569 | Islet Neogenesis Associated Protein (INGAP) modulates gene expression in cultured neonatal rat islets. |
Q72246346 | Islet amyloid polypeptide (IAPP) in patients with neuroendocrine tumours |
Q42522847 | Islet amyloid polypeptide (IAPP) secretion from pancreatic islets isolated from non-obese diabetic (NOD) mice |
Q31133741 | Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets |
Q51747033 | Islet neogenesis-associated protein (INGAP): the role of its endogenous production as a positive modulator of insulin secretion. |
Q45980649 | Islet neogenesis-associated protein pentadecapeptide (INGAP-PP): mechanisms involved in its effect upon beta-cell mass and function. |
Q78162219 | Islet neuronal abnormalities associated with impaired insulin secretion in type 2 diabetes in the Chinese hamster |
Q44921461 | Isolation and characterisation of an unexpected class of insulinotropic peptides in the skin of the frog Agalychnis litodryas |
Q44336387 | Isolation and characterization of a hemoglobin-derived opioid peptide from the human pituitary gland |
Q69601206 | Isolation and characterization of a neurotensin-like decapeptide from a canine upper small intestinal extract |
Q48175810 | Isolation and characterization of beta-endorphin-(1-9) from human and rat pituitaries |
Q69671050 | Isolation and characterization of bovine pancreastatin |
Q50782561 | Isolation and characterization of four VIP-related peptides from red-bellied newt, Cynops pyrrhogaster. |
Q43415665 | Isolation and characterization of human thyrotropin-releasing hormone (TRH) from an endocrine pancreatic tumor |
Q73828211 | Isolation and characterization of putative trefoil peptide receptors |
Q39555728 | Isolation and characterization of schistostatin-2(11-18) from the desert locust, Schistocerca gregaria: a truncated analog of schistostatin-2. |
Q54441125 | Isolation and characterization of substance P, substance P 5-11, and substance K from two metastatic ileal carcinoids. |
Q72506853 | Isolation and chemical characterization of somatostatin-28 from rat hypothalamus |
Q52535831 | Isolation and identification of Lom-SG-SASP, a salivation stimulating peptide from the salivary glands of Locusta migratoria. |
Q44695055 | Isolation and identification of islet amyloid polypeptide in normal human pancreas |
Q56429434 | Isolation and partial characterization of an endothelial cell growth factor from the bovine kidney: homology with basic fibroblast growth factor |
Q69529502 | Isolation and partial sequence of elasmobranch VIP |
Q39038534 | Isolation and primary structure of a novel adipokinetic peptide from the pyrgomorphid grasshopper, Phymateus leprosus |
Q38568008 | Isolation and primary structure of a novel avian pancreatic polypeptide from five species of Eurasian crow |
Q45223655 | Isolation and primary structure of an amphibian neurotensin |
Q51596995 | Isolation and sequence determination of two N-terminal fragments of islet amyloid polypeptide in rat pancreas. |
Q43900083 | Isolation and sequence of rat peptide YY and neuropeptide Y |
Q48634411 | Isolation and structural elucidation of eight kinins from the retrocerebral complex of the American cockroach, Periplaneta americana |
Q68880687 | Isolation and structures of coho salmon (Oncorhynchus kisutch) glucagon and glucagon-like peptide |
Q48931789 | Isolation and structures of xenopsin-related peptides from rat stomach, liver and brain |
Q44174163 | Isolation of five tachykinin-related peptides from the midgut of the cockroach Leucophaea maderae: existence of N-terminally extended isoforms |
Q46658999 | Isolation of scorpion (Androctonus amoreuxi) putative alpha neurotoxins and parallel cloning of their respective cDNAs from a single sample of venom |
Q43606416 | Isolation, characterization and biological activity of a CRF-related diuretic peptide from Periplaneta americana L |
Q44168195 | Isolation, identification and functional significance of [Hyp2]Met-callatostatin and des Gly-Pro Met-callatostatin, two further post-translational modifications of the blowfly neuropeptide Met-callatostatin |
Q43876111 | Isolation, identification and synthesis of locustamyoinhibiting peptide (LOM-MIP), a novel biologically active neuropeptide from Locusta migratoria |
Q40286773 | Isoproterenol stimulates monocyte chemoattractant protein-1 expression and secretion in 3T3-L1 adipocytes |
Q42809795 | JMV641: a potent bombesin receptor antagonist that inhibits Swiss 3T3 cell proliferation |
Q43701523 | K(+)-p-nitrophenylphosphatase inhibition by neurotensin involves high affinity neurotensin receptor: influence of potassium concentration and enzyme phosphorylation |
Q67902303 | Kallidin applied to the human nasal mucosa produces algesic response not blocked by capsaicin desensitization |
Q37237647 | Keratinocytes express cytokines and nerve growth factor in response to neuropeptide activation of the ERK1/2 and JNK MAPK transcription pathways |
Q39123206 | Key amino acid residues in the melanocortin-4 receptor for nonpeptide THIQ specific binding and signaling |
Q30746215 | Kinestatin: a novel bradykinin B2 receptor antagonist peptide from the skin secretion of the Chinese toad, Bombina maxima |
Q48271394 | Kinetics of four 11C-labelled enkephalin peptides in the brain, pituitary and plasma of rhesus monkeys |
Q51460746 | Kinin B1 receptor-mediated motor responses in normal or inflamed rat urinary bladder in vivo. |
Q74419559 | Kinin receptors mediating the effect of bradykinin on gastric acid secretion |
Q56983579 | L-Nitroarginine methyl ester attenuates the development of morphine tolerance and dependence in mice |
Q39749317 | L-carnitine attenuates oxidant injury in HK-2 cells via ROS-mitochondria pathway |
Q51580569 | LHRH and somatostatin effects on the cell proliferation of the gastric epithelium of suckling and weaning rats. |
Q61838881 | LHRH antagonist inhibits gastric cell proliferation in suckling rats |
Q43850978 | Lack of a distinctive behavioural effect of chromogranin-derived peptides in rodents |
Q48454563 | Lack of angiotensin II conversion to angiotensin III increases water but not alcohol consumption in aminopeptidase A-deficient mice. |
Q46344416 | Lack of beneficial effect of a tachykinin receptor antagonist in experimental colitis |
Q42488303 | Lack of biologic activity or specific binding of amino-terminal pro-ANP segments in the rat. |
Q28290082 | Lack of obestatin effects on food intake: should obestatin be renamed ghrelin-associated peptide (GAP)? |
Q51649513 | Large and small forms of cholecystokinin in human plasma: measurement using high pressure liquid chromatography and radioimmunoassay. |
Q48115538 | Lateral hypothalamic serotonin is not stimulated during central leptin hypophagia |
Q28572917 | Lateralized learning and memory effects of vasoactive intestinal peptide infused into the rat hippocampal CA1 area |
Q81103385 | Leptin ameliorates burn-induced multiple organ damage and modulates postburn immune response in rats |
Q40535031 | Leptin and prolactin modulate the expression of SOCS-1 in association with interleukin-6 and tumor necrosis factor-alpha in mammary cells: a role in differentiated secretory epithelium. |
Q38487253 | Leptin blocks the fasting-induced increase of pERK1/2 in the paraventricular nucleus of rats |
Q81420989 | Leptin concentrations in the abdominal subcutaneous adipose tissue of patients with anorexia nervosa assessed by in vivo microdialysis |
Q38306306 | Leptin deficiency leads to the regulation of kinin receptors expression in mice |
Q39603731 | Leptin differentially regulates NPY secretion in hypothalamic cell lines through distinct intracellular signal transduction pathways |
Q52164557 | Leptin effects on pulsatile gonadotropin releasing hormone secretion from the adult rat hypothalamus and interaction with cocaine and amphetamine regulated transcript peptide and neuropeptide Y. |
Q45244191 | Leptin fragments induce Fos immunoreactivity in rat hypothalamus |
Q38307707 | Leptin is a potent stimulator of bone growth in ob/ob mice |
Q46631120 | Leptin modulates enteric neurotransmission in the rat proximal colon: an in vitro study |
Q34056747 | Leptin physiology: a second look |
Q42443400 | Leptin suppresses basal insulin secretion from rat pancreatic islets |
Q47375112 | Leptin-derived peptides that stimulate food intake and increase body weight following peripheral administration |
Q45244176 | Leptin-like effects of MTII are augmented in MSG-obese rats |
Q48975324 | Leptin-programmed rats respond to cold exposure changing hypothalamic leptin receptor and thyroid function differently from cold-exposed controls. |
Q34056731 | Leptin: a possible link between food intake, energy expenditure, and reproductive function. |
Q48002559 | Lessons from the adrenomedullin knockout mouse |
Q36711782 | Lessons from the gastrin knockout mice |
Q40872210 | Levels of angiotensin and molecular biology of the tissue renin angiotensin systems |
Q42621023 | Ligand association with the rabbit kidney and brain Y1, Y2 and Y5-like neuropeptide Y (NPY) receptors shows large subtype-related differences in sensitivity to chaotropic and alkylating agents |
Q46494284 | Ligand binding and functional effects of systematic double D-amino acid residue substituted neuropeptide Y analogs on Y1 and Y2 receptor types. |
Q68456004 | Limited proteolysis of the vasoactive intestinal peptide receptor: comparison of its folded structure in the membrane-bound and detergent-solubilized states |
Q87861461 | Linagliptin enhances neural stem cell proliferation after stroke in type 2 diabetic mice |
Q43224245 | Liraglutide, but not vildagliptin, restores normoglycaemia and insulin content in the animal model of type 2 diabetes, Psammomys obesus |
Q48968861 | Local cerebral blood flow following the intrastriatal administration of vasoactive intestinal peptide or peptide histidine isoleucine in the rat. |
Q56990826 | Local inflammation of the rat paw enhances opioid receptor density in paw tissue and their axonal transport in sciatic nerve |
Q32078865 | Localisation and neural control of the release of calcitonin gene-related peptide (CGRP) from the isolated perfused porcine ileum |
Q60640279 | Localisation and plasma release of atrial natriuretic peptide immunoreactivity (ANP-IR) in the rat |
Q52453465 | Localisation of a particulate luliberin hydrolysing activity in microsomal membranes of guinea pig brain. |
Q46547857 | Localization and characterization of gonadotropin-releasing hormones in the brain, gonads, and plasma of a dipnoi (lungfish, Protopterus annectens). |
Q49053369 | Localization and characterization of neuropeptide Y/peptide YY receptors in the brain of the smooth dogfish (Mustelis canis). |
Q71630205 | Localization and inhibitory actions of galanin at the feline lower esophageal sphincter |
Q71241845 | Localization and quantitation of angiotensin AT1 and AT2 receptors in the pregnant and non-pregnant sheep uterus |
Q58449374 | Localization in the gastrointestinal tract of immunoreactive prosomatostatin |
Q33933589 | Localization of NK1 and NK3 receptors in guinea-pig brain |
Q70159223 | Localization of atrial natriuretic peptide, ANP-(99-126) binding sites in the rat thymus and spleen with quantitative autoradiography |
Q43459109 | Localization of calbindin D28K-like immunoreactivity in fish gill: a light microscopic and immunoelectron histochemical study |
Q77535605 | Localization of motilin binding sites in subcellular fractions from rabbit antral and colonic smooth muscle tissue |
Q57743851 | Localization of mu, delta and kappa opioid receptor mRNAs in human brain |
Q44240042 | Localization of mu-opioid receptor 1A on sensory nerve fibers in human skin. |
Q84227975 | Localization of neuroendocrine regulatory peptide-1 and-2 in human tissues |
Q38346679 | Localization of neuropeptide Y receptor Y5 mRNA in the guinea pig brain by in situ hybridization |
Q43455041 | Localization of peripheral benzodiazepine binding sites and diazepam-binding inhibitor (DBI) mRNA in mammary glands and dimethylbenz(a)antracene (DMBA)-induced mammary tumors in the rat. |
Q44809407 | Localization of receptors for atrial natriuretic polypeptide (ANP) in the glomerulus: in vitro electron microscopic autoradiographical investigation using 125I-labeled ANP. |
Q71606188 | Localization of substance P NK-1 receptors in rat tongue |
Q72892401 | Localization of γ-melanocyte stimulating hormone (γMSH) immunoreactivity in rat brain and pituitary |
Q44583790 | Localization, transmission, spontaneous mutations, and variation of function of the Dpp4 (Dipeptidyl-peptidase IV; CD26) gene in rats |
Q40465215 | Location and secretion of brain angiotensinogen |
Q74338116 | Location of renin-angiotensin system components in the hypoglossal nucleus of the rat |
Q41768362 | Locustakinin, a novel myotropic peptide from Locusta migratoria, isolation, primary structure and synthesis. |
Q48836950 | Locustatachykinin III and IV: two additional insect neuropeptides with homology to peptides of the vertebrate tachykinin family. |
Q40497622 | Long-acting analogue of vasoactive intestinal peptide, [R15, 20, 21, L17]-VIP-GRR (IK312532), protects rat alveolar L2 cells from the cytotoxicity of cigarette smoke |
Q42169987 | Long-lasting smooth-muscle relaxation by a novel PACAP analogue in human bronchi |
Q38307702 | Long-term differential modulation of genes encoding orexigenic and anorexigenic peptides by leptin delivered by rAAV vector in ob/ob mice. Relationship with body weight change |
Q43520649 | Long-term downregulation of protease-activated receptor-2 expression in distal colon in rats following bacillary dysentery |
Q44643694 | Long-term estradiol treatment improves VIP-mediated vasodilation in atherosclerotic proximal coronary arteries |
Q42482706 | Long-term infusion of nutrients (total parenteral nutrition) suppresses circulating ghrelin in food-deprived rats |
Q48107270 | Long-term maintenance of growth hormone secretion in perifused rat anterior pituitary cells |
Q40153145 | Long-term serotonin effects in the rat are prevented by terguride. |
Q46009878 | Losartan exerts renoprotection through NAD(P)H oxidase downregulation in a renovascular model of hypertension. |
Q43227819 | Loss of RegI in conjunction with gastrin deficiency in mice facilitates efficient gastric ulcer healing but is dispensable for hyperplasia and tumourigenesis |
Q51578962 | Loss of the adrenoceptor-mediated secretory drive on the rat parotid gland during eating and the effect on parasympathetic substance P and VIP. |
Q68087392 | Low hepatic clearance of peptide YY (PYY) in the perfused rat liver |
Q84506295 | Low pre-transplant adiponectin multimers are associated with adverse allograft outcomes in kidney transplant recipients a 3-year prospective study |
Q28577384 | Low-affinity CCK-1 receptors inhibit bombesin-stimulated secretion in rat pancreatic acini--implication of the actin cytoskeleton |
Q60628055 | Low-dose buprenorphine detoxification in long term methadone addicts |
Q44627686 | Low-dose ghrelin infusion--evidence against a hormonal role in food intake |
Q42488842 | Loxiglumide inhibits cholecystokinin stimulated somatostatin secretion and simultaneously enhances gastric acid secretion in humans |
Q81305786 | Luminal and parenteral TFF2 and TFF3 dimer and monomer in two models of experimental colitis in the rat |
Q54124935 | Luminal receptors for bradykinin on the canine tracheal epithelium: functional subtyping. |
Q42632565 | Luminal responses to bradykinin on the isolated canine tracheal epithelium: effects of bradykinin antagonists |
Q54134406 | Luminal tachykinin receptors on canine tracheal epithelium: functional subtyping. |
Q77535620 | Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of IGF-II in tumors |
Q36755180 | MEN 10,573 and MEN 10,612, novel cyclic pseudopeptides which are potent tachykinin NK-2 receptor antagonists |
Q72099734 | Maintained peptidergic innervation of the knee joint in an animal model of antigen-induced arthritis |
Q72265295 | Mammalian gonadotropin-releasing hormone (GnRH) identified by primary structure in Russian sturgeon, Acipenser gueldenstaedti |
Q44306510 | Manipulation of neonatal gonadal steroid milieu and leptin secretion in later life in male and female rats |
Q48311548 | Mapping of angiotensin AT1 receptors in the rat limbic system |
Q78729805 | Mapping of cyclosporin A binding sites in cyclophilin A by using synthetic peptides |
Q40766324 | Mapping the ligand binding site of the NK-1 receptor |
Q46099408 | Marked depression of brain cholecystokinin and vasoactive intestinal polypeptide levels in Eck fistula dogs |
Q120907391 | Marked gastrointestinal hormone surges accompany the massive bowel adaptation associated with feeding in the burmese python |
Q53858270 | Marsupial possum neurotensin: a unique mammalian regulatory peptide exhibiting structural homology to the avian analogue. |
Q72287121 | Mass spectrometric and biological characterization of guinea-pig corticotrophin |
Q78162216 | Mast cells contribute to PACAP-induced dermal oedema in mice |
Q51636241 | Meal stimulated levels of pancreatic polypeptide (PP) and vasoactive intestinal polypeptide (VIP) in gastroplasty for morbid obesity. |
Q42446744 | Meal-stimulated and atropine-inhibited secretion of pancreatic polypeptide in healthy subjects, members of MEA I families and patients with malignant endocrine tumours of the gastrointestinal tract |
Q42476686 | Meal-stimulated exocrine pancreatic secretion and release of GI peptides in normal and nicotine-treated rats |
Q71466276 | Measurement and localization of angiotensin-like immunoreactivity in juxtaglomerular cells of the rat |
Q70130292 | Measurement and partial characterization of the multiple forms of neurokinin A-like immunoreactivity in carcinoid tumours |
Q41811312 | Measurement of T-kinin in rat plasma using a specific radioimmunoassay. |
Q79372115 | Measurements of chromogranin B can serve as a complement to chromogranin A |
Q34775112 | Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumours |
Q72099754 | Mechanism for substance P-induced activation of human neutrophils and eosinophils |
Q36914086 | Mechanism of action of chromogranin A on catecholamine release: molecular modeling of the catestatin region reveals a beta-strand/loop/beta-strand structure secured by hydrophobic interactions and predictive of activity |
Q68755004 | Mechanism of inhibitory action of peptide YY on cholecystokinin-induced contractions of isolated dog ileum |
Q71603503 | Mechanism of luteinizing hormone-releasing hormone degradation by subcellular fractions of rat hypothalamus and pituitary |
Q48949779 | Mechanism of neurotensin degradation by rat brain peptidases |
Q69432623 | Mechanism of neurotensin depolarization of rabbit colonic smooth muscle |
Q34019820 | Mechanisms and functions of AT(1) angiotensin receptor internalization |
Q71640493 | Mechanisms mediating the effects of cholecystokinin on avian small intestine longitudinal smooth muscle |
Q41560320 | Mechanisms of action of long-acting analogs of somatostatin |
Q48868162 | Mechanisms of brain inactivation of centrally-acting thyrotrophin-releasing hormone (TRH) analogues: a high-performance liquid chromatography study |
Q51594213 | Mechanisms of proton-induced stimulation of CGRP release from rat antrum. |
Q40997207 | Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors |
Q44384742 | Mechanisms regulating adrenomedullin gene expression in the left ventricle: role of mechanical load |
Q69979991 | Mechanisms underlying intracisternal TRH-induced stimulation of gastric acid secretion in rats |
Q46854572 | Mediators involved in the hyperthermic action of neuromedin U in rats |
Q48615915 | Mediators of glucagon-like peptide 2-induced blood flow: responses in different vascular sites |
Q40190529 | Melanocortin-3 receptor activates MAP kinase via PI3 kinase |
Q78729819 | Melanocortins and opioids modulate early postnatal growth in rats |
Q69351531 | Melanocyte stimulating hormone and melanin concentration hormone may be structurally and evolutionarily related |
Q43267614 | Melittin promotes exocytosis in neuroendocrine cells through the activation of phospholipase A₂. |
Q43212503 | Meprin-alpha metalloproteases enhance lipopolysaccharide-stimulated production of tumour necrosis factor-alpha and interleukin-1beta in peripheral blood mononuclear cells via activation of NF-kappaB. |
Q72287124 | Mesencephalic grafts increase preprotachykinin-A mRNA expression in striatal grafts in an in oculo co-graft model |
Q44696194 | Met-enkephalyl-Arg6-Phe7 immunoreactivity in a human neuroblastoma cell line: effect of dibutyryl 3':5'-cyclic AMP and reserpine |
Q44396133 | Metabolic clearance rates of oxyntomodulin and glucagon in the rat: contribution of the kidney |
Q37698704 | Metabolic effects and mechanism of action of the chromogranin A-derived peptide pancreastatin |
Q72265291 | Metabolism of Big endothelin-1 (1-38) and (22-38) in the human circulation in relation to production of endothelin-1 (1-21) |
Q74428998 | Metabolism of beta-endorphin in plasma studied by liquid chromatography-electrospray ionization mass spectrometry |
Q58356821 | Metabolism of enkephalins in head membranes of the leech Theromyzon tessulatum by peptidases: isolation of an enkephalin-degrading aminopeptidase |
Q58356853 | Metabolism of enkephalins in head membranes of the leech Theromyzon tessulatum by peptidases: isolation of an enkephalin-degrading aminopeptidase |
Q30976346 | Metabolism of glucagon by dipeptidyl peptidase IV (CD26). |
Q58448432 | Metabolism of glucagon-like peptide-2 in pigs: Role of dipeptidyl peptidase IV |
Q44057276 | Metabolism of i.v. administered 45 kDa epidermal growth factor in the rat. |
Q71852216 | Metabolism of vasopressin, oxytocin and their analogues [Mpa1, D-Arg8]-vasopressin (dDAVP) and [Mpa1, D-Tyr(Et)2, Thr4, Orn8]-oxytocin (antocin) in human kidney and liver homogenates |
Q46205865 | Methionine enkephalin increases CNS suppressive control exerted over gill reflex behaviours and associated neural activity in Aplysia california |
Q48085064 | Methionine enkephalin metabolism by murine macrophage ectopeptidase(s). |
Q48510326 | Methionine5-enkephalin and opiate binding sites in the neurohypophysis of the bird, Gallus domesticus |
Q44351179 | Metorphamide, a C-terminally amidated opioid peptide, in human adrenal and human phaeochromocytoma |
Q42504136 | Microdialysis in the estimation of interstitial myocardial neuropeptide Y release |
Q70396035 | Microinjections of growth hormone-releasing factor into the medial preoptic area/suprachiasmatic nucleus region of the hypothalamus stimulate food intake in rats |
Q38021017 | Mini-review: the evolution of neuropeptide signaling |
Q46811334 | Mitogenic effects of both amidated and glycine-extended gastrin-releasing peptide in defunctioned and azoxymethane-treated rat colon in vivo |
Q70923145 | Mobilization of gastric histamine during repeated administration of a proton potassium adenosine triphosphatase inhibitor in intact and antrectomized rats |
Q45879915 | Mobilizing of haematopoietic stem cells to ischemic myocardium by plasmid mediated stromal-cell-derived factor-1alpha (SDF-1alpha) treatment. |
Q46103170 | Modification of atrial natriuretic peptide system in cold-induced hypertensive rats |
Q48156173 | Modulation by angiotensin III of nociception-related and arterial pressure-related neuronal responsiveness in the nucleus reticularis gigantocellularis of the rat. |
Q67507508 | Modulation by neurotensin and neuromedin N of adherence and chemotaxis capacity of murine lymphocytes |
Q72585236 | Modulation of acetylcholine-induced secretion of gastric bombesin-like immunoreactivity by cholinergic and histamine H2-receptors, somatostatin and intragastric pH |
Q51504284 | Modulation of chronotropic and inotropic heart vagus actions as a non-pressor effect of angiotensin II in the anaesthetized rat. |
Q44583800 | Modulation of corticotropin-releasing hormone receptor type 2 mRNA expression by CRH deficiency or stress in the mouse heart |
Q35160851 | Modulation of electrical activity in gastrointestinal smooth muscle by peptides |
Q44535401 | Modulation of granulocyte functions by peptide YY in the rat: age-related differences in Y receptors expression and plasma dipeptidyl peptidase 4 activity |
Q41635535 | Modulation of human natural killer activity by vasoactive intestinal peptide (VIP) family. VIP, glucagon and GHRF specifically inhibit NK activity |
Q42503699 | Modulation of insulin like growth factor I (IGF-I) binding sites on erythrocytes by IGF-I treatment in patients with Laron syndrome (LS). |
Q79843918 | Modulation of kinin B1 receptor expression by endogenous angiotensin II in hypertensive rats |
Q72699400 | Modulation of locomotor activity by substance P in rats |
Q56983586 | Modulation of morphine and cocaine effects by inhibition of nitric oxide synthase |
Q31943742 | Modulation of nitrergic relaxant responses by peptides in the mouse gastric fundus |
Q42463131 | Modulation of proopiomelanocortin gene expression by ethanol in mouse anterior pituitary corticotrope tumor cell AtT20. |
Q73246721 | Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism |
Q72440636 | Modulation of tachyphylaxis to angiotensin II in rabbit isolated aorta by the angiotensin AT1 receptor antagonist, losartan |
Q40414993 | Modulation of the (Na(+)+K+)ATPase activity by Angiotensin-(1-7) in MDCK cells. |
Q44753738 | Modulatory effect of endothelin-1 and -3 on neuronal norepinephrine release in the rat posterior hypothalamus. |
Q43701509 | Modulatory effect of two novel CGRP receptor antagonists on nasal vasodilatatory responses to exogenous CGRP, capsaicin, bradykinin and histamine in anaesthetised pigs |
Q44999736 | Molecular and morphometric analysis of the rat ventral prostate injected with leptin. |
Q40851263 | Molecular aspects of the tachykinin receptors |
Q79838184 | Molecular basis of melanocortin-4 receptor for AGRP inverse agonism |
Q28507688 | Molecular biology and pharmacology of multiple NPY Y5 receptor species homologs |
Q51324830 | Molecular characterization and tissue expression of peptide YY in Schizothorax prenanti: effects of periprandial changes and fasting on expression in the hypothalamus. |
Q36785039 | Molecular cloning and expression of rat V1a and V2 arginine vasopressin receptors |
Q42694385 | Molecular cloning and functional characterization of a vasotocin receptor subtype expressed in the pituitary gland of the domestic chicken (Gallus domesticus): avian homolog of the mammalian V1b-vasopressin receptor. |
Q40535056 | Molecular cloning and functional expression of the mouse CRF2(a) receptor splice variant |
Q40855075 | Molecular cloning of a human oxytocin receptor |
Q42599888 | Molecular cloning of an unusual bicistronic cholecystokinin receptor mRNA expressed in chicken brain: a structural and functional expression study |
Q45158379 | Molecular cloning of growth hormone secretagogue-receptor and effect of quail ghrelin on gastrointestinal motility in Japanese quail |
Q31001918 | Molecular cloning, sequence analysis and translation of proenkephalin mRNA from rat heart |
Q45327852 | Molecular evolution of mammalian incretin hormone genes |
Q33177758 | Molecular evolution of peptide tyrosine--tyrosine: primary structure of PYY from the lampreys Geotria australis and Lampetra fluviatilis, bichir, python and desert tortoise. |
Q34141384 | Molecular evolution of proglucagon. |
Q73150035 | Molecular evolution of the neuropeptide Y (NPY) family of peptides: cloning of three NPY-related peptides from the sea bass (Dicentrarchus labrax) |
Q78729809 | Molecular forms of rat angiotensinogen in plasma and brain: identification by isoelectric focusing and immunoblot analysis |
Q48352463 | Molecular forms of somatostatin, substance P and neurotensin in fresh human cerebral cortex |
Q72412242 | Molecular heterogeneity of canine cholecystokinin in portal and peripheral plasma |
Q40080125 | Molecular identification and characterization of the dog motilin receptor |
Q28200901 | Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP |
Q69628168 | Molecular properties of solubilized CCK receptor from guinea-pig pancreas |
Q45202574 | Monoaminergic neuronal development is not affected in PACAP-gene-deficient mice |
Q47895629 | Monocytes of allergics and non-allergics produce, store and release the neurotrophins NGF, BDNF and NT-3. |
Q72650855 | Monosodium glutamate exposure in the neonate alters hypothalamic and pituitary neuropeptide levels in the adult |
Q67866576 | Morphine inhibits TRH-induced gastric contractile activity |
Q81201352 | Morphological analysis of ghrelin and its receptor distribution in the rat pancreas |
Q42169900 | Morphological and functional effects of PACAP in 6-hydroxydopamine-induced lesion of the substantia nigra in rats |
Q41333667 | Morphological changes of BM-N4 cells induced by bombyxin, an insulin-related peptide of Bombyx mori |
Q73056679 | Morphological evidence for neural interactions between leptin and orexin in the hypothalamus |
Q44077185 | Morphological examination of the termination pattern of substance P-immunoreactive nerve fibers in human antral mucosa |
Q34698705 | Morphological interaction between galanin-like peptide- and dopamine-containing neurons in the rat arcuate nucleus |
Q61852954 | Morphometry of gastric endocrine cells in hypergastrinemic patients treated with the somatostatin analogue octreotide |
Q44959955 | Mortal hyperkalemia disturbances in rats are NO-system related. The life saving effect of pentadecapeptide BPC 157. |
Q41194945 | Mothers and their infants: peptide-mediated physiological, behavioral and affective changes during suckling |
Q34974146 | Motilides: a long and winding road: lessons from mitemcinal (GM-611) on diabetic gastroparesis |
Q69674877 | Motilin receptors in rabbit stomach and small intestine |
Q51656983 | Motilin release by intravenous infusion of nutrients and somatostatin in conscious dogs. |
Q67701874 | Motility regulating effects of galanin on smooth muscle of porcine ileum |
Q28290950 | Motor hyperactivity caused by a deficit in dopaminergic neurons and the effects of endocrine disruptors: a study inspired by the physiological roles of PACAP in the brain |
Q60682518 | Mu and delta opiates induce analgesia when injected into the PAG or NRM in preweanling rats |
Q72099781 | Multiple actions of substance P and other tachykinins on sympathetic neurons in rat prevertebral ganglia |
Q114953657 | Multiple actions of substance P and other tachykinins on sympathetic neurons in rat prevertebral ganglia |
Q77535595 | Multiple forms of rat stomach histidine decarboxylase may reflect posttranslational activation of the enzyme |
Q62511966 | Multiple hormone secretion by a human pancreatic glucagonoma in culture |
Q71658612 | Multiple molecular forms of tachykinins in rat spinal cord: a study comparing different extraction methods |
Q40844566 | Multiple regulation of adenylyl cyclase activity by G-protein coupled receptors in human foetal lung fibroblasts |
Q72542640 | Multiple subcutaneous injections of somatostatin induce tachyphylaxis of the suppression of plasma insulin, but not glucagon, in the rat |
Q67914106 | Multiple subtypes of endothelin receptors in porcine tissues: characterization by ligand binding, affinity labeling and regional distribution |
Q43516687 | Multiple tachykinins (neurokinin A, neuropeptide K and substance P) in capsaicin-sensitive sensory neurons in the guinea-pig |
Q46721861 | Muscarinic activity modulated by C-type natriuretic peptide in gastric smooth muscles of guinea-pig stomach |
Q44277691 | Muscle insulin binding and plasma levels in relation to liver glucokinase activity, glucose metabolism and dietary carbohydrates in rainbow trout |
Q43062736 | Mutagenesis of human neuropeptide Y/peptide YY receptor Y2 reveals additional differences to Y1 in interactions with highly conserved ligand positions |
Q47667156 | Mutagenesis of the AT1 receptor reveals different binding modes of angiotensin II and [Sar1]-angiotensin II. |
Q24290791 | Mutation of FKBP associated protein 48 (FAP48) at proline 219 disrupts the interaction with FKBP12 and FKBP52 |
Q84779840 | Mutational analysis of predicted extracellular domains of human growth hormone secretagogue receptor 1a |
Q47885770 | Mutational analysis of the angiotensin II type 2 receptor: contribution of conserved extracellular amino acids |
Q77123844 | Mutational analysis of the angiotensin type 2 receptor: contribution of conserved amino acids in the region of the sixth transmembrane domain |
Q84950478 | Myocardial angiogenesis after chronic ghrelin treatment in a rat myocardial infarction model |
Q43915917 | N-terminal chromogranin-derived peptides as dilators of bovine coronary resistance arteries |
Q72534511 | N-terminal fragments of intestinal cholecystokinin: evidence for release of CCK-8 by cleavage on the carboxyl side of Arg74 of proCCK |
Q52553279 | N-terminal modifications to AKH-I from Locusta migratoria: assessment of biological potencies in vivo and in vitro. |
Q48276830 | N-terminal pro-atrial natriuretic peptide and exercise prescription in patients with myocardial infarction |
Q43818780 | N-terminal proteolytic processing of porcine chromogranin A in parathyroid tissue |
Q71664555 | N-terminally elongated fragments of galanin(1-16) inhibit insulin secretion from isolated mouse islets |
Q67657014 | N-terminally extended substance P is released together with substance P from rat spinal cord |
Q48250664 | N-terminally extended tachykinins in human cerebrospinal fluid |
Q51072678 | NKP608: a selective NK-1 receptor antagonist with anxiolytic-like effects in the social interaction and social exploration test in rats. |
Q44643669 | NPR-C receptors are involved in C-type natriuretic peptide response on bile secretion |
Q37171381 | NPY L7P polymorphism and metabolic diseases |
Q40997215 | NPY Y1 antagonists: structure-activity relationships of arginine derivatives and hybrid compounds with arpromidine-like partial structures |
Q44921486 | NPY and NPY Y1 receptor effects on noradrenaline overflow from the rat brain in vitro |
Q48358909 | NPY and food intake: discrepancies in the model |
Q48359474 | NPY messenger RNA is increased in medial hypothalamus of anorectic tumor-bearing rats |
Q51494145 | NPY receptor subtypes involved in the contraction of the proximal colon of the rat. |
Q40997193 | NPY upregulates genes containing cyclic AMP response element in human neuroblastoma cell lines bearing Y1 and Y2 receptors: involvement of CREB. |
Q42452276 | NPY, NPY receptors, and DPP IV activity are modulated by LPS, TNF-alpha and IFN-gamma in HUVEC. |
Q40997179 | NPY-induced feeding involves the action of a Y1-like receptor in rodents |
Q48359421 | NPY-induced overfeeding suppresses hypothalamic NPY mRNA expression: potential roles of plasma insulin and leptin. |
Q70364573 | Naloxone blockade of growth hormone-releasing factor-induced feeding |
Q52235654 | Naloxone blocks conditioned place preference induced by substance P and [pGlu6]-SP(6–11) |
Q72125994 | Naloxone enhances angiotensin II-induced increase in serum luteinizing hormone concentrations in normal women |
Q35792517 | Naming progastrin-derived peptides |
Q84335612 | Nasal administration of a novel recombinant human parathyroid hormone (1-34) analog for the treatment of osteoporosis of ovariectomized rats |
Q49011965 | Natriuretic peptide system in the rat submaxillary gland |
Q51516843 | Natriuretic peptide system: a link between fat mass and cardiac hypertrophy and hypertension in fat-fed female rats. |
Q51816644 | Natriuretic peptide/natriuretic peptide receptor-A (NPR-A) system has inhibitory effects in renal fibrosis in mice. |
Q38238276 | Natriuretic peptides and cerebral hemodynamics |
Q36101327 | Natriuretic peptides as prognostic and diagnostic markers in Chagas' disease |
Q37398185 | Natriuretic peptides as regulatory mediators of secretory activity in the digestive system. |
Q46371396 | Natriuretic peptides cause relaxation of human and guinea-pig gallbladder muscle through interaction with natriuretic peptide receptor-B. |
Q46962721 | Natriuretic peptides cause relaxation of human esophageal mucosal muscle |
Q31874641 | Natriuretic peptides increase cAMP production in human thyrocytes via the natriuretic peptide clearance receptor (NPR-C). |
Q48163350 | Natriuretic pro-peptides in idiopathic intracranial hypertension |
Q47403853 | Natural killer cell functions mediated by the neuropeptide substance P |
Q72699396 | Natural purified porcine gastric inhibitory polypeptide (GIP) stimulates exocrine pancreas secretion due to contamination with a cholecystokinin-like substance |
Q63608694 | Nedocromil preserves neuropeptides in neurons associated with airway smooth muscle and reduces adenovirus-induced airway hyperreactivity |
Q43569237 | Negative control by Sandostatin on pancreatic and duodenal growth: a possible implication of insulin-like growth factor I |
Q48390817 | Neither intravenous nor intracerebroventricular administration of obestatin affects the secretion of GH, PRL, TSH and ACTH in rats |
Q44200108 | Neonatal PACAP administration in rats delays puberty through the influence of the LHRH neuronal system |
Q45828262 | Neonatal endotoxin exposure changes neuroendocrine, cardiovascular function and mortality during polymicrobial sepsis in adult rats. |
Q38502275 | Nerve growth factor stimulates proliferation, adhesion and thymopoietic cytokine expression in mouse thymic epithelial cells in vitro |
Q53384143 | Nerve growth factor synthesis in human vascular smooth muscle cells and its regulation by dexamethasone. |
Q39497806 | Nesfatin-1 in advanced lung cancer patients with weight loss |
Q51330079 | Nesfatin-1 in childhood and adolescent obesity and its association with food intake, body composition and insulin resistance. |
Q47803911 | Nesfatin-1 influences the excitability of glucosensing neurons in the hypothalamic nuclei and inhibits the food intake |
Q37767920 | Nesfatin-1--role as possible new potent regulator of food intake |
Q67959878 | Neural influence on oxytocin-induced changes of adrenomedullary catecholamines in the pigeon |
Q35165383 | Neural regulation of blood pressure by leptin and the related peptides |
Q48983479 | Neural regulation of gastric acid secretion in rats: influence of dermorphin |
Q72699376 | Neural regulation of peptide YY secretion |
Q72068855 | Neural release of substance P causes dilation of arterioles in rat striated muscle |
Q38334802 | Neural-restrictive silencers in the regulatory mechanism of pituitary adenylate cyclase-activating polypeptide gene expression |
Q44010946 | Neuregulin-1β regulates tyrosine kinase receptor expression in cultured dorsal root ganglion neurons with excitotoxicity induced by glutamate |
Q46290538 | Neuro-hormonal control of bone metabolism: vasoactive intestinal peptide stimulates alkaline phosphatase activity and mRNA expression in mouse calvarial osteoblasts as well as calcium accumulation mineralized bone nodules |
Q71560505 | Neuroanatomical dissociation of thyrotropin-releasing hormone induced shaking behavior and thermogenic mechanisms |
Q72022673 | Neurochemical characterization of preprotachykinin B(50–79) immunoreactivity in the rat |
Q40965889 | Neurochemical markers of human fungiform papillae and taste buds |
Q37201066 | Neuroendocrine dysregulation of food intake in eating disorders |
Q43207186 | Neuroendocrine markers are expressed in human mammary glands |
Q73521118 | Neuroendocrine peptide levels in the gastrointestinal tract of mice after unilateral cervical vagotomy |
Q41294108 | Neuroendocrine peptides stimulate adenyl cyclase in normal and malignant prostate cells |
Q72358274 | Neuroendocrine regulation of growth hormone secretion in sheep. VII. Effects of GABA |
Q45733050 | Neuroendocrine regulatory peptide-1 and neuroendocrine regulatory peptide-2 influence differentially feeding and penile erection in male rats: sites of action in the brain. |
Q81317513 | Neuroendocrinological regulation of food intake |
Q70297721 | Neurogenic relaxation mediated by vasoactive intestinal polypeptide (VIP) in the isthmus of the human fallopian tube |
Q42448842 | Neurohormonal regulation of histamine and pancreastatin secretion from isolated rat stomach ECL cells. |
Q31874763 | Neurohormonal regulation of secretion from isolated rat stomach ECL cells: a critical reappraisal |
Q40916512 | Neurohypophyseal peptides and psychiatric diseases |
Q40916489 | Neurohypophysial peptide systems: processing machinery, hydroosmotic regulation, adaptation and evolution |
Q40916524 | Neurohypophysial peptides in the human hypothalamus in relation to development, sexual differentiation, aging and disease. |
Q51689141 | Neurokinin 1 receptors mediate substance P-induced changes in ion transport in guinea-pig ileum |
Q48109135 | Neurokinin A in cerebral vessels: characterization, localization and effects in vitro |
Q72099763 | Neurokinin A, but not neurokinin B and substance P, induces codeine-resistant coughs in awake guinea-pigs |
Q73689719 | Neurokinin A, calcitonin gene-related peptide, and dynorphin A (1-8) in spinal dorsal horn contribute to descending inhibition evoked by nociceptive afferent pathways: an immunocytochemical study |
Q69353494 | Neurokinin A, neurokinin B and neuropeptide K in the rabbit iris: a study comparing different extraction methods |
Q34287152 | Neurokinin B causes concentration-dependent relaxation of isolated human placental resistance vessels |
Q77425680 | Neurokinin B- and substance P-like immunoreactivity are co-localized in enteric nerves of rat ileum |
Q48250639 | Neurokinin-1, -2 and -3 receptors are candidates for a role in the opiate withdrawal response in guinea-pigs |
Q39080355 | Neuromedin B stimulates the hypothalamic-pituitary-gonadal axis in male rats. |
Q79746782 | Neuromedin U stimulates contraction of human long saphenous vein and gastrointestinal smooth muscle in vitro |
Q41547820 | Neuromedin-B receptor transfected BALB/3T3 cells: signal transduction and effects of ectopic receptor expression on cell growth |
Q51609387 | Neuromedin-N inhibits migrating myoelectric complex and induces irregular spiking in the small intestine of rats; comparison with neurotensin. |
Q69873767 | Neuromodulation of the cardiac vagus: comparison of neuropeptide Y and related peptides |
Q44131114 | Neuron restrictive silencer factor as a modulator of neuropeptide gene expression |
Q34519425 | Neuronal effects of orexins: relevant to sympathetic and cardiovascular functions |
Q81201359 | Neuronal interactions between galanin-like-peptide- and orexin- or melanin-concentrating hormone-containing neurons |
Q48456465 | Neuronal interactions between neuropeptide W- and orexin- or melanin-concentrating hormone-containing neurons in the rat hypothalamus |
Q69500062 | Neuronal localization and motor effects of gastrin-releasing peptide (GRP) in rat uterus |
Q48887294 | Neuronal location of the bombesin-like immunoreactivity in the central nervous system of the rat. |
Q73954469 | Neuronal protection from apoptosis by pituitary adenylate cyclase-activating polypeptide |
Q48891831 | Neuronal responses to iontophoretically applied angiotensin II, losartan and aldosterone, as well as gustatory stimuli, in non-anesthetized control and desoxycorticosterone acetate-pretreated rats |
Q58341001 | Neuropeptide B and W regulate leptin and resistin secretion, and stimulate lipolysis in isolated rat adipocytes |
Q68042491 | Neuropeptide K suppresses feeding in the rat |
Q46061905 | Neuropeptide S produces antinociceptive effects at the supraspinal level in mice |
Q53527730 | Neuropeptide W in the rat pancreas: potentiation of glucose-induced insulin release and Ca2+ influx through L-type Ca2+ channels in beta-cells and localization in islets. |
Q81299287 | Neuropeptide W is expressed in the noradrenalin-containing cells in the rat adrenal medulla |
Q51788148 | Neuropeptide Y (NPY) Y2 receptors of rabbit kidney cortex are largely dimeric. |
Q40997201 | Neuropeptide Y (NPY) actions on the corticotroph cell of the anterior pituitary gland are not mediated by a direct effect |
Q48359487 | Neuropeptide Y (NPY) levels in alcoholic and food restricted male rats: implications for site selective function |
Q48359639 | Neuropeptide Y (NPY) neurons in the arcuate nucleus (ARH) and dorsomedial nucleus (DMH), areas activated during lactation, project to the paraventricular nucleus of the hypothalamus (PVH). |
Q71246594 | Neuropeptide Y (NPY) reduces myocardial perfusion and inhibits the force of contraction of the isolated perfused rabbit heart |
Q48233321 | Neuropeptide Y (NPY)-induced feeding behavior in female rats: comparison with human NPY ([Met17]NPY), NPY analog ([norLeu4]NPY) and peptide YY. |
Q31001909 | Neuropeptide Y 16-36 inhibits mucociliary activity but does not affect blood flow in the rabbit maxillary sinus in vivo |
Q48861246 | Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptors |
Q77512805 | Neuropeptide Y Y1 and Y2 receptor-mediated stimulation of mitogen-activated protein kinase activity |
Q40997174 | Neuropeptide Y Y1 receptor antisense oligodeoxynucleotides enhance food intake in energy-deprived rats |
Q73150048 | Neuropeptide Y Y1 receptor mediated mesenteric vasoconstriction in the pig in vivo |
Q51571175 | Neuropeptide Y Y5 receptors inhibit kindling acquisition in rats. |
Q68053278 | Neuropeptide Y and control of vascular resistance in skeletal muscle |
Q61219024 | Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors |
Q72879325 | Neuropeptide Y and neuropeptide Y 3-36: isolation from human pancreatic endocrine tumours |
Q54422681 | Neuropeptide Y and peptide YY mediate nonadrenergic vasoconstriction and modulate sympathetic responses in rats. |
Q51819094 | Neuropeptide Y and sympathetic vascular control in man. |
Q70250424 | Neuropeptide Y and vasoactive intestinal peptide coexist in rat thyroid nerve fibers emanating from the thyroid ganglion |
Q44883440 | Neuropeptide Y and vasoactive intestinal polypeptide in cerebral arteries of the rat: relationships between innervation pattern and mechanical response |
Q46791740 | Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers |
Q74338130 | Neuropeptide Y effects on murine natural killer activity: changes with ageing and cAMP involvement |
Q72358280 | Neuropeptide Y functions as a physiologic regulator of cephalic phase acid secretion |
Q40864013 | Neuropeptide Y gene expression in immortalized rat hippocampal and pheochromocytoma-12 cell lines |
Q46895732 | Neuropeptide Y in guinea pig, rabbit, rat and man. Identical amino acid sequence and oxidation of methionine-17 |
Q71644385 | Neuropeptide Y in salivary glands of the rat: origin, release and secretory effects |
Q46520428 | Neuropeptide Y induced modulation of dopamine synthesis in the striatum |
Q45176345 | Neuropeptide Y induces cardiomyocyte hypertrophy via calcineurin signaling in rats |
Q39860181 | Neuropeptide Y induces gonadotropin-releasing hormone gene expression directly and through conditioned medium from mHypoE-38 NPY neurons |
Q68489805 | Neuropeptide Y inhibits cAMP accumulation in renal proximal convoluted tubules |
Q67509881 | Neuropeptide Y inhibits sympathetic neurotransmission in ipsilaterally innervated but not contralaterally reinnervated superior tarsal smooth muscle of the rat |
Q71982495 | Neuropeptide Y is expressed in islet somatostatin cells of the hamster pancreas: a combined immunocytochemical and in situ hybridization study |
Q48068593 | Neuropeptide Y is expressed in subpopulations of insulin- and non-insulin-producing islet cells in the rat after dexamethasone treatment: a combined immunocytochemical and in situ hybridisation study |
Q46378114 | Neuropeptide Y modulates the action of vasodilator agents in guinea-pig epicardial coronary arteries |
Q42508911 | Neuropeptide Y potentiates beta-adrenergic stimulation of lipolysis in 3T3-L1 adipocytes. |
Q41199375 | Neuropeptide Y receptor gene regulation in mouse adrenocortical Y-1 cells |
Q77512754 | Neuropeptide Y receptors involved in calcium channel regulation in PC12 cells |
Q48832585 | Neuropeptide Y regulates the leptin receptors in rat hypothalamic and pituitary explant cultures. |
Q72026620 | Neuropeptide Y stimulates proliferation of human vascular smooth muscle cells: cooperation with noradrenaline and ATP |
Q42507366 | Neuropeptide Y suppresses the neurogenic inflammatory response in the rabbit eye; mode of action |
Q52200628 | Neuropeptide Y-like immunoreactive primary afferents in the periodontal tissues following dental injury in the rat. |
Q46807845 | Neuropeptide Y-like immunoreactivity in adrenaline cells of adrenal medulla and in tumors and plasma of pheochromocytoma patients |
Q52249774 | Neuropeptide Y-like immunoreactivity in intramural ganglia of the newborn guinea pig urinary bladder. |
Q44960704 | Neuropeptide Y-like immunoreactivity in perivascular nerve fibres of the guinea-pig |
Q73629322 | Neuropeptide Y1 receptors in the rat genital tract |
Q40728441 | Neuropeptide Y: a central regulator of energy homeostasis |
Q46693664 | Neuropeptide Y: prejunctional inhibition of vagally induced contractions in the guinea pig trachea |
Q53872496 | Neuropeptide Y: presence in perivascular noradrenergic neurons and vasoconstrictor effects on skeletal muscle blood vessels in experimental animals and man. |
Q41736619 | Neuropeptide families: evolutionary perspectives |
Q36792055 | Neuropeptide immunoreactivity and co-existence in cardiovascular nerves and autonomic ganglia of the estuarine crocodile, Crocodylus porosus, and cardiovascular effects of neuropeptides. |
Q71689527 | Neuropeptide levels in discrete brain regions in the iminodipropionitrile-induced persistent dyskinesia rat model |
Q69011479 | Neuropeptide modification of chloride secretion in guinea pig distal colon |
Q28300711 | Neuropeptide modulation of GABA receptor C1- channels |
Q46625923 | Neuropeptide release from isolated myenteric nerve endings derived from the guinea pig myenteric plexus |
Q38342309 | Neuropeptidergic characterization of the leptin receptor mutated obese Koletsky rat. |
Q74160979 | Neuropeptides 2000. 10th Annual meeting of the European Neuropeptide Club. Innsbruck, Austria, May 10-13, 2000. Abstracts |
Q73258921 | Neuropeptides 2000. Proceedings of the 10th Annual Meeting of the European Neuropeptide Club. Innsbruck, Austria, May 10-13, 2000 |
Q60731309 | Neuropeptides and the human immune response: Effects on isolated spleen and thymic lymphocytes |
Q54631303 | Neuropeptides as central integrators of autonomic nerve activity: effects of TRH, SRIF, VIP and bombesin on gastric and adrenal nerves |
Q38628570 | Neuropeptides as growth factors. Possible roles in human diseases |
Q61713995 | Neuropeptides in Alzheimer's disease: a postmortem study |
Q52237140 | Neuropeptides of the primary sensory neurones in rat skin: an ontogenic study |
Q67506693 | Neuropeptides of the vasoactive intestinal peptide/helodermin/pituitary adenylate cyclase activating peptide family elevate plasma cAMP in mice: comparison with a range of other regulatory peptides |
Q79755983 | Neuropeptides regulate expression of matrix molecule, growth factor and inflammatory mediator mRNA in explants of normal and healing medial collateral ligament |
Q42258080 | Neuropharmacological evaluation of RX 77368--a stabilised analogue of thyrotropin-releasing hormone (TRH). |
Q34280429 | Neuroprotection by endogenous and exogenous PACAP following stroke. |
Q45202584 | Neuroprotective action of endogenous PACAP in cultured rat cortical neurons. |
Q82824828 | Neuroprotective properties of l-carnosine in the brain slices exposed to autoblood in the hemorrhagic stroke model in vitro |
Q72645795 | Neurotensin and substance P: differential effects on plasma cholesterol levels in conscious ovariectomized rats |
Q48914236 | Neurotensin decreases high affinity [3H]-ouabain binding to cerebral cortex membranes |
Q51634468 | Neurotensin in diabetes and obesity. |
Q71339445 | Neurotensin increases net fluid secretion and transit rate in the small intestine of man |
Q72526995 | Neurotensin inhibition of gastric exocrine secretions in the cat |
Q72721231 | Neurotensin interacts with carbachol, secretin, and caerulein in the stimulation of the exocrine pancreas of the rat in vitro |
Q43093483 | Neurotensin modulates central muscarinic receptors, an effect which does not involve the high-affinity neurotensin receptor (NTS1). |
Q40173160 | Neurotensin receptor binding and neurotensin-induced growth signaling in prostate cancer PC3 cells are sensitive to metabolic stress |
Q72946791 | Neurotensin receptors in the rat bronchi |
Q69674886 | Neurotensin stimulates pancreatic exocrine secretion in rats |
Q54483543 | Neurotensin-induced antinociception and hypothermia in mice: antagonism by TRH and structural analogs of TRH. |
Q70096906 | Neurotensin-induced colonic motor responses in dogs: a mediation by prostaglandins |
Q70364576 | Neurotensin-like immunoreactivity generated by pepsin from human plasma and gastric tissue |
Q70942064 | Neurotensin-like immunoreactivity in odontoblasts and their processes in rat maxillary molar teeth and the effect of pulpotomy |
Q34060785 | Neurotensin: peptide for the next millennium |
Q44044369 | Neurotransmissions of antidepressant-like effects of kisspeptin-13. |
Q85063926 | Neutral aminopeptidase and dipeptidyl peptidase IV in the development of collagen II-induced arthritis |
Q48738061 | Neutral endopeptidase 24.11 in rat peripheral tissues: comparative localization by 'ex vivo' and 'in vitro' autoradiography |
Q46246502 | Neutral endopeptidase modulates endothelin-1-induced airway smooth muscle contraction in guinea-pig trachea |
Q41028130 | Neutrophil extracted lipocortin inhibits corticotropin secretion in the AtT-20 D16:16 clonal mouse pituitary cell line. Lipocortin inhibition of ACTH release in vitro |
Q33927963 | New frontiers in the biology of GLP-2. |
Q37194075 | Newly developed angiotensin II-infused experimental models in vascular biology |
Q48419561 | Nicotine administration effects on feeding and cocaine-amphetamine-regulated transcript (CART) expression in the hypothalamus |
Q45202570 | Nicotine stimulates prolactin-releasing peptide (PrRP) cells and non-PrRP cells in the solitary nucleus |
Q51364713 | Nitric oxide (NO)--production and regulation of insulin secretion in islets of freely fed and fasted mice. |
Q48891799 | Nitric oxide and drinking behaviour |
Q51576262 | Nitric oxide is involved in the inhibitory action of cholecystokinin octapeptide (CCK-OP) on proximal colonic motility. |
Q72026613 | Nitric oxide modulates the calcitonin gene-related peptide-induced relaxation in guinea pig gallbladder strips in vitro |
Q46582576 | Nitric oxide released by accessory cells mediates the gastrin-releasing peptide effect on murine lymphocyte chemotaxis |
Q33208037 | Nociceptin antagonism: probing the receptor by N-acetyl oligopeptides |
Q54109739 | Nociceptin, a novel endogenous ligand for the ORL1 receptor, dilates isolated resistance arteries from the rat. |
Q45151358 | Nociceptin/orphanin FQ prevents ethanol-induced gastric lesions in the rat. |
Q69444736 | Non-amidated forms of VIP (glycine-extended VIP and VIP-free acid) have full bioactivity on smooth muscle |
Q72099900 | Non-specific activity of (+/-)CP-96,345 in models of pain and inflammation |
Q30683742 | Nonpeptide antagonists for kinin receptors. |
Q70460033 | Nonpeptide vasopressin antagonist and its application in the correction of experimental hyponatremia in rats |
Q72591272 | Noradrenergic and neuropeptide Y-immunoreactive nerves in the pancreatic islets of spontaneously hypertensive rats |
Q68115273 | Norepinephrine amplifies effects of vasopressin on the isolated rat heart |
Q48939578 | Novel CCK-B receptor agonists: diketopiperazine analogues derived for CCK4 bioactive conformation |
Q48175823 | Novel N-terminal fragments of pro-gamma-melanocyte-stimulating hormone isolated from pig pituitary |
Q40855051 | Novel approaches to the study of oxytocin neurotransmission in the rat brain |
Q37799097 | Novel aspects of angiotensin II action in the heart. Implications to myocardial ischemia and heart failure |
Q40995844 | Novel aspects of gastrin-induced activation of histidine decarboxylase in rat stomach ECL cells |
Q52753231 | Novel biological effects of alloferon and its selected analogues: structure-activity study. |
Q39908953 | Novel endomorphin analogues with antagonist activity at the mu-opioid receptor in the gastrointestinal tract |
Q60627952 | Novel evidence of ghrelin and growth hormone segretagogue receptor expression by human ocular tissues |
Q80235126 | Novel extended and branched N-terminal analogs of VIP |
Q48350182 | Novel localization of orexin A in the tubular cytotypes of the rat testis. |
Q82729516 | Novel potent agonist [(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 and antagonist [Nphe1,(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 of nociceptin/orphanin FQ receptor |
Q44343635 | Novel scaffolds for non-peptide mimetics of delta opioid receptor agonists based on peptide leads |
Q72099830 | Novel substance P analogues inhibit circular muscle contraction of guinea pig ileum and depolarization of new born rat spinal cord induced by substance P |
Q48654801 | Novel variants of adrenocorticotrophic hormone in porcine anterior pituitary |
Q43275262 | Novel, non-peptidic somatostatin receptor subtype 5 antagonists improve glucose tolerance in rodents |
Q39823503 | Nuclear PTHrP targeting regulates PTHrP secretion and enhances LoVo cell growth and survival |
Q71644368 | Nucleotides regulate the binding affinity of the recombinant type A cholecystokinin receptor in CHO K1 cells |
Q44700861 | Nutrient inhibition of ghrelin secretion in the fasted rat. |
Q61978431 | OPG, RANK and RANK ligand expression in thyroid lesions |
Q42611082 | Obestatin prevents analgesic tolerance to morphine and reverses the effects of mild morphine withdrawal in mice. |
Q68184723 | Occurrence of VIP and peptide HM in human pancreas and their influence on pancreatic endocrine secretion in man |
Q44583802 | Octopus, which owns the most advanced brain in invertebrates, has two members of vasopressin/oxytocin superfamily as in vertebrates |
Q41572946 | Octreotide (SMS 201-995) inhibits the growth of colon peritoneal carcinomatosis in BDIX rats |
Q71241848 | Octreotide differentially modulates human Caco-2 intestinal epithelial cell proliferation and differentiation by decreasing intracellular cAMP |
Q54313958 | Octreotide inhibits increases in short-circuit current induced in rat colon by VIP, substance P, serotonin and aminophylline. |
Q54511632 | Octreotide modulates the effects on fibrosis of TNF-α, TGF-β and PDGF in activated rat hepatic stellate cells. |
Q35288129 | Oligomerization of neuropeptide Y (NPY) Y2 receptors in CHO cells depends on functional pertussis toxin-sensitive G-proteins |
Q69671055 | Omeprazole and ranitidine, antisecretagogues with different modes of action, are equally effective in causing hyperplasia of enterochromaffin-like cells in rat stomach |
Q58449496 | On the accuracy of radioimmunological determination of somatostatin in plasma |
Q51452148 | On the effect of xenin and xenin fragments on exocrine pancreas secretion in vivo. |
Q77425672 | On the mechanism of relaxin action: the involvement of adenylyl cyclase signalling system |
Q72534480 | On the presence of NK2 receptor subtypes in peripheral and central tissues |
Q114684093 | Ontogenic development of PACAP and PACAP receptors in rat brain |
Q114684092 | Ontogenic development of rat galanin and neurotensin immunoreactivity and mRNA in the gastrointestinal tract of the rat |
Q51808051 | Ontogenic pattern of nucleobindin-2/nesfatin-1 expression in the gastroenteropancreatic tissues and serum of Sprague Dawley rats. |
Q36590153 | Ontogeny of PACAP receptors in the human cerebellum: perspectives of therapeutic applications |
Q46933284 | Ontogeny of a new enteric peptide, neuropeptide W (NPW), in the developing rat stomach |
Q52264656 | Ontogeny of a novel pituitary protein (7B2) in the human fetal intestine. |
Q24653666 | Ontogeny of apelin and its receptor in the rodent gastrointestinal tract |
Q52201959 | Ontogeny of gastrin and cholecystokinin in the colon and duodenum of sheep. |
Q68567830 | Ontogeny of glucagon messenger RNA and encoded precursor in the rat intestine |
Q52256304 | Ontogeny of glucagon-like immunoreactive peptides in rat intestine. |
Q71466271 | Ontogeny of immunoreactive glicentin in the human gastrointestinal tract and endocrine pancreas |
Q41043058 | Ontogeny of neuropeptides in the rat urinary bladder |
Q68997758 | Ontogeny of peptide-containing neurons in human gut--an immunocytochemical study |
Q48831323 | Ontogeny of pituitary adenylate cyclase activating polypeptide and its receptor mRNA in the mouse brain |
Q68097183 | Ontogeny of pituitary responsiveness to corticotropin-releasing hormone in rat |
Q48360258 | Ontogeny of prolyl endopeptidase and pyroglutamyl peptidase I in rat tissues |
Q48364192 | Ontogeny of substance P in the digestive tract, spinal cord and hypothalamus of the human fetus |
Q67514141 | Ontogeny of the distribution and colocalization of calbindin D28K within neural and endocrine cells of the gastrointestinal tract of fetal and neonatal sheep |
Q52246928 | Ontogeny of the novel tachykinins neurokinin A, neurokinin B and neuropeptide K in the rat central nervous system. |
Q42457442 | Ontogeny of the response to growth hormone-releasing factor |
Q43689197 | Ontogeny of two topologically distinct TRH-degrading pyroglutamate aminopeptidase activities in the rat liver |
Q71717803 | Ontogeny of vasoactive intestinal peptide in the human fetal digestive tract |
Q44345610 | Opioid and non-opioid binding of beta-endorphin to bovine adrenal medullary membranes |
Q40710523 | Opioid control of vasopressin and oxytocin release |
Q42206464 | Opioid inhibition of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation of rats |
Q38290148 | Opioid peptide receptor studies. 4. Antisense oligodeoxynucleotide to the delta opioid receptor delineates opioid receptor subtypes |
Q44339315 | Opioid peptide release evoked by noxious stimulation of the hind instep of rats |
Q44352325 | Opioid peptides, particularly dynorphin, after amygdaloid-kindled seizures |
Q35185222 | Opioid receptors in the gastrointestinal tract |
Q72580079 | Opioids and Their Receptors: Cloning and Beyond. Proceedings of the 25th International Narcotics Research Conference (INRC). North Falmouth, Massachusetts, 16-21 July 1994. Abstracts |
Q44334952 | Opiorphin highly improves the specific binding and affinity of MERF and MEGY to rat brain opioid receptors |
Q70942100 | Opposite changes in the content of oxytocin- and vasopressin-like immunoreactive peptides in the rat thymus during aging |
Q37083796 | Opposite effects of angiotensin II and angiotensin (1-7) on impulse propagation, excitability and cardiac arrhythmias. Is the overexpression of ACE2 arrhythmogenic? |
Q39995671 | Opposite effects of oxytocin on proliferation of osteosarcoma cell lines. |
Q49053455 | Opposite regulation of brain angiotensin type 1 and type 2 receptors in cold-induced hypertension |
Q52723331 | Oral activity of FMRFamide-related peptides on the pea aphid Acyrthosiphon pisum (Hemiptera: Aphididae) and degradation by enzymes from the aphid gut. |
Q28569684 | Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction |
Q68092246 | Oral administration of epidermal growth factor in suckling rats stimulates cell DNA synthesis in fundic and antral gastric mucosae as well as in intestinal mucosa and pancreas |
Q82306340 | Oral delivery of mouse [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, in male Swiss Webster mice: a study comparing the pharmacokinetics of oral delivery to intraperitoneal, subcutaneous, intramuscular, and intranasal administra |
Q83431805 | Oral delivery of octreotide acetate in Intravail® improves uptake, half-life, and bioavailability over subcutaneous administration in male Swiss webster mice |
Q43948090 | Orexin A and B in vitro modify orexins receptors expression and gonadotropins secretion of anterior pituitary cells of proestrous rats |
Q38325628 | Orexin A effects on the olfactory bulb spontaneous activity and odor responsiveness in freely breathing rats |
Q53912629 | Orexin actions in hypothalamic paraventricular nucleus: physiological consequences and cellular correlates. |
Q47781285 | Orexin administration to mice that underwent chronic stress produces bimodal effects on emotion-related behaviors |
Q43878292 | Orexin gene expression and regulation by photoperiod in the sheep hypothalamus |
Q48568351 | Orexin-1 receptor expression after global ischemia in mice |
Q77601397 | Orexin/hypocretin neurons: chemical phenotype and possible interactions with melanin-concentrating hormone neurons |
Q43878295 | Orexins and adipoinsular axis function in the rat. |
Q34519419 | Orexins and feeding: special occasions or everyday occurrence? |
Q33788753 | Orexins and orexin receptors: implication in feeding behavior |
Q77763742 | Orexins, a novel family of hypothalamic neuropeptides, modulate pituitary luteinizing hormone secretion in an ovarian steroid-dependent manner |
Q30671606 | Orexins/hypocretins in the ob/ob mouse: hypothalamic gene expression, peptide content and metabolic effects |
Q34096115 | Orexins: a role in medullary sympathetic outflow |
Q52163370 | Organ-specific mRNA distribution of C-type natriuretic peptide in neonatal and adult mice. |
Q40491055 | Organization of substance P primary sensory neurons: ultrastructural and physiological correlates |
Q46467508 | Orlistat reduces gallbladder emptying by inhibition of CCK release in response to a test meal |
Q54099275 | Osteogenic differentiation of bone marrow mesenchymal stem cells by adenovirus-mediated expression of leptin. |
Q42830500 | Osteogenic growth peptide C-terminal pentapeptide [OGP(10-14)] acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes |
Q77763710 | Osteopenia after gastrectomy, fundectomy or antrectomy: an experimental study in the rat |
Q37183736 | Overconsumption and obesity: peptides and susceptibility to weight gain |
Q33217387 | Overeating of palatable food is associated with blunted leptin and ghrelin responses |
Q52561215 | Overexpression of Bcl-2 inhibits nuclear localization of annexin I during tumor necrosis factor-alpha-mediated apoptosis in porcine renal LLC-PK1 cells. |
Q42169979 | Overexpression of PACAP in the pancreas failed to rescue early postnatal mortality in PACAP-null mice. |
Q45176368 | Overexpression of a dominant negative GIP receptor in transgenic mice results in disturbed postnatal pancreatic islet and beta-cell development |
Q40802186 | Overexpression of parathyroid hormone-related protein promotes cell growth in the rat intestinal cell line IEC-6. |
Q79808941 | Overfeeding during lactation modulates insulin and leptin signaling cascade in rats' hearts |
Q46875376 | Oxyntomodulin (glicentin-(33-69)): pharmacokinetics, binding to liver cell membranes, effects on isolated perfused pig pancreas, and secretion from isolated perfused lower small intestine of pigs |
Q69894305 | Oxytocin and glucose oxidation in the rat uterus |
Q47744561 | Oxytocin and oxytocin-receptor mRNA expression in the human gastrointestinal tract: a polymerase chain reaction study |
Q40855069 | Oxytocin antagonists and their therapeutic use. |
Q70959682 | Oxytocin antisense reduces salt intake in the baroreceptor-denervated rat |
Q44131103 | Oxytocin decreases plasma levels of thyroid-stimulating hormone and thyroid hormones in rats. |
Q70761237 | Oxytocin gene expression and action in bovine preovulatory follicles |
Q84044736 | Oxytocin in the periaqueductal grey regulates nociception in the rat |
Q48760673 | Oxytocin increases nitric oxide production in the paraventricular nucleus of the hypothalamus of male rats: correlation with penile erection and yawning |
Q41366391 | Oxytocin inhibits ACTH and peripheral catecholamine secretion in the urethane-anesthetized rat. |
Q55041935 | Oxytocin is expressed throughout the human gastrointestinal tract. |
Q48350524 | Oxytocin levels in the posterior pituitary and in the heart are modified by voluntary wheel running. |
Q40916584 | Oxytocin modulation of gonadotrophin release |
Q69822683 | Oxytocin receptors and contractile response of the myometrium after long term infusion of prostaglandin F2 alpha, indomethacin, oxytocin and an oxytocin antagonist in rats |
Q48124316 | Oxytocin response to challenging stimuli in elderly men. |
Q39972185 | Oxytocin stimulates glucose uptake in skeletal muscle cells through the calcium-CaMKK-AMPK pathway |
Q43237249 | Oxytocin treatment alleviates stress-aggravated colitis by a receptor-dependent mechanism |
Q40916600 | Oxytocin, a male intragonadal hormone |
Q40916612 | Oxytocin- and vasopressin-like immunoreactivity in the rat thymus: characterization and possible involvement in the immune response. |
Q40916689 | Oxytocin-endothelin interactions in the uterus |
Q40855038 | Oxytocin-responsive cells in the mammalian nervous system |
Q80592301 | Oxytocinase/insulin-regulated aminopeptidase is distributed throughout the sheep, female reproductive tract and is regulated by oestrogen in the uterus |
Q31116940 | PAC1 and PACAP expression, signaling, and effect on the growth of HCT8, human colonic tumor cells. |
Q46940015 | PAC1 receptor localization in a model nervous system: light and electron microscopic immunocytochemistry on the earthworm ventral nerve cord ganglia. |
Q43701512 | PACAP 1-38 as neurotransmitter in the porcine antrum |
Q43227818 | PACAP ameliorates oxidative stress in the chicken inner ear: an in vitro study |
Q77123885 | PACAP and PACAP receptors in insulin producing tissues: localization and effects |
Q51537022 | PACAP and VIP inhibit pyloric muscle through VIP/PACAP-preferring receptors. |
Q40497636 | PACAP facilitate the nerve regeneration factors in the facial nerve injury |
Q44200120 | PACAP inhibits anoxia-induced changes in physiological responses in horizontal cells in the turtle retina |
Q44397753 | PACAP is expressed in secretory granules of insulin and glucagon cells in human and rodent pancreas. Evidence for generation of cAMP compartments uncoupled from hormone release in diabetic islets |
Q43814003 | PACAP mediates the neural proliferative pathway of Mastomys enterochromaffin-like cell transformation |
Q47885858 | PACAP stimulates pancreatic exocrine secretion via the vagal cholinergic nerves in sheep |
Q44651404 | PACAP, a VIP-like peptide, in neurons of the esophagus |
Q46757035 | PACAP- and PHI-mediated sustained relaxation in circular muscle of gastric fundus: findings obtained in PACAP knockout mice. |
Q40693308 | PACAP-27 tyrosine phosphorylates mitogen activated protein kinase and increases VEGF mRNAs in human lung cancer cells. |
Q48649527 | PACAP-38, a novel peptide from ovine hypothalamus, is a potent modulator of amylase release from dispersed acini from rat pancreas |
Q46833473 | PACAP-induced plasma extravasation in rat skin |
Q37092303 | PACAP38 protects rat cortical neurons against the neurotoxicity evoked by sodium nitroprusside and thrombin |
Q60731316 | PHV-42 a novel gastric peptide, stimulates gastric acid secretion in man |
Q45244201 | PI-PLCbeta is involved in the modulation of the proximal tubule Na+-ATPase by angiotensin II. |
Q46915645 | PKA-Bad-14-3-3 and Akt-Bad-14-3-3 signaling pathways are involved in the protective effects of PACAP against ischemia/reperfusion-induced cardiomyocyte apoptosis. |
Q44700865 | PLA2/PGE2 are involved in the inhibitory effect of bradykinin on the angiotensin-(1-7)-stimulated Na(+)-ATPase activity of the proximal tubule |
Q40549185 | PPARalpha agonists stimulate progastrin production in human colorectal carcinoma cells |
Q45334508 | PTH-receptors regulate norepinephrine release in human heart and kidney |
Q40483950 | PTH-related protein enhances LoVo colon cancer cell proliferation, adhesion, and integrin expression |
Q39180268 | PTHrP is a novel mediator for TGF-β-induced apoptosis |
Q74665109 | PYY immunoneutralization does not alter lipid-induced inhibition of gastric emptying in rats |
Q37677910 | PYY(1-36) is the major form of PYY in rat distal small intestine: quantification using high-resolution mass spectrometry |
Q36781779 | PYY: a neuropeptide in the canine enteric nervous system |
Q31033828 | Pachymedusa dacnicolor tryptophyllin-1: structural characterization, pharmacological activity and cloning of precursor cDNA. |
Q54205307 | Pancreastatin inhibits insulin-stimulated glycogen synthesis but not glycolysis in rat hepatocytes. |
Q51611490 | Pancreastatin-like immunoreactivity in human carcinoid disease. |
Q70116168 | Pancreatectomy, amino acids and glucagon: effect on canine renal autoregulation |
Q43224247 | Pancreatic beta-cell responses to GLP-1 after near-normalization of blood glucose in patients with type 2 diabetes |
Q47204785 | Pancreatic glucagon and bombesin inhibit meal size in ventromedial hypothalamus-lesioned rats |
Q44997718 | Pancreatic hormone response to neuropeptide Y (NPY) perifusion in vitro |
Q69882593 | Pancreatic polypeptide immunoreactivity in medullary carcinoma of the thyroid: identification and characterisation by radioimmunoassay, immunocytochemistry and high performance liquid chromatography |
Q51652611 | Pancreatic polypeptide is not involved in the regulation of the migrating motor complex in man. |
Q71777521 | Pancreatic polypeptide response to ethanol in humans and dogs |
Q71363420 | Pancreatic polypeptide, microinjected into the dorsal vagal complex, potentiates glucose-stimulated insulin secretion in the rat |
Q54520747 | Pancreatic spasmolytic polypeptide (PSP): I. Preparation and initial chemical characterization of a new polypeptide from porcine pancreas. |
Q51651813 | Pancreatic spasmolytic polypeptide (PSP): II. Radioimmunological determination of PSP in porcine tissues, plasma and pancreatic juice. |
Q71948660 | Pancreatic spasmolytic polypeptide (PSP): III. Pharmacology of a new porcine pancreatic polypeptide with spasmolytic and gastric acid secretion inhibitory effects |
Q40660044 | Paracrine effects of PAMP and adrenomedullin on the human adrenal H295R cell line: PAMP but not adrenomedullin stimulates DHEA secretion |
Q42451372 | Parallel activation of cyclic AMP phosphodiesterase and cyclic AMP-dependent protein kinase in two human gut adenocarcinoma cells (HT 29 and HRT 18) in culture, by vasoactive intestinal peptide (VIP) and other effectors activating the cyclic AMP sys |
Q69832398 | Parallel bioassay of 27 bombesin-like peptides on 9 smooth muscle preparations. Structure-activity relationships and bombesin receptor subtypes |
Q51801328 | Parallel inactivation of Y2 receptor and G-proteins in CHO cells by pertussis toxin. |
Q67535464 | Parasympathetic NANC-secretion of saliva in the mink, and effects of substance P and VIP |
Q47562242 | Parasympathetic non-adrenergic, non-cholinergic reflex secretion of parotid acinar granules in rats pretreated with atropine and adrenoceptor antagonists |
Q46898200 | Parasympathetic non-adrenergic, non-cholinergic transmission in rat parotid glands: effects of cholecystokinin-A and -B receptor antagonists on the secretory response |
Q46880171 | Parathyroid hormone (PTH) and parathyroid hormone-related protein (PTHrP) relax cholecystokinin-induced tension in guinea pig gallbladder strips |
Q43953594 | Parathyroid hormone-related protein and lung injury after pulmonary thromboendarterectomy |
Q40745072 | Parathyroid hormone-related protein enhances PC-3 prostate cancer cell growth via both autocrine/paracrine and intracrine pathways |
Q40787409 | Parathyroid hormone-related protein overexpression in the human colon cancer cell line HT-29 enhances adhesion of the cells to collagen type I. |
Q40657269 | Parathyroid hormone-related protein upregulates integrin expression via an intracrine pathway in PC-3 prostate cancer cells |
Q39222043 | Parp1 deficient mice are protected from streptozotocin-induced diabetes but not caerulein-induced pancreatitis, independent of the induction of Reg family genes |
Q43550456 | Partial characterization of four forms of immunoreactive gonadotropin-releasing hormone in the brain and terminal nerve of the spiny dogfish (Elasmobranchii; Squalus acanthias) |
Q53894618 | Partial depletion of neuropeptide Y from noradrenergic perivascular and cardiac axons by 6-hydroxydopamine and reserpine. |
Q48089495 | Partial identification, synthesis and immunolocalization of locustamyoinhibin, the third myoinhibiting neuropeptide isolated from Locusta migratoria |
Q52388006 | Participation of endogenous neuropeptide Y in the suppression of baroreceptor reflex response by locus coeruleus in the rat. |
Q43162891 | Participation of extracellular Ca(2+) or ghrelin in peptide-mediated contraction of strips from rat urinary bladder. |
Q68062552 | Participation of pertussis toxin-sensitive GTP-binding regulatory proteins in the suppression of baroreceptor reflex by neurotensin in the rat |
Q72099875 | Participation of spinal cord substance P in hyperalgesia induced by repeated cold stress |
Q40491045 | Participation of substance P in spinal physiological responses to peripheral aversive stimulation |
Q60627429 | Participation of the inducible nitric oxide synthase on atrial natriuretic peptide plasma concentration during endotoxemic shock |
Q57718707 | Participation of transmembrane proline 82 in angiotensin II AT1 receptor signal transduction |
Q49117348 | Passive avoidance behavior: Opposite effects of oxytocin analogs with agonist and antagonist properties |
Q37983724 | Pathogenic involvement of heregulin-β(1) in anti-atherogenesis |
Q34060779 | Pathway specific expression of neuropeptides and autonomic control of the vasculature |
Q73517095 | Pathways mediating CRF-induced inhibition of gastric emptying in rats |
Q34060733 | Pathways of inflammation and cell death in the lung: modulation by vasoactive intestinal peptide |
Q42460430 | Patterning of renal cGMP production by the natriuretic peptide receptor type A and blood pressure in spontaneously hypertensive rats. |
Q51610848 | Patterns of immunoreactive pancreatic polypeptide in human plasma. |
Q47796566 | Peculiarities of immunocorrective effects of the bone marrow regulatory peptides (myelopeptides). |
Q48863457 | Pentagastrin in the circulation acts directly on the brain to depress motility of the stomach in sheep |
Q71342759 | Peptidase inhibitors potentiate lysylbradykinin-induced bronchoconstriction in the rat |
Q69604660 | Peptide T does not affect induction of pineal N-acetyltransferase by vasoactive intestinal peptide |
Q70581481 | Peptide YY in the mammalian pancreas: immunocytochemical localization and immunochemical characterization |
Q69432619 | Peptide YY interacts with secretin and duodenal acidification to inhibit gastric acid secretion |
Q71644398 | Peptide YY-induced alteration of colonic electrolyte transport in the rat |
Q48264304 | Peptide YY-like immunoreactivity in the central nervous system of the rat. |
Q42477923 | Peptide YY/neuropeptide Y Y1 receptor expression in the epithelium and mucosal nerves of the human colon |
Q28237831 | Peptide analogs of thymopentin distinguish distinct thymopoietin receptor specificities on two human T cell lines |
Q68567846 | Peptide biology: the value of non-mammalian models. Bayliss & Starling 10th annual meeting. Egham, 2-3 September 1990. Abstracts |
Q48745357 | Peptide drugs that have been developed to treat type 2 diabetes show neuroprotective effects |
Q69710205 | Peptide histidine isoleucine (PHI) immunoreactivity in the rat retina: identification and characterisation by radioimmunoassay, immunohistochemistry and high-performance liquid chromatography |
Q68053274 | Peptide histidine methionine (PHM) increases ileostomy output |
Q72534507 | Peptide histidine methionine and vasoactive intestinal peptide levels in human cerebrospinal fluid: age-related changes and absence of a correlation with serum prolactin |
Q68108897 | Peptide histidine valine (PHV) is present and biologically active in the human female genital tract |
Q60731318 | Peptide histidine valine-42, a novel prepro-VIP derived peptide, is a potent inhibitor of spontaneous contractions of rat uterus |
Q68441924 | Peptide injections into the amygdala of conscious rats: effects on blood pressure, heart rate and plasma catecholamines |
Q72645791 | Peptide receptors in human lung tumor cells in culture: vasoactive intestinal peptide (VIP) and secretin interaction with the Calu-1 and SW-900 cell lines |
Q48485585 | Peptide receptors in the gut as therapeutic targets: Symposium organized in honor of the retirement of Theo Peeters, Leuven September 28th 2008. |
Q84877918 | Peptide therapy with pentadecapeptide BPC 157 in traumatic nerve injury |
Q67657007 | Peptide-containing nerve fibers in the circumvallate papillae |
Q70158952 | Peptide-containing nerve fibers in the fungiform papillae of pigs and rats |
Q46825125 | Peptide-containing nerve fibers in the parathyroid glands of different species |
Q58449155 | Peptide-evoked release of amylase from isolated acini of the rat parotid gland |
Q72099777 | Peptide-immunoreactive neuronal structures in the human celiac/superior mesenteric ganglionic complex (CSM) |
Q53641094 | Peptides and obesity: the PYY3-36 story. |
Q42443883 | Peptides from the N-terminal domain of chromogranin A (vasostatins) exert negative inotropic effects in the isolated frog heart |
Q52751449 | Peptides isolated from human liver with specific inhibitory effects on reassociation/reactivation of in vitro dissociated lactic dehydrogenase (LDH-M4 and −H4) isozymes |
Q68062550 | Peptides related to insulin-like growth factor 1 in the gastro-entero-pancreatic system of bony and cartilaginous fish |
Q33258617 | Peptidomic analysis of skin secretions from Rana heckscheri and Rana okaloosae provides insight into phylogenetic relationships among frogs of the Aquarana species group. |
Q114947949 | Peptone stimulates CCK-releasing peptide (DBI) gene expression by activating intestinal submucosal cholinergic neurons |
Q70942092 | Pericardial repair depresses canine cardiac catecholamines and met-enkephalin |
Q72078841 | Perinatal development of galanin-like immunoreactivity in chromaffin tissues of the rabbit |
Q50491570 | Perinatal malnutrition programs gene expression of leptin receptors isoforms in testis and prostate of adult rats. |
Q47991458 | Peripheral "chicken" obestatin administration does not affect feed intake and gut muscle contractility of meat-type and layer-type chicks (Gallus gallus domesticus). |
Q46312790 | Peripheral GLP-1 gastroprotection against ethanol: the role of exendin, NO, CGRP, prostaglandins and blood flow |
Q58448604 | Peripheral administration of GLP-2 to humans has no effect on gastric emptying or satiety |
Q69500067 | Peripheral and central origin of Phe-Met-Arg-Phe-amide immunoreactivity in rat spinal cord |
Q48274495 | Peripheral axotomy of the rat mandibular trigeminal nerve leads to an increase in VIP and decrease of other primary afferent neuropeptides in the spinal trigeminal nucleus |
Q58042919 | Peripheral but not central leptin treatment increases numbers of circulating NK cells, granulocytes and specific monocyte subpopulations in non-endotoxaemic lean and obese LEW-rats |
Q70545486 | Peripheral cholecystokinin type A receptors mediate oxytocin secretion in vivo |
Q48111451 | Peripheral ghrelin interacts with orexin neurons in glucostatic signalling |
Q42463657 | Peripheral infusion of nociceptin/orphanin FQ influences the response of rat gastric and colonic mucosa to repeated stress |
Q37467184 | Peripheral mechanisms in the control of appetite and related experimental therapies in obesity |
Q60731327 | Peripheral neuronal systems show marked increases in VIP/PHI and CCK content following injury |
Q42240525 | Peripheral opioid receptors influencing heart rate in rats: evidence for endogenous tolerance |
Q43479642 | Peripheral versus central components of the effects of dermorphin on intestinal motility in the fed rat. |
Q71507415 | Peripherally and centrally administered bombesin induce Fos-like immunoreactivity in different brain regions in rats |
Q69878252 | Permeability of epidural somatostatin and morphine into the intrathecal space of dogs |
Q42528483 | Persistent decreased plasma cholecystokinin levels in celiac patients under gluten-free diet: respective roles of histological changes and nutrient hydrolysis. |
Q67988657 | Pertussis toxin blocks the dipsogenic actions of carbachol, but does not block the dipsogenic and pressor actions of angiotensin II |
Q41644209 | Pertussis toxin non-sensitive G protein mediates cholinergic stimulation for secretion of pancreastatin and somatostatin from QGP-1N cells |
Q41204792 | Pertussis toxin sensitive G-proteins are not involved in the mitogenic signaling pathway of insulin-like growth factor-I in normal rat kidney epithelial (NRKE) cells |
Q30952257 | Phage library-screening: a powerful approach for generation of targeting-agents specific for normal pancreatic islet-cells and islet-cell carcinoma in vivo |
Q47667135 | Pharmacokinetic profile of orexin A and effects on plasma insulin and glucagon in the rat. |
Q69444732 | Pharmacokinetics and organ catabolism of cholecystokinin octapeptide in pigs |
Q79438637 | Pharmacokinetics of 125I-GST-TatdMt, a recombinant fusion protein possessing potent anti-obesity activity, after intravenous, nasal, oral, and subcutaneous administration |
Q70047438 | Pharmacokinetics of synthetic alpha-human atrial natriuretic polypeptide in normal men; effect of aging |
Q54138663 | Pharmacokinetics, distribution and elimination of a synthetic octapeptide analogue of somatostatin in the rat |
Q43841149 | Pharmacokinetics, tissue distribution, excretion, and antiviral activity of pegylated recombinant human consensus interferon-α variant in monkeys, rats and guinea pigs |
Q35394017 | Pharmacologic antagonism of ghrelin receptors attenuates development of nicotine induced locomotor sensitization in rats |
Q40764730 | Pharmacological analysis of CCK(2) receptor ligands using COS-7 and SK-N-MC cells, expressing the human CCK(2) receptor |
Q40414988 | Pharmacological analysis of CCK2 receptors up-regulated using engineered transcription factors |
Q46230268 | Pharmacological analysis of receptors for bombesin-related peptides on guinea pig gallbladder smooth muscle |
Q51660625 | Pharmacological analysis of receptors involved in tachykininergic contraction induced by electrical transmural stimulation in the rabbit iris sphincter muscle |
Q60349853 | Pharmacological and biochemical characterization of bradykinin B2 receptors in the mouse colon: Influence of the TNBS-induced colitis |
Q45068909 | Pharmacological and functional biochemical properties of D-Ala2-D-Nle5-enkephalin-Arg-Phe |
Q48707138 | Pharmacological characterisation of oxytocin binding sites in the ovine pineal gland |
Q47885905 | Pharmacological characterization and selectivity of the NPY antagonist GR231118 (1229U91) for different NPY receptors |
Q60054772 | Pharmacological characterization of central tachykinin: 5-HT interactions |
Q45712623 | Pharmacological characterization of cholecystokinin receptors mediating contraction of human gallbladder and ascending colon |
Q43700689 | Pharmacological characterization of the novel helodermin/VIP receptor present in human SUP-T1 lymphoma cell membranes |
Q31068244 | Pharmacological comparison of rat and human melanocortin 3 and 4 receptors in vitro |
Q45244185 | Pharmacological concentration of angiotensin-(1-7) activates NADPH oxidase after ischemia-reperfusion in rat heart through AT1 receptor stimulation. |
Q80942692 | Pharmacological effects and lung-binding characteristics of a novel VIP analogue, [R15, 20, 21, L17]-VIP-GRR (IK312532) |
Q51420978 | Pharmacological evidence for both neuronal and smooth muscular PAC1 receptors and a VIP-specific receptor in rat colon. |
Q42223052 | Pharmacological profile of a new peptidic gastrin antagonist |
Q37767054 | Pharmacological profile of lixisenatide: A new GLP-1 receptor agonist for the treatment of type 2 diabetes |
Q72099813 | Pharmacological properties of a slow C-fiber response induced by stimulation of greater splanchnic nerve in an isolated spinal cord-nerve preparation of the newborn rat |
Q41411306 | Pharmacological study of gastrin-mediated amylase release in pancreatic acinar cells (AR4-2J). |
Q35618856 | Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes |
Q48312745 | Phosphoinositide hydrolysis increase by angiotensin-(1--7) in neonatal rat brain |
Q46815552 | Phosphoramidon and thiorphan suppress the generation of endothelin (ET) from exogenous big-endothelin by guinea pig Clara cells |
Q41134093 | Phosphorylation of gastrin-related peptides: physiological casein kinase like enzyme in Golgi membranes from bovine adrenal chromaffin cells and GH3 cells |
Q36774785 | Phylogenetic analysis of the sequences of gastrin-releasing peptide and its receptors: biological implications. |
Q51641345 | Physiological circulating levels of secretin-like immunoreactivity in the human do not stimulate free fatty acid production. |
Q35994148 | Physiological roles of prolactin-releasing peptide. |
Q77943876 | Pig splenic nerve: peptides derived from chromogranins by proteolytic processing during axonal transport |
Q43985033 | Pigment epithelium-derived factor in ulcerative colitis: possible relationship with disease activity. |
Q39348006 | Pioglitazone attenuates the detrimental effects of advanced glycation end-products in the pancreatic beta cell line HIT-T15. |
Q46553680 | Pituitary adenylate cyclase activating peptide (PACAP) in guinea-pig lung: distribution and dilatory effects |
Q42640040 | Pituitary adenylate cyclase activating polypeptide (PACAP) redistributes the blood within the pancreas of anesthetized rats |
Q41361303 | Pituitary adenylate cyclase activating polypeptide (PACAP) stimulates growth hormone release from GH3 cells through type II PACAP receptor |
Q72699393 | Pituitary adenylate cyclase activating polypeptide (PACAP)-like immunoreactivity in ganglioneuroblastoma and neuroblastoma |
Q48156193 | Pituitary adenylate cyclase activating polypeptide (PACAP)-like immunoreactivity in human hypothalamus: co-localization with arginine vasopressin |
Q35226864 | Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research |
Q71241842 | Pituitary adenylate cyclase activating polypeptide (PACAP): occurrence and vasodilatory effect in the human uteroplacental unit |
Q42169925 | Pituitary adenylate cyclase activating polypeptide and PAC1 receptor signaling increase Homer 1a expression in central and peripheral neurons |
Q78729836 | Pituitary adenylate cyclase activating polypeptide is expressed in autonomic neurons |
Q67525434 | Pituitary adenylate cyclase activating polypeptide stimulates gallbladder motility in conscious dogs |
Q44487518 | Pituitary adenylate cyclase activating polypeptide-27 (PACAP-27) inhibits pentagastrin-stimulated gastric acid secretion in conscious rats |
Q51492343 | Pituitary adenylate cyclase-activating polypeptide (PACAP) induces duodenal phasic contractions via the vagal cholinergic nerves in sheep. |
Q44200126 | Pituitary adenylate cyclase-activating polypeptide (PACAP) prevents hippocampal neurons from apoptosis by inhibiting JNK/SAPK and p38 signal transduction pathways. |
Q46095492 | Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates cyclic AMP formation as well as peptide output of cultured pituitary melanotrophs and AtT-20 corticotrophs |
Q46945847 | Pituitary adenylate cyclase-activating polypeptide (PACAP) type 1 receptor (PAC1R) co-localizes with activity-dependent neuroprotective protein (ADNP) in the mouse brains |
Q45202587 | Pituitary adenylate cyclase-activating polypeptide (PACAP)-like immunoreactivity in the brain of a teleost, Uranoscopus japonicus: immunohistochemical relationship between PACAP and adenohypophysial hormones |
Q44200099 | Pituitary adenylate cyclase-activating polypeptide and growth hormone-releasing hormone-like peptide in sturgeon, whitefish, grayling, flounder and halibut: cDNA sequence, exon skipping and evolution |
Q44077176 | Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide attenuate glutamate-induced nNOS activation and cytotoxicity |
Q42169943 | Pituitary adenylate cyclase-activating polypeptide enhances the hyperpolarization-activated nonselective cationic conductance, Ih, in dissociated guinea pig intracardiac neurons |
Q42169869 | Pituitary adenylate cyclase-activating polypeptide inhibits caspase-3 activity but does not protect cerebellar granule neurons against beta-amyloid (25-35)-induced apoptosis |
Q45202580 | Pituitary adenylate cyclase-activating polypeptide promotes differentiation of mouse neural stem cells into astrocytes |
Q46431485 | Pituitary adenylate cyclase-activating polypeptide: localization and differential influence on isolated hearts from rats and guinea pigs |
Q43813985 | Pituitary aminopeptidase activities involved in blood-pressure regulation are modified by dietary cholesterol: sex differences |
Q43882163 | Pituitary and hypothalamic hormones in normal and neoplastic adrenal medullae: biologically active corticotropin-releasing hormone and corticotropin |
Q48696632 | Pituitary response to growth hormone-releasing factor in rats with functional or anatomical lesions of the central nervous system that inhibit endogenous growth hormone secretion |
Q48920153 | Pituitary somatostatin receptors: dissociation at the pituitary level of receptor affinity and biological activity for selective somatostatin analogs |
Q47252839 | Pituitary β-endorphin content during spontaneous food intake and body weight cycles in the dormouse, Glis glis |
Q70743778 | Pituitary-adrenal mediation of bombesin-induced inhibition of gastrointestinal transit in rats |
Q45096832 | Plasma N-terminal pro-brain natriuretic peptide levels are positively correlated with pulmonary arterial pressure in atrial septal defect patients |
Q60808350 | Plasma adrenomedullin and endothelin-1 concentration during low-dose dobutamine infusion: Relationship between pulmonary uptake and pulmonary vascular pressure/flow characteristics |
Q75400696 | Plasma adrenomedullin concentration is increased in patients with peripheral arterial occlusive disease associated with vascular inflammation |
Q43736427 | Plasma clearance and tissue binding of rANP[99–126] and iso-rANP[1–45] in the rat |
Q67977964 | Plasma concentration of neuropeptide Y in patients with adrenal hypertension |
Q52544504 | Plasma concentrations of arginine vasopressin, oxytocin and angiotensin in patients with hymenoptera venom anaphylaxis. |
Q45239064 | Plasma concentrations of regulatory peptides in obesity following modified sham feeding (MSF) and a liquid test meal |
Q46187221 | Plasma ghrelin levels after two high-carbohydrate meals producing different insulin responses in patients with metabolic syndrome |
Q80481462 | Plasma ghrelin levels during exercise - effects of intensity and duration |
Q51565374 | Plasma glicentin in diabetic and gastrectomized patients. |
Q28216724 | Plasma levels and cardiovascular gene expression of urotensin-II in human heart failure |
Q68494710 | Plasma levels of 7B2 (a novel pituitary polypeptide) and its molecular forms in plasma and urine in patients with chronic renal failure: possible degradation by the kidney |
Q48886406 | Plasma levels of DSIP in infants in the first year of life and SIDS risk |
Q73636423 | Plasma levels of N-terminal peptide of pro-atrial natriuretic peptides in myoskeletal injuries |
Q70020576 | Plasma levels of immunoreactive atrial natriuretic hormone in patients with diabetes mellitus |
Q83455150 | Plasma levels of leptin and orexin A in the restrictive type of anorexia nervosa |
Q51516852 | Plasma levels of n-decanoyl ghrelin, another acyl- and active-form of ghrelin, in human subjects and the effect of glucose- or meal-ingestion on its dynamics. |
Q51640787 | Plasma levels of neurotensin in gastroplasty for morbid obesity. |
Q72235876 | Plasma molecular forms of gastrin, neurotensin and somatostatin in pregnancy and gestational diabetes after an oral glucose load or a mixed meal |
Q46169868 | Plasma neuropeptide Y levels relate cigarette smoking and smoking cessation to body weight regulation |
Q77512788 | Plasma neuropeptide Y of children with neuroblastoma in relation to stage, age and prognosis, and tissue neuropeptide Y |
Q51379546 | Plasma nociceptin/orphanin FQ levels are lower in patients with chronic ischemic cardiovascular diseases--A pilot study. |
Q81007442 | Plasma transforming growth factor beta1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type B |
Q42918870 | Plasminogen activator inhibitor (PAI)-1 suppresses inhibition of gastric emptying by cholecystokinin (CCK) in mice. |
Q28119134 | Pneumadin: a new lung peptide which triggers antidiuresis |
Q72837536 | Polyamine regulation of atrial natriuretic peptide in cultured cardiocytes |
Q39908888 | Polypeptide from Chlamys farreri modulates UVB-induced activation of NF-kappaB signaling pathway and protection HaCaT cells from apoptosis |
Q46829241 | Porcine glucagon-like peptide-2: structure, signaling, metabolism and effects |
Q38310383 | Possible implication of the transcriptional regulator Id3 in PACAP-induced pro-survival signaling during PC12 cell differentiation |
Q39590344 | Possible involvement of PACAP and PACAP type 1 receptor in GnRH-induced FSH β-subunit gene expression |
Q79791854 | Possible role of adrenomedullin in the regulation of Fontan circulation: mature form of plasma adrenomedullin is extracted in the lung in patients with Fontan procedure |
Q71051690 | Possible role of the duodenum in the entero-PP axis |
Q44073781 | Possible role of vasoactive intestinal peptide in the hyperprolactinemia induced by ethanol |
Q127740984 | Post-translational processing of human chromogranin B is tissue-specific |
Q84504717 | Postconditioning with curaglutide, a novel GLP-1 analog, protects against heart ischemia-reperfusion injury in an isolated rat heart |
Q51731808 | Postnatal development of galanin-like peptide mRNA expression in rat hypothalamus. |
Q38291884 | Postnatal profile of plasma leptin concentrations in male and female rats: relation with the maturation of the pituitary-gonadal axis |
Q47227830 | Postnatal regulation of hypothalamic neuropeptide expression by leptin: implications for energy balance and body weight regulation |
Q44397771 | Postnatally disturbed pancreatic islet cell distribution in human islet amyloid polypeptide transgenic mice |
Q45795007 | Postpartum reversibility of impaired incretin effect in gestational diabetes mellitus. |
Q31874684 | Postprandial cell proliferation in the esophageal epithelium of rats |
Q50981589 | Postprandial glucose-dependent insulinotropic polypeptide and insulin responses in patients with chronic pancreatitis with and without secondary diabetes. |
Q49013091 | Postsynaptic inhibitory effects of Met- and Leu-enkephalin on endocrine and adjacent neurones in the preoptic-septal region of the guinea pig |
Q46443421 | Posttranscriptional activation of BNP gene expression in response to increased left ventricular wall stress: role of calcineurin and PKC. |
Q46986378 | Potencies of various neurotensin-(8-13) analogs for inhibition of heat-induced edema in the anesthetized rat. |
Q42248995 | Potent central nervous system action of p-Glu-His-(3,3'-dimethyl)-Pro NH2, a stabilized analog of TRH, to stimulate gastric secretion in rats |
Q40803554 | Potent stimuli for vasopressin release, hypertonic saline and hemorrhage, cause antipyresis in the rat. |
Q69081233 | Potential involvement of galanin in the regulation of fluid homeostasis in the rat |
Q35094450 | Potential role of intermedin/adrenomedullin 2 in early embryonic development in rats |
Q51660602 | Potentiating effect of peptidase inhibitors on a C fiber-evoked response in the isolated spinal cord preparation of the neonatal rat |
Q72534474 | Potentiation of sensory tachykininergic and parasympathetic cholinergic transmission by epidermal growth factor |
Q45919926 | Potentiation of spinal NMDA-mediated nociception by cocaine- and amphetamine-regulated transcript peptide via PKA and PKC signaling pathways in rats. |
Q69671045 | Pre- and postjunctional actions of neuropeptide Y and related peptides |
Q40062144 | Pre-clinical evaluation of a new orally-active CCK-2R antagonist, Z-360, in gastrointestinal cancer models |
Q48219918 | Precursor forms of neurotensin (NT) in cat: processing with pepsin yields NT-(3-13) and NT-(4-13). |
Q72022669 | Pregastric and postabsorptive inhibitory effects of water on angiotensin-induced Fos in rat brain |
Q38353183 | Pregnancy-induced hyperphagia is associated with increased gene expression of hypothalamic agouti-related peptide in rats. |
Q43069589 | Preliminary use of insulin-like growth factor-I as a biomarker for sorting high-dose donepezil responders among Japanese patients with Alzheimer's disease |
Q38349934 | Prepro-orexin and feeding-related peptide receptor expression in dehydration-induced anorexia. |
Q70942080 | PreproPACAP-derived peptides occur in VIP-producing tumours and co-exist with VIP |
Q72534462 | Preprotachykinin mRNA expression in the synovial tissue of chronic arthritis |
Q93518648 | Presence and actions of vasopressin-like peptides in the rabbit anterior uvea |
Q58356814 | Presence and biochemical properties of a molluscan invertebrate angiotensin-converting enzyme |
Q73062198 | Presence and localization of CCK receptor subtypes in calf pancreas |
Q44016676 | Presence and release of SR-17 (chromogranin B(586-602)) in the porcine splenic nerve and its enzymatic degradation by CD26/dipeptidyl peptidase IV. |
Q67473382 | Presence and release of immunoreactive atrial natriuretic peptide in granulosa cells of the pig ovarian follicle |
Q50786035 | Presence and release of the chromogranin B-derived secretolytin-like peptide KR-11 from the porcine spleen. |
Q61855154 | Presence of ACTH and β-endorphin immunoreactive molecules in the freshwater snail Planorbarius corneus (L.) (Gastropoda, Pulmonata) and their possible role in phagocytosis |
Q51822323 | Presence of a N-terminal signal peptide in class II G protein-coupled receptors: crucial role for expression of the human VPAC1 receptor. |
Q48105281 | Presence of calcitonin gene-related peptide receptors coupled to adenylate cyclase in human gliomas |
Q82731115 | Presence of dendroaspis natriuretic peptide and its binding to NPR-A receptor in rabbit kidney |
Q72484706 | Presence of dynorphin-like immunoreactivity in rat pituitary gland and hypothalamus |
Q67866572 | Presence of endothelin-1 and endothelin-3 in peripheral tissues and central nervous system of the pig |
Q84362976 | Presence of immunoreactive salusin-beta in human plasma and urine |
Q49121298 | Presence of ranatensin-like and bombesin-like peptides in amphibian brains |
Q81034839 | Presence of substance P and the neurokinin-1 receptor in tenocytes of the human Achilles tendon |
Q28580541 | Presenilins in the heart: presenilin-2 expression is increased by low glucose and by hypoxia in cardiac cells |
Q39825960 | Preserved insulin secretion capacity and graft function of cryostored encapsulated rat islets |
Q43878298 | Pressor response to microinjection of orexin/hypocretin into rostral ventrolateral medulla of awake rats |
Q48876410 | Pressor responses in rats following intravenous dynorphin A(1-13) administration are blocked by AVP-V1 receptor antagonism |
Q69912977 | Pressor, tachycardic and feeding responses in conscious rats following i.c.v. administration of dynorphin. Central blockade by opiate and alpha 1-receptor antagonists |
Q46678556 | Presynaptic effects of neuropeptide Y on [3H]noradrenaline and [3H]acetylcholine release |
Q44339288 | Presynaptic modulation by noradrenaline and an opioid of the substance P-induced release of [3H]acetylcholine from the myenteric plexus |
Q51660614 | Primary afferent-evoked slow EPSPs and responses to substance P of dorsal horn neurons in the adult rat spinal cord slices |
Q93623296 | Primary structure of glucagon and a partial sequence of oxyntomodulin (glucagon-37) from the guinea pig |
Q48267545 | Primary structure of neuropeptide Y from brains of the American alligator (Alligator mississippiensis). |
Q34302909 | Primary structure of solitary form of gonadotropin-releasing hormone (GnRH) in cichlid pituitary; three forms of GnRH in brain of cichlid and pumpkinseed fish |
Q48795663 | Primary structure of three forms of gonadotropin-releasing hormone (GnRH) from the pacu brain |
Q48738069 | Primary structure of two forms of gonadotropin-releasing hormone from brains of the American alligator (Alligator mississippiensis). |
Q67884917 | Priming of normal human neutrophils by tachykinins: tuftsin-like inhibition of in vitro chemotaxis stimulated by formylpeptide or interleukin-8 |
Q34060762 | Principles of tachykininergic co-transmission in the peripheral and enteric nervous system |
Q48012211 | Prior regular exercise reverses the decreased effects of sleep deprivation on brain-derived neurotrophic factor levels in the hippocampus of ovariectomized female rats |
Q46053034 | Pro-angiogenic activity of Urotensin-II on different human vascular endothelial cell populations |
Q44348198 | Pro-opiocortin peptides in rat cerebrospinal fluid |
Q70150881 | Pro-opiomelanocortin peptides in the human fetal pituitary |
Q48097081 | Pro-opiomelanocortin-derived peptides in the pig pituitary: alpha- and gamma 1-melanocyte-stimulating hormones and their glycine-extended forms |
Q73150079 | Pro-xenopsin(s) in vesicles of mammalian brain, liver, stomach and intestine is apparently released into blood and cerebral spinal fluid |
Q81420531 | ProCNP and CNP are expressed primarily in male genital organs |
Q81550991 | Proceedings from the GLP1 Meeting on the Occasion of the 80th Birthday of Prof. Dr. med. Dr. hc (em.) Werner Creutzfeldt |
Q78454787 | Proceedings of the 5th International Meeting: VIP, PACAP, Secretin, Glucagon and Related Peptides. November 4-8, 2001. Santa Barbara, California, USA |
Q57950945 | Processing of chromogranins/secretogranin in patients with diabetic retinopathy |
Q48349732 | Processing of the thyrotropin releasing hormone (TRH) precursor in Xenopus skin and bovine hypothalamus: evidence for the existence of extended forms of TRH. |
Q28578687 | Production and autocrine/paracrine effects of endogenous insulin-like growth factor-1 in rat cardiac fibroblasts |
Q41449216 | Production and secretion of chromogranin A and pancreastatin by the human pancreatic carcinoma cell line QGP-1N on stimulation with carbachol |
Q40657264 | Production of recombinant human relaxin 3 in AtT20 cells |
Q43701504 | Progesterone and norethisterone have different effects on tachykinin-like immunoreactivity in rat cortex and striatum |
Q84554400 | Proghrelin peptides: Desacyl ghrelin is a powerful inhibitor of acylated ghrelin, likely to impair physiological effects of acyl ghrelin but not of obestatin A study of pancreatic polypeptide secretion from mouse islets |
Q81453010 | Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas |
Q41206405 | Proglucagon processing in islet and intestinal cell lines |
Q54646044 | Prognostic value of somatostatin receptor subtype 2 expression in colorectal cancer. |
Q77882840 | Program and Abstracts of the 23rd Annual Winter Neuropeptide Conference. February 2-5, 2002. Breckenridge, Colorado, USA |
Q40672118 | Prohormone convertase 2 enzymatic activity and its regulation in neuro-endocrine cells and tissues |
Q40924524 | Prohormone convertase-1 is essential for conversion of chromogranin A to pancreastatin |
Q81496868 | Prohormone convertases 1/3, 2, furin and protein 7B2 (Secretogranin V) in endocrine cells of the human pancreas |
Q46101836 | Prokineticin 2 is involved in the thermoregulation and energy expenditure |
Q45835185 | Prolactin is a potential physiological modulator of swine ovarian follicle function. |
Q45925829 | Prolactin-releasing peptide regulates cardiac contractility. |
Q35134682 | Prolactin-releasing peptides |
Q82037427 | Prolonged effects of intracerebroventricular angiotensin II on drinking, eating and locomotor behavior in mice |
Q41869418 | Prolonged exposure of cardiac cells to renin plus angiotensinogen reduces intracellular renin in the failing heart. On the role of angiotensin II-AT1 complex internalization |
Q42060368 | Prolonged pheromonotropic activity of pseudopeptide mimics of insect pyrokinin neuropeptides after topical application or injection into a moth |
Q52242642 | Promoting effect of bombesin on the cell proliferation in the rat endocrine pancreas during the early postnatal period. |
Q69351529 | Promotion of differentiation in human colon carcinoma cells by vasoactive intestinal polypeptide |
Q51745798 | Pronounced increases in brain levels of calcitonin gene-related peptide after kainic acid induced seizures. |
Q54623265 | Pronounced substance P innervation in irradiation-induced enteropathy--a study on human colon. |
Q48673193 | Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord |
Q70124508 | Properties of histidyl-proline diketopiperazine [cyclo(His-Pro)] binding sites in rat liver |
Q72154951 | Properties of the VIP-PACAP type II receptor stably expressed in CHO cells |
Q44077173 | Propranolol blocks the tachycardia induced by galanin (1-15) but not by galanin (1-29). |
Q44921498 | Prosomatostatin is proteolytically processed at the amino terminal segment by subtilase SKI-1. |
Q72235870 | Prosomatostatin-I is processed to somatostatin-26 and somatostatin-14 in the pancreas of the bowfin, Amia calva |
Q51830519 | Prostaglandins may not mediate inhibition of gastric acid secretion by somatostatin in the rat. |
Q46483536 | Protease-activated receptor-1 (PAR1) and PAR2 but not PAR4 mediate relaxations in lower esophageal sphincter |
Q39682241 | Protecting effects of vasonatrin peptide against carbon tetrachloride-induced liver fibrosis |
Q44616127 | Protective effect of bradykinin antagonist Hoe-140 during in vivo myocardial ischemic-reperfusion injury in the cat |
Q45176370 | Protective effect of central thyrotropin-releasing hormone analog on cerulein-induced acute pancreatitis in rats |
Q46947721 | Protective effect of short-term treatment with parathyroid hormone 1-34 on oxidative stress is involved in insulin-like growth factor-I and nuclear factor erythroid 2-related factor 2 in rat bone marrow derived mesenchymal stem cells |
Q36101343 | Protective effect of the inhibition of the renin-angiotensin system on aging |
Q81538720 | Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart |
Q50158282 | Protective effects of somatostatin against gastric damage induced by hemorrhagic shock, stress and PAF in the rat. |
Q46963654 | Protective role of adrenomedullin in burn-induced remote organ damage in the rat. |
Q45268407 | Protective role of ghrelin against carbon tetrachloride (CCl4)-induced coagulation disturbances in rats |
Q42516895 | Protein distribution of the orexin-2 receptor in the rat central nervous system |
Q37151456 | Protein intake and energy balance |
Q40006953 | Protein kinase C inhibitors alter neurotensin receptor binding and function in prostate cancer PC3 cells |
Q77535601 | Protein kinase C mediates the contractile actions of pituitary adenylate cyclase activating polypeptide in guinea pig gallbladder strips |
Q45244195 | Protein kinase C-mediated inhibition of renal Ca2+ ATPase by physiological concentrations of angiotensin II is reversed by AT1- and AT2-receptor antagonists |
Q46339399 | Proteinase-activated receptor-1 (PAR1) and PAR2 mediate relaxation of guinea pig internal anal sphincter |
Q40483943 | Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1. |
Q57268666 | Proteolytic processing of chromogranin A by the prohormone convertase PC2 |
Q72671843 | Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV |
Q39177483 | PsT-1: a new tryptophyllin peptide from the skin secretion of Waxy Monkey Leaf Frog, Phyllomedusa sauvagei |
Q40981977 | Pseudodipeptide analogs of the pyrokinin/PBAN (FXPRLa) insect neuropeptide family containing carbocyclic Pro-mimetic conformational components |
Q38462794 | Pulmonary administered palmitic-acid modified exendin-4 peptide prolongs hypoglycemia in type 2 diabetic db/db mice |
Q80606042 | Pulses of somatostatin release are slightly delayed compared with insulin and antisynchronous to glucagon |
Q72176509 | Purification and amino acid sequence of human motilin isolated from a motilin containing liver metastasis |
Q72699398 | Purification and amino acid sequence of motilin from cat small intestine |
Q70158957 | Purification and amino acid sequence of vasoactive intestinal peptide, peptide histidine isoleucinamide and secretin from the ovine small intestine |
Q73828206 | Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio |
Q53851956 | Purification and characterization of antimicrobial peptides from the skin secretions of the carpenter frog Rana virgatipes (Ranidae, Aquarana). |
Q51647761 | Purification and characterization of canine intestinal motilin. |
Q36888544 | Purification and characterization of islet hormones (insulin, glucagon, pancreatic, polypeptide and somatostatin) from the Burmese python, Python molurus |
Q44473708 | Purification and characterization of luteinizing hormone-releasing hormone from codfish brain |
Q42809815 | Purification and partial characterization of a mitogenic factor from bovine liver: structural homology with basic fibroblast growth factor. |
Q48172589 | Purification of a neuropeptide Y-related peptide from the brain of the sea lamprey and its effect on steroidogenesis |
Q48175891 | Purification of a novel DBI processing product, DBI39-75, and characterization of its binding site in rat brain |
Q48916562 | Purification of bovine cholecystokinin-58 and sequencing of its N-terminus |
Q42047695 | Purification of cationic cystine-rich peptides from rat bone marrow. Primary structures and biological activity of the rat corticostatin family of peptides |
Q69592974 | Purification of the pancreatic cholecystokinin receptor |
Q28582303 | Purification, cDNA sequence, and tissue distribution of rat uroguanylin |
Q40916546 | Putative factors implicated in the structural plasticity of the hypothalamo-neurohypophysial system |
Q34350123 | Pyroglutamyl peptidase I and prolyl endopeptidase in human semen: increased activity in necrozoospermia. |
Q48766181 | Quantification of Locusta diuretic hormone in the central nervous system and corpora cardiaca: influence of age and feeding status, and mechanism of release |
Q71624629 | Quantitation of N-terminally extended tachykinins in cerebrospinal fluid from healthy subjects |
Q73022730 | Quantitative analysis of growth-related factors in human pituitary adenomas. Lowered insulin-like growth factor-I and its receptor mRNA in growth hormone-producing adenomas |
Q48434936 | Quantitative autoradiographic determination of angiotensin-converting enzyme binding in rat pituitary and adrenal glands with 125I-351A, a specific inhibitor |
Q41415917 | Quantitative in vitro autoradiographic characterization of [125I]angiotensin III binding sites in rat adrenal gland |
Q72154957 | Quantitative modifications induced by angiotensin II on rat bile secretion |
Q73185223 | REGPEP 2000: 13th International Symposium on Regulatory Peptides. Cairns, Queensland, Australia. 22-26 October 2000. Abstracts |
Q74798867 | REGPEP 2002. Abstracts of the 14th International Symposium on Regulatory Peptides. Boston, Massachusetts, USA. August 31-September 3, 2002 |
Q71507424 | RGD-containing peptides induce endothelium-dependent and independent vasorelaxations of rat aortic rings |
Q34183915 | RNAi knockdown of the Akt1 gene increases the chemosensitivity of gastric cancer cells to cisplatin both in vitro and in vivo |
Q80270367 | RT-PCR and immunocytochemistry studies support the presence of somatostatin, cortistatin and somatostatin receptor subtypes in rat Kupffer cells |
Q39902655 | RXFP1-inactive relaxin activates human glucocorticoid receptor: further investigations into the relaxin-GR pathway |
Q47237191 | RYIRFamide: a turbellarian FMRFamide-related peptide (FaRP). |
Q43948861 | Rabbit neuromedin U-25: lack of conservation of a posttranslational processing site. |
Q72533595 | Radioimmunoassay for catfish pancreatic somatostatin-22 |
Q41503650 | Radioimmunoassay for fibroblast growth factor (FGF): release by the bovine anterior pituitary in vitro |
Q44572742 | Radioimmunoassay of [D-Trp6]-luteinizing hormone-releasing hormone: its application to animal pharmacokinetic studies after single injection and long-acting formulation administration |
Q49106911 | Radioimmunoassay of delta sleep-inducing peptide using an iodinated p-hydroxyphenylpropionic acid derivative as tracer |
Q53915204 | Radioimmunoassay of neuropeptide Y. |
Q48687061 | Radioimmunoassay of pancreatic polypeptide in mammalian and submammalian vertebrates using a carboxyl-terminal hexapeptide antiserum |
Q77123836 | Radioimmunoassay of regulatory peptides in the presence of acetonitrile: marked improvement of cholecystokinin assays |
Q48711390 | Rat brain TRH receptors: kinetics, pharmacology, distribution and ionic effects |
Q42451093 | Rat gastric relaxation induced by stimulation of endothelin-1 selective receptors |
Q48480761 | Rat immunoreactive cholecystokinin (CCK): characterization using two chromatographic techniques |
Q72217570 | Rat liver injury induced by hypoxic ischemia and reperfusion: protective action by somatostatin and two derivatives |
Q67659817 | Rat pancreastatin inhibits both pancreatic exocrine and endocrine secretions in rats |
Q44397780 | Rat progastrin processing yields peptides with altered potency at the CCK-B receptor. |
Q44451606 | Rat stomach ECL cells: mode of activation of histidine decarboxylase |
Q74665112 | Rat stomach ECL-cell histidine decarboxylase activity is suppressed by ergocalciferol but unaffected by parathyroid hormone and calcitonin |
Q33927958 | Reactive oxygen species and vascular cell apoptosis in response to angiotensin II and pro-atherosclerotic factors |
Q34019811 | Reactive oxygen species as mediators of angiotensin II signaling |
Q42522456 | Receptor binding of pancreatic spasmolytic polypeptide (PSP) in rat intestinal mucosal cell membranes inhibits the adenylate cyclase activity |
Q69822681 | Receptor binding of pancreatic spasmolytic polypeptide in intestinal mucosal cells and membranes |
Q49104863 | Receptor binding of somatostatin-14 and somatostatin-28 in rat brain: differential modulation by nucleotides and ions |
Q72099894 | Receptor characterization of the spinal action of neurokinins on nociception: a three receptor hypothesis |
Q47871659 | Receptor mechanisms of bradykinin-mediated activation of prenodal lymphatic smooth muscle |
Q44451604 | Receptor mechanisms of prenodal lymphatic constriction by dopamine |
Q69832401 | Receptor occupancy and adenylate cyclase activation in rat liver and heart membranes by 10 glucagon analogs modified in position 2,3, 4, 25, 27 and/or 29 |
Q73053562 | Receptor subtype mediating the action of circulating endothelin on glucose metabolism and hemodynamics in perfused rat liver |
Q46520461 | Receptor subtypes for vasonatrin peptide in renal glomeruli and arteries |
Q68869985 | Receptor type for cholecystokinin on isolated intestinal muscle cells of the guinea pig |
Q72154971 | Receptor-independent mechanisms are involved in the priming of neutrophil's oxidase by vasoactive intestinal peptide |
Q84950654 | Receptor-mediated inhibition of small bowel migrating complex by GLP-1 analog ROSE-010 delivered via pulmonary and systemic routes in the conscious rat |
Q72358290 | Receptor-mediated internalization of angiotensin II in bovine adrenal medullary chromaffin cells in primary culture |
Q44277682 | Reciprocal paracrine pathways link atrial natriuretic peptide and somatostatin secretion in the antrum of the stomach |
Q73150062 | Recombinant granulocyte colony-stimulating factor induces production of human neutrophil peptides in lung cancer patients with neutropenia |
Q72287118 | Recombinant human chromogranin A: expression, purification and characterization of the N-terminal derived peptides |
Q48359403 | Reduced BAT function as a mechanism for obesity in the hypophagic, neuropeptide Y deficient monosodium glutamate-treated rat. |
Q48673172 | Reduced cholecystokinin in the brain of LEC rats with hepatic encephalopathy |
Q67535459 | Reduced gastric acid inhibitory effect of a pGIP(1-30)NH2 fragment with potent pancreatic amylase inhibitory activity |
Q42169907 | Reduced hypothermic and hypnotic responses to ethanol in PACAP-deficient mice |
Q33758028 | Reduced neurogenesis in the rat hippocampus following high fructose consumption |
Q69931253 | Reduced somatostatin-28-(1-12)-like immunoreactivity in cerebral cortex of dogs with an Eck fistula and somatostatin molecular forms in brain |
Q48650521 | Reduced somatostatin-like immunoreactivity in the brain of LEC rats with hepatic encephalopathy |
Q48216927 | Reduced somatostatin-like immunoreactivity in the brain of dogs with an Eck fistula |
Q28568447 | Reduced urocortin 1 immunoreactivity in the non-preganglionic Edinger-Westphal nucleus during late pregnancy in rats |
Q47394799 | Reduction of infarct size by orally administered des-aspartate-angiotensin I in the ischemic reperfused rat heart |
Q60727878 | Reevaluation of sst1 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-7 |
Q46786664 | Reg IV is differently expressed in enteroendocrine cells of human small intestine and colon |
Q46987275 | Reg genes are CCK2 receptor targets in ElasCCK2 mice pancreas. |
Q72099803 | Regional differences in contractile responses to tachykinin agonists and to electrical field stimulation are dependent on distribution of proteinase activity |
Q48519093 | Regional distribution and in vivo release of tachykinin-like immunoreactivities in rat brain: evidence for regional differences in relative proportions of tachykinins |
Q48613964 | Regional distribution and the dynamics of n-decanoyl ghrelin, another acyl-form of ghrelin, upon fasting in rodents |
Q60731331 | Regional distribution of PHI, CCK, VIP and substance P in the feline urinary system |
Q44512287 | Regional distribution of endothelin receptor in porcine cardiovascular tissues |
Q44215164 | Regional distribution of neuropeptide γ and other tachykinin peptides derived from the substance P gene in the rat |
Q69378651 | Regional distribution of somatostatin receptor affinity states in rat brain: effects of divalent cations and GTP |
Q51357299 | Regulated endocrine-specific protein 18 (RESP18) is localized to and regulated in A-like cells and G-cells in rat stomach. |
Q41565431 | Regulated expression of angiotensin II (AT2) binding sites in R3T3 cells |
Q43207163 | Regulated expression of the human gastrin gene in mice |
Q38359861 | Regulation and role of p21-activated kinase 3 by corticotropin-releasing factor in mouse pituitary |
Q44813400 | Regulation of ANP secretion in insulin-dependent diabetes mellitus and the influence of autonomic neuropathy |
Q36060606 | Regulation of IGF-1 but not TGF-β1 by NGF in the smooth muscle of the inflamed urinary bladder |
Q44554637 | Regulation of NGF and BDNF by dexamethasone and theophylline in human peripheral eosinophils in allergics and non-allergics |
Q38306368 | Regulation of TFF3 expression by homeodomain protein CDX2. |
Q54564804 | Regulation of angiotensin II receptors levels during rat induced pulpitis. |
Q40825828 | Regulation of angiotensin II type 1 (AT1) receptor function |
Q42810618 | Regulation of apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes |
Q74338109 | Regulation of apoptosis by somatostatin and substance P in peritoneal macrophages |
Q43155679 | Regulation of autonomic nerve activities by central pituitary adenylate cyclase-activating polypeptide |
Q40467635 | Regulation of corticotropin-releasing factor receptor type 2beta mRNA by mitogen-activated protein kinases in aortic smooth muscle cells. |
Q41520171 | Regulation of endometrial cancer cell growth by insulin-like growth factors and the luteinizing hormone-releasing hormone antagonist SB-75. |
Q44980526 | Regulation of expression of the receptors controlling gastric acidity |
Q44878434 | Regulation of hypoxia-induced release of corticotropin-releasing factor in the rat hypothalamus by norepinephrine |
Q38307716 | Regulation of in vivo TSH secretion by leptin |
Q80173094 | Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues |
Q73056782 | Regulation of leptin secretion: effects of aging on daily patterns of serum leptin and food consumption |
Q43846497 | Regulation of neurotensin secretion in a mammalian C cell line: effect of dexamethasone |
Q42465442 | Regulation of neurotensin secretion in mammalian C cell lines: potassium and norepinephrine affect the rapid release of the peptide |
Q44200129 | Regulation of neurotrophic peptide expression in sympathetic neurons: quantitative analysis using radioimmunoassay and real-time quantitative polymerase chain reaction |
Q35095518 | Regulation of pancreatic physiology by adrenomedullin and its binding protein. |
Q35095500 | Regulation of production and secretion of adrenomedullin in the cardiovascular system |
Q77512781 | Regulation of rat adrenal neuropeptide Y (NPY) content: effects of ACTH, dexamethasone and hypophysectomy |
Q48395766 | Regulation of somatostatin and growth hormone-releasing factor by gonadal steroids in fetal rat hypothalamic cells in culture |
Q77123906 | Regulation of the action of the novel cholecystokinin-releasing peptide diazepam binding inhibitor by inhibitory hormones and taurocholate |
Q40916650 | Regulation of the extent of polyadenylation of vasopressin and growth hormone mRNAs in response to physiological stimuli. |
Q77535615 | Regulation of the renal Na-HCO3 cotransporter: IX. Modulation by insulin, epidermal growth factor and carbachol |
Q51301603 | Regulatory Peptides--past, present and future. |
Q40215150 | Regulatory expression of bone morphogenetic protein-6 system in aldosterone production by human adrenocortical cells |
Q69931247 | Regulatory mechanisms in the luminal and portal release of vasoactive intestinal polypeptide during vagal nerve stimulation in the cat |
Q67690049 | Regulatory peptide and serotonin content and brush-border enzyme activity in the rat gastrointestinal tract following neonatal treatment with capsaicin; lack of effect on epithelial markers |
Q72518606 | Regulatory peptides and gut hormones. Abstracts presented at the Bayliss and Starling Society national scientific meeting December 1981 |
Q37607754 | Regulatory peptides from chromogranin A and secretogranin II: putative modulators of cells and tissues involved in inflammatory conditions |
Q93677286 | Regulatory peptides in the brain and in the gastrointestinal tract. Abstracts of the Bayliss & Starling Society national scientific meeting. 18th-19th December 1985, London, U.K. |
Q58449414 | Regulatory peptides in the lower esophageal sphincter of man |
Q51660635 | Relations of contractile hyperreactivity to tachykinins in rabbit trachea |
Q44011999 | Relationship between circulating levels of calcitonin gene-related peptide, nitric oxide metabolites and hemodynamic changes in human septic shock |
Q44788435 | Relationship between contents of adrenomedullin and distributions of neutral endopeptidase in blood and tissues of rats in septic shock |
Q72473008 | Relationship between intravenous ethanol, alcohol-induced inhibition of pancreatic secretion and plasma concentration of immunoreactive pancreatic polypeptide, vasoactive intestinal peptide, and somatostatin in man |
Q72367619 | Relationship between postprandial release of CCK and PP in health and in chronic pancreatitis |
Q79507511 | Relationship between renal and cardiovascular changes in a murine model of glucose intolerance |
Q54469756 | Relationship between substance P, intestinal wall compliance and vascular resistance in the canine ileum |
Q72382822 | Relationship of CCK/gastrin receptor binding to amylase release in dog pancreatic acini |
Q44368793 | Relationship of fetuin-A levels to weight-dependent insulin resistance and type 2 diabetes mellitus |
Q71774482 | Relationship of neuropeptides to nitrergic innervation of the canine laryngeal glands |
Q79382591 | Relaxation induced by N-terminal fragments of chromogranin A in mouse gastric preparations |
Q50786127 | Relaxin inhibits early steps in vascular inflammation. |
Q39795613 | Relaxin-3 and receptors in the human and rhesus brain and reproductive tissues. |
Q50519619 | Relaxing effect of insulin in renal arteries from diabetic rats. |
Q63608730 | Release and degradation of neurotensin during perfusion of rat small intestine with lipid |
Q42496399 | Release of PYY from pig intestinal mucosa; luminal and neural regulation. |
Q72568093 | Release of bombesin-like immunoreactivity from the isolated perfused rat stomach |
Q41978161 | Release of calcitonin gene-related peptide from rat enteric nerves is Ca2+-dependent but is not induced by K+ depolarization |
Q33372364 | Release of calcitonin gene-related peptide in the pig nasal mucosa by antidromic nerve stimulation and capsaicin |
Q47570875 | Release of different fractions of epidermal growth factor from human platelets in vitro: preferential release of 140 kDa fraction |
Q71441905 | Release of gastric inhibitory polypeptide (GIP) during calcium infusion and in hyperparathyroidism |
Q42464418 | Release of ileal neurotensin in the rat by neurotransmitters and neuropeptides |
Q48351303 | Release of immunoreactive met-enkephalin by intraventricular beta-endorphin in anesthetized rats |
Q73444364 | Release of neuropeptide Y and hemodynamic changes during surgical removal of human pheochromocytomas |
Q44700873 | Release of peptide YY by fat in the proximal but not distal gut depends on an atropine-sensitive cholinergic pathway |
Q28566362 | Release of regulatory gut peptides somatostatin, neurotensin and vasoactive intestinal peptide by acid and hyperosmolal solutions in the intestine in conscious rats |
Q39736600 | Release of salusin-beta from human monocytes/macrophages. |
Q40766308 | Release of tachykinins and its metabolism in the airway |
Q51867328 | Release of vasoactive intestinal polypeptide by electrical field stimulation of rabbit ileum. |
Q74752839 | Renal aminopeptidase activities in animal models of hypertension |
Q80098194 | Renal atrial natriuretic peptide receptors binding properties and function are resistant to DOCA-salt-induced hypertension in rats |
Q73828214 | Renal content and output of epidermal growth factor in long-term adrenergic agonist-treated rats |
Q73117236 | Renal effects of angiotensin II receptor subtype 1 and 2-selective ligands injected into the paraventricular nucleus of conscious rats |
Q30800384 | Renal effects of long-term leptin infusion and preventive role of losartan treatment in rats |
Q68184719 | Renal function during bovine neurotensin infusion in man |
Q56775023 | Renal function in transgenic rats expressing an angiotensin-(1–7)-producing fusion protein |
Q42142603 | Renal glomerular endothelin receptors in rats with high-output heart failure |
Q45022316 | Renal hemodynamic response to galanin: importance of elevated plasma glucose |
Q45116986 | Renal hyperemia in portal hypertension is not mediated by gastrointestinal peptides |
Q70233876 | Renal origin of rat urinary epidermal growth factor |
Q68869978 | Renal uptake and excretion of epidermal growth factor from plasma in the rat |
Q67535106 | Renal, cardiovascular and endocrine effects of centrally administered galanin in the anaesthetised rat |
Q36970791 | Renoprotection by pituitary adenylate cyclase-activating polypeptide in multiple myeloma and other kidney diseases |
Q37802015 | Reprint of: Catestatin: A multifunctional peptide from chromogranin A |
Q33986391 | Reprint of: Chromogranin A: a new proposal for trafficking, processing and induction of granule biogenesis |
Q37799095 | Reprint of: Metabolic effects and mechanism of action of the chromogranin A-derived peptide pancreastatin. |
Q71367155 | Requirement for prostaglandin synthesis in secretion of atrial natriuretic factor from isolated rat heart |
Q44215295 | Rescue of thymocytes from cell death by vasoactive intestinal peptide |
Q38307712 | Resistance to the anorexic and thermogenic effects of centrally administrated leptin in obese aged rats |
Q86123168 | Resistin induces lipolysis and suppresses adiponectin secretion in cultured human visceral adipose tissue |
Q43765492 | Respiratory and cardiovascular effects of thyrotropin-releasing hormone as modified by isoflurane, enflurane, pentobarbital and ketamine |
Q126857398 | Respiratory and circulatory effects of opioid peptides microinjected into the solitary tract nucleus |
Q51647842 | Response of gastric inhibitory polypeptide (GIP) to oral administration of nutrients in normal and pancreatectomized dogs. |
Q71371304 | Response of gastric inhibitory polypeptide to fat ingestion in normal dogs |
Q48700867 | Response of leptin mRNA to 24-h food deprivation and refeeding is influenced by age in rats |
Q51567078 | Response of neuropeptide Y-deficient mice to feeding effectors. |
Q70842054 | Response of the exocrine pancreas to graded doses of secretin in calcium-treated and normal dogs |
Q67916517 | Responses of the rat pituitary-adrenal axis to hypotensive infusions of corticotropin-releasing factor, vasoactive intestinal peptide and other depressor agents |
Q46203794 | Responses to systemic angiotensin II in lactating and non-lactating goats |
Q43699043 | Restoration of endogenous substance P is associated with inhibition of apoptosis of retinal cells in diabetic rats |
Q44337750 | Restraint changes pentobarbital-induced sleeping time in rats: evidence that arousal is modulated by brain corticotropin-releasing hormone and opioid in stress |
Q51623783 | Restricted feeding schedules alter the circadian rhythms of serum insulin and gastric inhibitory polypeptide. |
Q50511666 | Resveratrol attenuates angiotensin II-induced senescence of vascular smooth muscle cells. |
Q40839238 | Retinoic acid treatment enhances the acetylcholine contents in the human teratocarcinoma cell line NTera-2. |
Q86654356 | Retraction notice to “Erythropoietin as a possible mechanism for the effects of intermittent hypoxia on bodyweight, serum glucose and leptin in mice” [Regul. Pept. 165(2–3) (2010) 168–173] |
Q57556200 | Reversal by cholecystokinin of apomorphine-induced inhibition of dopamine release in the nucleus accumbens of the rat |
Q43770801 | Reversal of alpha-difluoromethylornithine inhibition of caerulein-induced pancreatic growth by putrescine |
Q35994138 | Reverse pharmacology of orexin: from an orphan GPCR to integrative physiology |
Q43872783 | Rhesus monkey gastroenteropancreatic hormones: relationship to human sequences |
Q35074649 | Rhythmic, reciprocal ghrelin and leptin signaling: new insight in the development of obesity |
Q68055627 | Right atrial predominance of atrial natriuretic peptide secretion in isolated perfused rat atria |
Q43155676 | Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction |
Q70761254 | Role of AVP in the regulation of vascular tonus and blood pressure in patients with chronic renal failure |
Q48729052 | Role of AgRP on Ghrelin-induced feeding in the hypothalamic paraventricular nucleus |
Q38357518 | Role of CREB in vasoactive intestinal peptide-mediated wound healing in human bronchial epithelial cells. |
Q42452272 | Role of Ca2+ in the secretory and biosynthetic response of porcine gonadotropes to substance P and gonadotropin-releasing hormone |
Q51598213 | Role of GABA and opioids in the regulation of the vasopressin response to physical exercise in normal men. |
Q71664541 | Role of GH and IGF-I in the regulation of IGF-I, IGF-I receptor and IGF binding protein gene expression in the rat spleen |
Q70235229 | Role of H2-receptors in gastrogenic hyperglycemia and hyperinsulinemia in dogs |
Q44889546 | Role of IRS-4 in PI3-K activation by insulin in HepG2 cells, modulation by Angiotensin II. |
Q48943471 | Role of Lys215 located in the fifth transmembrane domain of the AT2 receptor in ligand-receptor interaction |
Q48250693 | Role of NK-1 receptor in central cardiovascular regulation in rats: studies on a novel non-peptide antagonist, CP-96,345, of substance P NK-1 receptor |
Q83378282 | Role of NPR-C natriuretic receptor in nitric oxide system activation induced by atrial natriuretic peptide |
Q45244203 | Role of PGI2 and effects of ACE inhibition on the bradykinin potentiation by angiotensin-(1-7) in resistance vessels of SHR. |
Q79577565 | Role of PI3K and PKB/Akt in acute natriuretic and NO-mimetic effects of leptin |
Q45274653 | Role of Ras/PKCzeta/MEK/ERK1/2 signaling pathway in angiotensin II-induced vascular smooth muscle cell proliferation |
Q43227822 | Role of Rho kinase and oxidative stress in cardiac fibrosis induced by aldosterone and salt in angiotensin type 1a receptor knockout mice. |
Q67284399 | Role of acetylcholine, histamine and gastrin in the acid response to intracisternal injection of TRH analog, RX 77368, in the rat |
Q36023982 | Role of angiotensin II and corticotropin-releasing hormone in hemodynamic responses to cocaine and stress |
Q44849012 | Role of bradykinin in gastric vasodilation caused by hypertonic saline and acid back diffusion |
Q79543806 | Role of c-fos gene in vasoactive intestinal peptide promoted synthesis of pulmonary surfactant phospholipids |
Q44131110 | Role of calcitonin gene-related peptide (CGRP) in chronic hypoxia-induced pulmonary hypertension in the mouse. Influence of gene transfer in vivo |
Q42513912 | Role of calcitonin gene-related peptide and its antagonist on the evoked discharge frequency of wide dynamic range neurons in the dorsal horn of the spinal cord in rats |
Q44878418 | Role of calcitonin gene-related peptide in the phenol-induced neurogenic hypertension in rats |
Q79754501 | Role of capsaicin-sensitive afferents and sensory neuropeptides in endotoxin-induced airway inflammation and consequent bronchial hyperreactivity in the mouse |
Q40916518 | Role of central oxytocinergic pathways in the expression of penile erection |
Q44131131 | Role of cholecystokinin in mediating GRP-stimulated gastric, biliary and pancreatic functions in man |
Q42464562 | Role of cholecystokinin in the control of gastric somatostatin in the rat: in vivo and in vitro studies |
Q67977972 | Role of cholecystokinin in the intestinal fat- and acid-induced inhibition of gastric secretion |
Q60627426 | Role of dexamethasone on vasopressin release during endotoxemic shock |
Q73521132 | Role of endogenous CCK in the inhibition of gastric emptying by peptone and Intralipid in rats |
Q80128139 | Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187 |
Q46800965 | Role of endogenous endothelin-1 in stress-induced gastric mucosal damage and acid secretion in rats. |
Q79450624 | Role of endogenous nitric oxide in classic preconditioning in rat hearts |
Q36714807 | Role of endogenous nitric oxide in the control of gastric acid secretion, blood flow and gastrin release in conscious dogs |
Q82731107 | Role of endogenous oxytocin in cardiac ischemic preconditioning |
Q42486387 | Role of extracellular and intracellular calcium on proctolin-induced contractions in an insect visceral muscle |
Q67657011 | Role of gastrin and cholecystokinin in the growth-promoting action of bombesin on the gastroduodenal mucosa and the pancreas |
Q31108730 | Role of gastrin in the development of gastric mucosa, ECL cells and A-like cells in newborn and young rats |
Q44073754 | Role of gastrin-releasing peptide in pepsinogen secretion from the isolated perfused rat stomach |
Q70842043 | Role of histamine H2-receptors in gastric and pancreatic release of somatostatin-like immunoreactivity during the gastric phase of meal |
Q44330500 | Role of kappa- and delta-opioid receptors in the antinociceptive effect of oxytocin in formalin-induced pain response in mice |
Q72099748 | Role of leukotriene B4 in substance P-induced granulocyte infiltration in mouse skin |
Q75216293 | Role of metabolism and receptor responsiveness in the attenuated responses to Angiotensin II in mice compared to rats |
Q42494906 | Role of motilin in the control of intestinal absorption, and gastric and biliary secretions in the rat. |
Q43850980 | Role of neuropeptide Y Y(2) receptors in modulation of cardiac parasympathetic neurotransmission |
Q70685260 | Role of neurotensin in the regulation of exocrine pancreatic secretion in dogs |
Q32036552 | Role of nitric oxide in angiotensin IV-induced increases in cerebral blood flow |
Q73568769 | Role of nitric oxide on atrial natriuretic peptide release induced by angiotensin II in superfused rat atrial tissue |
Q42062079 | Role of parathyroid hormone-related protein in the pro-inflammatory and pro-fibrogenic response associated with acute pancreatitis |
Q45274663 | Role of pituitary adenylate cyclase-activating peptide (PACAP) in the cyclic recruitment of immature follicles in the rat ovary |
Q69795682 | Role of protein kinase C and phosphorylation in bombesin-evoked gastrin release from isolated perfused rat stomach |
Q70158962 | Role of salivary glands and epidermal growth factor (EGF) in gastric secretion and mucosal integrity in rats exposed to stress |
Q43286291 | Role of selenium compounds on tyrosine hydroxylase activity, adrenomedullin and total RNA levels in hearts of rats |
Q42436638 | Role of spasmolytic polypeptide in healing of stress-induced gastric lesions in rats |
Q72099785 | Role of substance P in regulating sympatho-adrenal function in conscious rats |
Q85040591 | Role of tachykinin and neurokinin receptors in the regulation of ovine omasal contractions |
Q43813993 | Role of tachykinin receptors in the central processing of afferent input from the acid-threatened rat stomach |
Q48868715 | Role of the AMP-activated protein kinase (AMPK) signaling pathway in the orexigenic effects of endogenous ghrelin |
Q50732997 | Role of the Cys18-Cys274 disulfide bond and of the third extracellular loop in the constitutive activation and internalization of angiotensin II type 1 receptor. |
Q51656307 | Role of the duodenum in motilin release. |
Q46356752 | Role of the rat gastrointestinal mucosa in catabolism of endothelin peptides. |
Q51546186 | Role of vagal fibers and bombesin/gastrin-releasing peptide-neurons in distention-induced gastrin release in rats. |
Q44273589 | Role of vasoactive intestinal polypeptide (VIP) and endogenous somatostatin on the secretion of epidermal growth factor (EGF): studies on duodenal tissue cultures |
Q69926795 | Role of vasoactive intestinal polypeptide (VIP) in the neurogenic vasodilatation of the portal vein in the rabbit |
Q48292956 | Roles for adenosine A1- and A2-receptors in the control of thyrotrophin and prolactin release from the anterior pituitary gland |
Q46806258 | Roles of neuropeptide Y and noradrenaline in sympathetic neurotransmission to the thoracic vena cava and aorta of guinea-pigs |
Q44921493 | Roles of oxytocin in spatial learning and memory in the nucleus basalis of Meynert in rats |
Q40403537 | Roles of peptides in enteric neuromuscular transmission |
Q51553238 | SOCS-3 expression in leptin-sensitive neurons of the hypothalamus of fed and fasted rats. |
Q72099799 | SP/CGRP-immunoreactive nerves in the tracheal epithelium of rats: immunohistochemical and ultrastructural study |
Q40766313 | SR 48968, a neurokinin A (NK2) receptor antagonist |
Q84138205 | Salt-induced downregulation of renal aquaporins is prevented by losartan |
Q45112801 | Salusins promote cardiomyocyte growth but does not affect cardiac function in rats |
Q70652007 | Sar1-p-benzoylphenylalanine-angiotensin, a new photoaffinity probe for selective labeling of the type 2 angiotensin receptor |
Q44616123 | Sarcosine1,glycine8 angiotensin II is an AT1 angiotensin II receptor subtype selective antagonist |
Q49011653 | Seasonal variation in thyrotropin-releasing hormone (TRH) content of different brain regions and the pineal in the mammalian hibernator, Citellus lateralis |
Q68919798 | Secretin N-terminal hexapeptide potentiates insulin release in mouse islets |
Q42170022 | Secretin and autism: a basic morphological study about the distribution of secretin in the nervous system |
Q67239498 | Secretin exerts inhibition of the 8BrcAMP-stimulated 86Rb influx into avian red blood cells |
Q70816516 | Secretin, VIP, and PHI stimulate rat proximal duodenal surface epithelial bicarbonate secretion in vivo |
Q49134224 | Secretin--a new stress hormone? |
Q33287940 | Secretion of ghrelin from rat stomach ghrelin cells in response to local microinfusion of candidate messenger compounds: a microdialysis study |
Q41598966 | Secretion of immunoreactive ANF from FRTL-5 rat thyroid cells: regulation by calcium ionophore A23187 |
Q45112803 | Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes |
Q42462601 | Secretion of inflammatory mediators by isolated rat Kupffer cells: the effect of octreotide |
Q41509369 | Secretion of neurotensin from a human pancreatic islet cell carcinoma cell line (QGP-1N). |
Q58449359 | Secretion of neurotensin from isolated perfused porcine ileum |
Q42508407 | Secretion of the trefoil factor TFF3 from the isolated vascularly perfused rat colon. |
Q58449341 | Secretion uncouples glucose inhibition of glucagon-producing cells resulting in a simultaneous stimulation of both glucagon and insulin release |
Q48795670 | Secretogranin II (SgII) distribution and processing studies in human normal and adenomatous anterior pituitaries using new polyclonal antibodies |
Q84413091 | Secretogranin III in human neuroendocrine tumours: a comparative immunohistochemical study with chromogranins A and B and secretogranin II |
Q34616493 | Secretoneurin and the tachykinins substance P and neurokinin-A/B in NMDA-induced excitotoxicity in the rat retina |
Q37652759 | Secretoneurin as a hormone regulator in the pituitary |
Q69762512 | Secretory actions of vasoactive intestinal polypeptide, peptide histidine isoleucine and helodermin in rat small intestine: the effects of putative VIP antagonists upon VIP-induced ion secretion |
Q60032457 | Secretory and electrophysiological characteristics of insulin cells from gastrectomized mice: Evidence for the existence of insulinotropic agents in the stomach |
Q41141023 | Segmental distribution of colonic neuropeptides in Hirschsprung's disease |
Q31982058 | Segregation of the intra- and extrahypothalamic neuropeptide Y and catecholaminergic inputs on paraventricular neurons, including those producing thyrotropin-releasing hormone. |
Q33744641 | Selected tetrapeptides lead to a GLP-1 release from the human enteroendocrine cell line NCI-H716 |
Q43288886 | Selective amino acid deficiency in patients with impaired glucose tolerance and type 2 diabetes |
Q72099794 | Selective blockage of sensory response of the carotid body to hypoxia by NK-1 receptor antagonist CP-96,345 |
Q72321287 | Selective constriction of small cutaneous arteries by NPY matches distribution of NPY in sympathetic axons |
Q43625220 | Selective down-regulation of AT2 receptors in uterine arteries from pregnant ewes given 24-h intravenous infusions of angiotensin II. |
Q83216788 | Selective effect of INGAP-PP upon mouse embryonic stem cell differentiation toward islet cells |
Q43878301 | Selective excitation of GABAergic neurons in the substantia nigra of the rat by orexin/hypocretin in vitro. |
Q45114707 | Selective expression of vasoactive intestinal peptide (VIP)2/pituitary adenylate cyclase-activating polypeptide (PACAP)3 receptors in rabbit and guinea pig gastric and tenia coli smooth muscle cells |
Q45068893 | Selective reduction in ventral hippocampal acetylcholine release in awake galanin-treated rats and galanin-overexpressing transgenic mice |
Q48327418 | Selective serotonin reuptake inhibitor (fluoxetine) decreases the effects of ghrelin on memory retention and food intake |
Q48793078 | Selective time-dependent effects of insulin on brain phosphoinositide metabolism |
Q48900208 | Sensitivity of spontaneously hypertensive and of Wistar Kyoto rats to the antidipsogenic action of eledoisin |
Q47871761 | Sensory CGRP depletion by capsaicin exacerbates hypoxia-induced pulmonary hypertension in rats |
Q29042424 | Sensory circumventricular organs: central roles in integrated autonomic regulation |
Q40766343 | Sensory neuropeptide release by bradykinin: mechanisms and pathophysiological implications |
Q44274304 | Sensory neuropeptides are potent chemoattractants for human basophils in vitro |
Q39899090 | Sequencing and cardiac expression of natriuretic peptide receptors A and C in normal and heart failure pigs |
Q43049150 | Sequencing and characterization of trypsin modulating oostatic factor (TMOF) from the ovaries of the grey fleshfly, Neobellieria (Sarcophaga) bullata |
Q70150230 | Sequential use of the PAP and immunogold staining method for the light microscopical double staining of tissue antigens |
Q45244211 | Serotonin-induced enhancement of vasopressin and oxytocin secretion in rat neurohypophyseal tissue culture |
Q79731997 | Serotonin-producing enterochromaffin (EC) cells of gastrointestinal mucosa in dexamethasone-treated rats |
Q72594896 | Serotoninergic control of somatostatin and gastrin release from the isolated rat stomach |
Q87680463 | Serum adropin levels are decreased in patients with acute myocardial infarction |
Q34180208 | Serum leptin activity in obese and lean patients. |
Q43117149 | Serum levels and urinary excretion of salusin-alpha in renal insufficiency. |
Q39485610 | Serum levels of growth arrest specific protein 6 are increased in preeclampsia |
Q39762417 | Serum levels of the adipokine chemerin are increased in preeclampsia during and 6 months after pregnancy |
Q43511426 | Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors |
Q83032608 | Serum salusin-alpha level in rheumatoid arthritis |
Q28212621 | Shear stress attenuates endothelin and endothelin-converting enzyme expression through oxidative stress |
Q46105902 | Short-chain fatty acid signaling pathways in bovine mammary epithelial cells |
Q44192900 | Short-term exercise combined with Acipimox administration induces an increase in plasma ACTH and its subsequent fall in the recovery phase in bulimic women. |
Q46321050 | Short-term oral oleoyl-estrone decreases the expression of ghrelin in the rat stomach |
Q34969463 | Short-term physiological hyperleptinemia decreases arterial blood pressure |
Q47579351 | Short-term regulation of tyrosine hydroxylase activity and expression by endothelin-1 and endothelin-3 in the rat posterior hypothalamus. |
Q40766319 | Signal transduction and ligand-binding domains of the tachykinin receptors |
Q40081234 | Signal transduction for formation/release of interleukin-8 caused by a PAR2-activating peptide in human lung epithelial cells |
Q40491031 | Signal transduction mechanisms of substance P effects on ion channels |
Q70651996 | Signal transduction mediated by angiotensin II receptor subtypes expressed in rat renal mesangial cells |
Q35873468 | Signal transduction of V1-vascular vasopressin receptors |
Q34019805 | Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase |
Q46513754 | Signaling cascade that mediates endothelial nitric oxide synthase activation induced by atrial natriuretic peptide |
Q36576150 | Signaling mechanisms of secretin receptor. |
Q36584206 | Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions. |
Q50475478 | Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+ -ATPase activity. |
Q84026393 | Signalling pathway of goldfish melanin-concentrating hormone receptors 1 and 2 |
Q73246718 | Signals related to glucose metabolism regulate islet amyloid polypeptide (IAPP) gene expression in human pancreatic islets |
Q70180732 | Significance of Ca2+, Rb+ fluxes, of cAMP and cGMP for the CCK8-modulated insulin release |
Q68755001 | Significance of gastric endocrine tumor and age-related gut peptide alterations in Mastomys |
Q46073318 | Significance of salivary adrenomedullin in the maintenance of oral health: stimulation of oral cell proliferation and antibacterial properties. |
Q46607724 | Significance of the adrenergic system in the regulation of vasopressin secretion in rat neurohypophyseal tissue cultures |
Q84203043 | Significantly increased CCL5/RANTES and CCR7 mRNA levels in localized scleroderma |
Q42436634 | Simultaneous observation of endocrine and exocrine functions of the pancreas responding to somatostatin in man. |
Q43117153 | Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling |
Q47227825 | Single intracerebroventricular bolus injection of a recombinant adenovirus expressing leptin results in reduction of food intake and body weight in both lean and obese Zucker fa/fa rats |
Q30658328 | Singular contributions of fish neuroendocrinology to mammalian regulatory peptide research |
Q84782119 | Sitagliptin protects renal ischemia reperfusion induced renal damage in diabetes |
Q44677076 | Site-specific effects of dietary salt intake on guanylin and uroguanylin mRNA expression in rat intestine |
Q84588283 | Slower gastric emptying in high-fat diet induced obese rats is associated with attenuated plasma ghrelin and elevated plasma leptin and cholecystokinin concentrations |
Q73393070 | Small intestinal and pancreatic microstructures are modified by an intraduodenal CCK-A receptor antagonist administration in neonatal calves |
Q44110042 | Solubilization and characterization of CCK receptors from mouse pancreas |
Q69345974 | Solubilization of active and stable receptors for vasoactive intestinal peptide from rat liver |
Q51647451 | Somatostatin 1-28 circulates in human plasma. |
Q48504815 | Somatostatin and GABA correlate with cervical autonomic nerve activity |
Q69870740 | Somatostatin and intestinal calcium transport in the rat |
Q70923132 | Somatostatin and macrophage function: modulation of hydrogen peroxide, nitric oxide and tumor necrosis factor release |
Q74665105 | Somatostatin and octreotide modulate the function of Kupffer cells in liver cirrhosis |
Q72551956 | Somatostatin and the interdigestive migrating motor complex in man |
Q69861384 | Somatostatin binding sites in cytosolic fraction isolated from rabbit antral and fundic gastric mucosa |
Q72556784 | Somatostatin depletion of the gut and pancreas induced by cysteamine is not prevented by vagotomy or by dopamine agonists |
Q53631091 | Somatostatin down-regulates LFA-1 activation by modulating Rap1 expression in CD4+ and CD8+ T cells. |
Q48054954 | Somatostatin expression in human renal cortex and mesangial cells |
Q42142845 | Somatostatin immunohistochemistry of hippocampal slices with lucifer yellow-stained pyramidal neurons responding to somatostatin. |
Q44516458 | Somatostatin inhibition of gastrin gene expression: involvement of pertussis toxin-sensitive and -insensitive pathways |
Q42453626 | Somatostatin inhibition of phosphoinositides turnover in isolated rat acinar pancreatic cells: interaction with bombesin |
Q51641609 | Somatostatin inhibits bombesin-induced effects on migrating myoelectric complexes in the small intestine of the rat |
Q43451912 | Somatostatin inhibits dendritic cell responsiveness to Helicobacter pylori |
Q71605421 | Somatostatin inhibits gastrin-induced histamine secretion and synthesis in the rat |
Q40705234 | Somatostatin inhibits glucagon-like peptide-1-induced insulin secretion and proliferation of RINm5F insulinoma cells |
Q40415011 | Somatostatin inhibits insulin release via SSTR2 in hamster clonal beta-cells and pancreatic islets |
Q44332834 | Somatostatin inhibits intestinal mucosal mast cell degranulation in normal conditions and during mast cell hyperplasia. |
Q42464567 | Somatostatin inhibits pepsinogen secretion via a cyclic AMP-independent pathway |
Q53563000 | Somatostatin modulates T cells development in adult rat thymus. |
Q73517111 | Somatostatin modulates the function of Kupffer cells |
Q54179363 | Somatostatin receptor gene expression in neuroblastoma. |
Q46798540 | Somatostatin receptors (sst2) regulate cGMP production in rat retina |
Q48738117 | Somatostatin receptors in the senescent rat brain: a quantitative autoradiographic study |
Q42474981 | Somatostatin release induced by gastrin-releasing peptide in man. Effect of proximal gastric vagotomy and cholinergic blockade |
Q51625500 | Somatostatin response to glucose before and after prolonged fasting in lean and obese non-diabetic subjects. |
Q54288939 | Somatostatin selectively inhibits excitatory contractile pathways of the feline lower esophageal sphincter |
Q33216451 | Somatostatin, misoprostol and galanin inhibit gastrin- and PACAP-stimulated secretion of histamine and pancreastatin from ECL cells by blocking specific Ca2+ channels |
Q73403316 | Somatostatin- and urotensin II-related peptides: molecular diversity and evolutionary perspectives |
Q77123878 | Somatostatin-14 modulates acid-dependent inhibition of meal-stimulated gastrin via muscarinic pathways in dogs |
Q44277685 | Somatostatin-induced gastric protection against ethanol: involvement of nitric oxide and effects on gastric mucosal blood flow |
Q41528343 | Somatostatin: a potential antigrowth factor for the exocrine pancreas |
Q69908502 | Somatostatin: peripheral venoconstrictive activity and interaction with monoamines in man |
Q39777797 | Soybean beta 51-63 peptide stimulates cholecystokinin secretion via a calcium-sensing receptor in enteroendocrine STC-1 cells. |
Q28323619 | Spantide II, a novel tachykinin antagonist having high potency and low histamine-releasing effect |
Q44334446 | Spantide-induced antinociception in the opioid mechanism |
Q42515995 | Spatio-temporal localization of vasoactive intestinal peptide and neutral endopeptidase in allergic murine lungs |
Q72668730 | Special issue: Insulin-like growth factors |
Q78791113 | Specific N-terminal CGRP fragments mitigate chronic hypoxic pulmonary hypertension in rats |
Q71507407 | Specific adrenomedullin binding sites and hypotension in the rat systemic vascular bed |
Q45151353 | Specific enkephalin-degrading aminopeptidase activity in the HPT and HPO axes of rats with breast cancer induced by N-methyl nitrosourea. |
Q48662785 | Specific expression of galanin in the peri-infarct zone after permanent focal cerebral ischemia in the rat. |
Q34157070 | Specific interaction between the hop1 intracellular loop 3 domain of the human PAC(1) receptor and ARF. |
Q37365822 | Specific modulation of protein kinase activity via small peptides. |
Q46486121 | Specific monoclonal antibodies neutralize the action of PACAP 1-27 or PACAP 1-38 on intestinal muscle strips in vitro |
Q72961775 | Specific photoaffinity crosslinking of [125I]cholecystokinin to pancreatic plasma membranes. Evidence for a disulfide-linked Mr 76000 peptide in cholecystokinin receptors |
Q41248480 | Specific substance P binding sites in rat thymus and spleen: in vitro autoradiographic study |
Q72099863 | Spinal effects of selective NK-1 and NK-2 receptor antagonists on bladder motility in anesthetized rats |
Q60679696 | Spinal opiate sensitivity in models of inflammatory pain |
Q44733465 | Sprouting of aberrant neuropeptide Y-immunoreactive sympathetic nerves into neonatally denervated smooth muscle |
Q48226106 | Src and Pyk2 mediate angiotensin II effects in cultured rat astrocytes |
Q83651881 | Stanniocalcin 1 affects redox status of swine granulosa cells |
Q45202565 | State-dependent effects of orexins on the serotonergic dorsal raphe neurons in the rat. |
Q73053544 | Stem cell factor influences neuro-immune interactions: the response of mast cells to pituitary adenylate cyclase activating polypeptide is altered by stem cell factor |
Q42213551 | Stimulating effect of pentagastrin on cancer cell proliferation kinetics in chemically induced colon cancer in rats |
Q72534486 | Stimulation and propagation of the ascending enteric reflex contraction: role of tachykinins and acetylcholine |
Q72518594 | Stimulation by thyrotropin-releasing hormone of vagal outflow to the thyroid gland |
Q72699386 | Stimulation by vasoactive intestinal peptide (VIP) of phagocytic function in rat macrophages. Protein kinase C involvement |
Q47871714 | Stimulation of ACTH and GH release by angiotensin II in normal men is mediated by the AT1 receptor subtype |
Q72639932 | Stimulation of canine pancreatic polypeptide, gastrin, and gastric acid secretion by ranatensin, litorin, bombesin nonapeptide and substance P |
Q71363403 | Stimulation of natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) activities in murine leukocytes by bombesin-related peptides requires the presence of adherent cells |
Q46771367 | Stimulation of pancreatic amylase release is associated with a parallel sustained increase of cytoplasmic calcium |
Q28333383 | Stimulation of rat adrenal medulla can induce differential changes in the peptide and mRNA levels of chromogranins, neuropeptides and other constituents of chromaffin granules |
Q43546807 | Stimulation of rat pancreatic exocrine secretion by cocaine- and amphetamine-regulated transcript peptide |
Q72900091 | Stimulation of the adenylate cyclase of a B16 melanoma cell line by pro-opiocortin-related peptides — A structure-activity study |
Q43748171 | Stimulation of the hypothalamic-pituitary-adrenal axis by epidermal growth factor |
Q50627677 | Stimulatory and Inhibitory regulation of lipolysis by the NPR-A/cGMP/PKG and NPR-C/G(i) pathways in rat cultured adipocytes. |
Q42483222 | Stimulatory effect of endogenous orexin A on gastric emptying and acid secretion independent of gastrin. |
Q84782123 | Stimulatory effect of naloxone on plasma cortisol in human: Possible direct stimulatory action at the adrenal cortex |
Q42454104 | Stimulatory effect of vasoactive intestinal peptide (VIP) on cyclic AMP production in rat peritoneal macrophages |
Q42444897 | Stimulatory effect of xenin-8 on insulin and glucagon secretion in the perfused rat pancreas |
Q59874128 | Stimulatory effects of human pancreatic polypeptide on rat pancreatic acini |
Q68108902 | Stimulatory effects of islet amyloid polypeptide (amylin) on exocrine pancreas and gastrin release in conscious rats |
Q48957102 | Stress-induced changes of circulating neuropeptide Y in the rat: comparison with catecholamines |
Q40155949 | Structural and signaling requirements of the human melanocortin 4 receptor for MAP kinase activation |
Q41193232 | Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide |
Q71363383 | Structural modifications of non-mammalian gonadotropin-releasing hormone (GnRH) isoforms: design of novel GnRH analogues |
Q40963606 | Structural motifs of pituitary adenylate cyclase-activating polypeptide (PACAP) defining PAC1-receptor selectivity |
Q46715558 | Structural requirements for galanin action in the guinea-pig ileum |
Q58856397 | Structurally novel group of ligands selective for kappa opioid receptors |
Q40916535 | Structure and folding properties of neurophysin and its peptide complexes: biological implications |
Q48437452 | Structure and function relationships of three novel hGHRH-GGC analogs |
Q127120934 | Structure, analysis and secretion of human glucagon-like peptide-2 (GLP-2) |
Q40491091 | Structure, expression and second messenger-mediated regulation of the human and rat substance P receptors and their genes |
Q43701515 | Structure-activity and possible mode of action of S-Iamide neuropeptides on identified central neurons of Helix aspersa |
Q44016664 | Structure-activity and structure-binding studies of des-Asp(1)-angiotensin I analogues on the rabbit pulmonary artery |
Q33788742 | Structure-activity relationships of adrenomedullin in the circulation and adrenal gland |
Q40997222 | Structure-activity relationships with neuropeptide Y analogues: a comparison of human Y1-, Y2- and rat Y2-like systems |
Q70942084 | Structure-activity studies of RFamide analogues on central neurones of Helix aspersa |
Q48870548 | Structure-activity studies on different modifications of nociceptin/orphanin FQ: identification of highly potent agonists and antagonists of its receptor |
Q70107539 | Structure-activity studies with ACTH/alpha-MSH fragments on corticosteroid secretion of isolated zona glomerulosa and fasciculata cells |
Q72591718 | Structure-activity studies with somatostatin: role of lysine in positions 4 and 9 for gastric activity |
Q72484671 | Structure-activity studies with somatostatin: the role of tryptophan in position 8 |
Q71696089 | Structure-affinity studies of C-terminally modified analogs of neuropeptide Y led to a novel class of peptidic Y1 receptor antagonist |
Q67977967 | Structure-function studies of five natural, including catfish and dogfish, gonadotropin-releasing hormones and eight analogs on reproduction in Thai catfish (Clarias macrocephalus) |
Q72572183 | Studies of somatostatin-induced barrel rotation in rats |
Q71717808 | Studies on the characterisation of alpha-MSH-like immunoreactivity in rat hypothalamus |
Q70250428 | Studies on the physiological role and mechanism of action of neuropeptide Y in the regulation of luteinizing hormone secretion in the rat |
Q72440622 | Studies on the structure-activity of motilin in vivo. Effect of motilin synthetic analogues in conscious dog |
Q59659383 | Study of amylase release Ca++ mobilization related to CCKA and CCKB sub-type receptor occupancy in a rat pancreatic acinar cell line (AR4-2J) |
Q40172532 | Study of orexins signal transduction pathways in rat olfactory mucosa and in olfactory sensory neurons-derived cell line Odora: multiple orexin signalling pathways |
Q51065363 | Study on preparation and activity of a novel recombinant human parathyroid hormone(1-34) analog with N-terminal Pro-Pro extension. |
Q45970559 | Study on preparation and unique properties of a novel insulin analogue with N-terminal Arg-4, Pro-3, Lys-2, Pro-1extension at insulin B-chain. |
Q46783535 | Study on the constructions and activities of three novel hGHRH analogs with N-terminal prolyl modulation+. |
Q41194919 | Studying the central actions of angiotensin using the expression of immediate-early genes: expectations and limitations |
Q48630819 | Subcellular distribution of somatostatin-14, somatostatin-28 and somatostatin-28(1–12) in rat brain cortex and comparisons of their respective binding sites in brain and pituitary |
Q73568774 | Substance P (NK1) receptor in relation to substance P innervation in rat duodenum after irradiation |
Q39751433 | Substance P and calcitonin gene related peptide induce TGF-alpha expression in epithelial cells via mast cells and fibroblasts |
Q72706899 | Substance P and enkephalin in transected axons of medulla and spinal cord |
Q28298522 | Substance P and substance P receptor histochemistry in human neurodegenerative diseases |
Q41137295 | Substance P contracts the human iris sphincter: possible modulation by endogenous enkephalinase |
Q68964463 | Substance P distribution and effects in the canine epicardial coronary arteries |
Q55489654 | Substance P enhances cation permeability of neuronal cell lines. |
Q44625214 | Substance P enhances interferon-gamma production by human peripheral blood mononuclear cells |
Q78729815 | Substance P gene expression in acute experimental colitis |
Q44416584 | Substance P in the control of extrahepatic biliary motility in the cat. |
Q48250721 | Substance P in the retina and primary visual centers: its projection and plasticity after deafferentation |
Q40491888 | Substance P mediates AP-1 induction in A549 cells via reactive oxygen species |
Q40491035 | Substance P receptor (NK-1) in the central nervous system: possible functions from a morphological aspect |
Q67698841 | Substance P, neurokinin A and calcitonin gene-related peptide during development of the rat gastrointestinal tract |
Q38350051 | Substance P, neurokinin A, vasoactive intestinal polypeptide and gastrin releasing peptide in the intestine and pancreas of spontaneously obese-diabetic mice. |
Q69067210 | Substance P-, CGRP- and NPY-immunoreactive nerve fibers in rat sciatic nerve-end neuromas |
Q72099879 | Substance P-containing primary afferent receives inhibitory modulation directly from enkephalin- and GABA-containing interneurons in the dorsal horn of the chicken |
Q72099859 | Substance P-evoked circular muscle contractions have a close connection with serotonergic neurons in guinea-pig ileum |
Q72099849 | Substance P-evoked release of amino acid transmitters from the newborn rat spinal cord |
Q72099914 | Substance P-induced elevation of intracellular calcium in transfected Chinese hamster ovary cells: role of inositol trisphosphate |
Q72099722 | Substance P-induced inflammation in the rat knee joint is mediated by neurokinin 1 (NK1) receptors |
Q46746377 | Substance P-like immunoreactivity in capsaicin-sensitive structures of the rat thymus |
Q72099872 | Substance P/calcitonin gene-related peptide (CGRP)-immunoreactive nerve terminals in the whole mount preparations of the dog urethra |
Q71051694 | Sulfation of gastrin in Zollinger--Ellison sera: evidence for association between sulfation and proteolytic processing |
Q70985897 | Sulfation of gastrin: Effect on immunoreactivity |
Q44615426 | Sulphated CCK-8-like peptides in the neural ganglion of the protochordate Ciona intestinalis |
Q31982043 | Suppressed neuropeptide Y (NPY) mRNA in rat amygdala following restraint stress. |
Q69342002 | Suppression of salt intake in the rat by neurokinin A: comparison with the effect of kassinin |
Q46351495 | Suppression of sensory C fiber-mediated contractions by neuropeptide Y Y1 receptors in the guinea pig bronchi |
Q67524487 | Suppression of superoxide release from human monocytes by somatostatin-related peptides |
Q44200148 | Suppression of tumorigenicity in neuroblastoma cells by upregulation of human vasoactive intestinal peptide receptor type 1. |
Q30830252 | Survival and neurotransmitter plasticity in cultured rat colonic myenteric neurons |
Q45151361 | Sustained inhibitory effect of Agouti Related Protein on the ACTH-induced cortisol production by bovine cultured adrenal cells |
Q83505510 | Sustained-release adrenomedullin ointment accelerates wound healing of pressure ulcers |
Q48353345 | Sympathetic and hyperthermic reactions by orexin A: role of cerebral catecholaminergic neurons. |
Q72534499 | Sympathetic nerves, but not the adrenal gland, contribute to elevated plasma levels of met-enkephalin in rats with acute cholestatic hepatitis |
Q47871732 | Sympathetic pathways mediate GLP-1 actions in the gastrointestinal tract of the rat. |
Q33302365 | Synaptic interaction between ghrelin- and ghrelin-containing neurons in the rat hypothalamus |
Q33302606 | Synaptic relationships between proopiomelanocortin- and ghrelin-containing neurons in the rat arcuate nucleus |
Q72594901 | Synchronizing, sedative and anticonvulsive effects of centrally administered somatostatin in the conscious rabbit |
Q44168204 | Synergism between diuretic peptides controlling ion and fluid transport in insect malpighian tubules |
Q51328388 | Synergism by individual macronutrients explains the marked early GLP-1 and islet hormone responses to mixed meal challenge in mice. |
Q67901240 | Synergism of atrial pressure and adrenergic stimulation for ANF release in the rat |
Q34056736 | Synergistic interaction between CCK and leptin to regulate food intake |
Q40765441 | Synthesis and characterization of tetramethylrhodaminethiocarbamoyl-(Glu(1))-epidermal mitosis-inhibiting pentapeptide. |
Q31168789 | Synthesis and conformational properties of phosphopeptides related to the human tau protein |
Q53577454 | Synthesis and evaluation of a glibenclamide glucose-conjugate: a potential new lead compound for substituted glibenclamide derivatives as islet imaging agents. |
Q44397769 | Synthesis of biologically active canine CCK-58. |
Q40916589 | Synthesis of oxytocin in amnion, chorion and decidua: a potential paracrine role for oxytocin in the onset of human parturition |
Q46187891 | Synthesis of porcine leumorphin and some of its biological activities |
Q73629309 | Synthesis, solution structure, binding activity, and cGMP activation of human guanylin and its disulfide isomer |
Q44849005 | Synthetic peptide immunocortin stimulates the production of 11-oxycorticosteroides by rat adrenal cortex through ACTH receptors. |
Q48123458 | Synthetic peptide octarphin (TPLVTLFK) inhibits the activity of the hypothalamus-pituitary-adrenal axis through nonopioid β-endorphin receptor |
Q71363412 | Synthetic peptides corresponding to residues 551 to 555 and 650 to 653 of the rat testicular follicle-stimulating hormone (FSH) receptor are sufficient for post-receptor modulation of Sertoli cell responsiveness to FSH stimulation |
Q44583786 | Systemic 5-hydroxy-L-tryptophan down-regulates the arcuate CART mRNA level in rats |
Q49050850 | Systemic administration of kainic acid produces elevations in TRH in rat central nervous system |
Q36487323 | Systemic ghrelin sensitizes cocaine-induced hyperlocomotion in rats |
Q71644390 | Systemic treatment with epidermal growth factor in the rat. Biomechanical properties of the growing small intestine |
Q39855401 | TGF-beta1 and TGF-beta2 strongly enhance the secretion of plasminogen activator inhibitor-1 and matrix metalloproteinase-9 of the human prostate cancer cell line PC-3. |
Q73828202 | TGFbeta1 autocrine growth control in isolated pancreatic fibroblastoid cells/stellate cells in vitro |
Q42498881 | TNFα increases hypothalamic PTP1B activity via the NFκB pathway in rat hypothalamic organotypic cultures |
Q48686885 | TRH-enkephalin interactions in the amygdaloid complex during gastric stress ulcer formation in rats |
Q46076526 | TRPV1, NK1 receptor and substance P immunoreactivity and gene expression in the rat lumbosacral spinal cord and urinary bladder after systemic, low dose vanilloid administration |
Q86408933 | Tachykinin (NK1, NK2 and NK3) receptor, transient receptor potential vanilloid 1 (TRPV1) and early transcription factor, cFOS, mRNA expression in rat tissues following systemic capsaicin treatment |
Q51660620 | Tachykinin NK-1 and NK-2 receptors in the circular muscle of the guinea-pig proximal colon |
Q51622509 | Tachykinin NK3 receptor mediates NANC hyperpolarization and relaxation via nitric oxide release in the circular muscle of the guinea-pig colon. |
Q44185914 | Tachykinin multiplicity in rat central nervous system as studied using antisera raised against substance P and neurokinin A. |
Q40465220 | Tachykinin receptors in gastrointestinal motility |
Q72534489 | Tachykinin receptors in the rat isolated uterus |
Q71708264 | Tachykinin receptors mediating contraction of guinea pig lung strips |
Q69032497 | Tachykinin release from rat spinal cord in vitro and in vivo in response to various stimuli |
Q35155862 | Tachykinin-induced vasodilatation in rat skin measured with a laser-Doppler flowmeter: evidence for receptor-mediated effects |
Q45712614 | Tachykinin-stimulated small bowel myoelectric pattern: sensitization by NO inhibition, reversal by neurokinin receptor blockade. |
Q34331425 | Tachykinins as modulators of the micturition reflex in the central and peripheral nervous system |
Q46186817 | Tachykinins depress a calcium-dependent potassium conductance in sympathetic preganglionic neurons |
Q51492333 | Tachykinins mediate changes in ion transport in porcine jejunum through release of prostaglandins and neurotransmitters. |
Q71367138 | Tachykinins stimulate nitric oxide generation by canine cultured tracheal epithelium |
Q46113912 | Tachykinins, via NK1 receptor activation, play a relevant role in plasma protein extravasation evoked by allergen challenge in the airways of sensitized guinea-pigs |
Q54662371 | Targeting TGF-beta1 increases hepatocyte growth factor (HGF/SF) levels in external auditory canal cholesteatoma (EACC) epithelial cell culture. |
Q37442033 | Targeting the ghrelin receptor to regulate food intake |
Q54648878 | Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression. |
Q40916631 | Terlipressin (glypressin) in the treatment of bleeding esophageal varices. State of the art. |
Q31874663 | The "in vivo" and "ex vivo" roles of cylcooxygenase-2, nuclear factor-kappaB and protein kinases pathways in the up-regulation of B1 receptor-mediated contraction of the rabbit aorta |
Q33680652 | The AT2 receptor: fact, fancy and fantasy |
Q73832201 | The AT4 receptor agonist [Nle1]-angiotensin IV reduces mechanically induced immediate-early gene expression in the isolated rabbit heart |
Q48098996 | The C-terminal extension of exendin-4 provides additional metabolic stability when added to GLP-1, while there is minimal effect of truncating exendin-4 in anaesthetized pigs |
Q39665008 | The C-terminal flanking peptide (CTFP) of progastrin inhibits apoptosis via a PI3-kinase-dependent pathway |
Q43166910 | The CCK(2) receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor development |
Q46950497 | The CCK-2/gastrin splice variant receptor retaining intron 4 transactivates the COX-2 promoter in vitro |
Q60488856 | The Galanin N-terminal fragment (1–15) interacts with neuropeptide Y in central cardiovascular control: Involvement of the NPY Y2 receptor subtype |
Q40158625 | The LIM domain homeobox gene isl-1 is a positive regulator of glycoprotein alpha 2 (GPA2), a subunit of thyrostimulin |
Q84073666 | The Mas receptor mediates modulation of insulin signaling by angiotensin-(1-7) |
Q44247077 | The N-terminal alanine-extended GLP-1/IgG-Fc fusion protein confers resistance to DPP-IV and reduces serum glucose level in db/db mice |
Q51644903 | The N-terminal tridecapeptide fragment of gastrin-17 inhibits gastric acid secretion. |
Q48359455 | The NPY Y1 receptor antagonist BIBP 3226 blocks NPY induced feeding via a non-specific mechanism |
Q73150038 | The NPY effects on murine leukocyte adherence and chemotaxis change with age. Adherent cell implication |
Q122749257 | The NPY/PP family in frogs and humans: Distant cousins, identical twins and a recent arrival |
Q72222005 | The Neurohypophysial Peptide Systems. Proceedings from a satellite symposium of the 9th International Congress of Endocrinology. Spa-Liege, Belgium, 6-11 September 1992 |
Q41227095 | The PC12 rat pheochromocytoma cell line expresses the prodynorphin gene and secretes the 8 kDa dynorphin product |
Q52992222 | The TGR(mRen2)27 transgenic rat model of hypertension. |
Q36600476 | The VIP-receptor system in neuroblastoma cells |
Q46393857 | The [pre-] history of the incretin concept |
Q43878304 | The action of orexin A on passive avoidance learning. Involvement of transmitters |
Q48820308 | The actions of neuropeptide SF on the hypothalamic-pituitary-adrenal axis and behavior in rats. |
Q59874115 | The activation peptide of pancreatic procolipase decreases food intake in rats |
Q34711902 | The activity front of the migrating motor complex of the human stomach but not of the small intestine is motilin-dependent |
Q73205405 | The activity of GR205171, a potent non-peptide tachykinin NK1 receptor antagonist, in the trigeminovascular system |
Q68481227 | The amino acid sequence of chymodenin, a hormone-like peptide from porcine duodenum, is identical to cytochrome C-oxidase, peptide VII |
Q72099889 | The amino-terminus of substance P mimics and MK-801 attenuates the effects of capsaicin on nociception and kainic acid-induced behavior in the mouse |
Q74428985 | The angiotensin II binding site on Mycoplasma hyorhynis is structurally distinct from mammalian AT1 and AT2 receptors |
Q95414191 | The angiotensin II type 1 receptor antagonist Losartan binds and activates bradykinin B2 receptor signaling |
Q72022660 | The antidiuretic effect of pneumadin requires a functional arginine vasopressin system |
Q37636996 | The antimicrobial peptides derived from chromogranin/secretogranin family, new actors of innate immunity |
Q28257815 | The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice |
Q63244979 | The application of dihydroetorphine to detoxification of heroin addicts |
Q51464972 | The autonomic nervous system regulates gastric ghrelin secretion in rats. |
Q72472993 | The biological activity of catfish pancreatic somatostatin |
Q70111251 | The biological relevance of HPLC-purified vasoactive intestinal polypeptide monoiodinated at tyrosine 10 or tyrosine 22 |
Q73828220 | The blocking effect of BmP02, one novel short-chain scorpion peptide on transient outward K(+) channel of adult rat ventricular myocyte |
Q37166396 | The blood-brain barrier: connecting the gut and the brain |
Q72668747 | The branching of insulin-like growth factor 1 and insulin: an immunohistochemical analysis during phylogeny |
Q34019802 | The cardiac renin-angiotensin system: novel signaling mechanisms related to cardiac growth and function |
Q41965171 | The cardiovascular actions of centrally administered neuropeptide Y. |
Q48199136 | The central melanocortin system regulates food intake in goldfish. |
Q51607186 | The characterization of radioimmunoassay for rat pancreatic polypeptide in serum |
Q48707119 | The characterization, localization and regulation of endothelin in ovine pars intermedia |
Q41575519 | The cholecystokinin antagonist, proglumide, increases food intake in the rat. |
Q69958141 | The cholecystokinin receptor antagonist CR1409 increases plasma cholecystokinin in rats |
Q40593601 | The cholecystokinin2-receptor mediates calcitonin secretion, gene expression, and proliferation in the human medullary thyroid carcinoma cell line, TT. |
Q52571068 | The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells. |
Q57950947 | The chromogranin A- derived N-terminal peptide vasostatin-I: In vivo effects on cardiovascular variables in the rabbit |
Q38331653 | The cloned guinea pig pancreatic polypeptide receptor Y4 resembles more the human Y4 than does the rat Y4. |
Q37399121 | The combination of GIP plus xenin-25 indirectly increases pancreatic polypeptide release in humans with and without type 2 diabetes mellitus. |
Q70277755 | The complete primary structure of pancreatic polypeptide from the European common frog, Rana temporaria |
Q69671052 | The constitution and properties of phosphorylated and unphosphorylated C-terminal fragments of progastrin from dog and ferret antrum |
Q68098459 | The contribution of the C-terminal undecapeptide sequence of urogastrone-epidermal growth factor to its biological action |
Q72358267 | The corrected primary structure of chicken (avian) pancreatic polypeptide |
Q84956212 | The correlation between resting serum leptin and serum angiogenic indices at rest and after submaximal exercise |
Q44011336 | The crustacean hyperglycemic hormone (CHH) releases amylase from the crayfish midgut gland |
Q68547188 | The depressor effect of secretin administered either centrally or peripherally in conscious rats |
Q40497628 | The development of VIP-ellipticine conjugates |
Q40491062 | The differential roles of substance P and neurokinin A in spinal cord hyperexcitability and neurogenic inflammation |
Q127932873 | The differing endocrinology of mid gut and lung neuroendocrine tumours |
Q57503588 | The direct effects of GLP-1 and GIP, alone or in combination, on human pancreatic islets |
Q36973905 | The discovery of ghrelin--a personal memory |
Q53304399 | The discovery of glucagon-like peptide 1. |
Q49060802 | The distribution of galanin message-associated peptide-like immunoreactivity in the pig. |
Q58448037 | The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients |
Q41669962 | The effect of HP-1 and related neutrophil granule peptides on DNA synthesis in HL60 cells |
Q69357666 | The effect of N-formyl-methionyl-leucyl-phenyl-alanine on cholinergic neurotransmission and its modulation by enkephalinase in rabbit airway smooth muscle |
Q67584411 | The effect of TGF alpha on intestinal solute transport |
Q54109736 | The effect of VIP/PACAP family of peptides on pancreatic blood flow and secretion in conscious dogs. |
Q71664560 | The effect of a single intraperitoneal dose of hrIL-1 alpha on substance P-, neurokinin A-, calcitonin gene-related peptide- and neuropeptide Y-like immunoreactivity in cerebrospinal fluid, plasma and knee joint synovial fluid in the rat |
Q81103390 | The effect of agouti-related protein on growth hormone secretion in adult male rats |
Q46507488 | The effect of angiotensin III on protein tyrosine kinase activity in rat pituitary |
Q46502346 | The effect of angiotensin-converting enzyme inhibitors on experimental colitis in rats |
Q43481502 | The effect of atrial natriuretic peptide on intestinal electrolyte transport |
Q69897826 | The effect of atropine and vagal stimulation on the release of neurotensin-like immunoreactivity in man |
Q71116269 | The effect of atropine on bombesin and gastrin releasing peptide stimulated gastrin, pancreatic polypeptide and neurotensin release in man |
Q47346920 | The effect of body weight on the calcitonin gene-related peptide-induced relaxation of guinea pig gallbladder strips |
Q43546794 | The effect of calcitonin gene-related peptide on pancreatic blood flow and secretion in conscious dogs |
Q72907251 | The effect of cholecystokinin octapeptide on pituitary-adrenal hormone secretion |
Q44643673 | The effect of chronic CRF1 receptor blockade on the central CCK systems of Fawn-Hooded rats |
Q44332846 | The effect of endomorphins on the release of 3H-norepinephrine from rat nucleus tractus solitarii slices |
Q44000184 | The effect of exercise intensity on plasma and tissue acyl ghrelin concentrations in fasted rats. |
Q60774388 | The effect of galanin and galanin fragments on blood pressure in the Cane toad, Bufo marinus |
Q74338179 | The effect of galanin on wide-dynamic range neuron activity in the spinal dorsal horn of rats |
Q58449380 | The effect of gastrin-releasing peptide on the endocrine pancreas |
Q58448213 | The effect of glucagon-like peptide-2 on arterial blood flow and cardiac parameters |
Q51804228 | The effect of hypertension on serum nitric oxide and vascular endothelial growth factor concentrations. A study in DOCA-Salt hypertensive ovariectomized rats. |
Q46342659 | The effect of ileal interposition surgery on enteroendocrine cell numbers in the UC Davis type 2 diabetes mellitus rat. |
Q40239795 | The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers. |
Q71742141 | The effect of losartan on drinking and NaCl intake in the rat in response to hyperosmotic and hypovolaemic stimuli: effect of route of administration and strain of rat |
Q80225724 | The effect of luminal ghrelin on pancreatic enzyme secretion in the rat |
Q42455315 | The effect of massive small bowel resection (MSBR) and small intestinal bypass (JIB) in the rat on the enteroinsular axis |
Q70223771 | The effect of naloxone on blood pressure, heart rate, plasma catecholamines, renin activity and aldosterone following exercise in healthy males |
Q93639152 | The effect of neurotensin and secretin on gastric acid secretion and mucosal blood flow in man |
Q42484801 | The effect of pentagastrin on the somatostatin receptor/effector system in rat pancreatic acinar membranes |
Q44200136 | The effect of pituitary adenylate cyclase activating polypeptide on cultured rat cardiocytes as a cardioprotective factor |
Q79283617 | The effect of relaxin on the oxytocin receptor in human uterine smooth muscle cells |
Q68994989 | The effect of secretin on acid and pepsin secretion and gastrin release in the totally isolated vascularly perfused rat stomach |
Q72484689 | The effect of somatostatin and 16,16-dimethyl-prostaglandin E2 on bombesin-stimulated canine gastric acid, plasma gastrin and pancreatic polypeptide secretion |
Q69025380 | The effect of somatostatin on baseline and stimulated acid secretion and vascular histamine release from the totally isolated vascularly perfused rat stomach |
Q42512605 | The effect of total parenteral nutrition (TPN) on gastrin release in the rat. |
Q42527853 | The effect of total parenteral nutrition (TPN) on the enteroinsular axis in the rat. |
Q42503259 | The effect of total parenteral nutrition in the rat on a sub-group of enteroendocrine cells |
Q53747191 | The effect of vagotomy on the increase in food intake induced by the cholecystokinin antagonist, proglumide. |
Q46989972 | The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptors |
Q37343491 | The effects of GLP-1 infusion in the hepatic portal region on food intake |
Q39377879 | The effects of NK-1 and NK-2 receptor antagonists on the capsaicin evoked synaptic response in the rat spinal cord in vitro |
Q36608527 | The effects of PACAP on neural cell proliferation |
Q38291288 | The effects of age on uptake, serum half-life and bioavailability of mouse [D-Leu-4]OB3, a synthetic peptide amide with leptin-like activity, in male C57BL/6J mice |
Q36468033 | The effects of arginine-8 vasopressin on blood vessels supplying the cerebral cortex |
Q71956643 | The effects of chronic administration of epidermal growth factor (EGF) to rats on the levels of endogenous EGF in the submandibular glands and kidneys |
Q46253418 | The effects of chronic low-dose capsaicin treatment on substance P levels |
Q44240035 | The effects of duodenal peptides on glucagon-like peptide-1 secretion from the ileum. A duodeno--ileal loop? |
Q53201466 | The effects of enteral ghrelin administration on the remodeling of the small intestinal mucosa in neonatal piglets. |
Q72078835 | The effects of galanin and galanin fragments on cardiac vagal action and blood pressure in the anaesthetised cat |
Q69353495 | The effects of hemorrhagic shock on thyrotropin-releasing hormone and its receptors in discrete regions of rat brain |
Q70923135 | The effects of intrathecal galanin message-associated peptide (GMAP) on the flexor reflex in rats |
Q72879320 | The effects of intravenous cholecystokinin, secretin and pentagastrin on electromyographic activity of the rumen in sheep |
Q68441908 | The effects of intravenously administered bombesin on pentagastrin-stimulated acid secretion in cats |
Q34125016 | The effects of para-chloromercuribenzoic acid and different oxidative and sulfhydryl agents on a novel, non-AT1, non-AT2 angiotensin binding site identified as neurolysin |
Q44200113 | The effects of pituitary adenylate cyclase-activating polypeptide on acute and chronic morphine actions in mice. |
Q44921474 | The effects of reduced oxygen tension on swine granulosa cell. |
Q60302737 | The effects of saltwater acclimation on neurotransmitters in the lingual salt glands of the estuarine crocodile, Crocodylus porosus |
Q44332885 | The effects of sarmesin, an Angiotensin II analogue on seizure susceptibility, memory retention and nociception |
Q48897149 | The effects of separate or combined infusions of corticotrophin-releasing factor and vasopressin either intraventricularly or into the amygdala on aggressive and investigative behaviour in the rat. |
Q42488663 | The effects of substance P, histamine and histamine antagonists on somatostatin and gastrin release from the isolated perfused rat stomach |
Q41578664 | The effects of tachykinins on inflammatory and immune cells |
Q53957211 | The effects of thyrotropin-releasing hormone, metabolites and analogues on locomotor activity in rats. |
Q72217567 | The effects of transforming growth factor alpha and somatostatin on regenerating hepatocytes in the rat |
Q51262482 | The effects of unilateral truncal vagotomy on gastric carcinogenesis in hypergastrinemic Japanese female cotton rats. |
Q51491299 | The elimination rates of intact GIP as well as its primary metabolite, GIP 3-42, are similar in type 2 diabetic patients and healthy subjects. |
Q43813988 | The exocytotic signaling pathway induced by nerve growth factor in the presence of lyso-phosphatidylserine in rat peritoneal mast cells involves a type D phospholipase |
Q47790914 | The expression of human resistin in different leucocyte lineages is modulated by LPS and TNFalpha |
Q43913345 | The fasting and food-stimulated serum gastrin concentration in 151 duodenal ulcer patients compared to 41 healthy subjects |
Q50671742 | The galanin-3 receptor antagonist, SNAP 37889, reduces operant responding for ethanol in alcohol-preferring rats. |
Q71706210 | The galanin-induced feeding stimulation is mediated via alpha 2-adrenergic receptors in goldfish |
Q126324520 | The gastrin-ECL cell axis: Gastrin induces secretion, activation and adaptation of ECL cells in rats |
Q83816682 | The gene expression of adrenomedullin, calcitonin-receptor-like receptor and receptor activity modifying proteins (RAMPs) in CCl4-induced rat liver cirrhosis |
Q30838986 | The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. |
Q88088275 | The ghrelin-GHSR-1a system in the ocular neuro-humoral regulation. Pearls and controversies |
Q43818772 | The heme oxygenase-1 pathway is involved in calcitonin gene-related peptide-mediated delayed cardioprotection induced by monophosphoryl lipid A in rats |
Q58449428 | The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera |
Q46220585 | The hypothalamus-pituitary-adrenal axis does not influence the protective effects of nociceptin/orphanin FQ on the rat gastric mucosa |
Q48734007 | The identification of leptin-derived peptides that are taken up by the brain |
Q42066124 | The identification of two myoinhibitory peptides, with sequence similarities to the galanins, isolated from the ventral nerve cord of Manduca sexta |
Q42474840 | The immunostaining for the hypothalamic vasoactive intestinal peptide, but not for beta-endorphin, dynorphin-A or methionine-enkephalin, is affected by the glucocorticoid milieu in the rat: correlation with the prolactin secretion |
Q45156960 | The importance of chromogranin A in the development and function of endocrine pancreas |
Q67866574 | The importance of gastric secretion in the feedback control of interdigestive and postprandial pancreatic secretion in rats |
Q51835849 | The importance of the nine-amino acid C-terminal sequence of exendin-4 for binding to the GLP-1 receptor and for biological activity. |
Q78729828 | The in vitro and in vivo resistance of synthetic enkephalin analogs to three enkephalin-hydrolyzing enzymes |
Q51847414 | The in vitro chronotropic and inotropic effects of vasoactive intestinal peptide (VIP) on the atria and ventricular papillary muscle from Cynomolgus monkey heart. |
Q59874076 | The in vitro intestinal absorption of enterostatin is limited by brush-border membrane peptidases |
Q40705226 | The increased proliferation of cultured neuroblastoma cells treated with vasoactive intestinal peptide is enhanced by simultaneous inhibition of neutral endopeptidase |
Q40916552 | The influence of gonadal steroids on the release and actions of neurohypophysial hormones |
Q48939569 | The influence of guanyl nucleotide on agonist and antagonist affinity at guinea-pig CCK-B/gastrin receptors: binding studies using [3H]PD140376. |
Q38302809 | The influence of interleukin-1beta on oxytocin signalling in primary cells of human decidua |
Q41343840 | The influence of mammalian and teleost somatostatins on the secretion of growth hormone from goldfish (Carassius auratus L.) pituitary fragments in vitro |
Q42522040 | The influence of nitric oxide on basal and cholecystokinin-8-induced proliferation and apoptosis in the rat pancreas |
Q43926881 | The inhibitory effect of anandamide on oxytocin and vasopressin secretion from neurohypophysis is mediated by nitric oxide |
Q42479075 | The inhibitory effect of neurotensin on synaptosomal membrane Na+, K+-ATPase is altered by antipsychotic administration |
Q31943770 | The inhibitory mechanism of GLP-1, but not glucagon, on fasted gut motility is dependent on the L-arginine/nitric oxide pathway |
Q82697263 | The insulin sensitizing effects of PPAR-γ agonist are associated to changes in adiponectin index and adiponectin receptors in Zucker fatty rats |
Q42495611 | The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects |
Q51465919 | The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance. |
Q37769338 | The interplay between chromogranin A-derived peptides and cardiac natriuretic peptides in cardioprotection against catecholamine-evoked stress |
Q58449408 | The intestinal mucosa preferentially releases somatostatin-28 in pigs |
Q36286888 | The intracrine hypothesis: an update |
Q54565478 | The involvement of transforming growth factor-beta1 secretion in urotensin II-induced collagen synthesis in neonatal cardiac fibroblasts. |
Q72472985 | The kinetics of somatostatin inhibition of gastric acid secretion |
Q53860593 | The left ventricle and hemodynamic patterns in essential hypertension. |
Q53116024 | The localization of oxytocin receptors in the islets of Langerhans in the rat pancreas. |
Q72699402 | The lung contents of endothelin are altered by thyroid hormone status in rat |
Q51730068 | The mechanism of action of bombesin on cat lower esophageal sphincter. |
Q72321291 | The mechanism of action of gastrin releasing peptide (GRP) in stimulating avian gastric acid secretion |
Q48250655 | The mechanism of central pressor actions of tachykinin NK-3 receptor in the paraventricular nucleus of the hypothalamus in rats |
Q72601848 | The mechanism of degradation of cyclo(-Asn-Phe-Phe-d-Trp-Lys-Thr-Phe-Gaba-) and the relative stabilities of this and other octapeptide somatostatin analogues in rat intestinal juice |
Q44710419 | The mechanisms of the inhibitory effect of ethanol on gastric emptying involve type A CCK receptors |
Q40595249 | The melanocortin receptor MCR4 controls fat consumption |
Q86260030 | The merger of Regulatory Peptides and Peptides |
Q70572716 | The molecular nature of cholecystokinin in the feline pancreas and related nervous structures |
Q58449506 | The molecular nature of vascularly released cholecystokinin from the isolated perfused porcine duodenum |
Q33325047 | The multifunctional protein GC1q-R interacts specifically with the i3 loop arginine cluster of the vasopressin V2 receptor. |
Q34060768 | The multiple actions of angiotensin II in atherosclerosis |
Q52566490 | The muscular contractions of the midgut of the cockroach, Diploptera punctata: effects of the insect neuropeptides proctolin and leucomyosuppressin. |
Q85304394 | The neuro-incretin concept |
Q36466127 | The neurobiology of neurotensin: focus on neurotensin-dopamine interactions |
Q33921600 | The neurobiology of urocortin |
Q72534522 | The neurogenic origin of hypertension in SHR may be mediated by angiotensin II through a receptor different from AT1 and AT2 |
Q74338171 | The neuropeptide calcitonin gene-related peptide differently modulates proliferation and differentiation of smooth muscle cells in culture depending on the cell type |
Q78617784 | The neuropeptide secretoneurin stimulates adhesion of human monocytes to arterial and venous endothelial cells in vitro |
Q80197544 | The neuroprotective effects of PACAP in monosodium glutamate-induced retinal lesion involve inhibition of proapoptotic signaling pathways |
Q42598595 | The neurotropic activity of a structural analog of ACTH(5-7). |
Q82254151 | The newly identified anorexigenic adipokine nesfatin-1 in hemodialysis patients: Are there associations with food intake, body composition and inflammation? |
Q46269899 | The non-peptide kinin receptor antagonists FR 173657 and SSR 240612: preclinical evidence for the treatment of skin inflammation |
Q28198114 | The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism |
Q80783907 | The novel peptide apelin regulates intrarenal artery tone in diabetic mice |
Q45202563 | The orexinergic synaptic innervation of serotonin- and orexin 1-receptor-containing neurons in the dorsal raphe nucleus |
Q71507427 | The oxytocin receptor antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin inhibits effects of the 5-HT1A receptor agonist 8-OH-DPAT on plasma levels of insulin, cholecystokinin and somatostatin |
Q40855044 | The oxytocin receptor: a target for steroid hormones. |
Q79369593 | The pancreatic polypeptide family and the migrating motor complex of the rat: differential effects in the duodenum and jejunum |
Q72699391 | The paraventriculo-infundibular corticotropin releasing factor (CRF) pathway as revealed by immunocytochemistry in long-term hypophysectomized or adrenalectomized rats |
Q46149301 | The pharmacological properties of FK888, a novel dipeptide NK1 antagonist |
Q40997186 | The pharmacology of neuropeptide Y (NPY) receptor-mediated feeding in rats characterizes better Y5 than Y1, but not Y2 or Y4 subtypes |
Q36075977 | The physiological role of GLP-1 in human: incretin, ileal brake or more? |
Q46369327 | The potency of dietary amino acids in elevating plasma cholecystokinin immunoreactivity in cats is related to amino acid hydrophobicity |
Q37442027 | The potential of ghrelin as a prokinetic. |
Q46703443 | The predominant role of brain angiotensinogen and angiotensin in environmentally induced hypertension |
Q56775006 | The pregnancy-induced increase of plasma angiotensin-(1–7) is blunted in gestational diabetes |
Q42078964 | The presence and actions of NPY in the canine endocrine pancreas |
Q48875653 | The presence and distribution of crustacean cardioactive peptide in the central and peripheral nervous system of the stick insect, Baculum extradentatum |
Q73828218 | The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers |
Q48546354 | The primary structure and tissue distribution of an amphibian neuropeptide Y |
Q60585315 | The primary structure of neuropeptide F (NPF) from the garden snail, Helix aspersa |
Q72591274 | The primary structure of pancreatic polypeptide from a primitive insectivorous mammal, the European hedgehog (Erinaceous europaeus) |
Q71854783 | The primary structure of porcine glicentin (proglucagon) |
Q44131107 | The primary structures and myotropic activities of two tachykinins isolated from the African clawed frog, Xenopus laevis. |
Q54691256 | The pro-angiogenic activity of urotensin-II on human vascular endothelial cells involves ERK1/2 and PI3K signaling pathways. |
Q48201873 | The prolonged increase in thyrotropin-releasing hormone in rat limbic forebrain regions following electroconvulsive shock |
Q72099729 | The proportion of CGRP-immunoreactive and SP-mRNA containing dorsal root ganglion cells is increased by a unilateral inflammation of the ankle joint of the rat |
Q79684613 | The protective effect of oxytocin on renal ischemia/reperfusion injury in rats |
Q43245529 | The protective effects of calcitonin gene-related peptide on gastric mucosa injury after cerebral ischemia reperfusion in rats |
Q67596108 | The purification and sequence analysis of an avian neuromedin U |
Q72078839 | The rabbit iris sphincter contains NK1 and NK3 but not NK2 receptors: a study with selective agonists and antagonists |
Q54235452 | The rabbit saphenous vein: a tissue preparation specifically enriched in NPY-Y1 receptor subtype. |
Q42464710 | The rat pancreatic islets: a reliable tool to study islet responses to cholecystokinin receptor occupation |
Q71777524 | The reactivity of mononucleotides with cholecystokinin/gastrin antisera |
Q69795678 | The receptor for epidermal growth factor is present in human fetal kidney, liver and lung |
Q44397776 | The reduction in hepatic insulin clearance after oral glucose is not mediated by gastric inhibitory polypeptide (GIP). |
Q72892408 | The regional distribution of gamma 3-melanotropin-like peptides in bovine brain is correlated with adrenocorticotropin immunoreactivity but not with beta-endorphin |
Q69900295 | The regulation of basal pancreatic polypeptide levels in dogs |
Q67486208 | The regulation of connective tissue metabolism by vasoactive intestinal polypeptide |
Q51590660 | The regulation of gastrin secretion in the chicken. |
Q40916606 | The regulation of neurohypophyseal peptide gene expression in gonadal tissues |
Q46446062 | The relationship between adiponectin, ageing and renal function in a bi-ethnic sample. |
Q80345675 | The relationship between urotensin II plasma immunoreactivity and left ventricular filling pressures in coronary artery disease |
Q44980529 | The relaxant effect of urocortin in rat pulmonary arteries |
Q42498335 | The release of 3H-1-methyl-4-phenylpyridinium from bovine adrenal chromaffin cells is modulated by somatostatin |
Q114684097 | The release of gastrin into the antral lumen of chronic dogs in response to feeding and its apparent dissociation from the release into the circulation by antral acidification |
Q40995856 | The renin-angiotensin system in hybrid NG108-15 cells. Renin gene is from mouse neuroblastoma, angiotensinogen and angiotensin-converting enzyme genes are of rat glioma origin. |
Q40766336 | The renin-angiotensin system in the brain: an update 1993. |
Q70192867 | The response of plasma gastric-inhibitory polypeptide (GIP) to slow and fast glucose ingestion in Billroth II resected patients and normal controls |
Q51777226 | The role of G-proteins in the dimerisation of human somatostatin receptor types 2 and 5. |
Q60054776 | The role of NK-3 and NK-4 receptors in the mediation of reciprocal hindlimb scratching induced by tachykinin receptor agonists |
Q40588872 | The role of NPY in the mediation of orexin-induced hypothermia |
Q36963284 | The role of PYY in feeding regulation |
Q51132805 | The role of TGF-beta1 as a determinant of foreign body reaction to alloplastic materials in rat fibroblast cultures: comparison of different commercially available polypropylene meshes for hernia repair. |
Q40923327 | The role of angiotensin II in ingestive behaviour: a brief review of angiotensin II, thirst and Na appetite |
Q45112789 | The role of arginine vasopressin in diabetes-associated increase in glucagon secretion |
Q48891875 | The role of brain angiotensin in thirst and AVP release induced by hemorrhage |
Q41171345 | The role of cholecystokinin in nociception, neuropathic pain and opiate tolerance |
Q46331562 | The role of ether-a-go-go-related gene K(+) channels in glucocorticoid inhibition of adrenocorticotropin release by rat pituitary cells |
Q44332840 | The role of hypothalamic histamine in leptin-induced suppression of short-term food intake in fasted rats |
Q44878424 | The role of luminal gastrin in the regulation of pancreatic juice secretion in preruminant calves |
Q82731095 | The role of mast cells in atrial natriuretic peptide-induced cutaneous inflammation |
Q40916507 | The role of neurohypophyseal peptides in the central mediation of complex social processes--evidence from comparative studies |
Q71634821 | The role of neuropeptides in the regulation of adrenal vascular tone: effects of vasoactive intestinal polypeptide, substance P, neuropeptide Y, neurotensin, Met-enkephalin, and Leu-enkephalin on perfusion medium flow rate in the intact perfused rat |
Q115447043 | The role of neuropeptides in the vascular leakage observed in experimental otitis media |
Q43192632 | The role of nitric oxide and potassium channels in the effect of adrenomedullin in human internal thoracic arteries. |
Q70761225 | The role of oxytocin and vasopressin in the initiation of preterm and term labour as well as primary dysmenorrhoea |
Q60350067 | The role of sensorial neuropeptides in the edematogenic responses mediated by B1 agonist des-Arg9-BK in rats pre-treated with LPS |
Q46009882 | The role of store-operated Ca2+ channels in adrenocorticotropin release by rat pituitary cells. |
Q46896803 | The role of substance P in the pathogenesis of experimental allergic neuritis |
Q58106047 | The role of the Asp-32 residue of cholecystokinin in gastric acid secretion and gastrin receptor recognition |
Q44878431 | The role of the pancreatic renin-angiotensin system in acinar digestive enzyme secretion and in acute pancreatitis. |
Q42527851 | The role of vagal afferents and carbon dioxide in the respiratory response to thyrotropin-releasing hormone |
Q69890718 | The role of vagal integrity in gastrin releasing peptide stimulated gastroenteropancreatic hormone release and gastric acid secretion |
Q48301229 | The role of vasopressin on ACTH secretion and biosynthesis in the ovine pituitary gland |
Q40916568 | The role of volume hormones in the excretion of water loads |
Q37441767 | The role(s) of somatostatin, structurally related peptides and somatostatin receptors in the gastrointestinal tract: a review |
Q72099910 | The roles of the putative third cytoplasmic loop and cytoplasmic carboxyl tail of NK-1 and NK-2 receptors in agonist stimulated second messenger responses in stably transfected CHO cells |
Q67881007 | The second annual PACAP Symposium. Satellite symposium for 21st Annual Meeting of the Society for Neuroscience. New Orleans, November 10, 1991. Abstracts |
Q49113030 | The secretory trypsin inhibitor like-peptide, PEC-60 increases dopamine D2 receptor agonist induced inhibition of GABA release in the dorsolateral neostriatum of the awake freely moving rat. An in vivo microdialysis study |
Q45068901 | The sequential cleavage of membrane anchored pro-EGF requires a membrane serine protease other than kallikrein in rat kidney |
Q80345660 | The smooth muscle pharmacology of maximakinin, a receptor-selective, bradykinin-related nonadecapeptide from the venom of the Chinese toad, Bombina maxima |
Q45176358 | The somatostatin subtype-2 receptor antagonist, BIM-23627, improves the catabolic effects induced by long-term glucocorticoid treatment in the rat. |
Q46735625 | The source of calcium for CCK-induced contraction of the guinea-pig gall bladder |
Q33212102 | The structural organization of aurein precursor cDNAs from the skin secretion of the Australian green and golden bell frog, Litoria aurea |
Q48454525 | The subcellular distribution of peptides immunoreactive for the amino-terminal of pro-cholecystokinin in rat brain |
Q44643678 | The therapeutic effect of recombinant human trefoil factor 3 on hypoxia-induced necrotizing enterocolitis in immature rat. |
Q39978993 | The transcriptional co-activator PGC-1alpha up regulates apelin in human and mouse adipocytes |
Q34104467 | The truncated metabolite GLP-2 (3-33) interacts with the GLP-2 receptor as a partial agonist |
Q45806775 | The urinary excretion of epidermal growth factor in the rat is reduced by aprotinin, a proteinase inhibitor |
Q46070827 | The use of microdialysis to characterize the endocrine production of human subcutaneous adipose tissue in vivo. |
Q60182070 | The vagus nerve as a regulator of growth hormone secretion |
Q34778864 | The vagus nerve, food intake and obesity |
Q67596111 | The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels |
Q40916679 | The vasopressin type 2 receptor gene. Chromosomal localization and its role in nephrogenic diabetes insipidus |
Q30838992 | The vasorelaxant effect of pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in isolated rat basilar arteries is partially mediated by activation of nitrergic neurons |
Q39101948 | Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line. |
Q48359467 | Thioperamide, a histamine H3 receptor antagonist, suppresses NPY-but not dynorphin A-induced feeding in rats |
Q48409050 | Through V2, not V1 receptor relating to endogenous opiate peptides, arginine vasopressin in periaqueductal gray regulates antinociception in the rat. |
Q40916616 | Thymic neurohypophysial-related peptides and T cell selection. |
Q85584647 | Thymohexin exhibits cytoprotective effect in experimental gastric lesions in rats both through the inhibition of inducible nitric oxide synthase and reduction of oxidative mucosal damage |
Q44255865 | Thymopentin antagonizes stress-induced changes of GABA/benzodiazepine receptor complex |
Q86479058 | Thymosin β4 enhances the healing of medial collateral ligament injury in rat |
Q48515000 | Thyrotrophin-releasing hormone inactivation by human postmortem brain |
Q48682741 | Thyrotropin releasing hormone prevents abnormalities of cortical acetylcholine and monoamines in mice following head injury |
Q48733376 | Thyrotropin releasing hormone: autonomic effects upon cardiorespiratory function in endotoxic shock |
Q40851558 | Thyrotropin-releasing hormone (TRH) analogues show enhanced CNS selectivity because of increased biological stability |
Q41117138 | Thyrotropin-releasing hormone action in the preoptic/anterior hypothalamus decreases thermoregulatory set point in ground squirrels |
Q36101339 | Thyrotropin-releasing hormone in cardiovascular pathophysiology |
Q33220228 | Thyrotropin-releasing hormone in the dorsal vagal complex stimulates pancreatic blood flow in rats |
Q70468563 | Thyrotropin-releasing hormone injected intracerebroventricularly in the rat stimulates exocrine pancreatic secretion via the vagus nerve |
Q46512539 | Thyrotropin-releasing hormone interacts with vasoactive intestinal peptide-specific receptor in guinea pig cecal circular smooth muscle cells |
Q67284406 | Thyrotropin-releasing hormone stimulates intestinal transit in young rats |
Q51311027 | Tibolone has anti-inflammatory effects in estrogen-deficient female rats on the natriuretic peptide system and TNF-alpha. |
Q44702399 | Time-course of capsaicin-evoked release of calcitonin gene-related peptide from rat spinal cord in vitro. Effect of concentration and modulation by Ruthenium Red |
Q46903226 | Time-dependent changes in ghrelin-immunoreactivity in dissociated neuronal cultures of the newborn rat neocortex |
Q77763720 | Time-dependent changes of levels of endogenous epidermal growth factor in submandibular glands, in kidneys, and in urine in rats during systemic treatment with EGF |
Q42521344 | Time-dependent decreases of atrial natriuretic peptide release from the isolated rat atrium: evidence for a readily releasable pool |
Q48250533 | Tissue distribution and effects of fasting and obesity on the ghrelin axis in mice. |
Q28145020 | Tissue distribution of prolactin-releasing peptide (PrRP) and its receptor |
Q35809634 | Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction |
Q71603495 | Tissue-specific expression of the insulin-like growth factor binding protein (IGFBP) mRNAs in mouse and rat development |
Q48345320 | Tissue-specific processing of neurotensin/neuromedin-N precursor in cat. |
Q48205888 | Tolerance to hypophagia induced by prolonged treatment with a CB1 antagonist is related to the reversion of anorexigenic neuropeptide gene expression in the hypothalamus |
Q44813689 | Toll-like receptor levels and caffeine responsiveness in rat pups during perinatal period |
Q48931943 | Tonic enhancement of the sensitivity of baroreceptor reflex response by endogenous substance P in the rat |
Q28334614 | Tonic suppression of baroreceptor reflex by endogenous neurotensin in the rat |
Q72099759 | Topical indomethacin decreases substance P immunoreactivity in human ocular aqueous humor |
Q48359592 | Topographic localization of neuropeptide Y mRNA in the monkey brainstem |
Q70477306 | Topographical and ontogenetic study of the neurons producing growth hormone-releasing factor in human hypothalamus |
Q127480956 | Total chromogranin a as marker of carcinoid tumors |
Q48328817 | Total ghrelin plasma level in patients with the restrictive type of anorexia nervosa |
Q44397766 | Total synthesis of human and rat coupling factor-6 amide and pressor effects in the rat. |
Q34669683 | Toward a theory of intracrine hormone action |
Q72671834 | Towards a Molecular Basis in Opioid Research. Proceedings of the 24th International Narcotics Research Conference (INRC). Skövde, Sweden, 10-15 July 1993 |
Q40098164 | Towards the therapeutic use of intranasal neuropeptide administration in metabolic and cognitive disorders |
Q40916643 | Transactivation of the rat oxytocin and vasopressin promoters by nuclear hormone receptors |
Q48263343 | Transcription, expression and tissue binding in vivo of INGAP and INGAP-related peptide in normal hamsters |
Q61757273 | Transcriptional control of the human cholecystokinin gene |
Q67698836 | Transcriptional regulation by cholecystokinin-pancreozymin in rat pancreas |
Q42169838 | Transcriptome of pituitary adenylate cyclase-activating polypeptide-differentiated PC12 cells |
Q45068904 | Transcripts of neurokinin B and neurokinin 3 receptor in superovulated rat ovaries and increased number of corpora lutea as a non-specific effect of intraperitoneal agonist application |
Q72265280 | Transduction mechanism of motilin and motilides in rabbit duodenal smooth muscle |
Q28192398 | Transendothelial migration of leukocytes and signalling mechanisms in response to the neuropeptide secretoneurin |
Q73517100 | Transforming growth factor alpha-immunoreactivity in neural tissues of the rat stomach |
Q48136718 | Transforming growth factor-alpha (TGF alpha) inhibition of parietal cell secretion: structural requirements for activity |
Q72837531 | Transforming growth factor-alpha and epidermal growth factor inhibit gastric acid secretion and stimulate release of somatostatin and neurotensin in the conscious rat |
Q33836483 | Transgenic models as tools for studying the regulation of human renin expression |
Q34101139 | Transgenic mouse models of angiotensin receptor subtype function in the cardiovascular system |
Q54074159 | Transglutaminase-mediated amine incorporation into substance P protects the peptide against proteolysis in vitro. |
Q40415748 | Transient receptor potential vanilloid 1-mediated expression and secretion of endothelial cell-derived calcitonin gene-related peptide |
Q73629319 | Transient transcriptional activation of gastrin during sodium butyrate-induced differentiation of islet cells |
Q46928305 | Transient, early release of glucagon-like peptide-1 during low rates of intraduodenal glucose delivery |
Q47572797 | Trauma, especially of the submandibular glands, causes release of epidermal growth factor into bloodstream in mice |
Q48401613 | Traumatic brain injury in mice and pentadecapeptide BPC 157 effect |
Q79172647 | Treatment with antileukinate, a CXCR2 chemokine receptor antagonist, protects mice against acute pancreatitis and associated lung injury |
Q54199485 | Treatment with cholecystokinin receptor antagonist loxiglumide enhances insulin response to intravenous glucose stimulation in postpancreatitic rats. |
Q40502858 | Treatment with interleukin-11 affects plasma leptin levels in inflamed and non-inflamed rabbits |
Q46425970 | Triiodothyronine (T3) stimulates food intake via enhanced hypothalamic AMP-activated kinase activity |
Q30319275 | Tripeptides from dietary proteins inhibit TNFalpha-induced monocyte adhesion to human aortic endothelial cells |
Q44131096 | Triple therapy with octreotide, galanin and serotonin induces necrosis and increases apoptosis of a rat colon carcinoma |
Q44332857 | Triple therapy with octreotide, galanin, and serotonin reduces the size and blood vessel density and increases apoptosis of a rat colon carcinoma |
Q44306518 | Trophic and steroidogenic effects of water deprivation on the adrenal gland of the adult female rat. |
Q43963222 | Two classes of endothelin receptors mediating contraction in esophageal muscularis mucosae |
Q72125991 | Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36 |
Q43625214 | Type-2 somatostatin receptor mRNA levels in breast and colon cancer determined by a quantitative RT-PCR assay based on dual label fluorogenic probe and the TaqMan technology |
Q47667196 | Typical Danish Caucasian type 2 diabetic patients do not commonly carry genetic variants in GIP and GLP-1 encoding regions of the proGIP and proglucagon genes |
Q60546006 | Tyrosine phosphorylation/dephosphorylation regulates peroxynitrite-mediated peptide nitration |
Q44347816 | UMB-3, a novel rabbit monoclonal antibody, for assessing μ-opioid receptor expression in mouse, rat and human formalin-fixed and paraffin-embedded tissues |
Q36600113 | Ultrastructural demonstration of ovine CRF-like immunoreactivity (oCRF-LI) in the rat hypothalamus: processes of magnocellular neurons establish membrane specializations with parvocellular neurons containing oCRF-LI |
Q36499199 | Ultrastructural immunocytochemical distribution of VIP-like immunoreactivity in dog ileum |
Q28574572 | Ultrastructural localization of neuropeptide FF, a new neuropeptide in the brain and pituitary of rats |
Q70215491 | Ultrastructural relation between cortical efferents and terminals containing enkephalin-like immunoreactivity in rat neostriatum |
Q53849389 | Ultrastructure of calcitonin gene-related peptide-immunoreactive nerve fibres in guinea-pig peribronchial ganglia |
Q38310216 | Unexpected effects of voluntary exercise training on natriuretic peptide and receptor mRNA expression in the ob/ob mouse heart |
Q48153239 | Unidirectional uptake of enkephalins at the blood-tissue interface of the blood-cerebrospinal fluid barrier: a saturable mechanism |
Q46270317 | Unique distributions of natriuretic hormones in dog brain |
Q67584422 | Unlike VIP, the VIP-related peptides PACAP, helodermin and helospectin suppress electrically evoked contractions of rat vas deferens |
Q37943922 | Unsulfated cholecystokinin: An overlooked hormone? |
Q73022726 | Up regulation of AT4 receptor levels in carotid arteries following balloon injury |
Q81802158 | Up-regulated synthesis of mature-type adrenomedullin in coronary circulation immediately after reperfusion in patients with anterior acute myocardial infarction |
Q48254442 | Up-regulation of galanin and corticotropin-releasing hormone mRNAs in the key hypothalamic and amygdaloid nuclei in a mouse model of visceral pain |
Q61774375 | Up-regulation of insulin binding in fish skeletal muscle by high insulin levels |
Q42479966 | Up-regulation of lymphocytic growth hormone secretion during the luteal phase of cycle and early pregnancy |
Q43813997 | Up-regulation of splenic prohormone convertases PC1 and PC2 in diabetic rats |
Q42463854 | Up-regulation of substance P in the lungs during acute myocardial ischemia and infarction in rats |
Q48517525 | Up-regulation of thyrotropin-releasing hormone (TRH) receptors in rat spinal cord after codepletion of serotonin and TRH. |
Q51979418 | Upregulation of intracardiac adrenomedullin and its receptor system in rats with volume overload-induced cardiac hypertrophy. |
Q33794112 | Upregulation of leptin-receptor in placental cells by hypoxia |
Q73413341 | Upregulation of secretin receptors on cholangiocytes after bile duct ligation |
Q40491049 | Upregulation, release and axonal transport of substance P and calcitonin gene-related peptide in adjuvant inflammation and regulatory function of nerve growth factor |
Q47885819 | Urinary excretion of epidermal growth factor and Tamm-Horsfall protein in three rat models with increased renal excretion of urine |
Q34400241 | Urinary immunoreactive brain natriuretic peptide in patients with renal disease |
Q48796228 | Urocortin 2 blocks the suppression of gastric antral contractions induced by lipopolysaccharide in freely moving conscious rats |
Q46186979 | Urodilatin and dopamine: a new interaction in the kidney |
Q74472299 | Uroguanylin: gene structure, expression, processing as a peptide hormone, and co-storage with somatostatin in gastrointestinal D-cells |
Q38359653 | Urotensin II is an autocrine/paracrine growth factor for aortic adventitia of rat. |
Q46899967 | Urotensin II-induced collagen synthesis in cultured smooth muscle cells from rat aortic media and a possible involvement of transforming growth factor-β1/Smad2/3 signaling pathway |
Q54351967 | Urotensin-II-stimulated expression of pro-angiogenic factors in human vascular endothelial cells. |
Q42687058 | Use of 125I-[Y39]exendin-4 to characterize exendin receptors on dispersed pancreatic acini and gastric chief cells from guinea pig. |
Q46570554 | Use of substance P fragments to differentiate substance P receptors of different tissues |
Q40916655 | Uterine oxytocin gene expression: a novel framework for oxytocin action |
Q48309934 | Utility of plasma apelin and other indices of cardiac dysfunction in the clinical assessment of patients with dilated cardiomyopathy |
Q45970557 | V1 receptor in ENS mediates the excitatory effect of vasopressin on circular muscle strips of gastric body in vitro in rats. |
Q44306503 | VIP and PACAP display different vasodilatory effects in rabbit coronary and cerebral arteries |
Q70818580 | VIP and PHI coexist with an NPY-like peptide in intramural neurones of the small intestine |
Q48457890 | VIP and PHI in cat neurons: co-localization but variable tissue content possible due to differential processing |
Q70942096 | VIP antagonist demonstrates differences in VIP- and PHI-mediated stimulation and inhibition of ACTH and corticosterone secretion in rats |
Q73246712 | VIP in the rat parotid gland in response to irradiation |
Q40036174 | VIP inhibits human HepG2 cell proliferation in vitro |
Q40619794 | VIP receptor 1 (VPAC1) promoter targets the expression of a reporter gene to cerebellum and adrenal medulla in transgenic mice |
Q51783024 | VIP release from enteric nerves is independent of extracellular calcium. |
Q50169166 | VIP-antiserum inhibits fluid secretion by the inflamed gallbladder mucosa |
Q68567833 | VIP-containing nerve fibres in the submandibular gland of the dog and protein secretion in vitro in response to VIP |
Q42475080 | Vagally induced release of gastrin, somatostatin and bombesin-like immunoreactivity from perfused rat stomach. Effect of stimulation frequency and cholinergic mechanisms |
Q48531389 | Vagally mediated cholestatic and choleretic effects of centrally applied Endothelin-1 through ETA receptors. |
Q59874017 | Vagotomy and accompanying pyloroplasty down-regulates ghrelin mRNA but does not affect ghrelin secretion |
Q39979305 | Vagotomy enhances experimental metastases of 4THMpc breast cancer cells and alters substance P level |
Q39909374 | Validation of different replication markers for the detection of beta-cell proliferation in human pancreatic tissue |
Q84573885 | Valsartan, a specific angiotensin II receptor blocker, inhibits pancreatic fluid secretion via vagal afferent pathway in conscious rats |
Q41542649 | Variations in affinities for the NK1 receptor: differences between the non-peptide substance P antagonists RP 67580 and CP-96,345 and the agonist septide |
Q51624397 | Variations of plasma immunoreactive motilin, pancreatic polypeptide, gastrin and somatostatin along the duodenal motility cycle in the pig. |
Q72104898 | Vasa nervorum constriction from substance P and calcitonin gene-related peptide antagonists: sensitivity to phentolamine and nimodipine |
Q45234051 | Vascular NK-1 receptor occurrence in normal and chronic painful Achilles and patellar tendons: studies on chemically unfixed as well as fixed specimens |
Q30987114 | Vascular control of the pig nasal mucosa: distribution and effect of somatostatin in relation to noradrenaline and neuropeptide Y |
Q71342754 | Vascular effects of oxytocin on human middle cerebral artery determined by transcranial Doppler sonography |
Q54264290 | Vascular effects of pituitary adenylate cyclase activating peptide: a comparison with vasoactive intestinal peptide |
Q50521820 | Vascular protein leakage in the rat parotid gland elicited by reflex stimulation, parasympathetic nerve stimulation and administration of neuropeptides. |
Q36983469 | Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating peptide (PACAP) receptor specific peptide analogues for PET imaging of breast cancer: In vitro/in vivo evaluation |
Q40097006 | Vasoactive intestinal peptide (VIP) increases vascular endothelial growth factor (VEGF) expression and secretion in human breast cancer cells. |
Q41486587 | Vasoactive intestinal peptide (VIP) mRNA expression in rat T and B lymphocytes. |
Q54648363 | Vasoactive intestinal peptide and helodermin inhibit phospholipase A2 activity in vitro. |
Q72382817 | Vasoactive intestinal peptide and substance P in salivary glands of the rat following denervation or duct ligation |
Q48436647 | Vasoactive intestinal peptide effects on GH3 pituitary tumor cells: high affinity binding, affinity labeling, and adenylate cyclase stimulation. Comparison with peptide histidine isoleucine and growth hormone-releasing factor |
Q42553599 | Vasoactive intestinal peptide expression in enteric neurons is upregulated by both colchicine and axotomy |
Q44989608 | Vasoactive intestinal peptide fluctuates in human blood with a circadian rhythm |
Q41317866 | Vasoactive intestinal peptide in the normal and inflamed feline gallbladder |
Q40565502 | Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cells. |
Q73117222 | Vasoactive intestinal peptide inhibits cytokine production in T lymphocytes through cAMP-dependent and cAMP-independent mechanisms |
Q69088779 | Vasoactive intestinal peptide inhibits the respiratory burst in human monocytes by a cyclic AMP-mediated mechanism |
Q41922655 | Vasoactive intestinal peptide mRNA and immunoreactivity are decreased in fetal alcohol syndrome model |
Q83445189 | Vasoactive intestinal peptide protects alveolar epithelial cells against hyperoxia via promoting the activation of STAT3 |
Q39624111 | Vasoactive intestinal peptide re-balances TREM-1/TREM-2 ratio in acute lung injury |
Q81404100 | Vasoactive intestinal peptide rescues cultured rat myenteric neurons from lipopolysaccharide induced cell death |
Q48121074 | Vasoactive intestinal peptide stimulates ACTH and corticosterone release after injection into the PVN. |
Q72358278 | Vasoactive intestinal peptide stimulates a cAMP-mediated Cl- current in avian salt gland cells |
Q45174523 | Vasoactive intestinal peptide stimulates ciliary motility in rabbit tracheal epithelium: modulation by neutral endopeptidase |
Q41616433 | Vasoactive intestinal peptide stimulates luteinizing hormone-releasing hormone release from median eminence synaptosomes |
Q71712903 | Vasoactive intestinal peptide stimulates prostate-specific antigen secretion by LNCaP prostate cancer cells |
Q73571481 | Vasoactive intestinal peptide supports induced migration of human keratinocytes and their colonization of an artificial polyurethane matrix |
Q41083290 | Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma |
Q54476870 | Vasoactive intestinal polypeptide (VIP) in the pig pancreas: role of VIPergic nerves in control of fluid and bicarbonate secretion. |
Q70215494 | Vasoactive intestinal polypeptide (VIP) inhibits neurally evoked smooth muscle activity of rat uterine cervix in vitro |
Q67584419 | Vasoactive intestinal polypeptide (VIP) inhibits rat alveolar macrophage phagocytosis and chemotaxis in vitro |
Q68806325 | Vasoactive intestinal polypeptide and acetylcholine stimulate exocrine secretion of epidermal growth factor from the rat submandibular gland |
Q46239316 | Vasoactive intestinal polypeptide induces neurogenic contraction of guinea-pig ileum. Involvement of acetylcholine and substance P |
Q40856783 | Vasoactive peptides and characterization of their receptors |
Q70942055 | Vasoconstrictor effects of galanin and distribution of galanin containing fibres in three species of elasmobranch fish |
Q46346300 | Vasodilator action of guinea pig vasoactive intestinal polypeptide (VIP): comparison with common mammalian VIP |
Q42524085 | Vasodilator effect of angiotensin-(1-7) in mature and sponge-induced neovasculature. |
Q62059209 | Vasodilator effects of peptides derived from egg white proteins |
Q36556806 | Vasodilatory effects of cholecystokinin: new role for an old peptide? |
Q42501071 | Vasopressin and angiotensin induce inositol lipid breakdown in rat adenohypophysial cells in primary culture |
Q40916500 | Vasopressin and behavior: from memory to olfaction |
Q40916662 | Vasopressin gene expression in explant and dispersed hypothalamic cultures |
Q40916574 | Vasopressin homeostasis: coordination of synthesis, storage and release |
Q42519784 | Vasopressin potentiation of the melatonin synthetic pathway via specific V1a receptors in the rat pineal gland |
Q41503253 | Vasopressin pressor antagonist injected centrally reverses behavioral effects of peripheral injection of vasopressin, but only at doses that reverse increase in blood pressure |
Q40916564 | Vasopressin receptors and effects during fetal development |
Q40916577 | Vasopressin regulation of cell growth in Swiss 3T3 cells |
Q52282236 | Vasopressin retards the acquisition of positively reinforced lever pressing in homozygous Brattleboro rats. |
Q48765859 | Vasopressin-like peptides in the rat brain: immunologic and chromatographic behavior and their response to water deprivation |
Q34096108 | Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation |
Q43813981 | Vasorelaxant effect of glucagon-like peptide-(7-36)amide and amylin on the pulmonary circulation of the rat. |
Q45176945 | Vasotocin analogues with selective natriuretic, kaliuretic and antidiuretic effects in rats. |
Q44509012 | Venous endotelin-1 (ET-1) and brain natriuretic peptide (BNP) plasma levels during 6-month bosentan treatment for pulmonary arterial hypertension |
Q44384743 | Ventricular adrenomedullin is associated with myocyte hypertrophy in human transplanted heart |
Q48631554 | Ventricular, paraventricular and circumventricular structures involved in peptide-induced satiety |
Q39751425 | Visinin-like protein 1 regulates natriuretic peptide receptor B in the heart |
Q33303086 | Visualization of ghrelin-producing neurons in the hypothalamic arcuate nucleus using ghrelin-EGFP transgenic mice |
Q85063921 | WITHDRAWN: Effect of blood glucose fluctuation on the function of rat pancreatic islets in vivo |
Q86207171 | WITHDRAWN: Effects of centrally-injected glucagon-like peptide-2 on gastric mucosal blood flow in rats; possible mechanisms |
Q44383105 | WITHDRAWN: Highly efficient agonist-induced internalization of somatostatin SST2 receptor in mouse dorsal root ganglion and spinal cord: Molecular evidence for mechanism of somatostatin inhibits neuropathic pain |
Q83267547 | WITHDRAWN: Involvement of Adenosine Signaling in Controlling the Release of Ghrelin from the Mouse Stomach |
Q46233134 | Weight-dependent differential contribution of insulin secretion and clearance to hyperinsulinemia of obesity |
Q46260782 | What difference exists in the pancreas of mammals with sanguivorous diet? A morphological, stereological and immunohistochemical study of the pancreatic islets of the hematophagous bat Diphylla ecaudata. |
Q34556091 | What do we know about the secretion and degradation of incretin hormones? |
Q48456903 | What may be the anatomical basis that secretin can improve the mental functions in autism? |
Q72246353 | Whole body autoradiography of CCK-8 in rats |
Q48891822 | Whole cell patch recordings from forebrain slices demonstrate angiotensin II inhibits potassium currents in subfornical organ neurons |
Q28212683 | Xenin plasma concentrations during modified sham feeding and during meals of different composition demonstrated by radioimmunoassay and chromatography |
Q44464312 | Xenopsin-related peptide generated in avian gastric extracts |
Q46476152 | Zonation of the metabolic action of vasopressin in the bivascularly perfused rat liver |
Q48318900 | [125I]CGP 42112 binding reveals differences between rat brain and adrenal AT2 receptor binding sites |
Q43743549 | [Arg3]substance P and neurokinin A from chicken small intestine |
Q38297969 | [D-LEU-4]-OB3, a synthetic leptin agonist, improves hyperglycemic control in C57BL/6J ob/ob mice |
Q45895427 | [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, augments the effects of orally delivered exenatide and pramlintide acetate on energy balance and glycemic control in insulin-resistant male C57BLK/6-m db/db mice |
Q57990467 | aFGF, bFGF and NGF differentially regulate neuropeptide expression in dorsal root ganglia after axotomy and induce autotomy |
Q52051567 | alpha-Fluoromethylhistidine influences somatostatin content, binding and inhibition of adenylyl cyclase activity in the rat frontoparietal cortex. |
Q42469352 | alpha-MSH and gamma-MSH inhibit IL-1beta induced activation of the hypothalamic-pituitary-adrenal axis through central melanocortin receptors |
Q46188950 | cDNA cloning of ghrelin and ontogeny of ghrelin mRNA expression in the gastrointestinal tract of African ostrich chicks |
Q85551578 | cGMP-PDE3-cAMP signal pathway involved in the inhibitory effect of CNP on gastric motility in rat |
Q56700831 | chimeric peptides define the structural requirements for specific ligand-receptor interaction of GLP-1 |
Q45176351 | eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells |
Q44277687 | eNOS-dependent vascular interaction between nitric oxide and calcitonin gene-related peptide in mice: gender selectivity and effects on blood aggregation |
Q48177755 | gamma 2-[corrected]-MSH-like immunoreactivity in porcine pituitary and adrenal medulla. An immunochemical and immunocytochemical study |
Q48619962 | β-Endorphin administered into the lateral ventricle of the brain causes pulmonary platelet trapping in rabbits |
Q70177477 | β-Endorphin controls vasopressin release during foot shock-induced stress in the rat |
Q60678640 | β-Endorphin-immunoreactive components in human cerebrospinal fluid |
Q83418575 | β-Endorphinergic system involvement in the inhibitory action of clonidine on induced sodium appetite |
Q72954216 | β-endorphin release by angiotensin II: studies on the mechanism of action |
Q56987862 | δ versus μ receptors: cardiovascular and respiratory effects of opiate agonists microinjected into nucleus tractus solitarius of cats |
Q60338885 | μ Opioid induced respiratory depression antagonized by κ opioid agonist MR-2034 but not by U-50,488H in freely moving rats |
Q72580916 | ‘Dynorphin’ in plasma: enzymatic artifact and authentic immunoreactivity |
Search more.